{
      "FullStudiesResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:09:28 23:22:14.126",
            "Expression": "mesenchymal stromal",
            "NStudiesAvail": 429205,
            "NStudiesFound": 326,
            "MinRank": 1,
            "MaxRank": 50,
            "NStudiesReturned": 50,
            "FullStudies": [
                  {
                        "Rank": 1,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01589549",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2011/128"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "CTN 2012/0174",
                                                            "SecondaryIdType": "Other Identifier",
                                                            "SecondaryIdDomain": "Therapeutics Goods Administration, Government of Australia"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Royal Perth Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells for Acute Graft Versus Host Disease",
                                          "OfficialTitle": "A Phase 2 Trial of Standard of Care Treatment Versus Mesenchymal Stromal Cell Therapy Together With Standard of Care for the Treatment of de Novo Acute Graft Versus Host Disease Following Allogeneic Bone Marrow Transplantation"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "June 2015",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "April 2012"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2015",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2016",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "April 26, 2012",
                                          "StudyFirstSubmitQCDate": "April 30, 2012",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "May 2, 2012",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "June 8, 2015",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "June 9, 2015",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "R.P.Herrmann",
                                                "ResponsiblePartyInvestigatorTitle": "Director, Cell and Tissue Therapies, Royal Perth Hospital",
                                                "ResponsiblePartyInvestigatorAffiliation": "Royal Perth Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "R.P.Herrmann",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Royal Perth Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "A randomised study of corticosteroid therapy with or without mesenchymal stromal cell therapy for newly diagnosed acute graft versus host disease after bone marrow transplantation or donor lymphocyte therapy.\n\nIt is hypothesised that mesenchymal stromal cell therapy will be superior",
                                          "DetailedDescription": "Patients with newly diagnosed untreated acute graft versus host disease grades 2-4 will receive methylprednisolone 2.5mg/kg intravenously and randomised to receive or not receive allogeneic human mesenchymal stromal cells 2X10E6 intravenously on two occasions at weekly intervals"
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Acute GVH Disease"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Acute graft versus host disease",
                                                      "Bone marrow transplantation",
                                                      "Mesenchymal stromal cells"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "66",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stromal cell therapy",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Mesenchymal stromal cell therapy in addition to corticosteroid therapy",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stromal cell therapy"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Corticosteroid therapy",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stromal cell therapy"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stromal cell therapy",
                                                            "InterventionDescription": "One arm will be randomised to receive mesenchymal stromal cell therapy in addition to corticosteroid therapy",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Corticosteroid therapy",
                                                                        "Mesenchymal stromal cell therapy"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Methylprednisolone",
                                                                        "Mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Survival at one year after onset of graft versus host disease",
                                                            "PrimaryOutcomeTimeFrame": "One year"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Response at 14 days after commencement of treatment for acute graft versus host disease",
                                                            "SecondaryOutcomeTimeFrame": "14 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Response at 28 days after commencement of treatment of acute graft versus host disease",
                                                            "SecondaryOutcomeTimeFrame": "28 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence of severe infection",
                                                            "SecondaryOutcomeTimeFrame": "One year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Disease free survival at one year",
                                                            "SecondaryOutcomeTimeFrame": "One year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Time to treatment failure, requiring salvage therapy",
                                                            "SecondaryOutcomeTimeFrame": "28 days"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nGrades 2-4 acute graft versus host disease after bone marrow transplantation up to day +180 after transplantation\n\nAge 18-55 years\n\nMust be receiving a calcineurin inhibitor\n\nExclusion Criteria:\n\nFailure to sign informed consent\nCorticosteroid therapy for 72 hours or greater\nECOG score equal to or greater than 3",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "55 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Duncan Purtill, MB, BS",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+61 8 61523788",
                                                            "CentralContactEMail": "duncan.purtill@health.gov.au"
                                                      },
                                                      {
                                                            "CentralContactName": "Richard Herrmann, MB, BS",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+61 8 92241987",
                                                            "CentralContactEMail": "richard.herrmann@health.wa.gov.au"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Duncan Purtill, MB, BS",
                                                            "OverallOfficialAffiliation": "Royal Perth Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Royal Perth Hospital",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Perth",
                                                            "LocationState": "Western Australia",
                                                            "LocationZip": "6000",
                                                            "LocationCountry": "Australia",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Megan Margaria, BN",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+61 8 92247038",
                                                                              "LocationContactEMail": "megan.margaria@health.wa.gov.au"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000006086",
                                                            "ConditionMeshTerm": "Graft vs Host Disease"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8341",
                                                            "ConditionBrowseLeafName": "Graft vs Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2832",
                                                            "ConditionBrowseLeafName": "Homologous Wasting Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionMeshList": {
                                                "InterventionMesh": [
                                                      {
                                                            "InterventionMeshId": "D000008775",
                                                            "InterventionMeshTerm": "Methylprednisolone"
                                                      }
                                                ]
                                          },
                                          "InterventionAncestorList": {
                                                "InterventionAncestor": [
                                                      {
                                                            "InterventionAncestorId": "D000000893",
                                                            "InterventionAncestorTerm": "Anti-Inflammatory Agents"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000000932",
                                                            "InterventionAncestorTerm": "Antiemetics"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000001337",
                                                            "InterventionAncestorTerm": "Autonomic Agents"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000018373",
                                                            "InterventionAncestorTerm": "Peripheral Nervous System Agents"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000045505",
                                                            "InterventionAncestorTerm": "Physiological Effects of Drugs"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000005765",
                                                            "InterventionAncestorTerm": "Gastrointestinal Agents"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000005938",
                                                            "InterventionAncestorTerm": "Glucocorticoids"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000006728",
                                                            "InterventionAncestorTerm": "Hormones"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000006730",
                                                            "InterventionAncestorTerm": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000018696",
                                                            "InterventionAncestorTerm": "Neuroprotective Agents"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000020011",
                                                            "InterventionAncestorTerm": "Protective Agents"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M10901",
                                                            "InterventionBrowseLeafName": "Methylprednisolone",
                                                            "InterventionBrowseLeafAsFound": "Unacceptable",
                                                            "InterventionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M1833",
                                                            "InterventionBrowseLeafName": "Methylprednisolone Acetate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M10902",
                                                            "InterventionBrowseLeafName": "Methylprednisolone Hemisuccinate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M13272",
                                                            "InterventionBrowseLeafName": "Prednisolone",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M229437",
                                                            "InterventionBrowseLeafName": "Prednisolone acetate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M211896",
                                                            "InterventionBrowseLeafName": "Prednisolone hemisuccinate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M248768",
                                                            "InterventionBrowseLeafName": "Prednisolone phosphate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M3369",
                                                            "InterventionBrowseLeafName": "Anti-Inflammatory Agents",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M3403",
                                                            "InterventionBrowseLeafName": "Antiemetics",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M8033",
                                                            "InterventionBrowseLeafName": "Gastrointestinal Agents",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M8199",
                                                            "InterventionBrowseLeafName": "Glucocorticoids",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M8941",
                                                            "InterventionBrowseLeafName": "Hormones",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M8940",
                                                            "InterventionBrowseLeafName": "Hormone Antagonists",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M19926",
                                                            "InterventionBrowseLeafName": "Neuroprotective Agents",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M21022",
                                                            "InterventionBrowseLeafName": "Protective Agents",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Infl",
                                                            "InterventionBrowseBranchName": "Anti-Inflammatory Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "AnEm",
                                                            "InterventionBrowseBranchName": "Antiemetics"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "NeuroAg",
                                                            "InterventionBrowseBranchName": "Neuroprotective Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Gast",
                                                            "InterventionBrowseBranchName": "Gastrointestinal Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ANeo",
                                                            "InterventionBrowseBranchName": "Antineoplastic Agents"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 2,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02387151",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "NL4724400013"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "2013-005407-14",
                                                            "SecondaryIdType": "EudraCT Number"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Leiden University Medical Center",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients",
                                          "OfficialTitle": "Safety of Allogeneic Bone Marrow Derived Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients",
                                          "Acronym": "Neptune"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "June 2019",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "March 2015",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "November 2018",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "November 2018",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "March 3, 2015",
                                          "StudyFirstSubmitQCDate": "March 6, 2015",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "March 12, 2015",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "June 30, 2019",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "July 2, 2019",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "M.E. J. Reinders",
                                                "ResponsiblePartyInvestigatorTitle": "MD/PhD",
                                                "ResponsiblePartyInvestigatorAffiliation": "Leiden University Medical Center"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Leiden University Medical Center",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This study will test whether selected allogeneic bone marrow derived MSCs are safe by assessing the composite end point Biopsy Proven Acute Rejection (BPAR)/ graft loss at 12 months.",
                                          "DetailedDescription": "Kidney transplantation has improved survival and quality of life for patients with end-stage renal disease. However, despite advances in immunosuppressive therapy, long-term allograft survival outcomes have not improved over the last decade.\n\nA promising novel therapeutic immunosuppressive option in the treatment of renal recipients with a profound effect on the fibrosis reaction is the clinical application of mesenchymal stromal cells (MSCs). Allogeneic MSCs offer the advantage of availability for clinical use without the delay required for expansion.\n\nAlthough it is believed that allo MSCs are immune privileged, they could possibly elicit an anti-donor immune response, which may increase the incidence of rejection/ graft loss and impact the allograft survival on the long term. These safety issues should be studied before further studies are planned with allogeneic MSCs in the transplant setting.\n\nMSCs are infused at a time point when immune suppression is lowered and the kidney is at increased risk for developing immune mediated injury. In addition, a large amount of the kidneys already has signs of fibrosis at this time point and MSCs might reduce the fibrosis which so importantly affects long term survival. MSCs will have no Human Leucocyte Antigen (HLA) sharing with the mismatches of the donor and the recipient should have no antibodies directed to the MSCs to reduce the anti-donor immune respons risk."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Rejection",
                                                      "Graft Loss"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal Stromal Cells",
                                                      "Rejection"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "mesenchymal stromal cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "allogeneic mesenchymal stromal cell infusion",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "mesenchymal stromal cells",
                                                            "InterventionDescription": "2 doses of 1-2x10^6 allogeneic bone marrow derives MSCs IV per/kg body weight at weeks 25 and 26 after transplantation",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "mesenchymal stromal cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "MSC",
                                                                        "bone marrow derived mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "biopsy proven acute rejection / graft loss",
                                                            "PrimaryOutcomeTimeFrame": "12 months after transplantation"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Comparison of fibrosis by quantitative Sirius Red scoring",
                                                            "SecondaryOutcomeTimeFrame": "Before MSC infusion (week 24 after transplantation) and 6 months after MSC infusion (week 52 after transplantation)"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Serious adverse events",
                                                            "SecondaryOutcomeTimeFrame": "12 months after transplantation"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Renal function measured by cGFR (MDRD formula) and iohexol clearance",
                                                            "SecondaryOutcomeTimeFrame": "week 24 after transplantation (before MSC infusion) and 52 after transplantation"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "CMV, BK infection (viremia, disease and syndrome; and subtypes of BK viremia) and other opportunistic infections",
                                                            "SecondaryOutcomeTimeFrame": "from baseline up to 26 weeks after MSC treatment"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Development of de novo donor specific antibodies (DSA) and immunological responses",
                                                            "SecondaryOutcomeTimeFrame": "at baseline, week 24 after transplantation (before MSC treatment) up to week 26 after MSC treatment"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nSubject is willing to participate in the study, must be able to give informed consent and the consent must be obtained prior to any study procedure.\nRecipients of a first kidney graft from a living-unrelated or non-HLA identical living related donor.\nPanel Reactive Antibodies (PRA) \u2264 50%.\nPatients must be able to adhere to the study visit schedule and protocol requirements.\nIf female and of child-bearing age, subject must be non-pregnant, non-breastfeeding, and use adequate contraception.\n\nExclusion Criteria:\n\nDouble organ transplant recipient.\nBiopsy proven acute rejection (according to the Banff criteria) in the 4 weeks before MSC infusion.\nPatients with evidence of active infection or abscesses (with the exception of an uncomplicated urinary tract infection) before MSC infusion.\nPatients suffering from hepatic failure.\nPatients suffering from an active autoimmune disease.\nA psychiatric, addictive or any disorder that compromises ability to give truly informed consent for participation in this study.\nUse of any investigational drug after transplantation.\nDocumented HIV infection, active hepatitis B, hepatitis C or tuberculosis according to current transplantation inclusion criteria.\nSubjects who currently an active opportunistic infection at the time of MSC infusion (e.g., herpes zoster [shingles], cytomegalovirus (CMV), Pneumocystis carinii (PCP), aspergillosis, histoplasmosis, or mycobacteria other than tuberculosis, BK) after transplantation.\nMalignancy (including lymphoproliferative disease) within the past 2-5 years (except for squamous or basal cell carcinoma of the skin that has been treated with no evidence of recurrence) according to current transplantation inclusion criteria\nKnown recent substance abuse (drug or alcohol).\nPatients who are recipients of ABO incompatible transplants.\nPatients with severe total hypercholesterolemia (>7.5 mmol/L) or total hypertriglyceridemia (>5.6 mmol/L) (patients on lipid lowering treatment with controlled hyperlipidemia are acceptable).",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "75 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Marlies EJ Reinders, MD/PhD",
                                                            "OverallOfficialAffiliation": "Leiden University Medical Center",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Leiden University Medical Center",
                                                            "LocationCity": "Leiden",
                                                            "LocationZip": "2333 ZA",
                                                            "LocationCountry": "Netherlands"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "26537851",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Reinders ME, Dreyer GJ, Bank JR, Roelofs H, Heidt S, Roelen DL, Zandvliet ML, Huurman VA, Fibbe WE, van Kooten C, Claas FH, Rabelink TJ, de Fijter JW. Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study. J Transl Med. 2015 Nov 4;13:344. doi: 10.1186/s12967-015-0700-0."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 3,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03509870",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2015-005580-16"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Steno Diabetes Center Copenhagen",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells to Non-healing Diabetic Foot Wounds",
                                          "OfficialTitle": "Uncontrolled Non-randomised Single Dose Study of Topically Applied Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells (REDDSTAR (ORBCEL-M)) in Patients With Non-healing Neuroischaemic Diabetic Foot Wounds'",
                                          "Acronym": "REDDSTAR"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "August 2020",
                                          "OverallStatus": "Terminated",
                                          "WhyStopped": "study stopped because of lack of recruitment",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "June 1, 2018",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "April 1, 2020",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "April 1, 2020",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "April 11, 2018",
                                          "StudyFirstSubmitQCDate": "April 25, 2018",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "April 26, 2018",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "August 17, 2020",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "August 19, 2020",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Steno Diabetes Center Copenhagen",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Leiden University Medical Center",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No",
                                          "IsUSExport": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "examine safety of topical application of single dose allogeneic bone marrow derived mesenchymal stromal cells to non-healing diabetic foot ulcers",
                                          "DetailedDescription": "1.1 Trial Phase\n\nPhase 1b\n\n1.2 Trial Aims and Objectives\n\nTo examine the safety of topical application of a single dose of allogeneic bone marrow derived mesenchymal stromal cells (REDDSTAR ORBCEL-M) seeded in a collagen scaffold to patients with non-healing neuroischaemic diabetic foot wounds.\n\n1.3 Patient Population\n\nPatients with non-healing neuroischaemic diabetic foot wounds despite standard care.\n\n1.4 Trial Setting\n\nSteno Diabetes Center Copenhagen, Denmark and Zelo Phase I Unit, Bispebjerg Hospital, Copenhagen, Denmark.\n\n1.5 Trial Intervention\n\nTopical application of allogeneic bone marrow derived mesenchymal stromal cells seeded in a collagen scaffold to patients with non-healing neuroischaemic diabetic foot wounds.\n\n1.6 Concurrent Control\n\nOpen label, uncontrolled, non-randomised, single dose study.\n\n1.7 Sample Size\n\n9\n\n1.8 Method of Participant Assignment\n\nAdministration of a single dose of allogeneic bone marrow-derived mesenchymal stromal cells seeded in a collagen scaffold.\n\n1.9 Examination Points\n\n0, 1 week, 2 weeks, 3 weeks, 4 weeks up until 12 weeks or until complete wound closure. After the week 12 visit, or ulcer closure, whichever occurs first, each patient will return to the clinic 1 (\u00b1 2 days), 2 (\u00b1 2 days), 4 (\u00b1 3 days), 8 (\u00b13 days), and 12 (\u00b13days) weeks later for follow-up visits to for adverse events, assess wound, wound closure and durability.\n\n1.10 Primary Outcome\n\nSerious adverse events that are attributable to intervention.\n\n1.11 Secondary Outcomes\n\nTime to complete wound closure (defined as from treatment day 1 to the first visit when closure is documented). Absolute and percent changes in wound area from baseline, at weekly intervals throughout. Durability of wound closure as measured at 4 week intervals for 12 weeks from date of wound closure."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Diabetic Foot Ulcer"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "diabetes"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignInterventionModelDescription": "unblinded single arm intervention",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)",
                                                      "DesignMaskingDescription": "open"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "2",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "mesenchymal stromal cells",
                                                            "ArmGroupType": "Other",
                                                            "ArmGroupDescription": "mesenchymal stromal cells in collagen scaffold",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "mesenchymal stromal cells",
                                                            "InterventionDescription": "mesenchymal stromal cells in a collagen scaffold",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "serious adverse events attributable to intervention",
                                                            "PrimaryOutcomeDescription": "Death\nSepticaemia\nAmputation of the limb administered with therapy\nWorsening of the ulcer of the limb administered with therapy\nAllergic reaction or anaphylaxis\nAbnormal laboratory results\nLocal or systemic reaction requiring hospital admission",
                                                            "PrimaryOutcomeTimeFrame": "24 weeks"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "healing",
                                                            "SecondaryOutcomeDescription": "time to complete wound closure",
                                                            "SecondaryOutcomeTimeFrame": "24 weeks"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAge 18-80 years.\nType 1 or Type 2 diabetes mellitus (with any kind or combination of pharmacological treatment for disease and/or complications to disease).\nHbA1c \u2264 97 mmol/mol (\u2264 11%).\nMales or non-pregnant females.\nUnderstand trial information document.\nProvide written informed consent.\nDuration of (diabetic foot) wound > 4 but < 52 weeks.\nReduction of < 50% area over 4 weeks despite standard care (standard care; off-loading, weekly debridement, dressings, orthotic).\nWound area with sharp debridement of \u2265 0.5 but \u2264 4.0 cm2.\nClinically non-infected wound.\nTexas wound stage 1a, 1c or 2a.\nLocation of wound below malleolus.\nAffected limb toe pressure \u2265 40 mmHg.\nAn ankle-brachial systolic pressure index between 0.7 and 1.3.\nDiagnosis of peripheral neuropathy using American Diabetes Association guidelines (monofilament/vibration sensation/biothesiometer).\nAble to adhere to study visit protocol.\nAdhere to offloading devices/orthotic.\n\nExclusion Criteria:\n\nLife expectancy of less than 12 months.\nPatients with a definite diagnosis of any immunodeficiency disorder.\nViral hepatitis [patient must have negative hepatitis B surface-antigen (HBsAg) and hepatitis C antibody (HepCAb) test results obtained within 2 weeks prior to the Treatment Day (Day 1)].\nActive, uncontrolled connective tissue disease.\nRenal failure as defined by serum creatinine > 220 \u00b5mol/L.\nLiver function tests that are > 2.0 times Upper Limit Normal.\nPoor nutritional status as measured by serum albumin < 30 g/L.\nActive cancer or a history of cancer in the 5 years prior to signing the informed consent form (history of basal cell carcinoma is allowed).\nActive wound infection (i.e. recent onset of erythema, oedema, and increased temperature of the foot with normal radiographs).\nDiabetic Charcot neuroarthropathy or other structural deformity that would prevent adequate off-loading of the study foot.\nTreatment with any systemic corticosteroid immunosuppressive chemotherapeutic agent, antiviral, or previous/current radiation therapy to lower extremity to be treated within 30 days prior to signing the informed consent form.\nHaving received another investigational drug or biologic within 30 days prior to signing the informed consent form or currently participating in an investigational drug or biologic study.\nA psychiatric condition or chronic alcohol or drug abuse problem, determined from the patient's medical history, which in the Investigator's opinion may pose a threat to patient compliance.\nHistory of non-compliance with treatment or clinical visit attendance (i.e. this study requires that patients will comply with the protocol and ulcer care regimen).\nAny unstable medical condition judged by the Principal Investigator that would cause the study to be detrimental to the patient.\nWounds caused primarily by untreated vascular insufficiency, or where patients are primarily eligible for vascular intervention to promote wound healing.\nWounds with an aetiology not related to diabetes.\nMore than three wounds on the target lower extremity.\nThe wound to be studied not anatomically distinct from another wound(s) (separated by < 1 cm from another wound or would interfere with standard of care treatment of another wound. Only one single wound per one study subject can be treated in this study.\nWounds which decrease in area by > 50% during the screening 4-week run-in period.\nUlcers with underlying osteomyelitis on the leg with the wound to be treated.\nPatients presenting with the clinical characteristics of cellulitis at the wound site (suppurative inflammation involving particularly the subcutaneous tissue, often mild erythema, tenderness, malaise, chills and fever).\nRevascularization surgery on the leg with the wound to be treated \u22648 weeks prior to signing the informed consent form.\nSurgery to lengthen Achilles tendon on the leg with the wound to be treated \u22648 weeks prior to signing the informed consent form.\nNecrosis, purulence, or sinus tracts that cannot be removed by debridement on foot to be treated.\nReceived dermal substitute or living skin equivalent within 30 days prior to signing the informed consent form.\nReceived prior (Regranex\u00ae/becaplermin) therapy within 30 days prior to signing the informed consent form.\nHas known history of clinical sensitivity reactions to products of bovine origin or to the primary or secondary dressings used in the trial.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "80 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Peter Rossing, MD",
                                                            "OverallOfficialAffiliation": "Steno Diabetes Center Copenhagen",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Steno Diabetes Center Copenhagen",
                                                            "LocationCity": "Gentofte",
                                                            "LocationZip": "2820",
                                                            "LocationCountry": "Denmark"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Undecided"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000017719",
                                                            "ConditionMeshTerm": "Diabetic Foot"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000016523",
                                                            "ConditionMeshTerm": "Foot Ulcer"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000003925",
                                                            "ConditionAncestorTerm": "Diabetic Angiopathies"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014652",
                                                            "ConditionAncestorTerm": "Vascular Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000002318",
                                                            "ConditionAncestorTerm": "Cardiovascular Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007871",
                                                            "ConditionAncestorTerm": "Leg Ulcer"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012883",
                                                            "ConditionAncestorTerm": "Skin Ulcer"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012871",
                                                            "ConditionAncestorTerm": "Skin Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000048909",
                                                            "ConditionAncestorTerm": "Diabetes Complications"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003920",
                                                            "ConditionAncestorTerm": "Diabetes Mellitus"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004700",
                                                            "ConditionAncestorTerm": "Endocrine System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003929",
                                                            "ConditionAncestorTerm": "Diabetic Neuropathies"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005534",
                                                            "ConditionAncestorTerm": "Foot Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M6267",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16837",
                                                            "ConditionBrowseLeafName": "Wounds and Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M19085",
                                                            "ConditionBrowseLeafName": "Diabetic Foot",
                                                            "ConditionBrowseLeafAsFound": "Diabetic Foot",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M18071",
                                                            "ConditionBrowseLeafName": "Foot Ulcer",
                                                            "ConditionBrowseLeafAsFound": "Foot Ulcers",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16358",
                                                            "ConditionBrowseLeafName": "Ulcer",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6272",
                                                            "ConditionBrowseLeafName": "Diabetic Angiopathies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16552",
                                                            "ConditionBrowseLeafName": "Vascular Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10035",
                                                            "ConditionBrowseLeafName": "Leg Ulcer",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14838",
                                                            "ConditionBrowseLeafName": "Skin Ulcer",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14826",
                                                            "ConditionBrowseLeafName": "Skin Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25157",
                                                            "ConditionBrowseLeafName": "Diabetes Complications",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7014",
                                                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6276",
                                                            "ConditionBrowseLeafName": "Diabetic Neuropathies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7810",
                                                            "ConditionBrowseLeafName": "Foot Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC19",
                                                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC14",
                                                            "ConditionBrowseBranchName": "Heart and Blood Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC10",
                                                            "ConditionBrowseBranchName": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 4,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04447833",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2020-02238"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Uppsala University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome",
                                          "OfficialTitle": "Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome Validation of Mechanistic Pathways and Clinical Efficacy",
                                          "Acronym": "ARDS-MSC-205"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "March 2021",
                                          "OverallStatus": "Active, not recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "June 17, 2020",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "January 30, 2021",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "June 30, 2025",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "June 20, 2020",
                                          "StudyFirstSubmitQCDate": "June 24, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 25, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "March 3, 2021",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "March 4, 2021",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Uppsala University",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Uppsala University Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This is an open label, dose escalating safety study of the advanced therapy investigational medicinal product (ATIMP) KI-MSC-PL-205, where patients diagnosed with SARS-CoV-2-induced severe acute respiratory distress syndrome (ARDS), according to the Berlin Definition, and who are on respirator/ventilator (used synonymously in this protocol) support due to respiratory insufficiency with or without concomitant circulatory problems, will be included and treated with a single dose of KI-MSC-PL-205."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "ARDS, Human",
                                                      "COVID"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal Stromal Stem Cells"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignInterventionModelDescription": "This is an open label, dose escalating safety study of the advanced therapy investigational medicinal product (ATIMP) KI-MSC-PL-205, where patients diagnosed with SARS-CoV-2-induced severe acute respiratory distress syndrome (ARDS).",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "7",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal Stem Cell Treatment",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Infusion of allogeneic bone marrow derived mesenchymal stromal stem cells (MSC). First three patients receive a singe dose of 1x10^6 MSC/kg dose, next six patients receive a single dose of 2x10^6 MSC/kg.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Mesenchymal Stromal Stem Cells - KI-MSC-PL-205"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Mesenchymal Stromal Stem Cells - KI-MSC-PL-205",
                                                            "InterventionDescription": "Allogeneic bone marrow derived mesenchymal stromal stem cells (MSCs).",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal Stem Cell Treatment"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Allogeneic Bone Marrow Derived Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "The incidence of pre-specified treatment related adverse events of interest (TRAEIs).",
                                                            "PrimaryOutcomeDescription": "The incidence of pre-specified treatment related adverse events of interest (TRAEIs) occurring during the 10 days interval beginning with the start of the ATIMP infusion:\n\nNew ventricular tachycardia, ventricular fibrillation or asystole within 10 days after infusion\nNew cardiac arrhythmia requiring cardioversion within 10 days after infusion\nClinical scenario consistent with transfusion incompatibility or transfusion-related infection within 10 days after infusion\nThromboembolic events (e.g. Pulmonary embolism) within 10 days after infusion\nCardiac arrest or death within 10 days after infusion",
                                                            "PrimaryOutcomeTimeFrame": "From drug administration to day 10 post-infusion"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Safety; All-cause mortality",
                                                            "SecondaryOutcomeDescription": "All-cause mortality at 60 days and then annually",
                                                            "SecondaryOutcomeTimeFrame": "60 days post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in Leucocytes",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in the leucocyte Count (number/L)",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in Trombocytes",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in the trombocyte Count (number/L)",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in plasma concentration of C-reactive protein (CRP)",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in the plasma concentration of CRP (mg/L)",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in plasma concentration of Prothrombin complex (PK)",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in the plasma concentration of PK (INR)",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in plasma concentration of Creatinine",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in the plasma concentration of creatinine (\u03bcmol/L)",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in plasma concentration of Aspartate amino transferase (ASAT)",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in the plasma concentration of ASAT (\u03bckat/L)",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in plasma concentration of Alanine amino transferase (ALAT)",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in the plasma concentration of ALAT (\u03bckat/L)",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in plasma concentration of N-terminal pro-brain natriuretic peptide (NT-proBNP)",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in the plasma concentration of NT-proBNP (ng/L)",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in Blood pressure",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in blood pressure (mmHg)",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in Body temperature",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in body temperature (\u00b0C)",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Efficacy; Changes in pulmonary compliance",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in pulmonary compliance (dynamic and static) until day 10 post-infusion",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Efficacy; Changes in driving pressure (Plateau pressure- PEEP)",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in driving pressure (Plateau pressure- PEEP) until day 10 post-infusion",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Efficacy; Changes in oxygenation (PaO2/FiO2)",
                                                            "SecondaryOutcomeDescription": "Changes from baseline (Day 1; prior to administration of ATIMP) in oxygenation (PaO2/FiO2) until day 10 post-infusion",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Efficacy; Duration of ventilator support",
                                                            "SecondaryOutcomeDescription": "Number of days with ventilator support",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion),day 1, 2, 3, 4, 7, 10 and 60 post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Efficacy; Pulmonary bilateral infiltrates",
                                                            "SecondaryOutcomeDescription": "Changes in amount of pulmonary bilateral infiltrates assessed by pulmonary X-ray from baseline (Day 1; prior to administration of ATIMP) until day 60",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Efficacy; Sequential Organ Failure Assessment (SOFA) score",
                                                            "SecondaryOutcomeDescription": "Changes in Sequential Organ Failure Assessment (SOFA) score from baseline (Day 1; prior to administration of ATIMP) and during the ICU-period",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, end of ICU"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Efficacy; Hospital stay",
                                                            "SecondaryOutcomeDescription": "Duration of ICU stay and hospital stay (number of days; whole hospital period + calculated from Day 1)",
                                                            "SecondaryOutcomeTimeFrame": "Day 60 post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Lung function",
                                                            "SecondaryOutcomeDescription": "Recovery of lung function assessed by Spirometry (FEV1, Vital Capacity) at day 60 and then annually",
                                                            "SecondaryOutcomeTimeFrame": "Day 60 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Lung fibrosis",
                                                            "SecondaryOutcomeDescription": "To assess development of lung fibrosis using the HRCT Fibrosis Score using Computed tomography (CT) at baseline and on day 1, 3, 7, 10, end of ICU-residence, end of hospital stay, day 60, 6 month and 12 month and end of study (if possible during the infectious stage depending on hospital safety regimen during the pandemic).",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 3, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Six minutes walk test",
                                                            "SecondaryOutcomeDescription": "Assessment of the patient's physical capacity by 6-Minute-Walk-Test (6MWT), starting at 6 months post Day 1 and then annually",
                                                            "SecondaryOutcomeTimeFrame": "6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in Quality of life",
                                                            "SecondaryOutcomeDescription": "Changes in Quality of Life by assessing the Short Form Health Survey (SF-36) score (starting at 6 months post Day 1 and then annually; patient reported outcome)",
                                                            "SecondaryOutcomeTimeFrame": "6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Blood biomarkers",
                                                            "SecondaryOutcomeDescription": "Change in blood biomarkers related to the proposed mechanisms of action of KI-MSC-PL-205 in ARDS",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 1, 2, 3, 4, 7 and 10 post-infusion, 6 months, 1, 2, 3, 4 and 5 years post-infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Sensitisation test",
                                                            "SecondaryOutcomeDescription": "Sensitisation tests (test for donor-specific antibodies) against KI-MSC-PL-205 donor",
                                                            "SecondaryOutcomeTimeFrame": "Baseline (pre-infusion), day 60 post-infusion"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nWilling and able to provide written informed consent prior to performing study procedures (and have given written consent)\nCoronavirus (SARS-CoV-2) infection confirmed by polymerase chain reaction (PCR) test at screening\nMale or female patient aged 18 to 65 years old\nPatient must fulfil the Berlin Definition of severe ARDS within 3 weeks to 48 hours prior to enrolment (Will be assessed once the patient has been admitted to the ICU)\nPatient is on respirator support within 3 weeks to 48 hours prior to enrolment (Will be assessed once the patient has been admitted to the ICU)\nPregnancy test in blood confirming negative results before enrolment (for women \u226455 years old)\n\nExclusion Criteria:\n\nHistory of any clinically significant disease or disorder which, in the opinion of the Investigator, may either put the patient at risk because of participation in the study, or influence the results or the patient's ability to participate in the study\nPatients with history of treated blood and/or solid organ malignancy with recurrence within five years prior to dosing of the ATIMP are to be excluded. Patients with history of cervix cancer and non-melanoma skin cancer with recurrence within two years prior to dosing of the ATIMP are to be excluded\nPregnant or breast feeding female\nPatient with a history of anti-coagulation therapy for other indications that short-term prophylaxis after surgery\nPatients with a history and/ or on-going treatment for entity associated with bleeding disorder or potential risk for bleeding (e.g. inflammatory bowel disease, gastro-esophagitis with or without ulcers, haemophilia and other bleeding disorders, inflammatory musculo-skeletal disease with potential bleeding complications)\nPatients with a history during the latest five years and/or on-going treatment for systemic infection (e.g. Septicaemia due to in vivo foreign body (e.g. stents, catheters, heart valve), tuberculosis, malaria, other opportunistic and parasite infections)\nPrisoner\nAny other irreversible disease or condition for which six-month mortality is estimated to be greater than 50%\nModerate to severe liver failure (Child-Pugh Score >12)\nReduced renal function with a creatinine clearance (Cockcroft-Gault Equation) < 45 mL/min/1.73m2\nSevere chronic respiratory disease with a PaCO2 >50 mmHg or the use of home oxygen\nMajor trauma in the prior 5 days\nLung transplant patient\nPatients on ECMO-support\nPatients with a previous history of severe burns\nDocumented deep venous thrombosis or pulmonary embolism within past three months\nKnown hypersensitivity to DMSO\nInvestigator considers the patient unlikely to comply with study procedures, restrictions and requirements",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Oscar Simonsson, MD, PhD",
                                                            "OverallOfficialAffiliation": "Uppsala University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Uppsala University Hospital",
                                                            "LocationCity": "Uppsala",
                                                            "LocationZip": "75185",
                                                            "LocationCountry": "Sweden"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000012128",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012127",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome, Newborn"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000055371",
                                                            "ConditionMeshTerm": "Acute Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012120",
                                                            "ConditionAncestorTerm": "Respiration Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14117",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14116",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Newborn",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27297",
                                                            "ConditionBrowseLeafName": "Acute Lung Injury",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14109",
                                                            "ConditionBrowseLeafName": "Respiration Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4927",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Infant",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T192",
                                                            "ConditionBrowseLeafName": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 5,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02057965",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "NL43712.000.13"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "2013-000819-25",
                                                            "SecondaryIdType": "EudraCT Number"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Leiden University Medical Center",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cell Therapy in Renal Recipients",
                                          "OfficialTitle": "Autologous Bone Marrow Derived Mesenchymal Stromal Cell Therapy in Combination With Everolimus to Preserve Renal Structure and Function in Renal Recipients",
                                          "Acronym": "MSCs"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2020",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Active, not recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "March 2014"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "January 2020",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "January 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "February 5, 2014",
                                          "StudyFirstSubmitQCDate": "February 6, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "February 7, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "September 15, 2020",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 17, 2020",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "M.E. J. Reinders",
                                                "ResponsiblePartyInvestigatorTitle": "MD/PhD",
                                                "ResponsiblePartyInvestigatorAffiliation": "Leiden University Medical Center"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Leiden University Medical Center",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This study will test the hypothesis that MSCs in combination with Everolimus facilitate Tacrolimus withdrawal, reduce fibrosis and decrease the incidence of opportunistic infections compared to standard tacrolimus dose.",
                                          "DetailedDescription": "Kidney transplantation has improved survival and quality of life for patients with end-stage renal disease. Despite excellent short-term results, long-term survival of transplanted kidneys has not improved accordingly in the last decades. Calcineurin inhibitors (CNI) have been the cornerstone of immunosuppressive therapy for many years, due to their efficacy in preventing acute rejection. However, CNI have nephrotoxic side effects that can directly contribute to renal dysfunction and compromise long-term outcomes. Consequently there is a strong interest in immunosuppressive (IS) regimens that maintain efficacy for the prevention of acute rejection, whilst reducing nephrotoxicity.\n\nIn this perspective the combination of mesenchymal stromal cells (MSCs) with a mTor inhibitor (Everolimus (Certican\u00ae)) might be an optimal strategy to facilitate CNI (tacrolimus) withdrawal. MSCs have IS properties and roles in tissue repair and everolimus is a proliferation signal inhibitor with potent immunosuppressant effects. In experimental studies the combination of mTor inhibitor and MSCs was shown to attenuate alloimmune responses and to promote allograft tolerance.\n\nIn total 70 de novo renal recipients, 18-75 years of ages will be recruited from the transplant clinics of the LUMC. Thirty five of these patients will be included in the Certican/ and MSC group and 35 patients in the Certican/ standard dose tacrolimus group. Patients of the MSC treated groups will receive two doses of autologous BM derived MSCs IV, 7 days apart, 6 and 7 weeks after transplantation in combination with Certican\u00ae (1.5 mg b.i.d.). At the time of the second MSC infusion tacrolimus will be withdrawn in 2 weeks (after 1 week dose of tacrolimus will be halved, after 2 weeks stopped). Patients in the control group will receive Certican\u00ae (1.5 mg b.i.d.) and standard dose tacrolimus (through levels 6-8 ng/ml after 6 weeks).\n\nPrimary goal is evaluate whether concentration-controlled Certican\u00ae with MSCs compared to Certican\u00ae with standard tacrolimus in renal transplant recipients reduces fibrosis by quantitative Sirius Red scoring."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Renal Transplant Rejection",
                                                      "Fibrosis"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal Stromal Cells",
                                                      "Allograft rejection",
                                                      "Fibrosis"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "70",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal Cells + Everolimus",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Intervention: two doses of autologous bone marrow (BM) derived Mesenchymal Stromal Cells IV, 7 days apart, 6 and 7 weeks after transplantation in combination with Certican\u00ae (1.5mg/day). Doses of MSCs will be 1-2x10^6 million MSCs per/kg body weight.\n\nAt the time of the second MSC infusion tacrolimus will be withdrawn in 2 weeks (after 1 week dose of tacrolimus wil be halved, after 2 weeks stopped)",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Everolimus + Tacrolimus",
                                                            "ArmGroupType": "No Intervention",
                                                            "ArmGroupDescription": "Patients in the control group will receive Certican\u00ae (1.5 mg b.i.d.) and standard dose tacrolimus (through levels 6-8 ng/ml after 6 weeks)."
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Mesenchymal Stromal Cells",
                                                            "InterventionDescription": "Two doses of autologous bone marrow (BM) derived MSCs IV, 7 days apart, 6 and 7 weeks after transplantation. Doses of MSCs will be 1-2x10^6 million MSCs per/kg body weight",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal Cells + Everolimus"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Bone marrow derived mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Fibrosis by quantitative Sirius Red scoring of MSC treated and untreated groups",
                                                            "PrimaryOutcomeTimeFrame": "at 6 months compared to 4 weeks post transplant"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Renal function and proteinuria",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of participants with CMV and BK infection an other opportunistic infections between groups",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of participants with adverse events",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "composite end point efficacy failure (biopsy proven acute rejection, graft loss or death)",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Presence of donor specific antibodies and immunologic monitoring",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Progression of subclinical cardiovascular disease in the different treatment groups bij assessing echocardiographic parameters",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nSubject is willing to participate in the study, must be able to give informed consent and the consent must be obtained prior to any study procedure.\nRecipients of a first kidney graft from a deceased, living-unrelated or non-HLA identical living related donor > 50 years of age.\nPanel Reactive Antibodies (PRA) \u2264 10%.\nPatients must be able to adhere to the study visit schedule and protocol requirements.\nIf female and of child-bearing age, subject must be non-pregnant, non-breastfeeding, and use adequate contraception.\n\nExclusion Criteria:\n\nDouble organ transplant recipient.\nBiopsy proven acute rejection (according to the Banff criteria) in the first 6 weeks after transplantation.\nPatients with evidence of active infection or abscesses (with the exception of an uncomplicated urinary tract infection) before MSC infusion.\nPatients suffering from hepatic failure.\nPatients suffering from an active autoimmune disease.\nPatients who have had a previous BM transplant.\nA psychiatric, addictive or any disorder that compromises ability to give truly informed consent for participation in this study.\nUse of any investigational drug after transplantation.\nDocumented HIV infection, active hepatitis B, hepatitis C or TB according to current transplantation inclusion criteria.\nSubjects who currently an active opportunistic infection at the time of MSC infusion (e.g., herpes zoster [shingles], cytomegalovirus (CMV), Pneumocystis carinii (PCP), aspergillosis, histoplasmosis, or mycobacteria other than TB, BK) after transplantation.\nMalignancy (including lymphoproliferative disease) within the past 2-5 years (except for squamous or basal cell carcinoma of the skin that has been treated with no evidence of recurrence) according to current transplantation inclusion criteria.\nKnown recent substance abuse (drug or alcohol).\nContraindications to undergo a BM biopsy.\nPatients who are recipients of ABO incompatible transplants.\nCold ischemia time >30 hrs.\nPatients with severe total hypercholesterolemia (>7.5 mmol/L) or total hypertriglyceridemia (>5.6 mmol/L) (patients on lipid lowering treatment with controlled hyperlipidemia are acceptable).",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "75 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Marlies EJ Reinders, MD/PhD",
                                                            "OverallOfficialAffiliation": "Leiden University Medical Center",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Leiden University Medical Center",
                                                            "LocationCity": "Leiden",
                                                            "LocationZip": "2333 ZA",
                                                            "LocationCountry": "Netherlands"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "23349326",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Reinders ME, de Fijter JW, Roelofs H, Bajema IM, de Vries DK, Schaapherder AF, Claas FH, van Miert PP, Roelen DL, van Kooten C, Fibbe WE, Rabelink TJ. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med. 2013 Feb;2(2):107-11. doi: 10.5966/sctm.2012-0114. Epub 2013 Jan 24."
                                                      },
                                                      {
                                                            "ReferencePMID": "25491391",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Reinders ME, Bank JR, Dreyer GJ, Roelofs H, Heidt S, Roelen DL, Al Huurman V, Lindeman J, van Kooten C, Claas FH, Fibbe WE, Rabelink TJ, de Fijter JW. Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients. J Transl Med. 2014 Dec 10;12:331. doi: 10.1186/s12967-014-0331-x."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000005355",
                                                            "ConditionMeshTerm": "Fibrosis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M7637",
                                                            "ConditionBrowseLeafName": "Fibrosis",
                                                            "ConditionBrowseLeafAsFound": "Fibrosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M18102",
                                                            "InterventionBrowseLeafName": "Tacrolimus",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M255",
                                                            "InterventionBrowseLeafName": "Everolimus",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ANeo",
                                                            "InterventionBrowseBranchName": "Antineoplastic Agents"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 6,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01090817",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "EC2009/123"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "CTN2010/0098",
                                                            "SecondaryIdType": "Other Identifier",
                                                            "SecondaryIdDomain": "Therapeutics Good Administration, Government of Australia"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Royal Perth Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease",
                                          "OfficialTitle": "A Multicentre Australian Phase 2 Study to Evaluate Safety and Efficacy of Mesenchymal Stromal Cells for Treating Biologic Refractory Crohn's Disease"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "June 2015",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2010"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "June 2014",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "June 2015",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "March 22, 2010",
                                          "StudyFirstSubmitQCDate": "March 22, 2010",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "March 23, 2010",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "June 7, 2015",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "June 9, 2015",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "R.P.Herrmann",
                                                "ResponsiblePartyInvestigatorTitle": "Director Cell and Tissue Therapies Western Australia",
                                                "ResponsiblePartyInvestigatorAffiliation": "Royal Perth Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "R.P.Herrmann",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "The Queen Elizabeth Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Concord Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Sir Charles Gairdner Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "The Alfred",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Despite the advent of newer biologic therapies such as infliximab for Crohn's disease, a form of autoimmune inflammatory bowel disease, a proportion of patients are refractory to such therapy and require surgery. The hypothesis is that mesenchymal stromal cell therapy using third party human cultured cells will be safe and effective"
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Crohn Disease"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "mesenchymal stromal cells",
                                                      "ileitis",
                                                      "colitis"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "21",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stromal cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Mesenchymal stromal cells administered weekly for 4 weeks",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Mesenchymal stromal cells (MSC) for infusion"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Mesenchymal stromal cells (MSC) for infusion",
                                                            "InterventionDescription": "MSC 2X10E6/kg recipient weight are infused over 15 minutes intravenously weekly for 4 weeks",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stromal cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "No other names"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Clinical response to MSC: Reduction of Crohn's disease Activity score by 100 points or more at six weeks post start of therapy",
                                                            "PrimaryOutcomeDescription": "Colonoscopy and biopsy as well as clinical parameters used for the Crohn's disease acivity (www.ibdaustralia.org/cdai/) will be undertaken at screening pre-therapy and at 6 weeks after start of therapy.",
                                                            "PrimaryOutcomeTimeFrame": "Six weeks"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence of infusional toxicity",
                                                            "SecondaryOutcomeDescription": "Subjects will receive mesenchymal stromal cell therapy, 2X10E6/kg weekly by IV infusion for 4 weeks and will be assessed for 4 hours post infusion",
                                                            "SecondaryOutcomeTimeFrame": "Six weeks"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Induction of remission",
                                                            "SecondaryOutcomeDescription": "Crohn's disease activity index assessed as below 150",
                                                            "SecondaryOutcomeTimeFrame": "Six weeks"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Improved quality of life",
                                                            "SecondaryOutcomeDescription": "Increase in IBDQ and SF-36 scores measured at six weeks",
                                                            "SecondaryOutcomeTimeFrame": "Six weeks"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Endoscopic improvement.",
                                                            "SecondaryOutcomeDescription": "Crohn's disease endoscopic improvement score will be measured at repeat endoscopy six weeks after start of treatment",
                                                            "SecondaryOutcomeTimeFrame": "Six weeks"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nColonic or small bowel Crohn's disease based on endoscopic appearances and histology\nRefractory to induction with infliximab or adalimumab; or have lost response to these agents; or have had side effects precluding their further use\nWhere there has been loss of response to one of these agents, the other must be tried before being eligible\nCrohn's disease activity score (CDAI) 250 or more.\nC-reactive protein >10mg/L\nSurgery must have been offered to the subject (if appropriate) and declined\nSigned informed consent\n\nExclusion Criteria:\n\nActive sepsis, perforating disease. Coexistent perianal fistulous disease is permitted, providing no co-existent infection within previous 4 weeks\nChronic stricturing disease in isolation\nCoexistent CMV disease\nPrior history of malignancy\nPregnant or unwilling to practice contraceptive therapy or breast feeding females\nLast biologic therapy must be greater than 4 weeks prior, must be on stable corticosteroid dose for 14 days prior, during therapy and for 14 days after therapy, must be on stable immunomodulator dose (eg, azathioprine) for 14 days prior, during therapy and for 14 days after.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "55 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Geoff Forbes, MD",
                                                            "OverallOfficialAffiliation": "Royal Perth Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Department of Gastroenterology and Hepatology, Royal Perth Hospital",
                                                            "LocationCity": "Perth",
                                                            "LocationState": "Western Australia",
                                                            "LocationZip": "6000",
                                                            "LocationCountry": "Australia"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "23872668",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Forbes GM, Sturm MJ, Leong RW, Sparrow MP, Segarajasingam D, Cummins AG, Phillips M, Herrmann RP. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. Clin Gastroenterol Hepatol. 2014 Jan;12(1):64-71. doi: 10.1016/j.cgh.2013.06.021. Epub 2013 Jul 19."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003424",
                                                            "ConditionMeshTerm": "Crohn Disease"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000015212",
                                                            "ConditionAncestorTerm": "Inflammatory Bowel Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005759",
                                                            "ConditionAncestorTerm": "Gastroenteritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005767",
                                                            "ConditionAncestorTerm": "Gastrointestinal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004066",
                                                            "ConditionAncestorTerm": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007410",
                                                            "ConditionAncestorTerm": "Intestinal Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M5472",
                                                            "ConditionBrowseLeafName": "Colitis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5790",
                                                            "ConditionBrowseLeafName": "Crohn Disease",
                                                            "ConditionBrowseLeafAsFound": "Crohn's Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9279",
                                                            "ConditionBrowseLeafName": "Ileitis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9596",
                                                            "ConditionBrowseLeafName": "Intestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M17069",
                                                            "ConditionBrowseLeafName": "Inflammatory Bowel Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8027",
                                                            "ConditionBrowseLeafName": "Gastroenteritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8035",
                                                            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6407",
                                                            "ConditionBrowseLeafName": "Digestive System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC06",
                                                            "ConditionBrowseBranchName": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 7,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01522716",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSC-cGVH"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Karolinska Institutet",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease",
                                          "OfficialTitle": "Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "November 2020",
                                          "OverallStatus": "Terminated",
                                          "WhyStopped": "New requirements for study approval with the Swedish Medical Products Agency",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "August 2011"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "March 2016",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "March 2017",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "January 24, 2012",
                                          "StudyFirstSubmitQCDate": "January 27, 2012",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "February 1, 2012",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "November 23, 2020",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "November 25, 2020",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Lena von Bahr",
                                                "ResponsiblePartyInvestigatorTitle": "Leg l\u00e4kare",
                                                "ResponsiblePartyInvestigatorAffiliation": "Karolinska Institutet"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Karolinska Institutet",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Region Stockholm",
                                                            "CollaboratorClass": "OTHER_GOV"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The aim of the study is to evaluate the safety and efficacy of mesenchymal stromal cells as treatment for steroid-refractory chronic graft-versus-host disease."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Graft-Versus-Host Disease"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "11",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stromal cell treatment",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stromal cells",
                                                            "InterventionDescription": "Allogenous mesenchymal stromal cells, to be injected intravenously at a dose of 1-2 million/kg at a frequency of once a month (frequency may be changed during the study if deemed appropriate by investigators) for 6-9 months.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stromal cell treatment"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Change in disease activity according to National Institute of Health criteria",
                                                            "PrimaryOutcomeDescription": "Patients are evaluated according to NIH criteria at 3, 6 and (if applicable) 9 months after initialising MSC treatment, and the score compared to baseline score.",
                                                            "PrimaryOutcomeTimeFrame": "Baseline to 9 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in disease activity as measured by histological examination",
                                                            "SecondaryOutcomeTimeFrame": "Baseline to 9 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in self-assessed disease activity and quality of life",
                                                            "SecondaryOutcomeTimeFrame": "Baseline to 9 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Safety (Adverse events, infections and relapse)",
                                                            "SecondaryOutcomeDescription": "Frequency of complications, infections and relapse",
                                                            "SecondaryOutcomeTimeFrame": "21 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Freedom from steroids at 1 year after MSC treatment",
                                                            "SecondaryOutcomeDescription": "Proportion of patients free from corticosteroids at 1 year after finishing MSC treatment.",
                                                            "SecondaryOutcomeTimeFrame": "1 year after finishing treatment"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nChronic graft-versus-host disease, grade moderate or severe despite at least 3 months treatment with calcineurin inhibitors and steroids OR\nChronic graft-versus-host disease, grade moderate or severe, where full treatment with calcineurin inhibitors and steroids is impossible due to intolerable side-effects\n\nExclusion Criteria:\n\nActive malignancy\nFulfilling criteria for previously initiated study for treatment of chronic graft-versus-host disease",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Hematology Center, Karolinska University Hospital Huddinge",
                                                            "LocationCity": "Stockholm",
                                                            "LocationCountry": "Sweden"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "32573983",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Boberg E, von Bahr L, Afram G, Lindstr\u00f6m C, Ljungman P, Heldring N, Petzelbauer P, Garming Legert K, Kadri N, Le Blanc K. Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study. Stem Cells Transl Med. 2020 Oct;9(10):1190-1202. doi: 10.1002/sctm.20-0099. Epub 2020 Jun 23."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000006086",
                                                            "ConditionMeshTerm": "Graft vs Host Disease"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8341",
                                                            "ConditionBrowseLeafName": "Graft vs Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2832",
                                                            "ConditionBrowseLeafName": "Homologous Wasting Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1303",
                                                            "ConditionBrowseLeafName": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 8,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02097641",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "UCSF-hMSC-ARDS-P2"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "1U01HL108713-01",
                                                            "SecondaryIdType": "U.S. NIH Grant/Contract",
                                                            "SecondaryIdLink": "https://reporter.nih.gov/quickSearch/1U01HL108713-01"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "University of California, San Francisco",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                                          "OfficialTitle": "Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) for the Treatment of Acute Respiratory Distress Syndrome (ARDS)",
                                          "Acronym": "START"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "March 2019",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "March 15, 2014",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "March 9, 2017",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "February 9, 2018",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "March 19, 2014",
                                          "StudyFirstSubmitQCDate": "March 24, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "March 27, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "ResultsFirstSubmitDate": "January 15, 2019",
                                          "ResultsFirstSubmitQCDate": "March 18, 2019",
                                          "ResultsFirstPostDateStruct": {
                                                "ResultsFirstPostDate": "April 10, 2019",
                                                "ResultsFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "March 18, 2019",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 10, 2019",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Michael A. Matthay",
                                                "ResponsiblePartyInvestigatorTitle": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorAffiliation": "University of California, San Francisco"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Michael A. Matthay",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "National Heart, Lung, and Blood Institute (NHLBI)",
                                                            "CollaboratorClass": "NIH"
                                                      },
                                                      {
                                                            "CollaboratorName": "Massachusetts General Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Stanford University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "University of Pittsburgh",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "University of Minnesota",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Ohio State University",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This was a Phase 2a, randomized, double-blind, placebo-controlled, multi-center trial to assess the safety and efficacy of a single dose of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) infusion in patients with Acute Respiratory Distress Syndrome (ARDS).",
                                          "DetailedDescription": "We carried out a randomized, double-blind placebo-controlled trial of allogeneic bone marrow derived human mesenchymal stromal cells for treatment of moderate to severe ARDS in 60 patients, 40 MSC and 20 placebo, in a 2:1 randomization. This trial is the extension of the Phase 1 pilot trial (NCT01775774). Patients were followed daily for adverse events through day 28, death or hospital discharge, whichever occurs first. Vital status was collected at 6 and 12 months after study enrollment."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Respiratory Distress Syndrome, Adult"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells",
                                                      "Acute Respiratory Distress Syndrome"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Triple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "60",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Human Mesenchymal Stromal Cells (hMSCs)",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells was administered intravenously over approximately 60-80 minutes.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Plasma-Lyte A (placebo)",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "A single dose of Plasma-Lyte A was administered intravenously over approximately 60-80 minutes.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Plasma-Lyte A"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells",
                                                            "InterventionDescription": "Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells was administered intravenously over approximately 60-80 minutes.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Human Mesenchymal Stromal Cells (hMSCs)"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Plasma-Lyte A",
                                                            "InterventionDescription": "Plasma-Lyte A placebo was administered intravenously over approximately 60-80 minutes.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Plasma-Lyte A (placebo)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Numbers of Patients Occurred Pre-specified Infusion Associated Events Occurring Within 6 Hours of Study Infusion",
                                                            "PrimaryOutcomeDescription": "Within 6 h of study product infusion:\n\nIncrease in vasopressor dose to the following values or higher:\nNorepinephrine 10 \u03bcg/min\nPhenylephrine 100 \u03bcg/min\nDopamine 10 \u03bcg/kg per min\nEpinephrine 0.1 \u03bcg/kg per min or addition of a third vasopressor\nNew ventricular tachycardia, ventricular fibrillation or asystole\nNew cardiac arrhythmia requiring cardioversion\nHypoxaemia requiring an increase in FiO2 of 0\u00b72 or more and an increase in PEEP of 5\u00b70 or more to maintain SpO2 in the target range of 88-95%\nClinical scenario consistent with transfusion incompatibility or transfusion-related infection (eg, urticaria, new bronchospasm)",
                                                            "PrimaryOutcomeTimeFrame": "6 hours"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Numbers of Patients Occurred Any Cardiac Arrest or Death Within 24 Hours of Study Infusion",
                                                            "PrimaryOutcomeDescription": "Within 24 h of study product infusion\n\n\u2022 Any cardiac arrest or death",
                                                            "PrimaryOutcomeTimeFrame": "24 hours"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Numbers of Patients Occurred Any Unexpected Severe Adverse Events (Including All-cause Deaths)",
                                                            "PrimaryOutcomeDescription": "Safety endpoint: Any unexpected severe adverse events in two groups",
                                                            "PrimaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "PaO2:FiO2 Change From Baseline to Day 3",
                                                            "SecondaryOutcomeDescription": "Efficacy endpoint: PaO2:FiO2 change from baseline to day 3",
                                                            "SecondaryOutcomeTimeFrame": "baseline and day 3"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Lung Injury Score From Baseline to Day 3",
                                                            "SecondaryOutcomeDescription": "Murray score for acute lung injury. The range is 0 to 4. The higher score, the worst outcome.",
                                                            "SecondaryOutcomeTimeFrame": "baseline and day 3"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Oxygenation Index Change From Baseline to Day 2",
                                                            "SecondaryOutcomeDescription": "Oxygenation index with the following validated measure of respiratory function: FiO2 (%) x mean airway pressure / PaO2",
                                                            "SecondaryOutcomeTimeFrame": "baseline and day 2"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "SOFA Score Change From Baseline to Day 3",
                                                            "SecondaryOutcomeDescription": "Sequential organ failure assessment score (SOFA). The SOFA score ranges from 0 to 24. The higher, the worse.",
                                                            "SecondaryOutcomeTimeFrame": "baseline and day 3"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of Patients Death to Day 28",
                                                            "SecondaryOutcomeDescription": "Efficacy endpoint: all-cause mortality at day 28",
                                                            "SecondaryOutcomeTimeFrame": "28 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Mortality to Day 60",
                                                            "SecondaryOutcomeDescription": "Efficacy endpoint: all-cause mortality at day 60",
                                                            "SecondaryOutcomeTimeFrame": "60 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of Ventilator-free Days to Day 28",
                                                            "SecondaryOutcomeDescription": "Efficacy endpoint: Number of ventilator-free days to day 28.",
                                                            "SecondaryOutcomeTimeFrame": "28 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Non-pulmonary Organ-failure-free Days to Day 28",
                                                            "SecondaryOutcomeDescription": "Efficacy endpoint: Non-pulmonary organ-failure-free days to day 28",
                                                            "SecondaryOutcomeTimeFrame": "28 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Angiopoietin 2 Change From Baseline to 6 h",
                                                            "SecondaryOutcomeDescription": "Biological markers of endothelial injury: angiopoietin 2",
                                                            "SecondaryOutcomeTimeFrame": "baseline and 6 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Angiopoietin 2 Change From Baseline to 24 h",
                                                            "SecondaryOutcomeDescription": "Biological markers of endothelial injury: angiopoietin 2",
                                                            "SecondaryOutcomeTimeFrame": "baseline and 24 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Interleukin 6 Change From Baseline to 6 h",
                                                            "SecondaryOutcomeDescription": "Biological markers of inflammation: interleukin 6",
                                                            "SecondaryOutcomeTimeFrame": "baseline and 6 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Interleukin 6 Change From Baseline to 24 h",
                                                            "SecondaryOutcomeDescription": "Biological markers of inflammation: interleukin 6",
                                                            "SecondaryOutcomeTimeFrame": "baseline and 24 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Interleukin 8 Change From Baseline to 6 h",
                                                            "SecondaryOutcomeDescription": "Biological markers of inflammation: interleukin 8",
                                                            "SecondaryOutcomeTimeFrame": "baseline and 6 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Interleukin 8 Change From Baseline to 24 h",
                                                            "SecondaryOutcomeDescription": "Biological markers of inflammation: interleukin 8",
                                                            "SecondaryOutcomeTimeFrame": "baseline and 24 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "RAGE Change From Baseline to 6 h",
                                                            "SecondaryOutcomeDescription": "Biological markers of alveolar epithelial injury: receptor for advanced glycation end products (RAGE)",
                                                            "SecondaryOutcomeTimeFrame": "baseline and 6 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "RAGE Change From Baseline to 24 h",
                                                            "SecondaryOutcomeDescription": "Biological markers of alveolar epithelial injury: receptor for advanced glycation end products (RAGE)",
                                                            "SecondaryOutcomeTimeFrame": "baseline and 24 hours"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients will be eligible for inclusion if they meet all of the below criteria. Criteria 1-3 must all be present within a 24-hour time period and at the time of enrollment:\n\nAcute onset (defined below) of:\n\nA need for positive pressure ventilation by an endotracheal or tracheal tube with a PaO2/FiO2 ratio < 200 with at least 8 cm H2O positive end-expiratory airway pressure (PEEP)\nBilateral infiltrates consistent with pulmonary edema on frontal chest radiograph\nNo clinical evidence of left atrial hypertension for bilateral pulmonary infiltrates.\n\nExclusion Criteria:\n\nAge less than 18 years\nGreater than 96 hours since first meeting ARDS criteria per the Berlin definition of ARDS\nPregnant or breast-feeding\nPrisoner\nPresence of any active malignancy (other than non-melanoma skin cancer) that required treatment within the last 2 years\nAny other irreversible disease or condition for which 6-month mortality is estimated to be greater than 50%\nModerate to severe liver failure (Childs-Pugh Score > 12)\nSevere chronic respiratory disease with a PaCO2 > 50 mm Hg or the use of home oxygen\nPatient, surrogate, or physician not committed to full support (exception: a patient will not be excluded if he/she would receive all supportive care except for attempts at resuscitation from cardiac arrest)\nMajor trauma in the prior 5 days\nLung transplant patient\nNo consent/inability to obtain consent\nMoribund patient not expected to survive 24 hours\nWorld Health Organization (WHO) Class III or IV pulmonary hypertension\nDocumented deep venous thrombosis or pulmonary embolism within past 3 months\nNo arterial line/no intent to place an arterial line\nNo intent/unwillingness to follow lung protective ventilation strategy or fluid management protocol\nCurrently receiving extracorporeal life support (ECLS) or high-frequency oscillatory ventilation (HFOV)",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Michael A Matthay, MD",
                                                            "OverallOfficialAffiliation": "University of California, San Francisco",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "University of California San Francisco",
                                                            "LocationCity": "San Francisco",
                                                            "LocationState": "California",
                                                            "LocationZip": "94143",
                                                            "LocationCountry": "United States"
                                                      },
                                                      {
                                                            "LocationFacility": "Stanford University",
                                                            "LocationCity": "Stanford",
                                                            "LocationState": "California",
                                                            "LocationZip": "94305",
                                                            "LocationCountry": "United States"
                                                      },
                                                      {
                                                            "LocationFacility": "Massachusetts General Hospital",
                                                            "LocationCity": "Boston",
                                                            "LocationState": "Massachusetts",
                                                            "LocationZip": "02114",
                                                            "LocationCountry": "United States"
                                                      },
                                                      {
                                                            "LocationFacility": "University of Minnesota Medical Center",
                                                            "LocationCity": "Saint Paul",
                                                            "LocationState": "Minnesota",
                                                            "LocationZip": "55108",
                                                            "LocationCountry": "United States"
                                                      },
                                                      {
                                                            "LocationFacility": "Ohio State University",
                                                            "LocationCity": "Columbus",
                                                            "LocationState": "Ohio",
                                                            "LocationZip": "43210",
                                                            "LocationCountry": "United States"
                                                      },
                                                      {
                                                            "LocationFacility": "University of Pittsburgh",
                                                            "LocationCity": "Pittsburgh",
                                                            "LocationState": "Pennsylvania",
                                                            "LocationZip": "15213",
                                                            "LocationCountry": "United States"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "30455077",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Matthay MA, Calfee CS, Zhuo H, Thompson BT, Wilson JG, Levitt JE, Rogers AJ, Gotts JE, Wiener-Kronish JP, Bajwa EK, Donahoe MP, McVerry BJ, Ortiz LA, Exline M, Christman JW, Abbott J, Delucchi KL, Caballero L, McMillan M, McKenna DH, Liu KD. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019 Feb;7(2):154-162. doi: 10.1016/S2213-2600(18)30418-1. Epub 2018 Nov 16."
                                                      },
                                                      {
                                                            "ReferencePMID": "33974564",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Wick KD, Leligdowicz A, Zhuo H, Ware LB, Matthay MA. Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS. JCI Insight. 2021 Jun 22;6(12). pii: 148983. doi: 10.1172/jci.insight.148983."
                                                      },
                                                      {
                                                            "ReferencePMID": "25593740",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Liu KD, Wilson JG, Zhuo H, Caballero L, McMillan ML, Fang X, Cosgrove K, Calfee CS, Lee JW, Kangelaris KN, Gotts JE, Rogers AJ, Levitt JE, Wiener-Kronish JP, Delucchi KL, Leavitt AD, McKenna DH, Thompson BT, Matthay MA. Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome. Ann Intensive Care. 2014 Jul 3;4:22. doi: 10.1186/s13613-014-0022-z. eCollection 2014."
                                                      },
                                                      {
                                                            "ReferencePMID": "24891325",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Asmussen S, Ito H, Traber DL, Lee JW, Cox RA, Hawkins HK, McAuley DF, McKenna DH, Traber LD, Zhuo H, Wilson J, Herndon DN, Prough DS, Liu KD, Matthay MA, Enkhbaatar P. Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia. Thorax. 2014 Sep;69(9):819-25. doi: 10.1136/thoraxjnl-2013-204980. Epub 2014 Jun 2."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "ResultsSection": {
                                    "ParticipantFlowModule": {
                                          "FlowPreAssignmentDetails": "Three patients who were randomly assigned to receive human mesenchymal stem cells, were excluded: 2 did not meet baseline stability criteria; 1 patient's PaO2:FiO2 > 200 mmHg.",
                                          "FlowRecruitmentDetails": "From March 24, 2014, to Feb 9, 2017, 1038 patients were screened for eligibility, of whom 975 were excluded, and 63 were randomly assigned to a treatment group. Three patients were not eligible for treatment after randomization and, therefore, 40 patients received human mesenchymal stem cells and 20 patients received placebo.",
                                          "FlowGroupList": {
                                                "FlowGroup": [
                                                      {
                                                            "FlowGroupId": "FG000",
                                                            "FlowGroupTitle": "Human Mesenchymal Stem Cells",
                                                            "FlowGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                      },
                                                      {
                                                            "FlowGroupId": "FG001",
                                                            "FlowGroupTitle": "Plasma-Lyte A",
                                                            "FlowGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                      }
                                                ]
                                          },
                                          "FlowPeriodList": {
                                                "FlowPeriod": [
                                                      {
                                                            "FlowPeriodTitle": "Overall Study",
                                                            "FlowMilestoneList": {
                                                                  "FlowMilestone": [
                                                                        {
                                                                              "FlowMilestoneType": "STARTED",
                                                                              "FlowAchievementList": {
                                                                                    "FlowAchievement": [
                                                                                          {
                                                                                                "FlowAchievementGroupId": "FG000",
                                                                                                "FlowAchievementNumSubjects": "40"
                                                                                          },
                                                                                          {
                                                                                                "FlowAchievementGroupId": "FG001",
                                                                                                "FlowAchievementNumSubjects": "20"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        },
                                                                        {
                                                                              "FlowMilestoneType": "COMPLETED",
                                                                              "FlowAchievementList": {
                                                                                    "FlowAchievement": [
                                                                                          {
                                                                                                "FlowAchievementGroupId": "FG000",
                                                                                                "FlowAchievementNumSubjects": "40"
                                                                                          },
                                                                                          {
                                                                                                "FlowAchievementGroupId": "FG001",
                                                                                                "FlowAchievementNumSubjects": "20"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        },
                                                                        {
                                                                              "FlowMilestoneType": "NOT COMPLETED",
                                                                              "FlowAchievementList": {
                                                                                    "FlowAchievement": [
                                                                                          {
                                                                                                "FlowAchievementGroupId": "FG000",
                                                                                                "FlowAchievementNumSubjects": "0"
                                                                                          },
                                                                                          {
                                                                                                "FlowAchievementGroupId": "FG001",
                                                                                                "FlowAchievementNumSubjects": "0"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "BaselineCharacteristicsModule": {
                                          "BaselineGroupList": {
                                                "BaselineGroup": [
                                                      {
                                                            "BaselineGroupId": "BG000",
                                                            "BaselineGroupTitle": "Human Mesenchymal Stem Cells (hMSCs)",
                                                            "BaselineGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                      },
                                                      {
                                                            "BaselineGroupId": "BG001",
                                                            "BaselineGroupTitle": "Plasma-Lyte A (Placebo)",
                                                            "BaselineGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                      },
                                                      {
                                                            "BaselineGroupId": "BG002",
                                                            "BaselineGroupTitle": "Total",
                                                            "BaselineGroupDescription": "Total of all reporting groups"
                                                      }
                                                ]
                                          },
                                          "BaselineDenomList": {
                                                "BaselineDenom": [
                                                      {
                                                            "BaselineDenomUnits": "Participants",
                                                            "BaselineDenomCountList": {
                                                                  "BaselineDenomCount": [
                                                                        {
                                                                              "BaselineDenomCountGroupId": "BG000",
                                                                              "BaselineDenomCountValue": "40"
                                                                        },
                                                                        {
                                                                              "BaselineDenomCountGroupId": "BG001",
                                                                              "BaselineDenomCountValue": "20"
                                                                        },
                                                                        {
                                                                              "BaselineDenomCountGroupId": "BG002",
                                                                              "BaselineDenomCountValue": "60"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "BaselineMeasureList": {
                                                "BaselineMeasure": [
                                                      {
                                                            "BaselineMeasureTitle": "Age, Categorical",
                                                            "BaselineMeasureParamType": "Count of Participants",
                                                            "BaselineMeasureUnitOfMeasure": "Participants",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineCategoryTitle": "<=18 years",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "0"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "0"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "0"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Between 18 and 65 years",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "30"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "12"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "42"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": ">=65 years",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "10"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "8"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "18"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Age, Continuous",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "years",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "55",
                                                                                                                  "BaselineMeasurementSpread": "17"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "55",
                                                                                                                  "BaselineMeasurementSpread": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "55",
                                                                                                                  "BaselineMeasurementSpread": "18"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Sex: Female, Male",
                                                            "BaselineMeasureParamType": "Count of Participants",
                                                            "BaselineMeasureUnitOfMeasure": "Participants",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Female",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "23"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "10"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "33"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Male",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "17"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "10"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "27"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Ethnicity (NIH/OMB)",
                                                            "BaselineMeasureParamType": "Count of Participants",
                                                            "BaselineMeasureUnitOfMeasure": "Participants",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Hispanic or Latino",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "4"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "2"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "6"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Not Hispanic or Latino",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "31"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "16"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "47"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Unknown or Not Reported",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "5"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "2"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "7"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Race (NIH/OMB)",
                                                            "BaselineMeasureParamType": "Count of Participants",
                                                            "BaselineMeasureUnitOfMeasure": "Participants",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineCategoryTitle": "American Indian or Alaska Native",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "0"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "0"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "0"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Asian",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "2"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "2"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "4"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Native Hawaiian or Other Pacific Islander",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "3"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "0"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "3"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Black or African American",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "4"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "1"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "5"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "White",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "27"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "13"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "40"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "More than one race",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "0"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "0"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "0"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Unknown or Not Reported",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "4"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "4"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "8"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Region of Enrollment",
                                                            "BaselineMeasureParamType": "Number",
                                                            "BaselineMeasureUnitOfMeasure": "participants",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassTitle": "United States",
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Cause of Acute Respiratory Distress Syndrome (ARDS)",
                                                            "BaselineMeasureParamType": "Count of Participants",
                                                            "BaselineMeasureUnitOfMeasure": "Participants",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Sepsis with pneumonia",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "19"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "12"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "31"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Sepsis without pneumonia",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "5"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "2"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "7"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Pneumonia without sepsis",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "11"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "5"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "16"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Aspiration only",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "4"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "1"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "5"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Other",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "1"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "0"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "1"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Arterial pressure",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "mm Hg",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "75",
                                                                                                                  "BaselineMeasurementSpread": "10"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "76",
                                                                                                                  "BaselineMeasurementSpread": "9"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "75",
                                                                                                                  "BaselineMeasurementSpread": "10"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Taking vasopressors at the time of infusion",
                                                            "BaselineMeasureParamType": "Count of Participants",
                                                            "BaselineMeasureUnitOfMeasure": "Participants",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "24"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "9"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "33"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Sequential Organ Failure Assessment (SOFA)",
                                                            "BaselineMeasureDescription": "SOFA score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems which are added up. Each score ranges from 0 to 4. SOFA score ranges from 0 (best) to 24 (worst).",
                                                            "BaselineMeasurePopulationDescription": "Data not recorded in one patient treated with Plasma-Lyte A (placebo).",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "units on a scale",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "19"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "59"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "8.1",
                                                                                                                  "BaselineMeasurementSpread": "3.3"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "6.9",
                                                                                                                  "BaselineMeasurementSpread": "2.7"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "7.7",
                                                                                                                  "BaselineMeasurementSpread": "3.2"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) III score",
                                                            "BaselineMeasureDescription": "The range of APACHE III is from 0 to 299. The higher score, the worse clinical outcome.",
                                                            "BaselineMeasurePopulationDescription": "Data not recorded in one patient treated with Plasma-Lyte (placebo).",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "units on a scale",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "19"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "59"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "104",
                                                                                                                  "BaselineMeasurementSpread": "31"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "89",
                                                                                                                  "BaselineMeasurementSpread": "33"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "99",
                                                                                                                  "BaselineMeasurementSpread": "32"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Minute ventilation",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "L/min",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "11.1",
                                                                                                                  "BaselineMeasurementSpread": "3.2"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "9.6",
                                                                                                                  "BaselineMeasurementSpread": "2.4"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "10.6",
                                                                                                                  "BaselineMeasurementSpread": "3.0"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Respiratory rate",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "breaths/min",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "27.8",
                                                                                                                  "BaselineMeasurementSpread": "6.6"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "24.5",
                                                                                                                  "BaselineMeasurementSpread": "6.3"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "26.7",
                                                                                                                  "BaselineMeasurementSpread": "6.6"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Tidal volume",
                                                            "BaselineMeasurePopulationDescription": "Data not recorded in one patient treated with hMSCs.",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "mL/kg predicted body weight",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "39"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "59"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "6.3",
                                                                                                                  "BaselineMeasurementSpread": "0.9"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "6.1",
                                                                                                                  "BaselineMeasurementSpread": "0.7"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "6.2",
                                                                                                                  "BaselineMeasurementSpread": "0.9"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Mean airway pressure",
                                                            "BaselineMeasurePopulationDescription": "Data not recorded in three patients treated with hMSCs and one patient treated with Plasma-Lyte A (placebo).",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "cm H2O",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "37"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "19"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "56"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "17.8",
                                                                                                                  "BaselineMeasurementSpread": "4.9"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "16.4",
                                                                                                                  "BaselineMeasurementSpread": "3.6"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "17.4",
                                                                                                                  "BaselineMeasurementSpread": "4.6"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Plateau airway pressure",
                                                            "BaselineMeasurePopulationDescription": "15 patients did not have baseline plateau pressure recorded.",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "cm H2O",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "30"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "15"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "45"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "26.4",
                                                                                                                  "BaselineMeasurementSpread": "5.7"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "23.7",
                                                                                                                  "BaselineMeasurementSpread": "5.1"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "25.5",
                                                                                                                  "BaselineMeasurementSpread": "5.6"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Positive end-expiratory pressure (PEEP)",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "cm H2O",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "12.4",
                                                                                                                  "BaselineMeasurementSpread": "3.7"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "10.8",
                                                                                                                  "BaselineMeasurementSpread": "2.6"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "11.8",
                                                                                                                  "BaselineMeasurementSpread": "3.4"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Driving pressure",
                                                            "BaselineMeasurePopulationDescription": "Data not recorded in 10 patients treated with hMSCs and in 5 patients treated with Plasma-Lyte (placebo).",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "cm H2O",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "30"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "15"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "45"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "14.0",
                                                                                                                  "BaselineMeasurementSpread": "4.1"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "12.5",
                                                                                                                  "BaselineMeasurementSpread": "4.3"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "13.5",
                                                                                                                  "BaselineMeasurementSpread": "4.2"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "PaO2/FiO2",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "kPa",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "18.1",
                                                                                                                  "BaselineMeasurementSpread": "4.3"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "19.1",
                                                                                                                  "BaselineMeasurementSpread": "5.2"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "18.4",
                                                                                                                  "BaselineMeasurementSpread": "4.6"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Oxygenation index",
                                                            "BaselineMeasureDescription": "Oxygenation index calculated as: FiO2 (%) x Mean Airway Pressure / PaO2",
                                                            "BaselineMeasurePopulationDescription": "Data not recorded in 3 patients treated with hMSCs and 1 patient treated with Plasma-Lyte (placebo).",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "kPa",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "37"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "19"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "56"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "108.1",
                                                                                                                  "BaselineMeasurementSpread": "45.9"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "95.7",
                                                                                                                  "BaselineMeasurementSpread": "41.2"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "103.9",
                                                                                                                  "BaselineMeasurementSpread": "44.4"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Lung injury score (LIS)",
                                                            "BaselineMeasureDescription": "LIS is a composite 4-point scoring system including the PaO2/FiO2, PEEP, lung compliance, and the extent of infiltrates on the chest X-ray. Each of the four components is categorized from 0 to 4, where a higher number is worse. The total Lung Injury Score is obtained by dividing the aggregate sum by the number of components used.",
                                                            "BaselineMeasureParamType": "Mean",
                                                            "BaselineMeasureDispersionType": "Standard Deviation",
                                                            "BaselineMeasureUnitOfMeasure": "units on a scale",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "3.1",
                                                                                                                  "BaselineMeasurementSpread": "0.4"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "3.0",
                                                                                                                  "BaselineMeasurementSpread": "0.5"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "3.1",
                                                                                                                  "BaselineMeasurementSpread": "0.4"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Ventilation mode",
                                                            "BaselineMeasureParamType": "Count of Participants",
                                                            "BaselineMeasureUnitOfMeasure": "Participants",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineClassDenomList": {
                                                                                    "BaselineClassDenom": [
                                                                                          {
                                                                                                "BaselineClassDenomUnits": "Participants",
                                                                                                "BaselineClassDenomCountList": {
                                                                                                      "BaselineClassDenomCount": [
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG000",
                                                                                                                  "BaselineClassDenomCountValue": "40"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG001",
                                                                                                                  "BaselineClassDenomCountValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineClassDenomCountGroupId": "BG002",
                                                                                                                  "BaselineClassDenomCountValue": "60"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              },
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Volume control",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "37"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "17"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "54"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Pressure-regulated volume control",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "1"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "2"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "3"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Other",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "2"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG001",
                                                                                                                  "BaselineMeasurementValue": "1"
                                                                                                            },
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG002",
                                                                                                                  "BaselineMeasurementValue": "3"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomeMeasuresModule": {
                                          "OutcomeMeasureList": {
                                                "OutcomeMeasure": [
                                                      {
                                                            "OutcomeMeasureType": "Primary",
                                                            "OutcomeMeasureTitle": "Numbers of Patients Occurred Pre-specified Infusion Associated Events Occurring Within 6 Hours of Study Infusion",
                                                            "OutcomeMeasureDescription": "Within 6 h of study product infusion:\n\nIncrease in vasopressor dose to the following values or higher:\nNorepinephrine 10 \u03bcg/min\nPhenylephrine 100 \u03bcg/min\nDopamine 10 \u03bcg/kg per min\nEpinephrine 0.1 \u03bcg/kg per min or addition of a third vasopressor\nNew ventricular tachycardia, ventricular fibrillation or asystole\nNew cardiac arrhythmia requiring cardioversion\nHypoxaemia requiring an increase in FiO2 of 0\u00b72 or more and an increase in PEEP of 5\u00b70 or more to maintain SpO2 in the target range of 88-95%\nClinical scenario consistent with transfusion incompatibility or transfusion-related infection (eg, urticaria, new bronchospasm)",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Count of Participants",
                                                            "OutcomeMeasureUnitOfMeasure": "Participants",
                                                            "OutcomeMeasureTimeFrame": "6 hours",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells (hMSCs)",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A (Placebo)",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "40"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "20"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "0"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "0"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Primary",
                                                            "OutcomeMeasureTitle": "Numbers of Patients Occurred Any Cardiac Arrest or Death Within 24 Hours of Study Infusion",
                                                            "OutcomeMeasureDescription": "Within 24 h of study product infusion\n\n\u2022 Any cardiac arrest or death",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Count of Participants",
                                                            "OutcomeMeasureUnitOfMeasure": "Participants",
                                                            "OutcomeMeasureTimeFrame": "24 hours",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells (hMSCs)",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A (Placebo)",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "40"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "20"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "1"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "0"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Primary",
                                                            "OutcomeMeasureTitle": "Numbers of Patients Occurred Any Unexpected Severe Adverse Events (Including All-cause Deaths)",
                                                            "OutcomeMeasureDescription": "Safety endpoint: Any unexpected severe adverse events in two groups",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Count of Participants",
                                                            "OutcomeMeasureUnitOfMeasure": "Participants",
                                                            "OutcomeMeasureTimeFrame": "12 months",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "40"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "20"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "20"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "5"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "PaO2:FiO2 Change From Baseline to Day 3",
                                                            "OutcomeMeasureDescription": "Efficacy endpoint: PaO2:FiO2 change from baseline to day 3",
                                                            "OutcomeMeasurePopulationDescription": "The values of PaO2:FiO2 were not available in 10 patients treated with hMSCs and in 2 patients treated with placebo.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "kPa",
                                                            "OutcomeMeasureTimeFrame": "baseline and day 3",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "30"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "18"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "3.7",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-1.2",
                                                                                                                  "OutcomeMeasurementUpperLimit": "10.8"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "3.5",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-2.7",
                                                                                                                  "OutcomeMeasurementUpperLimit": "8.3"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Lung Injury Score From Baseline to Day 3",
                                                            "OutcomeMeasureDescription": "Murray score for acute lung injury. The range is 0 to 4. The higher score, the worst outcome.",
                                                            "OutcomeMeasurePopulationDescription": "The values were missing in 9 hMSC patients and 2 placebo patients.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "units on a scale",
                                                            "OutcomeMeasureTimeFrame": "baseline and day 3",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "31"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "18"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "-0.50",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-1.00",
                                                                                                                  "OutcomeMeasurementUpperLimit": "-0.25"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "-0.33",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-0.67",
                                                                                                                  "OutcomeMeasurementUpperLimit": "-0.08"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Oxygenation Index Change From Baseline to Day 2",
                                                            "OutcomeMeasureDescription": "Oxygenation index with the following validated measure of respiratory function: FiO2 (%) x mean airway pressure / PaO2",
                                                            "OutcomeMeasurePopulationDescription": "The values were missing in 16 patients treated by MSC and 6 patients treated by placebo",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "kPa",
                                                            "OutcomeMeasureTimeFrame": "baseline and day 2",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "24"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "14"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "-30.3",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-67.9",
                                                                                                                  "OutcomeMeasurementUpperLimit": "14.9"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "-19.5",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-47.8",
                                                                                                                  "OutcomeMeasurementUpperLimit": "10.9"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "SOFA Score Change From Baseline to Day 3",
                                                            "OutcomeMeasureDescription": "Sequential organ failure assessment score (SOFA). The SOFA score ranges from 0 to 24. The higher, the worse.",
                                                            "OutcomeMeasurePopulationDescription": "The values were missing in 3 MSC patients and 1 placebo patient.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "units on a scale",
                                                            "OutcomeMeasureTimeFrame": "baseline and day 3",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "37"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "19"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "-2",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-4",
                                                                                                                  "OutcomeMeasurementUpperLimit": "0"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "-1",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-4",
                                                                                                                  "OutcomeMeasurementUpperLimit": "1"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Number of Patients Death to Day 28",
                                                            "OutcomeMeasureDescription": "Efficacy endpoint: all-cause mortality at day 28",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Count of Participants",
                                                            "OutcomeMeasureUnitOfMeasure": "Participants",
                                                            "OutcomeMeasureTimeFrame": "28 days",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "40"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "20"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "12"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "3"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Mortality to Day 60",
                                                            "OutcomeMeasureDescription": "Efficacy endpoint: all-cause mortality at day 60",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Count of Participants",
                                                            "OutcomeMeasureUnitOfMeasure": "Participants",
                                                            "OutcomeMeasureTimeFrame": "60 days",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "40"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "20"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "15"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "5"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Number of Ventilator-free Days to Day 28",
                                                            "OutcomeMeasureDescription": "Efficacy endpoint: Number of ventilator-free days to day 28.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "days",
                                                            "OutcomeMeasureTimeFrame": "28 days",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "40"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "20"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "2",
                                                                                                                  "OutcomeMeasurementLowerLimit": "0",
                                                                                                                  "OutcomeMeasurementUpperLimit": "23"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "17",
                                                                                                                  "OutcomeMeasurementLowerLimit": "0",
                                                                                                                  "OutcomeMeasurementUpperLimit": "24"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Non-pulmonary Organ-failure-free Days to Day 28",
                                                            "OutcomeMeasureDescription": "Efficacy endpoint: Non-pulmonary organ-failure-free days to day 28",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "days",
                                                            "OutcomeMeasureTimeFrame": "28 days",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "40"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "20"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "12",
                                                                                                                  "OutcomeMeasurementLowerLimit": "4",
                                                                                                                  "OutcomeMeasurementUpperLimit": "24"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "8",
                                                                                                                  "OutcomeMeasurementLowerLimit": "4",
                                                                                                                  "OutcomeMeasurementUpperLimit": "15"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Angiopoietin 2 Change From Baseline to 6 h",
                                                            "OutcomeMeasureDescription": "Biological markers of endothelial injury: angiopoietin 2",
                                                            "OutcomeMeasurePopulationDescription": "The biomarker values were missing in one patient treated with hMSC and one patient treated with placebo.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "pg/mL",
                                                            "OutcomeMeasureTimeFrame": "baseline and 6 hours",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "39"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "19"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "-1120",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-4706",
                                                                                                                  "OutcomeMeasurementUpperLimit": "-66"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "287",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-1005",
                                                                                                                  "OutcomeMeasurementUpperLimit": "2374"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Angiopoietin 2 Change From Baseline to 24 h",
                                                            "OutcomeMeasureDescription": "Biological markers of endothelial injury: angiopoietin 2",
                                                            "OutcomeMeasurePopulationDescription": "The values were not available in two patients treated with hMSC and two patients treated with placebo.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "pg/mL",
                                                            "OutcomeMeasureTimeFrame": "baseline and 24 hours",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "38"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "18"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "-2080",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-6404",
                                                                                                                  "OutcomeMeasurementUpperLimit": "47"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "-537",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-4294",
                                                                                                                  "OutcomeMeasurementUpperLimit": "1029"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Interleukin 6 Change From Baseline to 6 h",
                                                            "OutcomeMeasureDescription": "Biological markers of inflammation: interleukin 6",
                                                            "OutcomeMeasurePopulationDescription": "The values were not available in one patient treated with hMSC and one patient treated with placebo.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "pg/mL",
                                                            "OutcomeMeasureTimeFrame": "baseline and 6 hours",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "39"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "19"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "-51",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-124",
                                                                                                                  "OutcomeMeasurementUpperLimit": "4"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "-20",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-71",
                                                                                                                  "OutcomeMeasurementUpperLimit": "17"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Interleukin 6 Change From Baseline to 24 h",
                                                            "OutcomeMeasureDescription": "Biological markers of inflammation: interleukin 6",
                                                            "OutcomeMeasurePopulationDescription": "The values were not available in two patients treated with hMSC and two patients treated with placebo.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "pg/mL",
                                                            "OutcomeMeasureTimeFrame": "baseline and 24 hours",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "38"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "18"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "-34",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-137",
                                                                                                                  "OutcomeMeasurementUpperLimit": "4"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "-43",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-165",
                                                                                                                  "OutcomeMeasurementUpperLimit": "39"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Interleukin 8 Change From Baseline to 6 h",
                                                            "OutcomeMeasureDescription": "Biological markers of inflammation: interleukin 8",
                                                            "OutcomeMeasurePopulationDescription": "The values were not available in one patient treated with hMSC and one patient treated with placebo.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "pg/mL",
                                                            "OutcomeMeasureTimeFrame": "baseline and 6 hours",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "39"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "19"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "-2",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-24",
                                                                                                                  "OutcomeMeasurementUpperLimit": "3"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "-1",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-8",
                                                                                                                  "OutcomeMeasurementUpperLimit": "1"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Interleukin 8 Change From Baseline to 24 h",
                                                            "OutcomeMeasureDescription": "Biological markers of inflammation: interleukin 8",
                                                            "OutcomeMeasurePopulationDescription": "The values were not available in two patients treated with hMSC and two patients treated with placebo.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "pg/mL",
                                                            "OutcomeMeasureTimeFrame": "baseline and 24 hours",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "38"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "18"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "-5",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-34",
                                                                                                                  "OutcomeMeasurementUpperLimit": "4"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "-5",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-17",
                                                                                                                  "OutcomeMeasurementUpperLimit": "-1"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "RAGE Change From Baseline to 6 h",
                                                            "OutcomeMeasureDescription": "Biological markers of alveolar epithelial injury: receptor for advanced glycation end products (RAGE)",
                                                            "OutcomeMeasurePopulationDescription": "The values were not available in one patient treated with hMSC and one patient treated with placebo.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "pg/mL",
                                                            "OutcomeMeasureTimeFrame": "baseline and 6 hours",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "39"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "19"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "-326",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-888",
                                                                                                                  "OutcomeMeasurementUpperLimit": "-45"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "-322",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-624",
                                                                                                                  "OutcomeMeasurementUpperLimit": "-93"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "RAGE Change From Baseline to 24 h",
                                                            "OutcomeMeasureDescription": "Biological markers of alveolar epithelial injury: receptor for advanced glycation end products (RAGE)",
                                                            "OutcomeMeasurePopulationDescription": "The values were not available in two patients treated with hMSC and two patients treated with placebo.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Median",
                                                            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
                                                            "OutcomeMeasureUnitOfMeasure": "pg/mL",
                                                            "OutcomeMeasureTimeFrame": "baseline and 24 hours",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Human Mesenchymal Stem Cells",
                                                                              "OutcomeGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes."
                                                                        },
                                                                        {
                                                                              "OutcomeGroupId": "OG001",
                                                                              "OutcomeGroupTitle": "Plasma-Lyte A",
                                                                              "OutcomeGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "38"
                                                                                          },
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG001",
                                                                                                "OutcomeDenomCountValue": "18"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "-393",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-1118",
                                                                                                                  "OutcomeMeasurementUpperLimit": "-78"
                                                                                                            },
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG001",
                                                                                                                  "OutcomeMeasurementValue": "-411",
                                                                                                                  "OutcomeMeasurementLowerLimit": "-1057",
                                                                                                                  "OutcomeMeasurementUpperLimit": "-110"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "AdverseEventsModule": {
                                          "EventsFrequencyThreshold": "0",
                                          "EventsTimeFrame": "60 days",
                                          "EventsDescription": "All-cause mortality by day 60 after study product infusion\nSerious adverse events, expected and unexpected, also included any deaths through study day 28 (none of them were related to study product or study procedures per DSMB review)\nPlease see our Lancet Resp Medicine 2018 publication (citation included) for further details including adjusted analyses of baseline differences between the MSC and placebo treated groups",
                                          "EventGroupList": {
                                                "EventGroup": [
                                                      {
                                                            "EventGroupId": "EG000",
                                                            "EventGroupTitle": "Human Mesenchymal Stem Cells",
                                                            "EventGroupDescription": "A single dose of 10 million cells/kg PBW (predicted body weight) Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells administered intravenously over approximately 60-80 minutes.\n\nAllogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously over approximately 60-80 minutes.",
                                                            "EventGroupDeathsNumAffected": "15",
                                                            "EventGroupDeathsNumAtRisk": "40",
                                                            "EventGroupSeriousNumAffected": "17",
                                                            "EventGroupSeriousNumAtRisk": "40",
                                                            "EventGroupOtherNumAffected": "2",
                                                            "EventGroupOtherNumAtRisk": "40"
                                                      },
                                                      {
                                                            "EventGroupId": "EG001",
                                                            "EventGroupTitle": "Plasma-Lyte A",
                                                            "EventGroupDescription": "A single dose of Plasma-Lyte A will be administered intravenously over approximately 60-80 minutes.\n\nPlasma-Lyte A: Plasma-Lyte A placebo will be administered intravenously over approximately 60-80 minutes.",
                                                            "EventGroupDeathsNumAffected": "5",
                                                            "EventGroupDeathsNumAtRisk": "20",
                                                            "EventGroupSeriousNumAffected": "11",
                                                            "EventGroupSeriousNumAtRisk": "20",
                                                            "EventGroupOtherNumAffected": "2",
                                                            "EventGroupOtherNumAtRisk": "20"
                                                      }
                                                ]
                                          },
                                          "SeriousEventList": {
                                                "SeriousEvent": [
                                                      {
                                                            "SeriousEventTerm": "Lower extremity weakness",
                                                            "SeriousEventOrganSystem": "Nervous system disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Hospital readmission due to post-surgical pain",
                                                            "SeriousEventOrganSystem": "Surgical and medical procedures",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Acute renal failure",
                                                            "SeriousEventOrganSystem": "Renal and urinary disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Hospital readmission due to pyelonephritis",
                                                            "SeriousEventOrganSystem": "Renal and urinary disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Acute leukemia",
                                                            "SeriousEventOrganSystem": "Blood and lymphatic system disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Diffuse alveolar hemorrhage",
                                                            "SeriousEventOrganSystem": "Blood and lymphatic system disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Death due to cardiac arrest",
                                                            "SeriousEventOrganSystem": "Cardiac disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Myocardial ischemia",
                                                            "SeriousEventOrganSystem": "Cardiac disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Bradycardia",
                                                            "SeriousEventOrganSystem": "Cardiac disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Tachycardia",
                                                            "SeriousEventOrganSystem": "Cardiac disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Pericardial effusion",
                                                            "SeriousEventOrganSystem": "Cardiac disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Heart block",
                                                            "SeriousEventOrganSystem": "Cardiac disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Ischemic stroke",
                                                            "SeriousEventOrganSystem": "Cardiac disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Liver abscess",
                                                            "SeriousEventOrganSystem": "Hepatobiliary disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Acute pancreatitis",
                                                            "SeriousEventOrganSystem": "Hepatobiliary disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Death due to worsening respiratory failure",
                                                            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "3",
                                                                              "SeriousEventStatsNumAffected": "3",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Worsening respiratory failure, recovered",
                                                            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Aspiration pneumonitis",
                                                            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Calvarial bone marrow abnormality",
                                                            "SeriousEventOrganSystem": "Blood and lymphatic system disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "0",
                                                                              "SeriousEventStatsNumAffected": "0",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Pulmonary embolism",
                                                            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "1",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "2",
                                                                              "SeriousEventStatsNumAffected": "2",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Death due to multi-organ failure",
                                                            "SeriousEventOrganSystem": "General disorders",
                                                            "SeriousEventAssessmentType": "Non-systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumEvents": "8",
                                                                              "SeriousEventStatsNumAffected": "8",
                                                                              "SeriousEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG001",
                                                                              "SeriousEventStatsNumEvents": "2",
                                                                              "SeriousEventStatsNumAffected": "2",
                                                                              "SeriousEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "OtherEventList": {
                                                "OtherEvent": [
                                                      {
                                                            "OtherEventTerm": "Hepatitis",
                                                            "OtherEventOrganSystem": "Hepatobiliary disorders",
                                                            "OtherEventAssessmentType": "Non-systematic Assessment",
                                                            "OtherEventStatsList": {
                                                                  "OtherEventStats": [
                                                                        {
                                                                              "OtherEventStatsGroupId": "EG000",
                                                                              "OtherEventStatsNumAffected": "1",
                                                                              "OtherEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "OtherEventStatsGroupId": "EG001",
                                                                              "OtherEventStatsNumAffected": "0",
                                                                              "OtherEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OtherEventTerm": "Fecal and urinary incontinence",
                                                            "OtherEventOrganSystem": "Renal and urinary disorders",
                                                            "OtherEventAssessmentType": "Non-systematic Assessment",
                                                            "OtherEventStatsList": {
                                                                  "OtherEventStats": [
                                                                        {
                                                                              "OtherEventStatsGroupId": "EG000",
                                                                              "OtherEventStatsNumAffected": "0",
                                                                              "OtherEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "OtherEventStatsGroupId": "EG001",
                                                                              "OtherEventStatsNumAffected": "1",
                                                                              "OtherEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OtherEventTerm": "Deep venous thrombosis",
                                                            "OtherEventOrganSystem": "Vascular disorders",
                                                            "OtherEventAssessmentType": "Non-systematic Assessment",
                                                            "OtherEventStatsList": {
                                                                  "OtherEventStats": [
                                                                        {
                                                                              "OtherEventStatsGroupId": "EG000",
                                                                              "OtherEventStatsNumAffected": "1",
                                                                              "OtherEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "OtherEventStatsGroupId": "EG001",
                                                                              "OtherEventStatsNumAffected": "0",
                                                                              "OtherEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OtherEventTerm": "Acute anemia",
                                                            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
                                                            "OtherEventAssessmentType": "Non-systematic Assessment",
                                                            "OtherEventStatsList": {
                                                                  "OtherEventStats": [
                                                                        {
                                                                              "OtherEventStatsGroupId": "EG000",
                                                                              "OtherEventStatsNumAffected": "0",
                                                                              "OtherEventStatsNumAtRisk": "40"
                                                                        },
                                                                        {
                                                                              "OtherEventStatsGroupId": "EG001",
                                                                              "OtherEventStatsNumAffected": "1",
                                                                              "OtherEventStatsNumAtRisk": "20"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "MoreInfoModule": {
                                          "CertainAgreement": {
                                                "AgreementPISponsorEmployee": "No",
                                                "AgreementRestrictiveAgreement": "No"
                                          },
                                          "PointOfContact": {
                                                "PointOfContactTitle": "Michael A. Matthay, MD",
                                                "PointOfContactOrganization": "University of California San Francisco",
                                                "PointOfContactEMail": "michael.matthay@ucsf.edu",
                                                "PointOfContactPhone": "415-502-7434"
                                          }
                                    }
                              },
                              "DocumentSection": {
                                    "LargeDocumentModule": {
                                          "LargeDocList": {
                                                "LargeDoc": [
                                                      {
                                                            "LargeDocTypeAbbrev": "Prot_SAP",
                                                            "LargeDocHasProtocol": "Yes",
                                                            "LargeDocHasSAP": "Yes",
                                                            "LargeDocHasICF": "No",
                                                            "LargeDocLabel": "Study Protocol and Statistical Analysis Plan",
                                                            "LargeDocDate": "February 17, 2015",
                                                            "LargeDocUploadDate": "01/07/2019 14:42",
                                                            "LargeDocFilename": "Prot_SAP_000.pdf"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000012128",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012127",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome, Newborn"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000055371",
                                                            "ConditionMeshTerm": "Acute Lung Injury"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000013577",
                                                            "ConditionMeshTerm": "Syndrome"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000004194",
                                                            "ConditionAncestorTerm": "Disease"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012120",
                                                            "ConditionAncestorTerm": "Respiration Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14117",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14116",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Newborn",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27297",
                                                            "ConditionBrowseLeafName": "Acute Lung Injury",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14109",
                                                            "ConditionBrowseLeafName": "Respiration Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4927",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Infant",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T192",
                                                            "ConditionBrowseLeafName": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionMeshList": {
                                                "InterventionMesh": [
                                                      {
                                                            "InterventionMeshId": "C000012499",
                                                            "InterventionMeshTerm": "Plasma-lyte 148"
                                                      }
                                                ]
                                          },
                                          "InterventionAncestorList": {
                                                "InterventionAncestor": [
                                                      {
                                                            "InterventionAncestorId": "D000009883",
                                                            "InterventionAncestorTerm": "Ophthalmic Solutions"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000019999",
                                                            "InterventionAncestorTerm": "Pharmaceutical Solutions"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M85407",
                                                            "InterventionBrowseLeafName": "Plasma-lyte 148",
                                                            "InterventionBrowseLeafAsFound": "Developmental Delay",
                                                            "InterventionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M21013",
                                                            "InterventionBrowseLeafName": "Pharmaceutical Solutions",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M11966",
                                                            "InterventionBrowseLeafName": "Ophthalmic Solutions",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "PhSol",
                                                            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 9,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02150551",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "STOMP"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Children's National Research Institute",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease",
                                          "OfficialTitle": "Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "July 2020",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "September 2015"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 27, 2019",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "September 27, 2019",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "January 10, 2014",
                                          "StudyFirstSubmitQCDate": "May 29, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "May 30, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "July 10, 2020",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "July 14, 2020",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Catherine Bollard",
                                                "ResponsiblePartyInvestigatorTitle": "Director- Center for Emerging Technologies in Immune Cell Therapies (CETI)",
                                                "ResponsiblePartyInvestigatorAffiliation": "Children's National Research Institute"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Catherine Bollard",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "In this trial, investigators will infuse donor bone marrow mesenchymal stromal cells intravenously, as a treatment for pediatric Crohn's disease or ulcerative colitis that has not responded to conventional therapies. The goals of this study are to test the safety and tolerability of donor mesenchymal stromal cells in children with Inflammatory Bowel Disease.\n\nMesenchymal stromal cells support the development of blood cells within the bone marrow. When isolated from a donor and infused into an animal or human, they have been demonstrated to travel to areas of inflammation, to alter immune responses, to decrease pro-inflammatory cytokines, and to promote tissue repair. Infusion of these cells does not lead to rejection. These properties lead investigators to hypothesize that that these may be they may be beneficial in treating inflammatory bowel disease.",
                                          "DetailedDescription": "In this trial, investigators will infuse donor bone marrow mesenchymal stromal cells intravenously, as a treatment for pediatric Crohn's disease or ulcerative colitis that has not responded to conventional therapies. Mesenchymal stromal cells support the development of blood cells within the bone marrow. They have also been demonstrated to travel to areas of inflammation, to alter immune responses, to decrease pro-inflammatory cytokines, and to promote tissue repair. Infusion of these cells does not lead to rejection. These properties lead investigators to hypothesize that that these may be they may be beneficial in treating inflammatory bowel disease.\n\nInvestigators will culture donated bone marrow mesenchymal stromal cells in a unique automated system, and infuse the cells in a fresh, replicating stage of growth. This study is to test the safety and tolerability of donor mesenchymal stromal cells in children with Inflammatory Bowel Disease."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Inflammatory Bowel Diseases"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Crohn disease",
                                                      "ulcerative colitis",
                                                      "mesenchymal stromal cells",
                                                      "inflammatory bowel diseases"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "1",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal Cells (MSCs)",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "A fixed dose of Mesenchymal Stromal Cells (MSCs) will be studied: 1 x 106 cells/kg administered intravenously (IV) weekly for 4 consecutive weeks, with the option of an additional 4 weeks of treatment, at the discretion of the principal investigator.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Allogeneic bone marrow-derived mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Allogeneic bone marrow-derived mesenchymal stromal cells",
                                                            "InterventionDescription": "This study is a pilot phase 1 study of patients with moderately to severely active Crohn Disease (CD) and ulcerative colitis (UC) (\u2265 18 years, Mayo score: \u22656 or CDAI: \u02c3 220; <18 years, Pediatric Crohn's Disease Activity Index (PCDAI) :> 30) or Pediatric Ulcerative Colitis Activity Index (PUCAI) : >34). A fixed dose will be studied: 1 x 106 cells/kg administered intravenously (IV) weekly for 4 consecutive weeks, with the option of an additional 4 weeks of treatment, at the discretion of the principal investigator.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal Cells (MSCs)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of subjects who experience serious adverse events, adverse events, and/or early treatment discontinuations.",
                                                            "PrimaryOutcomeDescription": "Safety and tolerability of the administration of human allogeneic bone marrow-derived stromal cells to children and young adults with IBD, measured by the frequency of any SAEs, AEs and/or early treatment discontinuations. Weekly infusions for 8 weeks, post-treatment assessment 45 days after last infusion, three additional follow-up visits over 2 years.",
                                                            "PrimaryOutcomeTimeFrame": "45 days after the last infusion"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Proportion of patients with clinical response",
                                                            "SecondaryOutcomeDescription": "Proportion of subjects that achieve a clinical response by 45 days after last infusion, as defined by a decrease in PCDAI from baseline by greater than or equal to 12.5 points (for CD) or a decrease in PUCAI of greater than or equal to 20 points (for UC).",
                                                            "SecondaryOutcomeTimeFrame": "45 days after last infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of subjects demonstrating an improvement of laboratory tests reflecting systemic inflammation.",
                                                            "SecondaryOutcomeDescription": "Improvement in laboratory parameters (i.e. C-reactive protein, fecal calprotectin, anti-HLA antibodies, and viral specific T-cell activity)",
                                                            "SecondaryOutcomeTimeFrame": "45 days after last infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of subjects with endoscopic healing after treatment.",
                                                            "SecondaryOutcomeDescription": "Proportion of subjects with endoscopic improvement, as assessed by change in baseline endoscopic scores (Simple Endoscopic Score Crohn's Disease [SES-CD] for CD or Endoscopic SubScore within the Mayo Score for UC)",
                                                            "SecondaryOutcomeTimeFrame": "45 days after last infusion"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nFor the young adult cohort, patients must be ages 17 \u226422 years\nFor the pediatric cohort, patients must be ages 12 \u226416 years\nPatients must have moderate-severely active CD or UC (defined in section 2.3), and documented active disease on flexible sigmoidoscopy, colonoscopy or MR enterography within the preceding 2 months.\nPatients who have failed or are intolerant of biologic therapy. Specifically, the patient will have recurrence or persistence of active disease despite current or past treatment with a biologic. At the time of enrollment, study subjects may be currently receiving 5-aminosalicylates, corticosteroids (\u2264 20 mg daily or up to 0.5 mg/kg/day if weight <40 kg), methotrexate, 6MP/azathioprine, or a biologic (either as monotherapy or in combination). During the treatment phase, if the treating physician thinks that a medication dose should be lowered to avoid side effects, this should be recorded.\nPatient or parent/guardian capable of providing informed consent.\n\nExclusion Criteria:\n\n\u2022 Patients < 12 years of age or >22 years of age\nPregnant or breastfeeding. Serum pregnancy test must be negative at screening for female subjects of childbearing potential. Urine pregnancy test must remain negative at each of 4 infusion visits.\nPatients with toxic mega-colon or intestinal perforation\nEvidence of autoimmune chronic active hepatitis or sclerosing cholangitis.\nPatients with fever > 39\u00b0 C or clinically significant active infection within 1 week (i.e. chronic infections including Hepatitis B/C or HIV or acute infections, including urinary tract infection and respiratory tract infection)\nReceived an agent not approved by the FDA for marketed use in any indication or any small molecule inhibitors (i.e. naltrexone) within 60 days of enrollment.\nSubjects who are taking greater than 20 mg (or if body weight <40 kg, 0.5 mg/kg) of prednisone daily.\n\nClinically significant abnormal biochemical and hematological parameters, including:\n\nNeutrophil count < 1000 cells/mm3\nHemoglobin < 8 g/dl\nPlatelet count \u2264 130 cells/mm3\nCreatinine \u2265 1.2 x the upper limit of normal\nAlanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) \u2265 2x the upper limit of normal\nConjugated bilirubin greater than 1.2. mg/dL\nHas active infection with enteric pathogens as evidenced by positive microbiological culture of stool or C.difficile toxin PCR.\nHad bowel surgery other than perianal procedures (fistulotomy, seton placement, abscess drainage) within 3 months of enrollment.\nHas uveitis\nHas known pulmonary disease, excluding mild intermittent asthma",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "12 Years",
                                          "MaximumAge": "22 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Laurie S. Conklin, M.D.",
                                                            "OverallOfficialAffiliation": "Children's National Research Institute",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Children's National Medical Center",
                                                            "LocationCity": "Washington",
                                                            "LocationState": "District of Columbia",
                                                            "LocationZip": "20010",
                                                            "LocationCountry": "United States"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "AnnotationSection": {
                                    "AnnotationModule": {
                                          "UnpostedAnnotation": {
                                                "UnpostedResponsibleParty": "Catherine Bollard, Director- Center for Emerging Technologies in Immune Cell Therapies (CETI), Children's National Research Institute",
                                                "UnpostedEventList": {
                                                      "UnpostedEvent": [
                                                            {
                                                                  "UnpostedEventType": "Release",
                                                                  "UnpostedEventDate": "May 25, 2021"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Reset",
                                                                  "UnpostedEventDate": "June 17, 2021"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Release",
                                                                  "UnpostedEventDate": "July 15, 2021"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Reset",
                                                                  "UnpostedEventDate": "August 6, 2021"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Release",
                                                                  "UnpostedEventDate": "October 12, 2021"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Reset",
                                                                  "UnpostedEventDate": "November 9, 2021"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Release",
                                                                  "UnpostedEventDate": "January 12, 2022"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Reset",
                                                                  "UnpostedEventDate": "March 14, 2022"
                                                            }
                                                      ]
                                                }
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022",
                                          "SubmissionTracking": {
                                                "SubmissionInfoList": {
                                                      "SubmissionInfo": [
                                                            {
                                                                  "SubmissionReleaseDate": "May 25, 2021",
                                                                  "SubmissionResetDate": "June 17, 2021"
                                                            },
                                                            {
                                                                  "SubmissionReleaseDate": "July 15, 2021",
                                                                  "SubmissionResetDate": "August 6, 2021"
                                                            },
                                                            {
                                                                  "SubmissionReleaseDate": "October 12, 2021",
                                                                  "SubmissionResetDate": "November 9, 2021"
                                                            },
                                                            {
                                                                  "SubmissionReleaseDate": "January 12, 2022",
                                                                  "SubmissionResetDate": "March 14, 2022"
                                                            },
                                                            {
                                                                  "SubmissionReleaseDate": "April 20, 2022"
                                                            }
                                                      ]
                                                }
                                          }
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000007410",
                                                            "ConditionMeshTerm": "Intestinal Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000015212",
                                                            "ConditionMeshTerm": "Inflammatory Bowel Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000005767",
                                                            "ConditionAncestorTerm": "Gastrointestinal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004066",
                                                            "ConditionAncestorTerm": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005759",
                                                            "ConditionAncestorTerm": "Gastroenteritis"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M9596",
                                                            "ConditionBrowseLeafName": "Intestinal Diseases",
                                                            "ConditionBrowseLeafAsFound": "Bowel Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5472",
                                                            "ConditionBrowseLeafName": "Colitis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5473",
                                                            "ConditionBrowseLeafName": "Colitis, Ulcerative",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M17069",
                                                            "ConditionBrowseLeafName": "Inflammatory Bowel Diseases",
                                                            "ConditionBrowseLeafAsFound": "Inflammatory Bowel Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16358",
                                                            "ConditionBrowseLeafName": "Ulcer",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5790",
                                                            "ConditionBrowseLeafName": "Crohn Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8035",
                                                            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6407",
                                                            "ConditionBrowseLeafName": "Digestive System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8027",
                                                            "ConditionBrowseLeafName": "Gastroenteritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC06",
                                                            "ConditionBrowseBranchName": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 10,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02012153",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSC-Tx tolerance"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "2013-003221-29",
                                                            "SecondaryIdType": "EudraCT Number"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Mario Negri Institute for Pharmacological Research",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells in Kidney Transplant Recipients",
                                          "OfficialTitle": "Autologous Mesenchymal Stromal Cells to Induce Tolerance in Living-donor Kidney Transplant Recipients"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "November 2021",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "December 2013"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2022",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "March 2023",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "November 29, 2013",
                                          "StudyFirstSubmitQCDate": "December 10, 2013",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "December 16, 2013",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "November 24, 2021",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "November 26, 2021",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Mario Negri Institute for Pharmacological Research",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "A.O. Ospedale Papa Giovanni XXIII",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The general aim of the present study is to test a cell therapy with autologous ex-vivo expanded mesenchymal stromal cells (MSCs) as a strategy to induce tolerance in living-donor kidney transplant recipients. MSCs will be prepared accordingly to established protocols, starting from bone marrow explants of living-donor kidney transplant recipients obtained 3-4 months before kidney transplant. From these samples, MSCs will be expanded in Good Manufacturing Practice (GMP) approved facilities and used for the present study in patients undergoing kidney transplantation."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Kidney Transplant Rejection"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal stromal cells",
                                                      "Kidney transplantation",
                                                      "Tolerance"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "6",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal Cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "A single intravenous infusion of ex-vivo expanded autologous MSCs will be performed in patients in addition to the living-donor kidney transplantation.\n\n2x10 elevated to sxth power MSCs per kilogram body weight previously isolated from the same recipient will be infused intravenously the day before the kidney transplant procedure.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stromal Cells",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Circulating na\u00efve and memory T cell count (CD45RA/CD45RO) (flow cytometry analysis).",
                                                            "PrimaryOutcomeTimeFrame": "Changes from baseline at 6 and 12 months after transplant."
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "T-cell function by ELISPOT assay in mixed lymphocyte reaction.",
                                                            "PrimaryOutcomeTimeFrame": "Changes from baseline at 6 and 12 months after transplant."
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of adverse events.",
                                                            "PrimaryOutcomeDescription": "At each visit the overall clinical condition of the patient will be evaluated and any adverse event will be recorded.",
                                                            "PrimaryOutcomeTimeFrame": "Changes from baseline up to 48 months."
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Circulating regulatory T cell count.",
                                                            "PrimaryOutcomeTimeFrame": "Changes from baseline at 6 and 12 months after transplant."
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Urinary FOXP3 mRNA expression evaluated by real time quantitative PCR.",
                                                            "PrimaryOutcomeTimeFrame": "Changes from baseline at 6 and 12 months after transplant."
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nMale and female patients;\nAged 18 or older;\nLiving-donor (related and unrelated, spouse/husband) kidney transplant recipients;\nNon-Human Leukocyte Antigen (HLA) identical with the donor (one or two haplotype mismatches);\nFirst kidney transplant;\nCapable of understanding the purpose and risk of the study;\nWritten informed consent.\n\nExclusion Criteria:\n\nMSC donor positive for HIV-1, HIV-2, hepatitis B virus (HBV),hepatitis C virus (HCV), syphilis;\nSpecific contraindication to MSC infusion;\nAny clinical relevant condition that might affect study participation and/or study results;\nPregnant women and nursing mothers;\nUnwillingness or inability to follow study protocol in the investigator's opinion.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Norberto Perico, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "0039 035 45351",
                                                            "CentralContactEMail": "norberto.perico@marionegri.it"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Giuseppe Remuzzi, MD",
                                                            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Norberto Perico, MD",
                                                            "OverallOfficialAffiliation": "Istituto Di Ricerche Farmacologiche Mario Negri",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Giovanni Rota, MD",
                                                            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Federica Casiraghi",
                                                            "OverallOfficialAffiliation": "Istituto Di Ricerche Farmacologiche Mario Negri",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Martino Introna, MD",
                                                            "OverallOfficialAffiliation": "Laboratorio G. Lanzani, Bergamo, Italy",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Alessandro Rambaldi, MD",
                                                            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "U.O. Nefrologia e Dialisi",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Bergamo",
                                                            "LocationZip": "24127",
                                                            "LocationCountry": "Italy",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Piero Ruggenenti, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "0039 035 2674037",
                                                                              "LocationContactEMail": "pruggenenti@hpg23.it"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Eliana Gotti, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "29963053",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Perico N, Casiraghi F, Todeschini M, Cortinovis M, Gotti E, Portalupi V, Mister M, Gaspari F, Villa A, Fiori S, Introna M, Longhi E, Remuzzi G. Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy. Front Immunol. 2018 Jun 14;9:1359. doi: 10.3389/fimmu.2018.01359. eCollection 2018."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 11,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03042572",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "NL59038.000.16"
                                          },
                                          "Organization": {
                                                "OrgFullName": "UMC Utrecht",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs",
                                          "OfficialTitle": "Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs; A Double-blind, Randomized, Placebo-controlled Trial",
                                          "Acronym": "SAIL"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "May 2018",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "December 2018",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2020",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "July 2021",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "January 27, 2017",
                                          "StudyFirstSubmitQCDate": "February 1, 2017",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "February 3, 2017",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "May 2, 2018",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "May 3, 2018",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Martin Teraa, MD, PhD",
                                                "ResponsiblePartyInvestigatorTitle": "Surgical Resident & Postdoc Physician",
                                                "ResponsiblePartyInvestigatorAffiliation": "UMC Utrecht"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Martin Teraa, MD, PhD",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "ZonMw: The Netherlands Organisation for Health Research and Development",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The primary objective of this trial is to investigate whether intramuscular administration of allogeneic mesenchymal stromal cells (MSC) is safe and potentially effective, assessed as a composite outcome of mortality, limb status, clinical status (Rutherford classification) and pain score (visual analogue scale), in patients with no-option severe limb ischemia (SLI).\n\nThe investigators will conduct a double-blind, placebo-controlled randomized clinical trial to investigate the effect of allogeneic bone marrow(BM)-derived MSC in patients with SLI, who are not eligible for conventional surgical or endovascular therapies. The investigators intend to include 60 patients, who will be randomized to undergo 30 intramuscular injections with either BM-MSC (30 injection sites with 5*10^6 MSCs each) or placebo in the lower leg of the ischemic extremity. Primary outcome i.e. therapy success, a composite outcome considering mortality, limb status, clinical status (Rutherford classification) and changes in pain score, will be assessed at six months."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Peripheral Arterial Disease",
                                                      "Cardiovascular Diseases",
                                                      "Vascular Diseases"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Critical Limb Ischemia (CLI)",
                                                      "Severe Limb Ischemia (SLI)",
                                                      "Peripheral Artery Disease (PAD)",
                                                      "Peripheral Artery Occlusive Disease (PAOD)",
                                                      "Cardiovascular disease",
                                                      "Mesenchymal stromal cell (MSC)",
                                                      "Mesenchymal stem cell (MSC)"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2",
                                                      "Phase 3"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Quadruple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "60",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Allogeneic Mesenchymal Stromal Cell",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intramuscular Allogeneic Bone marrow-derived Mesenchymal Stromal Cell Injection",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Allogeneic Mesenchymal Stromal Cell"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Placebo",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Intramuscular placebo injection",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Allogeneic Mesenchymal Stromal Cell",
                                                            "InterventionDescription": "Intramuscular allogeneic BM-MSC injection: MSCs will be extracted from BM of healthy volunteers, expanded with human platelet lysate, and stored. Patients will receive intramuscular allogeneic BM-MSC injections at 30 sites in the lower leg of the ischemic limb. Blinded syringes are provided and cell suspensions will be injected intramuscularly by an experienced operator into multiple sites (30 sites, 1-1.5cm in depth, volume of 1.0mL containing 5*10^6 MSC per site; total 150*10^6 BM-MSCs) in the ischemic lower extremity. Injections will be performed under IV analgesia (fentanyl) and sedation (midazolam) if necessary.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Allogeneic Mesenchymal Stromal Cell"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Allogeneic bone marrow-derived mesenchymal stromal cells",
                                                                        "Allogeneic bone marrow-derived mesenchymal stem cells",
                                                                        "Allogeneic BM-MSC"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "Placebo",
                                                            "InterventionDescription": "Intramuscular placebo injections. Patients will receive intramuscular placebo injections at 30 prespecified sites in the lower leg of the ischemic limb. Blinded syringes are provided and will be injected intramuscularly by an experienced operator into multiple sites (30 sites, 1-1.5cm in depth, volume of 1.0mL placebo per site) in the ischemic lower extremity. Injections will be performed under IV analgesia (fentanyl) and sedation (midazolam) if necessary.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Therapy Success",
                                                            "PrimaryOutcomeDescription": "Composite outcome measure considering mortality, limb status, clinical classification and changes in pain score. To be a \"success\" a subject must: A, be alive; B, be without a major amputation on the index limb; C, have not worsened in Rutherford classification or visual analog pain scale; and D, have improved in either Rutherford classification or visual analog pain scale. Subjects not meeting all of the criteria are classified as failures.",
                                                            "PrimaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Major amputation",
                                                            "SecondaryOutcomeDescription": "Amputation sited proximal from the ankle joint",
                                                            "SecondaryOutcomeTimeFrame": "2, 6, 12, 24, and 60 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Minor amputation",
                                                            "SecondaryOutcomeDescription": "Amputation sited distal from the ankle joint",
                                                            "SecondaryOutcomeTimeFrame": "2, 6, 12, 24, and 60 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Therapy Success",
                                                            "SecondaryOutcomeDescription": "Composite outcome measure considering mortality, limb status, clinical classification and changes in pain score. To be a \"success\" a subject must: A, be alive; B, be without a major amputation on the index limb; C, have not worsened in Rutherford classification or visual analog pain scale; and D, have improved in either Rutherford classification or visual analog pain scale. Subjects not meeting all of the criteria are classified as failures.",
                                                            "SecondaryOutcomeTimeFrame": "2, 6, 12, 24, and 60 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Mortality",
                                                            "SecondaryOutcomeDescription": "Mortality",
                                                            "SecondaryOutcomeTimeFrame": "2, 6, 12, 24, and 60 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Ulcer healing",
                                                            "SecondaryOutcomeDescription": "Changes in the number and extent of leg ulcers,",
                                                            "SecondaryOutcomeTimeFrame": "2 and 6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in pain",
                                                            "SecondaryOutcomeDescription": "Resolution of rest pain and alteration in visual analogue pain (VAS) score",
                                                            "SecondaryOutcomeTimeFrame": "2, 6, 12, 24, and 60 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Pain-free walking distance",
                                                            "SecondaryOutcomeDescription": "Changes in pain free walking distance (treadmill at 3 km/h without incline)",
                                                            "SecondaryOutcomeTimeFrame": "2 and 6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Ankle-brachial index (ABI)",
                                                            "SecondaryOutcomeDescription": "Alterations in ankle-brachial index (ABI)",
                                                            "SecondaryOutcomeTimeFrame": "2 and 6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Toe-brachial index (TBI)",
                                                            "SecondaryOutcomeDescription": "Alterations in toe-brachial index (TBI)",
                                                            "SecondaryOutcomeTimeFrame": "2 and 6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Quality of life based on EuroQol 5D (EQ5D) questionnaire scores",
                                                            "SecondaryOutcomeDescription": "Alterations in quality of life assessed using EuroQoL 5D quality of life questionnaire",
                                                            "SecondaryOutcomeTimeFrame": "2, 6, 12, 24, and 60 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Quality of life based on Short Form 36 (SF36) questionnaire scores",
                                                            "SecondaryOutcomeDescription": "Alterations in quality of life assessed using Short Form 36 quality of life questionnaire",
                                                            "SecondaryOutcomeTimeFrame": "2, 6, 12, 24, and 60 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Clinical status according to Fontaine classification",
                                                            "SecondaryOutcomeDescription": "Alterations clinical status according to Fontaine classification",
                                                            "SecondaryOutcomeTimeFrame": "2, 6, 12, 24, and 60 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Clinical status according to Rutherford classification",
                                                            "SecondaryOutcomeDescription": "Alterations clinical status according to Rutherford classification",
                                                            "SecondaryOutcomeTimeFrame": "2, 6, 12, 24, and 60 months"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "Correlation of in-vitro angiogenic assay (Boyden chamber migration assays to test migration towards a platelet derived growth factor gradient) of donor MSC with clinical effect",
                                                            "OtherOutcomeDescription": "The investigators will use Boyden chamber migration assays to test migration towards a platelet derived growth factor gradient in order to test angiogenic capacity of the batches of donor Mesenchymal Stromal Cells (MSC) and correlate these with the primary and secondary outcomes (et al. Mol Ther. 2014).",
                                                            "OtherOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Correlation of in-vitro angiogenic assay (Endothelial repair assay using a scratch wound assay using MSC-derived conditioned medium) of donor MSC with clinical effect",
                                                            "OtherOutcomeDescription": "The investigators will use endothelial repair assays using a scratch wound assay with MSC-derived conditioned medium to test angiogenic capacity of the batches of donor Mesenchymal Stromal Cells (MSC) and correlate these with the primary and secondary outcomes (see Gremmels et al. Mol Ther. 2014).",
                                                            "OtherOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Correlation of in-vitro angiogenic assay (Matrigel tubule forming assay) of donor MSC with clinical effect",
                                                            "OtherOutcomeDescription": "The investigators will use matrigel tubule forming assays using MSC-derived conditioned medium to test angiogenic capacity of the batches of donor Mesenchymal Stromal Cells (MSC) and correlate these with the primary and secondary outcomes (see Gremmels et al. Mol Ther. 2014).",
                                                            "OtherOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAge > 18 years\n\nSevere Peripheral Artery Disease (PAD; Fontaine class III and / or IV):\n\nFontaine III (Rutherford 4): persistent, recurring rest pain requiring analgesia\nFontaine IV (Rutherford 5): non-healing ulcers present for > 4 weeks without evidence of improvement in response to conventional therapies\nAnkle brachial index < 0.6 or unreliable (non-compressible or not in proportion to the Fontaine classification)\nNot eligible for surgical or endovascular revascularization\nWritten informed consent.\n\nExclusion Criteria:\n\nHistory of neoplasm or malignancy in the past 10 years\nSerious known concomitant disease with life expectancy of less than one year\nRutherford 6 in which amputation on the short term (within 1-2 weeks) is inevitable\nPregnancy or unwillingness to use adequate contraception during study\nUncontrolled acute or chronic infection with systemic symptoms\nFollow-up impossible.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Joep GJ Wijnand, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+31 88 755 9747",
                                                            "CentralContactEMail": "J.G.J.Wijnand-2@umcutrecht.nl"
                                                      },
                                                      {
                                                            "CentralContactName": "Martin Teraa, MD, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+31 88 755 6965",
                                                            "CentralContactEMail": "m.teraa@umcutrecht.nl"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Marianne C Verhaar, MD, PhD",
                                                            "OverallOfficialAffiliation": "UMC Utrecht",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Gert Jan de Borst, MD, PhD",
                                                            "OverallOfficialAffiliation": "UMC Utrecht",
                                                            "OverallOfficialRole": "Study Chair"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "University Medical Center Utrecht",
                                                            "LocationCity": "Utrecht",
                                                            "LocationZip": "3508 GA",
                                                            "LocationCountry": "Netherlands",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Joep GJ Wijnand, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+31 88 755 9747",
                                                                              "LocationContactEMail": "J.G.J.Wijnand-2@umcutrecht.nl"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Martin Teraa, MD, PhD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+31 88 755 6965",
                                                                              "LocationContactEMail": "m.teraa@umcutrecht.nl"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Hendrik Gremmels, MD, PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "25567765",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Teraa M, Sprengers RW, Schutgens RE, Slaper-Cortenbach IC, van der Graaf Y, Algra A, van der Tweel I, Doevendans PA, Mali WP, Moll FL, Verhaar MC. Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) trial. Circulation. 2015 Mar 10;131(10):851-60. doi: 10.1161/CIRCULATIONAHA.114.012913. Epub 2015 Jan 7."
                                                      },
                                                      {
                                                            "ReferencePMID": "26460286",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Peeters Weem SM, Teraa M, de Borst GJ, Verhaar MC, Moll FL. Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials. Eur J Vasc Endovasc Surg. 2015 Dec;50(6):775-83. doi: 10.1016/j.ejvs.2015.08.018. Epub 2015 Oct 12. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "23426345",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Teraa M, Sprengers RW, van der Graaf Y, Peters CE, Moll FL, Verhaar MC. Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials. Ann Surg. 2013 Dec;258(6):922-9. doi: 10.1097/SLA.0b013e3182854cf1."
                                                      },
                                                      {
                                                            "ReferencePMID": "27612499",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Spreen MI, Gremmels H, Teraa M, Sprengers RW, Verhaar MC, Statius van Eps RG, de Vries JP, Mali WP, van Overhagen H; PADI and JUVENTAS Study Groups. Diabetes Is Associated With Decreased Limb Survival in Patients With Critical Limb Ischemia: Pooled Data From Two Randomized Controlled Trials. Diabetes Care. 2016 Nov;39(11):2058-2064. Epub 2016 Sep 9."
                                                      },
                                                      {
                                                            "ReferencePMID": "26908409",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Teraa M, Conte MS, Moll FL, Verhaar MC. Critical Limb Ischemia: Current Trends and Future Directions. J Am Heart Assoc. 2016 Feb 23;5(2). pii: e002938. doi: 10.1161/JAHA.115.002938. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "26511056",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Peeters Weem SM, Teraa M, den Ruijter HM, de Borst GJ, Verhaar MC, Moll FL. Quality of Life After Treatment with Autologous Bone Marrow Derived Cells in No Option Severe Limb Ischemia. Eur J Vasc Endovasc Surg. 2016 Jan;51(1):83-9. doi: 10.1016/j.ejvs.2015.09.010. Epub 2015 Oct 26."
                                                      },
                                                      {
                                                            "ReferencePMID": "26428987",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Teraa M, Schutgens RE, Sprengers RW, Slaper-Cortenbach I, Moll FL, Verhaar MC; Juventas Study Group. Core diameter of bone marrow aspiration devices influences cell density of bone marrow aspirate in patients with severe peripheral artery disease. Cytotherapy. 2015 Dec;17(12):1807-12. doi: 10.1016/j.jcyt.2015.08.004. Epub 2015 Sep 28."
                                                      },
                                                      {
                                                            "ReferencePMID": "26148006",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Wisman PP, Teraa M, de Borst GJ, Verhaar MC, Roest M, Moll FL. Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia. PLoS One. 2015 Jul 6;10(7):e0131356. doi: 10.1371/journal.pone.0131356. eCollection 2015."
                                                      },
                                                      {
                                                            "ReferencePMID": "25174586",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Gremmels H, Teraa M, Quax PH, den Ouden K, Fledderus JO, Verhaar MC. Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls. Mol Ther. 2014 Nov;22(11):1960-70. doi: 10.1038/mt.2014.161. Epub 2014 Sep 1."
                                                      },
                                                      {
                                                            "ReferencePMID": "24246031",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Gremmels H, Fledderus JO, Teraa M, Verhaar MC. Mesenchymal stromal cells for the treatment of critical limb ischemia: context and perspective. Stem Cell Res Ther. 2013;4(6):140."
                                                      },
                                                      {
                                                            "ReferencePMID": "24218170",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Teraa M, Fledderus JO, Rozbeh RI, Leguit RJ, Verhaar MC; Juventas Study Group{dagger}. Bone marrow microvascular and neuropathic alterations in patients with critical limb ischemia. Circ Res. 2014 Jan 17;114(2):311-4. doi: 10.1161/CIRCRESAHA.114.302791. Epub 2013 Nov 11."
                                                      },
                                                      {
                                                            "ReferencePMID": "24164351",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Niemansburg SL, Teraa M, Hesam H, van Delden JJ, Verhaar MC, Bredenoord AL. Stem cell trials for cardiovascular medicine: ethical rationale. Tissue Eng Part A. 2014 Oct;20(19-20):2567-74. doi: 10.1089/ten.TEA.2013.0332. Epub 2013 Dec 11."
                                                      },
                                                      {
                                                            "ReferencePMID": "23555959",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Westerweel PE, Teraa M, Rafii S, Jaspers JE, White IA, Hooper AT, Doevendans PA, Verhaar MC. Impaired endothelial progenitor cell mobilization and dysfunctional bone marrow stroma in diabetes mellitus. PLoS One. 2013;8(3):e60357. doi: 10.1371/journal.pone.0060357. Epub 2013 Mar 28."
                                                      },
                                                      {
                                                            "ReferencePMID": "23383236",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Teraa M, Sprengers RW, Westerweel PE, Gremmels H, Goumans MJ, Teerlink T, Moll FL, Verhaar MC; JUVENTAS study group. Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients. PLoS One. 2013;8(1):e55592. doi: 10.1371/journal.pone.0055592. Epub 2013 Jan 31."
                                                      },
                                                      {
                                                            "ReferencePMID": "22172473",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Setacci C, de Donato G, Teraa M, Moll FL, Ricco JB, Becker F, Robert-Ebadi H, Cao P, Eckstein HH, De Rango P, Diehm N, Schmidli J, Dick F, Davies AH, Lep\u00e4ntalo M, Apelqvist J. Chapter IV: Treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg. 2011 Dec;42 Suppl 2:S43-59. doi: 10.1016/S1078-5884(11)60014-2. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "20598482",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Sprengers RW, Teraa M, Moll FL, de Wit GA, van der Graaf Y, Verhaar MC; JUVENTAS Study Group; SMART Study Group. Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment. J Vasc Surg. 2010 Oct;52(4):843-9, 849.e1. doi: 10.1016/j.jvs.2010.04.057."
                                                      },
                                                      {
                                                            "ReferencePMID": "20488328",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Sprengers RW, Moll FL, Teraa M, Verhaar MC; JUVENTAS Study Group. Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia. J Vasc Surg. 2010 Jun;51(6):1564-8. doi: 10.1016/j.jvs.2010.02.020."
                                                      },
                                                      {
                                                            "ReferencePMID": "29242062",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Wijnand JGJ, Teraa M, Gremmels H, van Rhijn-Brouwer FCC, de Borst GJ, Verhaar MC; SAIL Study Group. Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia. J Vasc Surg. 2018 Feb;67(2):656-661. doi: 10.1016/j.jvs.2017.09.026. Epub 2017 Dec 11."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Undecided",
                                          "IPDSharingDescription": "Study outcomes will be published in international peer-reviewed journals and individual participant data (IPD) will become available on request."
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000002318",
                                                            "ConditionMeshTerm": "Cardiovascular Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000058729",
                                                            "ConditionMeshTerm": "Peripheral Arterial Disease"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000016491",
                                                            "ConditionMeshTerm": "Peripheral Vascular Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000014652",
                                                            "ConditionMeshTerm": "Vascular Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000009389",
                                                            "ConditionMeshTerm": "Neovascularization, Pathologic"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000050197",
                                                            "ConditionAncestorTerm": "Atherosclerosis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001161",
                                                            "ConditionAncestorTerm": "Arteriosclerosis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001157",
                                                            "ConditionAncestorTerm": "Arterial Occlusive Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008679",
                                                            "ConditionAncestorTerm": "Metaplasia"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M9695",
                                                            "ConditionBrowseLeafName": "Ischemia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M28366",
                                                            "ConditionBrowseLeafName": "Peripheral Arterial Disease",
                                                            "ConditionBrowseLeafAsFound": "Peripheral Arterial Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M18046",
                                                            "ConditionBrowseLeafName": "Peripheral Vascular Diseases",
                                                            "ConditionBrowseLeafAsFound": "Peripheral Arterial Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16552",
                                                            "ConditionBrowseLeafName": "Vascular Diseases",
                                                            "ConditionBrowseLeafAsFound": "Vascular Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11486",
                                                            "ConditionBrowseLeafName": "Neovascularization, Pathologic",
                                                            "ConditionBrowseLeafAsFound": "Neovascularization",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25341",
                                                            "ConditionBrowseLeafName": "Atherosclerosis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3621",
                                                            "ConditionBrowseLeafName": "Arteriosclerosis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3617",
                                                            "ConditionBrowseLeafName": "Arterial Occlusive Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10811",
                                                            "ConditionBrowseLeafName": "Metaplasia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC14",
                                                            "ConditionBrowseBranchName": "Heart and Blood Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M10997",
                                                            "InterventionBrowseLeafName": "Midazolam",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M7570",
                                                            "InterventionBrowseLeafName": "Fentanyl",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "AdjAn",
                                                            "InterventionBrowseBranchName": "Adjuvants, Anesthesia"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "CNSDep",
                                                            "InterventionBrowseBranchName": "Central Nervous System Depressants"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "PsychDr",
                                                            "InterventionBrowseBranchName": "Psychotropic Drugs"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Analg",
                                                            "InterventionBrowseBranchName": "Analgesics"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 12,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03818854",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "UCSF-hMSC-ARDS-P1P2-12"
                                          },
                                          "Organization": {
                                                "OrgFullName": "University of California, San Francisco",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome",
                                          "OfficialTitle": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) for the Treatment of Acute Respiratory Distress Syndrome",
                                          "Acronym": "STAT"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2022",
                                          "OverallStatus": "Recruiting",
                                          "StartDateStruct": {
                                                "StartDate": "November 26, 2019",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "July 1, 2023",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "July 1, 2024",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "January 24, 2019",
                                          "StudyFirstSubmitQCDate": "January 25, 2019",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "January 28, 2019",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "September 13, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 14, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Michael A. Matthay",
                                                "ResponsiblePartyInvestigatorTitle": "Professor",
                                                "ResponsiblePartyInvestigatorAffiliation": "University of California, San Francisco"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Michael A. Matthay",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "United States Department of Defense",
                                                            "CollaboratorClass": "FED"
                                                      },
                                                      {
                                                            "CollaboratorName": "Harborview Injury Prevention and Research Center",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Oregon Health and Science University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Vanderbilt University Medical Center",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "The University of Texas Health Science Center, Houston",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "University of Minnesota",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This is a Phase 2b, randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of a single dose of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) infusion in patients with Acute Respiratory Distress Syndrome (ARDS). This study is the extension of the Phase 1 pilot study (NCT01775774) and Phase 2a study (NCT02097641).",
                                          "DetailedDescription": "This clinical study design is a randomized, double-blinded, placebo-controlled Phase 2b clinical trial using a 10 million cell/kg dose of human Mesenchymal Stromal Cells (hMSCs). Subjects will be randomized in a 1:1 randomization scheme to receive hMSCs or cell reconstitution media (1:1 mix of 5% human serum albumin and 10% Dextran 40) as the placebo; the study will enroll 120 patients who achieve a stable clinical baseline and receive study product (either hMSCs or the placebo).\n\nThe Data and Safety Monitoring Board (DSMB) will review adverse outcomes and protocol compliance. A pre-specified interim review will occur after 60 subjects have been enrolled and received study product; enrollment will continue during the DSMB review. All pre-specified clinically important events and unexpected serious adverse events including death during hospitalization up to 60 days will be reported to the DSMB on an ongoing basis; the study will be stopped for a safety evaluation by the DSMB if they have any concerns or if three subjects have pre-specified clinically important events or unexpected serious adverse events except death since death will be common in this critically ill population due the nature of the underlying illness (e.g., ARDS)."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Respiratory Distress Syndrome, Adult"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Human Mesenchymal Stromal Cells",
                                                      "Acute Respiratory Distress Syndrome"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignInterventionModelDescription": "For this Phase 2b trial, after informed consent is given, an assignment will be made by computer-generated randomization to administer either hMSCs therapy or placebo with a 1:1 allocation to the hMSCs:placebo arms.",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Triple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "120",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Human Mesenchymal Stromal Cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "A single dose of 10 million cells/kg predicted body weight (PBW) Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells will administered intravenously over approximately 60-80 minutes.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Human Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Cell Reconstitution Media",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "A single dose of cell reconstitution media (1:1 mix of 5% human serum albumin and 10% Dextran 40) will administered intravenously over approximately 60-80 minutes.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Cell Reconstitution Media"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Human Mesenchymal Stromal Cells",
                                                            "InterventionDescription": "Immediately prior to administration, the study product will be thawed and diluted 1:1 with reconstitution media (1:1 mix of 5% human serum albumin and 10% Dextran 40). Additional reconstitution media is added to a final product volume of 300 mL.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Human Mesenchymal Stromal Cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "hMSCs"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Cell Reconstitution Media",
                                                            "InterventionDescription": "300 mL of reconstitution media (1:1 mix of 5% human serum albumin and 10% Dextran 40)",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Cell Reconstitution Media"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Change in oxygenation index (OI)",
                                                            "PrimaryOutcomeDescription": "Change in OI from baseline over the 36 hours following the infusion of study product",
                                                            "PrimaryOutcomeTimeFrame": "36 hours"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Acute Lung Injury Score (LIS)",
                                                            "SecondaryOutcomeDescription": "LIS over 7 days, or on the last day of positive pressure ventilation prior to day 7. The LIS is a composite 4-point scoring system including the PaO2/FiO2, PEEP, lung compliance, and the extent of infiltrates on the chest X-ray. Each of the four components is categorized from 0 to 4, where a higher number is worse. The total Lung Injury Score is obtained by dividing the aggregate sum by the number of components used.",
                                                            "SecondaryOutcomeTimeFrame": "7 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Pulmonary Dead Space Fraction",
                                                            "SecondaryOutcomeDescription": "Pulmonary Dead Space at day 1, 2, 3 and 7. The dead-space fraction is calculated as: (PaCO2 - PeCO2) \u00f7 PaCO2",
                                                            "SecondaryOutcomeTimeFrame": "7 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Chest radiograph assessment of pulmonary edema (RALE score)",
                                                            "SecondaryOutcomeDescription": "RALE score at day 1, 2, 3 and 7. To calculate RALE, each radiographic quadrant is scored for extent of consolidation (0-4) and density of opacification (1-3). The product of the consolidation and density scores for each of the four quadrants is summed. The RALE score ranges from 0 (best) to 48 (worst).",
                                                            "SecondaryOutcomeTimeFrame": "7 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Ventilator free-days",
                                                            "SecondaryOutcomeDescription": "Ventilator free-days over 7, 14 and 28 days",
                                                            "SecondaryOutcomeTimeFrame": "28 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Duration of assisted ventilation over 28 days",
                                                            "SecondaryOutcomeDescription": "Duration of assisted ventilation over 28 days in the survivors",
                                                            "SecondaryOutcomeTimeFrame": "28 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Percentage of patients achieving pressure support ventilation for 2 hours",
                                                            "SecondaryOutcomeDescription": "Percentage of patients achieving pressure support ventilation equal to 5 cm H2O with positive end-expiratory pressure (PEEP) equal to 5 cm H2O for 2 hours",
                                                            "SecondaryOutcomeTimeFrame": "28 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Occurrence of Infection",
                                                            "SecondaryOutcomeDescription": "Superficial incisional/wound infections, deep incisional wound infections, and organ/space infections, and ventilator associated pneumonia (all during the 14 days after enrollment)",
                                                            "SecondaryOutcomeTimeFrame": "14 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Sequential Organ Failure Assessment (SOFA) over 7 days",
                                                            "SecondaryOutcomeDescription": "SOFA score at 3 and 7 days. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems which are added up. Each score ranges from 0 to 4. SOFA score ranges from 0 (best) to 24 (worst).",
                                                            "SecondaryOutcomeTimeFrame": "7 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "All-cause hospital mortality",
                                                            "SecondaryOutcomeDescription": "All-cause hospital mortality at 14, 28 and 60 days",
                                                            "SecondaryOutcomeTimeFrame": "60 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Glasgow Outcome Score (GCS)",
                                                            "SecondaryOutcomeDescription": "Glasgow Outcome Score at hospital discharge. The GCS is a scale to evaluate level of consciousness in patients with acute brain injury. The scale assesses 3 functions: Eye Opening, Verbal Response, and Motor Response. GCS scores range from 15 (best) to 3 (worst)",
                                                            "SecondaryOutcomeTimeFrame": "60 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Percentage of patients occurred any thromboembolic events",
                                                            "SecondaryOutcomeDescription": "Thromboembolic events are measured by ultrasound of the deep venous system or CT-angiography of the chest ordered for clinical purposes/by treating clinicians",
                                                            "SecondaryOutcomeTimeFrame": "60 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Plasma angiopoietin-2",
                                                            "SecondaryOutcomeDescription": "Change in levels of plasma angiopoietin-2 from baseline compared to 6, 24, 48 and 72 hours",
                                                            "SecondaryOutcomeTimeFrame": "72 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Plasma Receptor for Advanced Glycation Endproducts (RAGE)",
                                                            "SecondaryOutcomeDescription": "Change in levels of plasma RAGE from baseline compared to 6, 24, 48 and 72 hours",
                                                            "SecondaryOutcomeTimeFrame": "72 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Plasma interleukin-6",
                                                            "SecondaryOutcomeDescription": "Change in levels of plasma interleukin-6 from baseline compared to 6, 24, 48 and 72 hours",
                                                            "SecondaryOutcomeTimeFrame": "72 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Plasma interleukin-8",
                                                            "SecondaryOutcomeDescription": "Change in levels of plasma interleukin-8 from baseline compared to 6, 24, 48 and 72 hours",
                                                            "SecondaryOutcomeTimeFrame": "72 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Plasma Soluble tumor necrosis factor 1 (sTNF-1)",
                                                            "SecondaryOutcomeDescription": "Change in levels of plasma sTNF-1 from baseline compared to 6, 24, 48 and 72 hours",
                                                            "SecondaryOutcomeTimeFrame": "72 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Plasma protein C",
                                                            "SecondaryOutcomeDescription": "Change in levels of plasma protein C from baseline compared to 6, 24, 48 and 72 hours",
                                                            "SecondaryOutcomeTimeFrame": "72 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Plasma lipoxin A4",
                                                            "SecondaryOutcomeDescription": "Change in levels of plasma lipoxin A4 from baseline compared to 6, 24, 48 and 72 hours",
                                                            "SecondaryOutcomeTimeFrame": "72 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Plasma Resolvin D1",
                                                            "SecondaryOutcomeDescription": "Change in levels of plasma Resolvin D1 from baseline compared to 6, 24, 48 and 72 hours",
                                                            "SecondaryOutcomeTimeFrame": "72 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Plasma angiopoietin-1",
                                                            "SecondaryOutcomeDescription": "Change in levels of plasma angiopoietin-1 from baseline compared to 6, 24, 48 and 72 hours",
                                                            "SecondaryOutcomeTimeFrame": "72 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Plasma keratinocyte growth factor (KGF)",
                                                            "SecondaryOutcomeDescription": "Change in levels of plasma KGF from baseline compared to 6, 24, 48 and 72 hours",
                                                            "SecondaryOutcomeTimeFrame": "72 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Urine microalbumin",
                                                            "SecondaryOutcomeDescription": "Change in levels of urine microalbumin from baseline compared to 24 and 48 hours",
                                                            "SecondaryOutcomeTimeFrame": "48 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Total protein in min-bronchoalveolar lavage (mBAL)",
                                                            "SecondaryOutcomeDescription": "Change in total protein levels in from baseline to day 2",
                                                            "SecondaryOutcomeTimeFrame": "2 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Tolerability of the hMSCs - incidence of pre-specified infusion-associated events and unexpected severe adverse events",
                                                            "SecondaryOutcomeDescription": "Tolerability of the hMSCs, defined as the incidence of pre-specified infusion-associated events and unexpected severe adverse events in ARDS patients treated with human MSCs",
                                                            "SecondaryOutcomeTimeFrame": "24 hours"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients will be eligible for inclusion if they meet all of the below criteria within 14 days of initial ICU admission. Criteria 1-3 must all be present within a 24-hour time period and at the time of enrollment:\n\nAcute onset (defined below) of:\n\nA need for positive pressure ventilation by an endotracheal or tracheal tube with a PaO2/FiO2 ratio <250 mmHg and \u22655 cm H2O positive end-expiratory airway pressure (PEEP), as per the Berlin Criteria.\nBilateral infiltrates consistent with pulmonary edema (defined below) on the frontal chest radiograph, or bilateral ground glass opacities on a chest CT scan.\nNo clinical evidence of left atrial hypertension as a primary explanation for the bilateral pulmonary infiltrates.\n\nIf the cause of ARDS is trauma, additional inclusion criteria will include ONE of the following relevant risk factors for developing ARDS:\n\nHypotension (systolic blood pressure[SBP] < 90 mmHg) in the field or in the first 24 h after injury, or\nTransfusion of 3 units of blood products in the first 24 hours following injury, or\nMeets the new Critical Administration Threshold (CAT) criteria with at least 3 units of blood in one hour, or\nBlunt or penetrating torso trauma, or\nLong bone fractures, or\nThe highest level of institutional trauma activation\n\nExclusion Criteria:\n\nAge less than 18 years\nGreater than 72 hours since first meeting ARDS criteria per the Berlin definition of ARDS\nGreater than 14 days since initial ICU admission\nInability to administer study product within 14 days of ICU admission\nPaO2/FiO2 \u2265 250 mmHg after consent obtained and before study product is administered\nUnable to obtain informed consent/no surrogate available\nPregnant or lactating\nIn custody of law enforcement officials\nBurns > 20% of total body surface area\nWHO Class III or IV pulmonary hypertension\nHistory of cancer treatment in the last 2 years except for non-melanotic skin cancers\nUnderlying medical condition for which 6-month mortality is estimated to be > 50%\nMoribund patient not expected to survive 24 hours\nAdvanced chronic liver disease (Child-Pugh Score > 12)\nSevere chronic respiratory disease with the use of home oxygen\n\nSevere traumatic brain injury - defined as:\n\nA patient who has undergone intracranial neurosurgical intervention for monitoring or therapy (intracranial pressure monitoring, external ventricular drain, craniotomy), or\nIntracranial injury by head CT (does not include patients with minimal subarachnoid injury and/or minor skull fracture), or\nPost-resuscitation Glasgow Coma Score (GCS) < 9 assessed after sedation interruption, or\nNon-survivable head injury as assessed by neurosurgery\nEvidence of anoxic brain injury\nHistory of stroke within the last 3 years\nNo intent/unwillingness to follow lung protective ventilation strategy\nCurrently receiving extracorporeal life support (ECLS) or high-frequency oscillatory ventilation (HFOV)\nAnticipated extubation within 24 hours of enrollment\nClinical evidence of left atrial hypertension as measured by a pulmonary arterial wedge pressure > 18mmHg or left ventricular failure measured by an echocardiogram with a left ventricular ejection fraction less than 40%. Clinical judgement will determine if either of these measurements needs to be carried out.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Michael Matthay, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "415-353-1206",
                                                            "CentralContactEMail": "michael.matthay@ucsf.edu"
                                                      },
                                                      {
                                                            "CentralContactName": "Hanjing Zhuo, MPH",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "415-502-7434",
                                                            "CentralContactEMail": "hanjing.zhuo@ucsf.edu"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Michael Matthay, MD",
                                                            "OverallOfficialAffiliation": "University of California, San Francisco",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "University of California Davis Medical Center",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Sacramento",
                                                            "LocationState": "California",
                                                            "LocationZip": "95817",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Rachael Callcut, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "916-547-9995",
                                                                              "LocationContactEMail": "racallcut@ucdavis.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Timothy Albertson, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Zuckerberg San Francisco General Hospital and Trauma Center",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "San Francisco",
                                                            "LocationState": "California",
                                                            "LocationZip": "94110",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Carolyn M Hendrickson, MD, MPH",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "628-206-8289",
                                                                              "LocationContactEMail": "Carolyn.Hendrickson@ucsf.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Carolyn M Hendrickson, MD, MPH",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Lucy Kornblith, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "University of California San Francisco",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "San Francisco",
                                                            "LocationState": "California",
                                                            "LocationZip": "94143",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Michael Matthay, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "415-353-1206",
                                                                              "LocationContactEMail": "michael.matthay@ucsf.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Hanjing Zhuo, MPH",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "415-502-7434",
                                                                              "LocationContactEMail": "hanjing.zhuo@ucsf.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Michael A Matthay, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Carolyn S Calfee, MD, MD, MAS",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Kathleen D Liu, MD, PhD, MAS",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Kirsten N Kangelaris, MD, MAS",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Oregon Health & Science University",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Portland",
                                                            "LocationState": "Oregon",
                                                            "LocationZip": "97239",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Martin A Schreiber, MD, FACS",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "503-494-6518",
                                                                              "LocationContactEMail": "schreibm@ohsu.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Martin Schreiber, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Akram Khan, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "David Zonies, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Vanderbilt University Medical Center",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Nashville",
                                                            "LocationState": "Tennessee",
                                                            "LocationZip": "37232",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Lorraine B Ware, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "615-322-7872",
                                                                              "LocationContactEMail": "lorraine.ware@Vanderbilt.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Lorraine B Ware, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Oscar Guillamondegui, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Jonathan Casey, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Memorial Hermann Hospital - Texas Medical Center",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Houston",
                                                            "LocationState": "Texas",
                                                            "LocationZip": "77030",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Laura H Moore, MD, FACS",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "713-500-7217",
                                                                              "LocationContactEMail": "laura.j.moore@uth.tmc.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Laura H Moore, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Charles E Wade, PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Charles Cox, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Erin Fox, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Lillian Kao, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Bela Patel, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Farrakh Khawanja, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Harborview Medical Center",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Seattle",
                                                            "LocationState": "Washington",
                                                            "LocationZip": "98112",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Bryce RH Robinson, MD, MS",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "206-482-2277",
                                                                              "LocationContactEMail": "brobinso@uw.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Bryce Robinson, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Nick Johnson, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No",
                                          "IPDSharingDescription": "We do not have plan to share IPD data to other researchers."
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000012128",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012127",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome, Newborn"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000055371",
                                                            "ConditionMeshTerm": "Acute Lung Injury"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000013577",
                                                            "ConditionMeshTerm": "Syndrome"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000004194",
                                                            "ConditionAncestorTerm": "Disease"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012120",
                                                            "ConditionAncestorTerm": "Respiration Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14117",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14116",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Newborn",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27297",
                                                            "ConditionBrowseLeafName": "Acute Lung Injury",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14109",
                                                            "ConditionBrowseLeafName": "Respiration Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4927",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Infant",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T192",
                                                            "ConditionBrowseLeafName": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M6258",
                                                            "InterventionBrowseLeafName": "Dextrans",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "AnCoag",
                                                            "InterventionBrowseBranchName": "Anticoagulants"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "BlSubst",
                                                            "InterventionBrowseBranchName": "Blood Substitutes"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 13,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02323789",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "ADSTEM001"
                                          },
                                          "Organization": {
                                                "OrgFullName": "King's College London",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa",
                                          "OfficialTitle": "A Phase I/II Study Evaluating Allogeneic Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa",
                                          "Acronym": "ADSTEM"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "March 2017",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Active, not recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "June 2015",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "July 2017",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "July 2017",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "December 18, 2014",
                                          "StudyFirstSubmitQCDate": "December 18, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "December 23, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "March 1, 2017",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "March 3, 2017",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "King's College London",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "To assess whether intravenously administered third-party bone marrow-derived mesenchymal stromal cells (MSCs) are safe and have an impact on disease severity in RDEB",
                                          "DetailedDescription": "This is a phase I/II clinical trial with a key objective of evaluating safety of third party bone MSCs intravenous infusions in 10 adults with the inherited severe skin fragility disorder, recessive dystrophic epidermolysis bullosa (RDEB). The main objectives of our study are to: (1) to assess the spectrum of clinical responses in adults with RDEB receiving intravenous MSCs; (2) to identify the best cohort of individuals to target for future trials and therapies; (3) to improve our understanding of in vivo and in vitro responsiveness to MSCs; (4) to identify candidate molecules germane to activating MSCs and making them clinically more potent, independently of the permissive conditions of the patient and (5) to assess its impact on reducing disease morbidity/severity in this population.\n\nThis is a prospective, non-randomised, open label study. All study participants will receive two intravenous MSC infusions at baseline Day 0 and Day 14 and will be followed up for a 12 month period following the first infusion. Each subject will undergo an initial screening including physical examination, assessment of vital signs and disease severity assessment."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Recessive Dystrophic Epidermolysis Bullosa"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Other",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Intervention arm",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "10 patients with RDEB will be selected to receive the intervention - mesenchymal stromal cells.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Mesenchymal stromal cells",
                                                            "InterventionDescription": "TC-MSC: a cell product containing mesenchymal stromal cells. Mesenchymal stromal cells are adherent non-haematopoietic multipotent cells that are expanded from bone marrow from healthy donors, using platelet lysate as source of growth factor.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Intervention arm"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "TC-MSC"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Lack of serious and severe adverse events (SAEs) related to the administration of the investigational medicinal product.",
                                                            "PrimaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Presence of new type VII collagen at the dermal-epidermal junction post treatment.",
                                                            "SecondaryOutcomeTimeFrame": "Day 14, Day 28, Day 60, Day 100 and Month 6."
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in general markers of inflammation",
                                                            "SecondaryOutcomeTimeFrame": "Day 14, Day 28, Day 60, Day 100, Month 6 and Month 12 compared to baseline"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in specific markers of inflammation",
                                                            "SecondaryOutcomeTimeFrame": "Day 14, Day 28, Day 60 and Month 6 compared to baseline"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in the clinical changes in the skin assessed with clinical photographs",
                                                            "SecondaryOutcomeTimeFrame": "Day 14, Day 28, Day 60, Day 100, Month 6 and Month 12."
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Differences in quality of life data",
                                                            "SecondaryOutcomeTimeFrame": "Day 28, Day 60, Day 100, Month 6 and Month 12 compared to baseline"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in BEBSS and EBDASI scores",
                                                            "SecondaryOutcomeTimeFrame": "at Day 28, Day 60, Day 100, Month 6 and Month 12 compared to baseline"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in Pain scores",
                                                            "SecondaryOutcomeTimeFrame": "Day 28, Day 60, Day 100, Month 6 and Month 12 compared to baseline"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in pruritus score using the Leuven Itch Scale (LIS)",
                                                            "SecondaryOutcomeTimeFrame": "Day 28, Day 60, Day 100, Month 6 and Month 12 compared to baseline."
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Quantification of total blister numbers over the entire body surface area",
                                                            "SecondaryOutcomeTimeFrame": "Day 28, Day 60, Day 100, Month 6 and Month 12 compared to baseline"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "10. Increase in the skin strength measured by time to blister formation after negative pressure skin suction test",
                                                            "SecondaryOutcomeTimeFrame": "Day 28, Day 60, Day 100, Month 6 and Month 12 compared to baseline"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Qualitative analyses based on a series of interview questions",
                                                            "SecondaryOutcomeDescription": "to reveal objective data on quality of sleep, skin healing time, amount of dressings used, improvement in oral diet, improvement in energy levels, mood, quality of family life/relationships.",
                                                            "SecondaryOutcomeTimeFrame": "between screening and Day 0, between Day 28 and Day 60, and between Month 6 and Month 12."
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nIndividuals with a diagnosis of RDEB confirmed by DNA analysis and skin immunofluorescence for partial or complete absence of type VII collagen.\nIndividuals \u2265 18 years and \u2264 65 years of age, both male and female\nIndividuals that have voluntarily signed and dated an informed consent form (ICF) prior to the first study intervention.\n\nExclusion Criteria:\n\nSubjects who have had other investigational medicinal products within 90 days prior to screening or during the treatment phase.\nSubjects who have received immunotherapy including oral corticosteroids for more than 1 week (intranasal and topical preparations are permitted).\nSubjects with a known allergy to any of the constituents of the investigational product.\nSubjects with a medical history or evidence of malignancy, including cutaneous squamous cell carcinoma.\nSubjects who are pregnant or of child-bearing potential who are not abstinent or practicing an acceptable means of contraception, as determined by the Investigator, for the duration of the treatment phase.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "John McGrath, FRCP/FSci/MD",
                                                            "OverallOfficialAffiliation": "King's College London",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Guys and St Thomas' hospital NHS Trust",
                                                            "LocationCity": "London",
                                                            "LocationZip": "SE1 9RT",
                                                            "LocationCountry": "United Kingdom"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000004820",
                                                            "ConditionMeshTerm": "Epidermolysis Bullosa"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000016108",
                                                            "ConditionMeshTerm": "Epidermolysis Bullosa Dystrophica"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000012868",
                                                            "ConditionAncestorTerm": "Skin Abnormalities"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000000013",
                                                            "ConditionAncestorTerm": "Congenital Abnormalities"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012873",
                                                            "ConditionAncestorTerm": "Skin Diseases, Genetic"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030342",
                                                            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012871",
                                                            "ConditionAncestorTerm": "Skin Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012872",
                                                            "ConditionAncestorTerm": "Skin Diseases, Vesiculobullous"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003095",
                                                            "ConditionAncestorTerm": "Collagen Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003240",
                                                            "ConditionAncestorTerm": "Connective Tissue Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M7128",
                                                            "ConditionBrowseLeafName": "Epidermolysis Bullosa",
                                                            "ConditionBrowseLeafAsFound": "Epidermolysis Bullosa",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M17738",
                                                            "ConditionBrowseLeafName": "Epidermolysis Bullosa Dystrophica",
                                                            "ConditionBrowseLeafAsFound": "Dystrophic Epidermolysis Bullosa",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12",
                                                            "ConditionBrowseLeafName": "Congenital Abnormalities",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14824",
                                                            "ConditionBrowseLeafName": "Skin Abnormalities",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14826",
                                                            "ConditionBrowseLeafName": "Skin Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14828",
                                                            "ConditionBrowseLeafName": "Skin Diseases, Genetic",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22839",
                                                            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14827",
                                                            "ConditionBrowseLeafName": "Skin Diseases, Vesiculobullous",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14197",
                                                            "ConditionBrowseLeafName": "Rheumatic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5475",
                                                            "ConditionBrowseLeafName": "Collagen Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5616",
                                                            "ConditionBrowseLeafName": "Connective Tissue Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2098",
                                                            "ConditionBrowseLeafName": "Epidermolysis Bullosa",
                                                            "ConditionBrowseLeafAsFound": "Epidermolysis Bullosa",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1991",
                                                            "ConditionBrowseLeafName": "Dystrophic Epidermolysis Bullosa",
                                                            "ConditionBrowseLeafAsFound": "Dystrophic Epidermolysis Bullosa",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4889",
                                                            "ConditionBrowseLeafName": "Recessive Dystrophic Epidermolysis Bullosa",
                                                            "ConditionBrowseLeafAsFound": "Recessive Dystrophic Epidermolysis Bullosa",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M11052",
                                                            "InterventionBrowseLeafName": "Mitogens",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 14,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02032446",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "EudraCT 2012-000582-21"
                                          },
                                          "Organization": {
                                                "OrgFullName": "A.O. Ospedale Papa Giovanni XXIII",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease",
                                          "OfficialTitle": "UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC) FOR THE TREATMENT OF SEVERE (GRADE III-IV) STEROID-RESISTANT GRAFT VERSUS HOST DISEASE (GvHD): A PHASE I/II TRIAL",
                                          "Acronym": "PTC-UC-MSC"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2019",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "September 2013"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 2016",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "September 2019",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "November 4, 2013",
                                          "StudyFirstSubmitQCDate": "January 8, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "January 10, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "January 17, 2019",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 18, 2019",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Rambaldi Alessandro",
                                                "ResponsiblePartyInvestigatorTitle": "Head Hematology and Bone Marrow Transplant Unit",
                                                "ResponsiblePartyInvestigatorAffiliation": "A.O. Ospedale Papa Giovanni XXIII"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "A.O. Ospedale Papa Giovanni XXIII",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Associazione Italiana per la Ricerca sul Cancro",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "MESENCHYMAL STROMAL CELLS (MSC) have shown promising albeit not always consistent therapeutic effects in the treatment of severe steroid-resistant acute Graf versus Host Disease. Remarkably, in all reported clinical studies the toxicity of Mesenchymal stromal cells administration has been found consistently negligible. The investigators believe that Umbilical Cord (UC) derived Mesenchymal stromal cells may represent a stronger immunosuppressive tool for such clinical emergency and no data suggest any change in the safety profile of these cells. For this reason, and in the best interest of the patient, the investigators plan to test the safety and activity of Umbilical Cord Mesenchymal stromal cells when given sequentially to another partially effective treatment of steroid resistant acute graf versus host disease such as Pentostatin."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Hematologic Malignancies"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "47",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Umbilical Cord Mesenchymal stromal cells (UC-MSC)",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Pentostatin will be given by intravenous infusion at a dose of 1 mg/m2 for 3 consecutive days. Thereafter, three Umbilical Cord Mesenchymal stromal cells (UC-MSC) infusions will be given at weekly interval starting from day 5. We will follow a dose escalating programme with progressively increasing doses of cells until the maximally tolerated dose (MTD) is achieved.\n\nThe dose escalating design will be characterised by the administration of 1x106 /kg UC-MSC per dose per three doses for the first three patients (total up to 3x106/kg). The second three patients will receive 2x106/kg UC-MSC per dose per three doses (total up to 6x106/kg). The third three patients will receive 3x106/kg UC-MSC per dose per three doses (total up to 9x106 cells/kg).\n\nSince three dosages of cells are programmed for each group of 3 patients, a minimum of 9 patients should be studied, unless unacceptable acute infusion related toxicity is observed.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC)",
                                                            "InterventionDescription": "pentostatin, dose 1 mg/m2\n\n\u00a7 MSC doses:\n\n3 patients \u2192 3 infusions of 1x106 cells /kg\n3 patients \u2192 3 infusions of 2x106 cells /kg\n3 patients \u2192 3 infusions of 3x106 cells /kg",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Umbilical Cord Mesenchymal stromal cells (UC-MSC)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "vital parameters",
                                                            "PrimaryOutcomeDescription": "Following infusion of UC-MSC, the patient will be monitored for acute infusion-related toxicity. Any toxicity will be treated at the discretion of the attending physician. Infusional toxicity is defined as any alteration of the vital parameters of the patient if they have appeared acutely and may be directly correlated to the UC-MSC infusion",
                                                            "PrimaryOutcomeTimeFrame": "one year"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "assessed of acute graft versus host disease (GvHD)",
                                                            "SecondaryOutcomeDescription": "graft versus host disease will be assessed at day +7, +9, +12, +14, +16, +19, +21, +28, + 35, +42 e +49 and after 6 months and 1 year from the last UC-MSC infusion. Efficacy on acute graft versus host disease is defined as complete or partial resolution of acute GvHD evaluated according to conventional staging and grading score systems.The efficacy will be evaluated at day +30 after the third UC-MSC infusion or, if less, at day +30 after the last UC-MSC infusion.",
                                                            "SecondaryOutcomeTimeFrame": "one year"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients are required to meet the following inclusion criteria:\n\nPatients with steroid refractory grade III-IV classic acute graft versus host disease (GvHD)occurring within 100 days after transplant or induced by donor lymphocyte infusions (DLI) or T-cell add back. Steroid refractory graft versus host disease (GvHD)is defined according to Pidala and Anasetti10 as follows: a) progression of at least 1 overall grade within 3 days of optimal steroid treatment; b) failure to demonstrate any overall grade improvement over 5 to 7 days; c) incomplete response by 14 days of 2 mg/kg/day of steroid therapy.\nPatients with persistent, recurrent, or late acute graft versus host disease (GvHD) (features of acute graft versus host disease occurring beyond 100 days, often during withdrawal of immune suppression).\nPatients with an overlap syndrome in which diagnostic or distinctive features of chronic graft versus host disease (GvHD) and acute graft versus host disease (GvHD) appear together79.\n\nExclusion Criteria:\n\n1. Inability to obtain written informed consent",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MaximumAge": "70 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "ALESSANDRO RAMBALDI, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "035.2673681",
                                                            "CentralContactPhoneExt": "0039",
                                                            "CentralContactEMail": "arambaldi@asst-pg23.it"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Alessandro Rambaldi, MD",
                                                            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "A O Papa Giovanni XXIII",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Bergamo",
                                                            "LocationZip": "24127",
                                                            "LocationCountry": "Italy",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Maria Luisa Ferrari, Study coordinator",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "035.2673681",
                                                                              "LocationContactPhoneExt": "0039",
                                                                              "LocationContactEMail": "mlferrari@asst-pg23.it"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Alessandra Algarotti, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Caterina Mic\u00f2, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Anna Grassi, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Ao S Croce E Carle",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Cuneo",
                                                            "LocationZip": "12100",
                                                            "LocationCountry": "Italy",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "NICOLA MORANDINI, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+3901716424478",
                                                                              "LocationContactEMail": "MORANDININ@GMAIL.COM"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "AO Careggi",
                                                            "LocationStatus": "Not yet recruiting",
                                                            "LocationCity": "Firenze",
                                                            "LocationZip": "50134",
                                                            "LocationCountry": "Italy",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Riccardo Saccardi, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "0557947672",
                                                                              "LocationContactEMail": "riccardo.saccardi@aou.unifi.it"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "IRCCS G Gaslini",
                                                            "LocationStatus": "Not yet recruiting",
                                                            "LocationCity": "Genova",
                                                            "LocationZip": "16147",
                                                            "LocationCountry": "Italy",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Edoardo Lanino, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "01056362405",
                                                                              "LocationContactEMail": "edoardolanino@gaslini.org"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico",
                                                            "LocationStatus": "Active, not recruiting",
                                                            "LocationCity": "Milano",
                                                            "LocationZip": "20122",
                                                            "LocationCountry": "Italy"
                                                      },
                                                      {
                                                            "LocationFacility": "Clinica Pediatrica San Gerardo",
                                                            "LocationStatus": "Active, not recruiting",
                                                            "LocationCity": "Monza",
                                                            "LocationZip": "20900",
                                                            "LocationCountry": "Italy"
                                                      },
                                                      {
                                                            "LocationFacility": "Azienda Ospedaliero-Universitaria Di Udine",
                                                            "LocationStatus": "Not yet recruiting",
                                                            "LocationCity": "Udine",
                                                            "LocationZip": "33100",
                                                            "LocationCountry": "Italy",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "RENATO FANIN, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+39.0432559662",
                                                                              "LocationContactEMail": "RENATO.FANIN@UNIUD.IT"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Ospedale San Bortolo",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Vicenza",
                                                            "LocationZip": "36100",
                                                            "LocationCountry": "Italy",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "ROBERTO RAIMONDI, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+39.0444753518",
                                                                              "LocationContactEMail": "RAIMONDI@HEMATO.VEN.IT"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "18468541",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringd\u00e9n O; Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008 May 10;371(9624):1579-86. doi: 10.1016/S0140-6736(08)60690-X."
                                                      },
                                                      {
                                                            "ReferencePMID": "21417678",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Capelli C, Gotti E, Morigi M, Rota C, Weng L, Dazzi F, Spinelli O, Cazzaniga G, Trezzi R, Gianatti A, Rambaldi A, Golay J, Introna M. Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate. Cytotherapy. 2011 Aug;13(7):786-801. doi: 10.3109/14653249.2011.563294. Epub 2011 Mar 18."
                                                      },
                                                      {
                                                            "ReferencePMID": "20350611",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Lucchini G, Introna M, Dander E, Rovelli A, Balduzzi A, Bonanomi S, Salvad\u00e8 A, Capelli C, Belotti D, Gaipa G, Perseghin P, Vinci P, Lanino E, Chiusolo P, Orofino MG, Marktel S, Golay J, Rambaldi A, Biondi A, D'Amico G, Biagi E. Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population. Biol Blood Marrow Transplant. 2010 Sep;16(9):1293-301. doi: 10.1016/j.bbmt.2010.03.017. Epub 2010 Mar 27."
                                                      },
                                                      {
                                                            "ReferencePMID": "16732175",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Ringd\u00e9n O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, L\u00f6nnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006 May 27;81(10):1390-7."
                                                      },
                                                      {
                                                            "ReferencePMID": "18820709",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "von Bonin M, St\u00f6lzel F, Goedecke A, Richter K, Wuschek N, H\u00f6lig K, Platzbecker U, Illmer T, Schaich M, Schetelig J, Kiani A, Ordemann R, Ehninger G, Schmitz M, Bornh\u00e4user M. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant. 2009 Feb;43(3):245-51. doi: 10.1038/bmt.2008.316. Epub 2008 Sep 29."
                                                      },
                                                      {
                                                            "ReferencePMID": "21393326",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "P\u00e9rez-Simon JA, L\u00f3pez-Villar O, Andreu EJ, Rif\u00f3n J, Muntion S, Diez Campelo M, S\u00e1nchez-Guijo FM, Martinez C, Valcarcel D, Ca\u00f1izo CD. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica. 2011 Jul;96(7):1072-6. doi: 10.3324/haematol.2010.038356. Epub 2011 Mar 10."
                                                      },
                                                      {
                                                            "ReferencePMID": "18703664",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, Troyer D, McIntosh KR. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells. 2008 Nov;26(11):2865-74. doi: 10.1634/stemcells.2007-1028. Epub 2008 Aug 14."
                                                      }
                                                ]
                                          },
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "Agenzia Italiana del Farmaco (AIFA)",
                                                            "SeeAlsoLinkURL": "http://www.agenziafarmaco.gov.it"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Yes",
                                          "IPDSharingDescription": "interim analysis"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000019337",
                                                            "ConditionMeshTerm": "Hematologic Neoplasms"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000006086",
                                                            "ConditionMeshTerm": "Graft vs Host Disease"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000009369",
                                                            "ConditionAncestorTerm": "Neoplasms"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009371",
                                                            "ConditionAncestorTerm": "Neoplasms by Site"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000006402",
                                                            "ConditionAncestorTerm": "Hematologic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M20467",
                                                            "ConditionBrowseLeafName": "Hematologic Neoplasms",
                                                            "ConditionBrowseLeafAsFound": "Hematologic Malignancies",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8341",
                                                            "ConditionBrowseLeafName": "Graft vs Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8642",
                                                            "ConditionBrowseLeafName": "Hematologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2832",
                                                            "ConditionBrowseLeafName": "Homologous Wasting Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC04",
                                                            "ConditionBrowseBranchName": "Neoplasms"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC15",
                                                            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M17393",
                                                            "InterventionBrowseLeafName": "Pentostatin",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ANeo",
                                                            "InterventionBrowseBranchName": "Antineoplastic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 15,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03461458",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "17-002136"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Mayo Clinic",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Autologous, Culture-Expanded Mesenchymal Stromal Cells for Degenerative Disc Disease",
                                          "OfficialTitle": "A Phase I Study Evaluating the Safety and Feasibility of Autologous, Culture-Expanded Adipose-Derived Mesenchymal Stromal Cells in Subjects With Painful Degenerative Disc Disease"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2022",
                                          "OverallStatus": "Terminated",
                                          "WhyStopped": "Principal Investigator transition",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "October 17, 2018",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "February 6, 2021",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "February 6, 2021",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "February 13, 2018",
                                          "StudyFirstSubmitQCDate": "March 8, 2018",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "March 12, 2018",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "January 23, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 25, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Wenchun Qu",
                                                "ResponsiblePartyInvestigatorTitle": "M.D., M.S., Ph.D.",
                                                "ResponsiblePartyInvestigatorAffiliation": "Mayo Clinic"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Mayo Clinic",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No",
                                          "IsUSExport": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "To determine the safety and feasibility of autologous, culture-expanded adipose-derived (AD) mesenchymal stromal cells (MSCs) in subjects with painful degenerative disc disease (DDD).",
                                          "DetailedDescription": "This study is a prospective, phase I dose-escalation study evaluating the safety and feasibility of intradiscally injected AD-MSCs in the treatment of painful degenerative disc disease. The investigators propose a blended open enrollment protocol of four cohorts, each comprised of 3 subjects, to allow for interim analysis following the completion of each cohort to review safety data prior to commencing treatment of the next cohort. A total of 12 subjects will be enrolled. Subjects will be screened at outpatient clinic visit appointments and interested qualified subjects will be consented and offered participation in this trial. Once consent has been obtained baseline values will be established and subjects will begin treatment and follow-up for the next 24 months. Baseline data will include physical examination of the axial skeleton and sacroiliac region, neurologic examination, clinical assessment of low back pain and function using validated Patient Reported Outcome Measures (PROMs), radiographs, peripheral blood analysis, and MRI imaging.\n\nAbdominal fat will be harvested through a small incision and processed by the Mayo Clinic IMPACT laboratory using current Good Manufacturing Practices (cGMPs) and previously established standard operating procedures (SOPs) to produce clinical grade, autologous, culture-expanded AD-MSCs for subsequent intradiscal injection. All injections will be performed using fluoroscopic guidance and all patients will be clinically evaluated immediately after procedure and at week 2 and 4 post-treatment to assess for acute adverse events (AEs). Following completion of their respective treatment cycle, each subject will be followed for study endpoints using a predetermined protocol, including clinical evaluation, radiography, MRI, and peripheral blood analysis. A final visit for evaluation and imaging will be conducted at the end of the study."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Degenerative Disc Disease"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Degenerative Disc Disease",
                                                      "Musculoskeletal Diseases",
                                                      "Lumbar"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Sequential Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "1",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "5\u00d710^6 AD-MSCs",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Subjects will receive one injection of 5 million Autologous Adipose-Derived Mesenchymal Stromal Cells",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Autologous Adipose-Derived Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "20\u00d710^6 AD-MSCs",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Subjects will receive one injection of 20 million Autologous Adipose-Derived Mesenchymal Stromal Cells",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Autologous Adipose-Derived Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Autologous Adipose-Derived Mesenchymal Stromal Cells",
                                                            "InterventionDescription": "Human, autologous, culture expanded, adipose-derived, mesenchymal stromal cells (AMSCs) produced on site in the Mayo Clinic Immune Progenitor and Cell Therapeutics Laboratory using current good manufacturing practices (cGMPs).",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "20\u00d710^6 AD-MSCs",
                                                                        "5\u00d710^6 AD-MSCs"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "AMSCs"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of patients who experience adverse events (AEs)",
                                                            "PrimaryOutcomeDescription": "An adverse event is 1) Defined as any untoward or undesirable medical occurrence in the form of signs, symptoms, abnormal findings, or diseases that emerge or worsen relative to baseline during the study regardless of causal relationship.",
                                                            "PrimaryOutcomeTimeFrame": "2 years post final injection"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in low back pain and function following injection of AD-MSCs",
                                                            "SecondaryOutcomeDescription": "Change in low back pain will be measured by a 10 cm visual analog scale (VAS) score, with one end of the scale 0 indicating no pain, and the other end 10 indicating the worst pain ever.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, treatment day, 2 weeks, 4 weeks, 3 months, 6 months, 12 months, 18 months, 24 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in low back pain and function following injection of AD-MSCs",
                                                            "SecondaryOutcomeDescription": "Change in low back pain and function will be measured by Global Health Scale (GHS) which includes health related questions with Likert Scales of 1 to 5, or 1 to 10. Based on the question, 1 may indicate a higher amount, or lower amount for the measured variable.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, treatment day, 2 weeks, 4 weeks, 3 months, 6 months, 12 months, 18 months, 24 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in low back pain and function following injection of AD-MSCs",
                                                            "SecondaryOutcomeDescription": "Change in low back pain and function will be measured by Oswestry Disability Index (ODI), which contains 10 questions about daily activities with scores ranging from 0 to 5, where 0 indicates no difficulty/disability, and 5 indicates the most severe difficulty/disability. The final score is multiplied by 2 to give a final score from 0 to 100, where 0 is no difficulty/disability and 100 is severe difficulty/disability.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, treatment day, 2 weeks, 4 weeks, 3 months, 6 months, 12 months, 18 months, 24 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in low back pain and function following injection of AD-MSCs",
                                                            "SecondaryOutcomeDescription": "Change in low back pain and function will be measured by Quality of Life (SF-36 questionnaire, which has questions regarding health and activity scored from 1 to 3, 1 to 5, or yes/no (1 to 2). Based on the question, 1 may indicate a lower amount/frequency or higher amount/frequency.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, treatment day, 2 weeks, 4 weeks, 3 months, 6 months, 12 months, 18 months, 24 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in low back pain and function following injection of AD-MSCs",
                                                            "SecondaryOutcomeDescription": "Change in low back pain and function will be measured by Narcotic Use Questionnaire, which includes questions regarding the current use of narcotics (yes/no) and how long participants have used narcotics for pain relief (days, months, years).",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, treatment day, 2 weeks, 4 weeks, 3 months, 6 months, 12 months, 18 months, 24 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes from Baseline in disc height index as measured by X-ray at 12 months and 24 months",
                                                            "SecondaryOutcomeDescription": "An x-ray will be performed using standard radiography technology and interpreted by a trained radiologist.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, 12 Months, 24 Months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes from Baseline in T2 weighted signal intensity of the Nucleus Pulposus (NP) as measured by MRI without contrast",
                                                            "SecondaryOutcomeDescription": "Images will be obtained by MRI and interpreted by a trained radiologist.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, 6 Months, 12 Months, 24 Months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nMale or female subjects 18 years of age and older\n\nPersons of childbearing potential must be non-nursing and have a negative serum pregnancy test prior to receiving the study drug and will agree to use adequate contraception (hormonal or barrier method or abstinence) from the time of screening to a period of 24 months following completion of the drug treatment cycle. Persons of childbearing potential are defined as premenopausal and not surgically sterilized, or post-menopausal for fewer than 2 years. A urine pregnancy test will be performed prior to the administration of the study drug to confirm negative results. If the urine pregnancy test is positive, the study drug will not be administered and the result will be confirmed by a serum pregnancy test. Serum pregnancy tests will be performed at a central clinical laboratory, whereas urine pregnancy tests will be performed by qualified personnel using a kit.\nPersons becoming pregnant during the study will continue to be monitored for the duration of the study or completion of the pregnancy, whichever is longer. Monitoring will include perinatal and neonatal outcome. Any serious adverse events (SAEs) associated with pregnancy will be recorded. The requirement for radiation (X-ray, MRI) will be removed.\n\nModerate radiographic degeneration of an Intervertebral Disc (IVD) from L1 to S1, with a disc suspected of causing chronic low back pain. Chronic low back pain is defined as the following:\n\nLow back pain for at least 6 months\nFailed at least 3 months of conservative back pain care. Conservative treatment regimens may include any or all of the following: initial rest, medications e.g., anti-inflammatory, analgesics, narcotics/opioids, muscle relaxants, massage, acupuncture, osteopathic or chiropractic manipulations, activity modification, home-directed lumbar exercise program, and non-invasive pain control treatments or procedures\nHave at a minimum undergone supervised physical therapy, such as daily walking routines, therapeutic exercises, and back education programs specifically for the treatment of low back pain AND taken a pain medication for back pain (e.g. NSAID and/or opioid medication).\nLow back pain of at least 30mm and not more than 90mm of 100mm on low back pain VAS (average pain over 24 hours)Radicular leg pain \u226420mm in both legs on a 100mm VAS scale\nOswestry Disability Index (ODI) score of at least 20 and no more than 90 on a 100 point scale.\n\nPatients must demonstrate radiographic evidence of mild to moderate degenerative disc disease as defined by radiographic evidence of modified Pfirrmann scores of 3, 4, 5 or 6 on MRI at the index disc. With respect to inclusion criteria, DDD is defined as radiographic evidence of change from normal disc morphology of the index disc identified by modified Pfirrmann score and Modic Type I or II changes.\n\n\u2022 Change from normal disc morphology of the index disc will be determined based on radiographic evaluation. Radiographs must show all of the following as determined by participating fellowship trained radiologists at Mayo Clinic:\n\nA modified Pfirrmann score of 3, 4, 5 or 6 on MRI at the index disc\nModic Grade II changes or less on MRI at the index disc\nWith or without contained disc protrusion at the index disc on MRI\nLeg pain, if present, is of nonradicular origin, i.e., not due to stimulation of nerve roots or dorsal root ganglion of a spinal nerve by compressive forces.\nLeg pain, if present, does not extend below the knee and is no greater than 50% of low back pain as measured on a visual analog scale. If bilateral leg pain is present, the worst leg pain is no greater than 50% of low back pain.\nFull understanding of the requirements of the study and willingness to comply with the treatment plan, including laboratory tests, diagnostic imaging, and follow-up visits and assessments.\nCan provide written informed consent and complete HIPAA documentation after the nature of the study is fully explained and prior to any study-related procedure.\n\nExclusion Criteria:\n\nSubjects who are pregnant or nursing, or subjects planning to become pregnant in the first 24 months post-treatment. If a subject becomes pregnant during the study, the subject will remain in the study and only the requirement for radiation (x-ray or MRI) will be removed.\nExtreme obesity, as defined by NIH Clinical Guidelines Body Mass Index (BMI > 40)\nHave undergone a surgical procedure (e.g. discectomy, intradiscal electrothermal therapy, intradiscal radiofrequency, artificial disc replacement, interbody fusion) on the disc at the index or adjacent level\n\nOsteoporosis, as defined by dual-energy X-ray absorptiometry (DEXA) scan. A DEXA T-score of \u2264 -2.5 will exclude the subject. The following at-risk subjects will be required to undergo a DEXA scan at screening:\n\nFemale subjects with a Simple Calculated Osteoporosis Risk Estimation (SCORE) of \u22656 and male subjects with a Male Osteoporosis Risk Estimation Score (MORES) of \u22656\nFemales \u226550 years of age or who are post-menopausal or post-hysterectomy with oophorectomy\nSubjects taking bisphosphonate medications for the treatment of osteoporosis\nSubjects with a history of chronic, high-dose steroid use (oral and/or inhaled). High-dose steroid use is defined as:\n\ni. Daily, chronic use of oral steroids of \u22655 mg/day\n\nii. Daily, chronic use of inhaled corticosteroids (at least twice per day)\n\niii. Use of short-term (less than 10 days) oral steroids at a daily dose >20mg prednisone (or equivalent ) within 1 month of study procedure\n\nAny lumbar intradiscal injection, including steroids, into the index or adjacent discs prior to treatment injection, with the exception of the following injections performed at least 2 weeks prior to study treatment:\n\ni. Contrast medium (discography or other diagnostic injection)\n\nii. Nerve-blocking anesthetics (e.g., lidocaine, bupivacaine)\n\niii. Antibiotics\n\niv. Saline\n\nHave undergone a procedure affecting the structure/biomechanics of the index disc level (e.g. posterolateral fusion)\nClinically relevant instability on flexion-extension as determined by the investigator by overlaying films.\nHave an acute fracture of the spine at the time of enrollment in the study or clinically compromised vertebral bodies at the affected level due to current or past trauma, e.g., sustained pathological fracture or multiple fractures of vertebrae.\nPresence of any of the following spinal deformities: scoliosis >10 degrees, spondylolysis at the index disc, spondylolisthesis > grade II at the index disc.\nPresence of sequestered fragments, facet cysts, severe spinal stenosis, or severe disc degeneration at the index level and/or adjacent levels (as defined by modified Pfirrmann score greater than 6) by MRI.\nPresence of a Grade V annular fissure on discography.\nPresence of multi-level disc disease (> 1 level of involvement).\nEpidural steroid injections within 8 weeks prior to treatment injection\nActive malignancy or tumor as source of symptoms or history of malignancy within the 5 years prior to enrollment in study, except history of basal cell carcinoma of the skin, squamous cell carcinoma of the skin, or squamous cell carcinoma of the cervix if fully excised and with clear margins.\nCurrently participating in another investigational trial and/or plans to participate in any other allogeneic stem cell/progenitor cell therapy trial\nHave been a recipient of prior allogeneic stem cell/progenitor cell therapy for any indication or autologous stem cell/progenitor cell therapy or other biological intervention to repair the index intervertebral disc\nAn average baseline morphine equivalent dose (MED) of >75mg/day, as determined by the investigator during Screening consultation.\nTaking systemic immunosuppressant medications or having a chronic, immunosuppressive state.\nTaking anti-rheumatic disease medication (including methotrexate or other antimetabolites) within 3 months prior to study enrollment.\nClinically significant abnormal hematology (complete blood count with differential), blood chemistry, or urinalysis screening laboratory results, including aspartate aminotransferase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), bilirubin, creatinine, and C-Reactive Protein (CRP).\nOngoing infectious disease, including but not limited to tuberculosis, HIV, hepatitis, and syphilis.\nUnexplained fever, defined as greater than 100.4 degrees Fahrenheit or 38.0 degrees Celsius, or mental confusion at baseline.\nClinically significant cardiovascular (e.g. history of myocardial infarction, congestive heart failure or uncontrolled hypertension > 90 mmHg diastolic and/or 180 mmHg systolic), neurologic (e.g. stroke, TIA) renal, hepatic, or endocrine disease (e.g. diabetes).\nHistory of clinically significant blood dyscrasia, including but not limited to anemia, thrombocytopenia, and monoclonal gammopathy.\nParticipation in a study of an experimental drug or medical device within one year\nKnown allergy to local anesthetics of other components of the study drug.\nKnown history of hypersensitivity or anaphylactic reaction to murine or bovine products or dimethyl sulfoxide (DMSO).\nAny contraindication to MRI according to MRI guidelines, or unwillingness to undergo MRI or X-ray procedures.\nHistory of or current evidence of alcohol or drug abuse or dependence, recreational use of illicit drug or prescription medications, or have use of medical marijuana within 30 days of study entry, as determined by the investigator during Screening consultation.\nAny illness or condition which, in the investigators' judgement will interfere with the patient's ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of the study results.\nBeing involved in active litigation related to subject's low back pain.\nHave a mental illness that could prevent completion of the study or protocol questionnaires.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Wenchun Qu, MD, MS, PhD",
                                                            "OverallOfficialAffiliation": "Mayo Clinic",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Mayo Clinic in Rochester",
                                                            "LocationCity": "Rochester",
                                                            "LocationState": "Minnesota",
                                                            "LocationZip": "55905",
                                                            "LocationCountry": "United States"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "Mayo Clinic Clinical Trials",
                                                            "SeeAlsoLinkURL": "https://www.mayo.edu/research/clinical-trials"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000013122",
                                                            "ConditionMeshTerm": "Spinal Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000055959",
                                                            "ConditionMeshTerm": "Intervertebral Disc Degeneration"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000001847",
                                                            "ConditionAncestorTerm": "Bone Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009140",
                                                            "ConditionAncestorTerm": "Musculoskeletal Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M12218",
                                                            "ConditionBrowseLeafName": "Pain",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11249",
                                                            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27558",
                                                            "ConditionBrowseLeafName": "Intervertebral Disc Degeneration",
                                                            "ConditionBrowseLeafAsFound": "Degenerative Disc Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M15071",
                                                            "ConditionBrowseLeafName": "Spinal Diseases",
                                                            "ConditionBrowseLeafAsFound": "Disc Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4278",
                                                            "ConditionBrowseLeafName": "Bone Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M5415",
                                                            "InterventionBrowseLeafName": "Coal Tar",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Derm",
                                                            "InterventionBrowseBranchName": "Dermatologic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 16,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03478215",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Pro00012858"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "U1111-1169-2289",
                                                            "SecondaryIdType": "Other Identifier",
                                                            "SecondaryIdDomain": "Universal Trial Number"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "The Methodist Hospital Research Institute",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells in Living Donor Kidney Transplantation",
                                          "OfficialTitle": "A Double-blind, Randomized, Controlled Dose Escalation Trial of Autologuous Mesenchymal Stromal Cells in Living Donor Kidney Transplant Recipients"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "March 2022",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "December 2016",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2023",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2023",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "March 18, 2016",
                                          "StudyFirstSubmitQCDate": "March 20, 2018",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "March 27, 2018",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "March 8, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "March 9, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Ahmed Osama Gaber, MD",
                                                "ResponsiblePartyInvestigatorTitle": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorAffiliation": "The Methodist Hospital Research Institute"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "The Methodist Hospital Research Institute",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Center for Cell and Gene Therapy, Baylor College of Medicine",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Kidney transplantation is a good treatment option for people with kidney disease. However, there is still much to learn about how to best care for the transplanted kidney and keep it functioning for a long time. Transplant recipients receive induction therapy and immunosuppression (anti-rejection) drugs to prevent their body from rejecting the new kidney. These drugs are used to prevent the immune system from attacking the transplanted kidney. This research study will evaluate the safety and activity of mesenchymal stromal stem cells (MSCs) infusion compared to saline-only infusion in reducing the immune suppression necessary to achieve optimal renal function in renal transplant recipients. All participants will receive routine care: basiliximab, tacrolimus, mycophenolate mofetil, and corticosteroids.",
                                          "DetailedDescription": "The study is a double-blind, randomized, controlled, dose-escalation and safety study of the investigational product, autologous MSCs, to be assessed for inducing immune suppression in living donor kidney transplant recipients as compared to saline, the placebo infusion. The investigator will obtain exploratory immune response markers to estimate the effect of autologous MSCs on the T- and B-cell response following living donor kidney transplantation. The usual routine care supportive drugs will be given to all: corticosteroids during induction, the calcineurin inhibitor tacrolimus (Prograf\u00ae, Astellas Pharma), and mycophenolate mofetil (Cellcept\u00ae, Genentech) for maintenance therapy. All subjects will receive basiliximab (Simulect\u00ae, Novartis), a standard drug used to induce immune suppression.\n\nUp to 24 patients will be enrolled at the Houston Methodist Hospital. Safety analyses will be conducted after the first 4 subjects have been enrolled and completed the first 30-90 days posttransplant, with subject 2 enrolled 30 days after subject 1 and subject 3 enrolled 30 days after subject 2 (eg, a 30-day window between subject enrollment days). If no safety signal has been detected, the next group of 4 subjects will be enrolled using no less than a 2-week enrollment window from subject 5, 2 weeks from subject 6, and so on. Subjects will be evaluated in the same manner until 8 subjects in the final dosing group have completed 90 days or a decision to stop the study has occurred, whichever comes first. Each subsequent dosing group will begin with a 30-day window of evaluation between subjects enrolled for the first 4 subjects enrolled in the group. If no adverse safety signal has been detected in the first 4 cases in that dosing group, the next 4 subjects enrolled will have a 2-week evaluation window between enrollments. This early evaluation approach will allow for the assessment of the inflammatory period occurring after transplantation. A final safety review will occur at the end of the study and a report will be written.\n\nThe study will provide information needed to select a MSC dose level to be used in subsequent clinical trials and to inform the design of subsequent trials."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Renal Transplantation",
                                                      "Mesenchymal Stem Cells"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "kidney transplantation",
                                                      "graft rejection"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Other",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Triple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "24",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal Stem Cells Infusion",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intervention: Mesenchymal stromal stem cells infusion. This is the active investigational intervention, administered intravenously at surgery and day 4 post-transplant in a dose-escalation fashion beginning as 1x10^6 cells for the first dose group, 2x10^6 cells for the second dose group, or 3x10^6 cells for the last dose group. The infusion set-up will be covered to mask the group assignment.\n\nParticipants will also receive BASILIXIMAB (Simulect, for all subjects at a standard dose, 20mg reconstituted with normal saline or 5% dextrose) on the day of surgery and day 3 or 4 post-transplant administered by a member of the anesthesia team; TACROLIMUS (Prograf for maintenance therapy), MYCOPHENOLATE MOFETIL (Cellcept for maintenance therapy), and CORTICOSTEROIDS as routine care.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stromal Stem Cells (MSCs) Infusion"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Placebo Infusion",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Placebo: A normal saline infusion. This is the placebo intervention to occur at surgery and day 4 post-transplant. The infusion set-up will be covered to mask the group assignment. Participants will also receive BASILIXIMAB (Simulect, for all subjects at a standard dose, 20mg reconstituted with normal saline or 5% dextrose) on the day of surgery and day 3 or 4 post-transplant administered by a member of the anesthesia team; TACROLIMUS (Prograf for maintenance therapy), MYCOPHENOLATE MOFETIL (Cellcept for maintenance therapy), and CORTICOSTEROIDS as routine care.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: Normal Saline (Placebo) Infusion"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stromal Stem Cells (MSCs) Infusion",
                                                            "InterventionDescription": "Investigational infusion bag containing autologous mesenchymal stromal cells wrapped to cover contents to maintain the blind.\n\nMesenchymal Stromal Stem Cells Infusion.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal Stem Cells Infusion"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Investigational autologous biological product"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "Normal Saline (Placebo) Infusion",
                                                            "InterventionDescription": "Matching infusion containing normal saline wrapped to cover contents to maintain the blind.\n\nNormal Saline (Placebo) Infusion.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Placebo Infusion"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Matching placebo infusion bag"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of participants without any infusional toxicity, occurring within 24 hours of infusion.",
                                                            "PrimaryOutcomeDescription": "Infusional toxicity will be assessed as the occurrence of either 1) two or more participants having deep vein thrombosis (Grade 2 thrombotic event); 2) any participant having evidence of the first-pass phenomenon of cells trapping in the lung as evidenced by (a) shortness of breath at rest, (b) requiring ventilator support, or (c) pulmonary edema with hypoxia requiring support; or 3) Grade 4 hypertension or hypotension; or 4) acute myocardial infarction; or 5) new onset congestive heart failure; or 6) capillary leak syndrome; or 7) acute kidney injury; or 8) biopsy-proven rejection.",
                                                            "PrimaryOutcomeTimeFrame": "24 hours from end of infusion"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of participants without any acute rejection, graft loss, or death at 6 months post transplant.",
                                                            "SecondaryOutcomeDescription": "Rejection will be determined as biopsy-proven allograft rejection (BPAR). Graft loss will be counted when the patient loses kidney function to the point that they require chronic renal replacement therapy (e.g., dialysis for more than 8 weeks or a re-transplant).",
                                                            "SecondaryOutcomeTimeFrame": "6 months post transplant"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nMales and females from 18 to 65 years of age\nPlanned to receive a primary kidney transplant from a living donor\n\nLow immunologic risk defined as\n\nNo history of current or historical antidonor human leukocyte antigen (HLA) antibodies (DSA)\nPanel of Reactive Antibodies (PRA) <20%, historical\nLow risk for thrombotic events and normal prothrombin time, international normalized ratio (INR) and partial thromboplastin time\nWomen of child bearing potential have a negative serum pregnancy test prior to transplantation\nWomen of child bearing potential (including perimenopausal women who have had a menstrual period within the previous 1 year) who agree to use 2 forms of effective birth control regimen (at least one of which is a barrier method) throughout the study period and for 6 weeks following the end of the study or the last dose of mycophenolate mofetil, whichever comes first.\nIn the opinion of the investigator, the subject is capable of understanding and complying with the protocol.\nSubjects must have signed the informed consent document prior to performance of any study related procedure including screening procedure.\n\nExclusion Criteria:\n\nRecipient of multiple organ transplantation or scheduled for multiple organ transplantation\nRecipient with a donor-specific anti-HLA antibody or positive cross-match requiring deviation from standard immunosuppressive therapy\nHepatitis C antibody positive, Hepatitis B antigen positive, or Hepatitis B core antibody positive\nCurrently participating in or has participated in an investigational drug or medical device study within 30 days or five half-lives, whichever is longer, prior to enrollment into this study\nConcurrent sepsis or active bacterial infection\nIn the opinion of the investigator is anatomically a high-risk renal transplant with higher chance for thrombosis or bleeding\nHave an active malignancy or history of solid, metastatic or hematologic malignancy with the exception of basal or squamous cell carcinoma of the skin that has been treated\nWomen of child bearing potential who are breastfeeding\nHistory of HIV infection\nSubject is unwilling or unable to comply with the protocol or to cooperate fully with the Investigator or the site personnel.\nSubject is not deemed medically stable for the study in the opinion of the Investigator or the subject's nephrologist.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Darrel Cleere, BSN,RN,CCRP",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "713-441-6232",
                                                            "CentralContactEMail": "dwcleere@houstonmethodist.org"
                                                      },
                                                      {
                                                            "CentralContactName": "Linda W Moore, MS,RDN,LD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "2818819977",
                                                            "CentralContactEMail": "lwmoore@houstonmethodist.org"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Ahmed O Gaber, MD",
                                                            "OverallOfficialAffiliation": "Houston Methodist Physicians Organization",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Houston Methodist Hospital System",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Houston",
                                                            "LocationState": "Texas",
                                                            "LocationZip": "77030",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "LaTisha Hargrove",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "713-441-6013",
                                                                              "LocationContactEMail": "lmhargrove@tmhs.org"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Darrel Cleere, RN,CCRP",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "713-441-6232",
                                                                              "LocationContactEMail": "DWCLEERE@houstonmethodist.org"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Ahmed O Gaber, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M3259",
                                                            "InterventionBrowseLeafName": "Anesthetics",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M18102",
                                                            "InterventionBrowseLeafName": "Tacrolimus",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M11280",
                                                            "InterventionBrowseLeafName": "Mycophenolic Acid",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M4006",
                                                            "InterventionBrowseLeafName": "Benzocaine",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M1830",
                                                            "InterventionBrowseLeafName": "Basiliximab",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "T433",
                                                            "InterventionBrowseLeafName": "Tannic Acid",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "CNSDep",
                                                            "InterventionBrowseBranchName": "Central Nervous System Depressants"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Infe",
                                                            "InterventionBrowseBranchName": "Anti-Infective Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ANeo",
                                                            "InterventionBrowseBranchName": "Antineoplastic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Ot",
                                                            "InterventionBrowseBranchName": "Other Dietary Supplements"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 17,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT05286255",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "115966"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Medical University of South Carolina",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias",
                                          "OfficialTitle": "Safety and Tolerability of Allogeneic Umbilical Cord Derived Mesenchymal Stromal Cells (UC-MSCs) to Limit COVID Associated ComplicatioNs: An Open Label, Phase 1 Study in Hospitalized Patients (SAMPSON-1)",
                                          "Acronym": "SAMPSON-1"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "May 2022",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "May 4, 2022",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "May 4, 2023",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "May 4, 2023",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "March 16, 2022",
                                          "StudyFirstSubmitQCDate": "March 16, 2022",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "March 18, 2022",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "May 4, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "May 10, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Charlie Strange",
                                                "ResponsiblePartyInvestigatorTitle": "Professor of Medicine",
                                                "ResponsiblePartyInvestigatorAffiliation": "Medical University of South Carolina"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Medical University of South Carolina",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Pandorum International, Inc.",
                                                            "CollaboratorClass": "UNKNOWN"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This is an open-label phase 1 clinical trial of allogeneic umbilical cord derived mesenchymal stromal cells (MSCs) for hospitalized individuals with COVID-19 or other viral pneumonias. Hospitalized individuals who are within 7 days of the onset of a viral pneumonia will be given 2 doses of MSCs at days 1 and 3 after consent. The safety of intravenous infusion will be tested and course of the oxygen response to treatment over 90 days will be evaluated.",
                                          "DetailedDescription": "Study Design: This open-label phase 1 trial in 10 patients will assess the efficacy and safety of UC-MSCs given on day 1 and 3 in hospitalized patients with acute respiratory symptoms between 1 and 7 days after the onset of symptoms.\n\nThe following will be assessed in all subjects:\n\nAge, sex, comorbidities, date of symptoms, source of infection, type of admission, APACHE II score, SOFA score, Clinical status, vital signs including temperature, respiratory rate, oxygen saturation, oxygen requirement, CBC with neutrophil counts, lymphocyte count, CRP, chest imaging (CT or X-ray), location and status in hospital.\nSafety and efficacy: Day 0 (baseline), 3, and 5. Monitoring at 14, 21 and 28 days and monthly for 3 months will be obtained by telephone consult and chart review with serial laboratory.\nSerum or plasma antibody titer to SARS-CoV-2: Day 0, and 5 (additional days 14, 21 and 28 may be included, as available).\nSARS-CoV-2 PCR from nasopharyngeal swabs: Day 0 and 5. (additional day 14, 28 and 60 day samples may be tested if available or at any time when there is clinical suspicion for COVID-19 persistence).\nOutcome measures: O2 requirement (PaO2/FiO2 ratio or SpO2/FIo2), supplemental oxygen strategy (nasal cannula, high flow nasal cannula, noninvasive ventilation, intubation and invasive mechanical ventilation, neuromuscular blocking agent use, prone positioning, corticosteroids, ECMO), vasopressors, renal support, ICU LOS, ICU mortality, Hospital LOS, Hospital mortality, 28 day mortality.\n\nStudy Agent:\n\n\u2022 Allogeneic UC-MSCs given intravenously at 1.2-1.5 x 106 cells/kg on day 1 and day 3 of study entry. A maximum dose of 100 x 106 cells would be given in each dose. All cellular product will be given with actively growing cells >24 hours from the time of thawing in the Center for Cellular Therapy (CCT) at MUSC. Any emerging FDA guidance will be followed.\n\nPrimary Safety Objective: Evaluate the safety of treatment with UC-MSCs in hospitalized patients with COVID-19 and respiratory symptoms.\n\nPrimary Safety Endpoint:\n\n1. Rapid deterioration of respiratory or clinical status within 6 hours after transfusion of UC-MSCs\n\nSecondary Safety Endpoints:\n\nCumulative incidence of serious adverse events during the study period\nTransfer to intensive care unit (ICU)\nType and duration of respiratory support (and other ICU support)\nICU mortality and length of stay\nHospital mortality and length of stay\nVentilator-free days\n28 day mortality\n\nExploratory Efficacy Objective: Evaluate changes in oxygenation, progression, and regression of viral pneumonias\n\nEfficacy Endpoint: Change from baseline in PaO2/FiO2 ratio at day 5 Biologic Samples will be serially collected to determine mechanisms of effect. Propensity matching of the cohort to the MUSC COVID-19 Biorepository population will provide a population for comparison."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "COVID-19 Pneumonia",
                                                      "Viral Pneumonia"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal Stromal Cells",
                                                      "ARDS",
                                                      "COVID-19",
                                                      "MSC",
                                                      "Stem Cells"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignInterventionModelDescription": "Open label, single group, Phase 1 study",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Allogeneic Mesenchymal Stromal Cell infusion",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intravenous infusion of 1.25-1.5 x 10^6 cells/kg with a maximal dose of 100 x 10^6 cells on days 1 and 3 after study enrollment.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Allogeneic Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Allogeneic Mesenchymal Stromal Cells",
                                                            "InterventionDescription": "Intravenous MSCs 1.2-1.5 x 10^6 cells/kg on Days 1 and 3 after study enrollment",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Allogeneic Mesenchymal Stromal Cell infusion"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Clinical deterioration",
                                                            "PrimaryOutcomeDescription": "Change in oxygen saturation or clinical symptoms",
                                                            "PrimaryOutcomeTimeFrame": "6 hours"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Serious Adverse Events",
                                                            "SecondaryOutcomeDescription": "Cumulative incidence of all serious adverse events",
                                                            "SecondaryOutcomeTimeFrame": "90 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "ICU transfer",
                                                            "SecondaryOutcomeDescription": "Need for transfer to an intensive care unit",
                                                            "SecondaryOutcomeTimeFrame": "90 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Respiratory support",
                                                            "SecondaryOutcomeDescription": "Type and duration of respiratory support",
                                                            "SecondaryOutcomeTimeFrame": "90 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Hospital mortality and length of stay",
                                                            "SecondaryOutcomeDescription": "Hospital mortality and length of stay",
                                                            "SecondaryOutcomeTimeFrame": "90 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Ventilator free days",
                                                            "SecondaryOutcomeDescription": "Days off of mechanical ventilation",
                                                            "SecondaryOutcomeTimeFrame": "90 Days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "28 day mortality",
                                                            "SecondaryOutcomeDescription": "28 day mortality",
                                                            "SecondaryOutcomeTimeFrame": "28 days"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "Change is PaO2/FiO2 ratio from baseline to day 5",
                                                            "OtherOutcomeDescription": "Change in oxygenation",
                                                            "OtherOutcomeTimeFrame": "5 days"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Anti-SARS-CoV-2 titers",
                                                            "OtherOutcomeDescription": "Antibody titers to the SARS-CoV-2 virus",
                                                            "OtherOutcomeTimeFrame": "14, 21 and 28 days"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Nasopharyngeal swab SARS-CoV-2 RT-PCR",
                                                            "OtherOutcomeDescription": "Rates, levels and duration of SARS-CoV-2 RNA in nasopharyngeal swabs using RT-PCR",
                                                            "OtherOutcomeTimeFrame": "Day 5"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nHospitalized with COVID-19 respiratory symptoms and confirmation via COVID-19 SARS-CoV-2 RT-PCR testing.\nPatient or their surrogate is willing and able to provide written informed consent and comply with all protocol requirements.\n\nDiagnosis with Mild or Moderate Pneumonia not requiring mechanical ventilation: Patient must have at least one of the following features:\n\ni. Bilateral pneumonia present on chest radiograph or computed tomography ii. Partial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2) on arterial blood gas showing: >100mmHg and \u2264 300mmHg regardless of oxygen dose at time of testing.\n\niii. Pulse oxygen saturation (SpO2) at rest \u2264 93% or any degree of hypoxia requiring supplemental oxygen\n\nPatient agrees to storage of specimens for future testing.\nWillingness to undergo mechanical ventilation for worsening\n\nExclusion Criteria:\n\nIntubation with mechanical ventilation prior to study enrolment. High flow nasal cannula and non-invasive mechanical ventilation is allowed.\nPneumonia caused by bacteria, mycoplasma, chlamydia, legionella, fungi or other viruses\nObstructive pneumonia induced by lung cancer or other known causes\nSignificant comorbid illness likely to impact the outcome of COVID-19 including but not limited to active malignancy other than skin cancer.\nPatients who are participating in other therapeutic clinical trials within 30 days of consent.\nHistory of long-term use of immunosuppressive agents including prednisone dose >5mg daily over the 30 days prior to enrollment.\nHistory of severe chronic respiratory disease and requirement for long-term oxygen therapy\nUndergoing hemodialysis or peritoneal dialysis\nEstimated or actual rate of creatinine clearance < 15 ml/min\nHistory of moderate and severe liver disease (Child-Pugh score >12)\nSubstance abuse sufficient that the patient is unlikely to comply with testing requirements.\nHistory of deep venous thrombosis, pulmonary embolism, cerebral vascular disease within the last 3 years\nKnown HIV, hepatitis virus, or syphilis infection\nCo-Infection of tuberculosis, influenza virus, adenovirus and other respiratory infection virus\nMoribund patient not expected to survive > 24hours\nAllergy to diphenhydramine, or hydrocortisone\nAny condition unsuitable for the study as determined by the investigators\nFemale subjects with positive pregnancy test, breastfeeding, or planning to become pregnant/breastfeed during the study period.\nReceipt of experimental therapy for COVID-19 with the exception of convalescent plasma, dexamethasone or another corticosteroid, or remdesivir in an open label study.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "80 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Charlie Strange, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "843-792-3174",
                                                            "CentralContactEMail": "strangec@musc.edu"
                                                      },
                                                      {
                                                            "CentralContactName": "Susan Norton, BS",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "843-792-6280",
                                                            "CentralContactEMail": "nortons@musc.edu"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Charlie Strange, MD",
                                                            "OverallOfficialAffiliation": "Medical University of South Carolina",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Medical University of South Carolina",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Charleston",
                                                            "LocationState": "South Carolina",
                                                            "LocationZip": "29425",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Charlton Strange, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "843-442-8061",
                                                                              "LocationContactEMail": "strangec@musc.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Susan Norton",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "843-792-6280",
                                                                              "LocationContactEMail": "nortons@musc.edu"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Yes",
                                          "IPDSharingDescription": "Biosamples are stored in the MUSC COVID-19 Biorepository",
                                          "IPDSharingInfoTypeList": {
                                                "IPDSharingInfoType": [
                                                      "Study Protocol",
                                                      "Informed Consent Form (ICF)",
                                                      "Clinical Study Report (CSR)"
                                                ]
                                          },
                                          "IPDSharingTimeFrame": "Samples and Matching Participant data will be shared at the end of the study",
                                          "IPDSharingAccessCriteria": "Email to strangec@musc.edu"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000086382",
                                                            "ConditionMeshTerm": "COVID-19"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000011014",
                                                            "ConditionMeshTerm": "Pneumonia"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000011024",
                                                            "ConditionMeshTerm": "Pneumonia, Viral"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000012141",
                                                            "ConditionAncestorTerm": "Respiratory Tract Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007239",
                                                            "ConditionAncestorTerm": "Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014777",
                                                            "ConditionAncestorTerm": "Virus Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000018352",
                                                            "ConditionAncestorTerm": "Coronavirus Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003333",
                                                            "ConditionAncestorTerm": "Coronaviridae Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030341",
                                                            "ConditionAncestorTerm": "Nidovirales Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012327",
                                                            "ConditionAncestorTerm": "RNA Virus Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M2562",
                                                            "ConditionBrowseLeafName": "COVID-19",
                                                            "ConditionBrowseLeafAsFound": "COVID-19",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13056",
                                                            "ConditionBrowseLeafName": "Pneumonia",
                                                            "ConditionBrowseLeafAsFound": "Pneumonia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13066",
                                                            "ConditionBrowseLeafName": "Pneumonia, Viral",
                                                            "ConditionBrowseLeafAsFound": "Viral Pneumonia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9435",
                                                            "ConditionBrowseLeafName": "Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5520",
                                                            "ConditionBrowseLeafName": "Communicable Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14130",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16674",
                                                            "ConditionBrowseLeafName": "Virus Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M19643",
                                                            "ConditionBrowseLeafName": "Coronavirus Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5707",
                                                            "ConditionBrowseLeafName": "Coronaviridae Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22838",
                                                            "ConditionBrowseLeafName": "Nidovirales Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14301",
                                                            "ConditionBrowseLeafName": "RNA Virus Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC01",
                                                            "ConditionBrowseBranchName": "Infections"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 18,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT00644410",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSC heart failure"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Rigshospitalet, Denmark",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Autologous Mesenchymal Stromal Cell Therapy in Heart Failure",
                                          "OfficialTitle": "A Single Centre, Randomised Controlled Study of the Effect of NOGA-guided Direct Intramyocardial Injection of Mesenchymal Stromal Cells on the Development of New Myocardium and Blood Vessels in Patients With Heart Failure"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "March 2015",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "September 2008"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "March 2015",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "March 2015",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "March 20, 2008",
                                          "StudyFirstSubmitQCDate": "March 25, 2008",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "March 26, 2008",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "March 16, 2015",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "March 17, 2015",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "JKastrup",
                                                "ResponsiblePartyInvestigatorTitle": "Professor",
                                                "ResponsiblePartyInvestigatorAffiliation": "Rigshospitalet, Denmark"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Rigshospitalet, Denmark",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "It is a single centre, randomised controlled study of the effect of NOGA-guided direct intramyocardial injection of mesenchymal stromal cells on the development of new myocardium and blood vessels in patients with heart failure.\n\nStem cells will be obtained from the bone marrow and culture expanded for 6 - 8 weeks before injected into the myocardium.\n\nThe patients will be followed with safety, clinical, MRI and CT endpoints for 1 year.",
                                          "DetailedDescription": "The primary objective is to investigate the regenerative capacity of direct intra-myocardial injection of mesenchymal stromal cells in patients with reduced left ventricular EF (\u226445%) and heart failure NYHA 2-3.\n\nA total of 60 patients with will be enrolled in the study and randomised 2: 1 to cells or placebo (saline).\n\nThe patients will be followed for 12 months. The primary endpoint is changes in left ventricle end-systolic volume (LVESV) at 6 months follow-up.\n\nThe secondary endpoints are changes in left ventricular ejection fraction (LVEF), end-diastolic volume and end-systolic mass at 6 months follow-up.\n\nOther secondary endpoints are NYHA, CCS, Kansas City Cardiomyopathy Questionnaire (KCCQ), 6 min walking test, and major adverse events endpoints: all-causes death, cardiovascular death, and hospitalization for worsening heart failure and MI at 12 months follow-up."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Congestive Heart Failure"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "heart failure",
                                                      "stem cell",
                                                      "mesenchymal stromal cell",
                                                      "mesenchymal stem cell"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Quadruple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "59",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "1",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "The number of mesenchymal stromal cells reached after two culture expansion passages.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stromal cell"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "2",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Saline",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Saline"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stromal cell",
                                                            "InterventionDescription": "Mesenchymal stromal cells 20 - 40 mill.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "1"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Saline",
                                                            "InterventionDescription": "12 injection with 0.2 ml saline",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "2"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Improvements in left ventricular function",
                                                            "PrimaryOutcomeTimeFrame": "6 and 12 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Clinical improvements",
                                                            "SecondaryOutcomeTimeFrame": "6 and 12 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nEF < 45 %\nNYHA 2 - 3\n\nExclusion Criteria:\n\nAcute coronary syndrome within last 6 weeks.\nPregnancy\nFEV1 <1.0\nCancer\nAny severe disease which could interfere with the treatment or the outcome",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "30 Years",
                                          "MaximumAge": "80 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Jens Kastrup, MD DMSc",
                                                            "OverallOfficialAffiliation": "Rigshospitalet, Denmark",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "The Heart Centre, Rigshospitalet University Hospital Copenhagen,",
                                                            "LocationCity": "Copenhagen",
                                                            "LocationZip": "2100",
                                                            "LocationCountry": "Denmark"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "25926562",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Mathiasen AB, Qayyum AA, J\u00f8rgensen E, Helqvist S, Fischer-Nielsen A, Kofoed KF, Haack-S\u00f8rensen M, Ekblond A, Kastrup J. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur Heart J. 2015 Jul 14;36(27):1744-53. doi: 10.1093/eurheartj/ehv136. Epub 2015 Apr 29."
                                                      },
                                                      {
                                                            "ReferencePMID": "22980293",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Mathiasen AB, J\u00f8rgensen E, Qayyum AA, Haack-S\u00f8rensen M, Ekblond A, Kastrup J. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial). Am Heart J. 2012 Sep;164(3):285-91. doi: 10.1016/j.ahj.2012.05.026."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000006333",
                                                            "ConditionMeshTerm": "Heart Failure"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000006331",
                                                            "ConditionAncestorTerm": "Heart Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000002318",
                                                            "ConditionAncestorTerm": "Cardiovascular Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8573",
                                                            "ConditionBrowseLeafName": "Heart Failure",
                                                            "ConditionBrowseLeafAsFound": "Heart Failure",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8571",
                                                            "ConditionBrowseLeafName": "Heart Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC14",
                                                            "ConditionBrowseBranchName": "Heart and Blood Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 19,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03268603",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "15-008008"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "UL1TR000135",
                                                            "SecondaryIdType": "U.S. NIH Grant/Contract",
                                                            "SecondaryIdLink": "https://reporter.nih.gov/quickSearch/UL1TR000135"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Mayo Clinic",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)",
                                          "OfficialTitle": "A Phase II Study of Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "February 2022",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "October 10, 2017",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2022",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "August 30, 2017",
                                          "StudyFirstSubmitQCDate": "August 30, 2017",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "August 31, 2017",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "February 14, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "February 16, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Nathan P. Staff",
                                                "ResponsiblePartyInvestigatorTitle": "Professor of Neurology",
                                                "ResponsiblePartyInvestigatorAffiliation": "Mayo Clinic"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Mayo Clinic",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "State of Minnesota Regenerative Medicine Minnesota",
                                                            "CollaboratorClass": "UNKNOWN"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this study is to determine the safety and efficacy of intrathecal treatment delivered to the cerebrospinal fluid (CSF) of mesenchymal stem cells in ALS patients every 3 months for a total of 4 injections over 12 months.\n\nMesenchymal stem cells (MSCs) are a type of stem cell that can be grown into a number of different kinds of cells. In this study, MSCs will be taken from the subject's body fat and grown. CSF is the fluid surrounding the spine.\n\nThe use of mesenchymal stem cells is considered investigational, which means it has not been approved by the Food and Drug Administration (FDA) for routine clinical use. However, the FDA has allowed the use of mesenchymal stem cells in this research study.",
                                          "DetailedDescription": "The Goal of the Proposed Study is to perform an open label, 60 subject, Phase II multi-site clinical trial to investigate the safety and efficacy of intrathecal treatment of aaMSCs in ALS. Patients will be treated with 10-100 million aaMSCs every 3 months for a total of 4 intrathecal injections over 12 months. Reduced dose treatments will be allowed based on specific adverse events. Multiple biomarkers will be tracked throughout the clinical trial and correlated with response to treatment. This study was initially performed at Mayo Clinic in Rochester and subsequently expanded to the two other Mayo Clinic sites in Arizona and Florida. All biopsies and stem cell injections take place at Mayo Clinic Rochester, regardless of where the subject initially enrolls into the study."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "ALS",
                                                      "Amyotrophic Lateral Sclerosis"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "60",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal Cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Autologous Adipose-derived Mesenchymal Stromal Cells (aaMSCs) will be administered intrathecally at a single dose in a volume of 5-10 mL, all patients will receive 5 x 10^7 intrathecal aaMSCs at the first injection (Visit 4). Subsequent doses may be reduced to 1 x 10^7 or increased to 1 x 10^8, based on Dose Modification Rules.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Autologous Adipose-derived Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Autologous Adipose-derived Mesenchymal Stromal Cells",
                                                            "InterventionDescription": "The investigational product consists of autologous adipose-derived Mesenchymal Stromal Cells (MSCs), suspended in 5-10 mL Lactated Ringer's. The MSC are provided in a sterile syringe labelled with appropriate patient and product identifiers ready for intrathecal injection.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of Adverse Events",
                                                            "PrimaryOutcomeDescription": "Number of adverse events will be recorded from the time of enrollment until the end of the follow-up period or, in the case of early withdrawal, to the time of study withdrawal.",
                                                            "PrimaryOutcomeTimeFrame": "approximately 2 years"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in slope of ALS Functional Rating Scale - Revised (ALSFRS-R)",
                                                            "SecondaryOutcomeDescription": "The ALSFRS-R includes 12 questions. Each task is rated on a five-point scale from 0 = can't do, to 4 = normal ability. Individual item scores are summed to produce a reported score of between 0=worst and 48=best.",
                                                            "SecondaryOutcomeTimeFrame": "baseline, approximately 1 year"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAll patients will have ALS diagnosed as possible, laboratory-supported probable, probable, or definite as defined by the World Federation of Neurology criteria for the diagnosis of ALS.\nExamination and neurophysiological testing confirm a pure motor syndrome compatible with the diagnosis of ALS. All other possible causes of weakness have been excluded by extensive investigations.\nAge greater than 18 years, if female, must be post-menopausal, had a hysterectomy, or agree to two forms of birth control.\nPermanent resident or citizen of the United States.\nGeographic accessibility to the study site and willingness and ability to comply with follow-up.\nHistory of a chronic onset of a progressive motor weakness of less than two years duration.\nSubjects must be taking a stable dose of riluzole for at least 30 days prior to enrolment or not be on riluzole, and not have been on it for at least 30 days prior to enrolment (riluzole-na\u00efve subjects are permitted in the study).\nAble to comply with protocol requirements, including MRI testing.\nCan provide written informed consent.\n\nExclusion Criteria:\n\nUse of Radicava\u00ae (edaravone) within 30 days of screening or intent to use Radicava\u00ae at any time during the course of the study including the follow up period.\nAny clinically significant medical condition (e.g., within six months of baseline, had myocardial infarction, angina pectoris, and/or congestive heart failure) that, in the opinion of the investigator, would compromise the safety of patient.\nPulmonary Slow Vital Capacity (SVC) less than 65% of predicted for age, gender, and body type.\nAutoimmunity, including Crohn's disease or rheumatoid arthritis\nCurrent use of immunosuppressant medication or use of such medication within 4 weeks of Screening visit (Visit 1).\nMalignancy 5 years prior to enrollment, including melanoma,with the exception of localized skin cancers (with no evidence of metastasis, significant invasion, or re-occurrence within three years of baseline).\nActive systemic or local infection near the lumbar puncture site.\nInability to lie flat for the duration of intrathecal cell transplantation, or inability to tolerate study procedures for any other reason.\nOther active systemic disease as defined by laboratory abnormalities delineated in Appendix IV.\nUse of herbal medications, nutritional supplements or other unapproved drugs or investigational medicinal products being used or studied for the treatment of ALS.\nUnwilling to forgo initiating the use of any new supplements during participation in the study.\nEnrolled in an investigational drug trial within 30 days of baseline visit\nPrior stem cell therapy for a neurological disease\nKokmen Short Test of Mental Status score <32\nPresence of a tracheostomy\nVentilator dependent\nPregnancy\nMen or women of childbearing potential who are unwilling to employ adequate contraception\nChronic low back pain requiring invasive procedures (i.e. epidural injections or lumbar spine surgery)",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Michelle M Turner",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "507-284-2676",
                                                            "CentralContactEMail": "RSTALSRESEARCH@mayo.edu"
                                                      },
                                                      {
                                                            "CentralContactName": "Megan Means, CCRP",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "507-293-0545",
                                                            "CentralContactEMail": "RSTALSRESEARCH@mayo.edu"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Nathan P Staff, MD, PhD",
                                                            "OverallOfficialAffiliation": "Mayo Clinic",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Anthony J Windebank, MD",
                                                            "OverallOfficialAffiliation": "Mayo Clinic",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Mayo Clinic",
                                                            "LocationStatus": "Active, not recruiting",
                                                            "LocationCity": "Scottsdale",
                                                            "LocationState": "Arizona",
                                                            "LocationZip": "85259",
                                                            "LocationCountry": "United States"
                                                      },
                                                      {
                                                            "LocationFacility": "Mayo Clinic",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Jacksonville",
                                                            "LocationState": "Florida",
                                                            "LocationZip": "32224",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Lisa Thuro",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "904-953-8630",
                                                                              "LocationContactEMail": "mayofloridaALSresearch@mayo.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Adrienne Graham",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "904-953-3726",
                                                                              "LocationContactEMail": "mayofloridaALSresearch@mayo.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Bjorn E. Oskarsson, M.D.",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Mayo Clinic in Rochester",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Rochester",
                                                            "LocationState": "Minnesota",
                                                            "LocationZip": "55905",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Michelle Turner",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactEMail": "RSTALSRESEARCH@mayo.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Carol Denny",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactEMail": "RSTALSRESEARCH@mayo.edu"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "Mayo Clinic Clinical Trials",
                                                            "SeeAlsoLinkURL": "https://www.mayo.edu/research/clinical-trials"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000016472",
                                                            "ConditionMeshTerm": "Motor Neuron Disease"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000000690",
                                                            "ConditionMeshTerm": "Amyotrophic Lateral Sclerosis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012598",
                                                            "ConditionMeshTerm": "Sclerosis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000019636",
                                                            "ConditionAncestorTerm": "Neurodegenerative Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009422",
                                                            "ConditionAncestorTerm": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009468",
                                                            "ConditionAncestorTerm": "Neuromuscular Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000013118",
                                                            "ConditionAncestorTerm": "Spinal Cord Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000002493",
                                                            "ConditionAncestorTerm": "Central Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000057177",
                                                            "ConditionAncestorTerm": "TDP-43 Proteinopathies"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000057165",
                                                            "ConditionAncestorTerm": "Proteostasis Deficiencies"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008659",
                                                            "ConditionAncestorTerm": "Metabolic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M14567",
                                                            "ConditionBrowseLeafName": "Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M18031",
                                                            "ConditionBrowseLeafName": "Motor Neuron Disease",
                                                            "ConditionBrowseLeafAsFound": "Lateral Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3176",
                                                            "ConditionBrowseLeafName": "Amyotrophic Lateral Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Amyotrophic Lateral Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M20711",
                                                            "ConditionBrowseLeafName": "Neurodegenerative Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11563",
                                                            "ConditionBrowseLeafName": "Neuromuscular Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M15067",
                                                            "ConditionBrowseLeafName": "Spinal Cord Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4894",
                                                            "ConditionBrowseLeafName": "Central Nervous System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27912",
                                                            "ConditionBrowseLeafName": "TDP-43 Proteinopathies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27900",
                                                            "ConditionBrowseLeafName": "Proteostasis Deficiencies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10791",
                                                            "ConditionBrowseLeafName": "Metabolic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T349",
                                                            "ConditionBrowseLeafName": "Amyotrophic Lateral Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Amyotrophic Lateral Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4699",
                                                            "ConditionBrowseLeafName": "Primary Lateral Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Lateral Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC10",
                                                            "ConditionBrowseBranchName": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 20,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01061099",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2008-4-5947"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Nationwide Children's Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta",
                                          "OfficialTitle": "A Pilot Study to Assess the Safety and Feasibility of Repeated Infusions of Mesenchymal Stromal Cells (MSC) in Children With Osteogenesis Imperfecta",
                                          "Acronym": "STOD3"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2015",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "February 2010"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "March 2013",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "February 2014",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "February 1, 2010",
                                          "StudyFirstSubmitQCDate": "February 1, 2010",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "February 2, 2010",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "April 23, 2015",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 24, 2015",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Edwin Horwitz",
                                                "ResponsiblePartyInvestigatorTitle": "Attending Physician",
                                                "ResponsiblePartyInvestigatorAffiliation": "Nationwide Children's Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Nationwide Children's Hospital",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This is a study to evaluate the safety and effectiveness of repeated Mesenchymal Stromal Cells (MSC) infusions to patients with Type II or III osteogenesis imperfecta (OI).\n\nParticipants will receive MSC infusions approximately every 4 months to complete a total of 6 infusions over 20 months. Participants will be followed for 4 months post their last MSC infusion.",
                                          "DetailedDescription": "This is a pilot study to evaluate the safety and efficacy of repeated MSC infusions to subjects with OI. This study will evaluate subjects on two separate strata. Stratum A will include subjects with a diagnosis of Type II or Type III osteogenesis imperfecta who have previously undergone a bone marrow transplant. Stratum A may use previously harvested and cryopreserved bone marrow mononuclear cells from original BMT donor or freshly harvested or cryopreserved bone marrow mononuclear cells obtained from a haploidentical healthy parent or sibling. Stratum B will include subjects with Type II or III osteogenesis imperfecta who have not undergone a bone marrow transplant. Stratum B will only receive freshly harvested or cryopreserved bone marrow mononuclear cells from a haploidentical healthy parent or sibling.\n\nParticipants will receive MSC infusions approximately every 4 months to complete a total of 6 infusions over 20 months. Participants will be followed for 12 months post their last MSC infusion."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Osteogenesis Imperfecta Type II",
                                                      "Osteogenesis Imperfecta Type III"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Type II or Type III Osteogenesis imperfecta",
                                                      "OI",
                                                      "Mesenchymal Stromal Cells",
                                                      "MSC"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "5",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Stratum A",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Subjects with a diagnosis of Type II or Type III osteogenesis imperfecta who have previously undergone a bone marrow transplant. Intervention: Mesenchymal Stromal Cells.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Stratum B",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Subjects with Type II or III osteogenesis imperfecta who have not undergone a bone marrow transplant. Intervention: Mesenchymal Stromal Cells.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stromal Cells",
                                                            "InterventionDescription": "Both cohorts will receive multiple infusions of ex-vivo expanded MSCs. Stratum A may use previously harvested and cryopreserved bone marrow mononuclear cells from original BMT donor or freshly harvested or cryopreserved bone marrow mononuclear cells obtained from a haploidentical healthy parent or sibling. Stratum B will only receive freshly harvested or cryopreserved bone marrow",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Stratum A",
                                                                        "Stratum B"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "ex-vivo expanded MSCs"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "To determine the safety or repeated infusions of donor-derived and MSCs in subjects with severe osteogenesis imperfecta > 5years after an allogeneic bone marrow transplant and no prior bone marrow transplant.",
                                                            "PrimaryOutcomeTimeFrame": "Completion of study"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "To determine if MSCs elicit an immune response after repeated infusions.",
                                                            "SecondaryOutcomeTimeFrame": "Completion of study"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To determine the change in clinical course (growth, bone mineral content, fracture rate, development/activities) of subjects after experimental MSC intervention therapy as compared with each subject's own pre-MSC intervention therapy.",
                                                            "SecondaryOutcomeTimeFrame": "Completion of Study"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nSubjects less than or equal to 19 years of age at the time of enrollment\nChildren with a diagnosis of severe of Type II or III osteogenesis imperfecta\nParent or sibling greater than or equal to 18 years of age, donor willing to or has already undergone HLA typing, and willing and able to provide bone marrow\nBMT greater than 5 years ago for Stratum A\n\nExclusion Criteria:\n\nDependent on supplemental oxygen\nConcurrent Infection",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MaximumAge": "19 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Alix Seif, MD",
                                                            "OverallOfficialAffiliation": "Children's Hospital of Philadelphia",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "The Children's Hospital of Philadelphia",
                                                            "LocationCity": "Philadelphia",
                                                            "LocationState": "Pennsylvania",
                                                            "LocationZip": "19104",
                                                            "LocationCountry": "United States"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "12084934",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8932-7."
                                                      },
                                                      {
                                                            "ReferencePMID": "11222364",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE, Brenner MK. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood. 2001 Mar 1;97(5):1227-31."
                                                      },
                                                      {
                                                            "ReferencePMID": "10086387",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999 Mar;5(3):309-13."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000010013",
                                                            "ConditionMeshTerm": "Osteogenesis Imperfecta"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010009",
                                                            "ConditionAncestorTerm": "Osteochondrodysplasias"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001848",
                                                            "ConditionAncestorTerm": "Bone Diseases, Developmental"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001847",
                                                            "ConditionAncestorTerm": "Bone Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009140",
                                                            "ConditionAncestorTerm": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030342",
                                                            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003095",
                                                            "ConditionAncestorTerm": "Collagen Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003240",
                                                            "ConditionAncestorTerm": "Connective Tissue Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M12088",
                                                            "ConditionBrowseLeafName": "Osteogenesis Imperfecta",
                                                            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12084",
                                                            "ConditionBrowseLeafName": "Osteochondrodysplasias",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11195",
                                                            "ConditionBrowseLeafName": "Mucopolysaccharidosis IV",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4278",
                                                            "ConditionBrowseLeafName": "Bone Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4279",
                                                            "ConditionBrowseLeafName": "Bone Diseases, Developmental",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11249",
                                                            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22839",
                                                            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14197",
                                                            "ConditionBrowseLeafName": "Rheumatic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5475",
                                                            "ConditionBrowseLeafName": "Collagen Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5616",
                                                            "ConditionBrowseLeafName": "Connective Tissue Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4306",
                                                            "ConditionBrowseLeafName": "Osteogenesis Imperfecta",
                                                            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4313",
                                                            "ConditionBrowseLeafName": "Osteogenesis Imperfecta Type VI",
                                                            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta Type",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4309",
                                                            "ConditionBrowseLeafName": "Osteogenesis Imperfecta Type III",
                                                            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta Type III",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4308",
                                                            "ConditionBrowseLeafName": "Osteogenesis Imperfecta Type II",
                                                            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta Type II",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T3909",
                                                            "ConditionBrowseLeafName": "Mucopolysaccharidosis Type IV",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 21,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01764100",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "PTC-MSC"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "2008-007869-23",
                                                            "SecondaryIdType": "EudraCT Number"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Azienda Ospedaliera San Gerardo di Monza",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD)",
                                          "OfficialTitle": "Mesenchymal Stromal Cells (MSC) for the Treatment of Severe (Grade II-IV) Steroid-resistant Graft Versus Host Disease (GVHD): a Phase I Trial",
                                          "Acronym": "MSC-GvHD"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2013",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "September 2009"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "May 2013",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "September 2013",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "May 5, 2010",
                                          "StudyFirstSubmitQCDate": "January 7, 2013",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "January 9, 2013",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "January 7, 2013",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 9, 2013",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Ettore Biagi, MD",
                                                "ResponsiblePartyInvestigatorTitle": "Ettore Biagi, MD",
                                                "ResponsiblePartyInvestigatorAffiliation": "Azienda Ospedaliera San Gerardo di Monza"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Ettore Biagi, MD",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This is a bicentric, prospective, non randomized study. Pediatric and adult patients will be treated.\n\nRationale: MSC have shown promising effects by reversal of severe therapy-resistant acute GvHD. As a common therapeutic line of action is not shared for steroid resistant GVHD, it is important to establish the toxicity and the feasibility of preparation and infusion of third party MSCs for acute steroid resistant GVHD and acute phases of chronic steroid resistant GVHD.\n\nA total of 10 patients (pediatric and adults) need to be enrolled in the study. Patients who present clinical signs of either acute or chronic steroid resistant GVHD will receive by intravenous infusion at least two fixed doses of mesenchymal stem cells with 5 to 7 days of interval one from the other, derived from HLA unrelated donor different from the HSC donor (third party donor) regardless of the rate of HLA mismatch.\n\nPrimary objectives are to establish the feasibility and the toxicity of preparation and infusions of third party MSCs for the treatment of steroid resistant acute and acute phases of chronic grade II-IV GVHD.\n\nSecondary objectives are:\n\nTo document the efficacy of MSC infusion in steroid resistant acute and acute phases of chronic GVHD grade II-IV.\nTo document the rate of GVHD recurrence in MSCs infused patients.\nTo document relapse of hematological malignancies post MSC infusions in patients undergoing MSCs treatment for steroid refractory GvHD.\nTo document the overall survival of MSC infused patients for steroid refractory GvHD."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Graft vs Host Disease"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal Cells (MSC)",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intravenous injections for a dose of 1 \u00b1 0.5 x 106 MSC/kg recipient body weight",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Genetic: Mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Genetic",
                                                            "InterventionName": "Mesenchymal stromal cells",
                                                            "InterventionDescription": "Mesenchymal stromal cells (MSC) intravenous infusion at least two fixed doses of mesenchymal stem cells (1 \u00b1 0.5 x 106/kg recipient body weight for each injection) with 5 to 7 days of interval one from the other, derived from HLA unrelated donor different from the HSC donor (third party donor).",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal Cells (MSC)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Any toxic effect reported during MSCs infusion or in the subsequent 10 days by clinical monitoring",
                                                            "PrimaryOutcomeTimeFrame": "During MSCs infusion or in the subsequent 10 days"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Feasibility as the possibility of producing adequate lots of patient dedicated MSCs for any patients presenting with steroid resistant GVHD",
                                                            "PrimaryOutcomeTimeFrame": "three years"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of patients with GvHD resolution",
                                                            "SecondaryOutcomeDescription": "Complete resolution of GvHD: Control of all signs and symptoms attributed to acute GvHD\nPartial resolution of GvHD: Control of some signs and symptoms attributed to acute GvHD with an improvement of overall grade\nRefractory GvHD: No change in signs or symptoms of GvHD within 10 days of MSC infusion.\nWorsening GvHD: Any progress of GvHD signs and symptoms that increase overall grade. a and b will be defined as response. c and d will be defined as no response.",
                                                            "SecondaryOutcomeTimeFrame": "One month"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Determination of recurrence of GvHD",
                                                            "SecondaryOutcomeTimeFrame": "After 1 month from MSCs infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Relapse of haematological disease",
                                                            "SecondaryOutcomeTimeFrame": "Every three months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Survival",
                                                            "SecondaryOutcomeTimeFrame": "Every three months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nInformed consent.\nPatients are required to meet the following inclusion criteria:\n\nAny patient that has undergone allogeneic stem cell transplantation with steroid refractory grades II-IV acute GvHD either occurring post transplant, or induced by donor lymphocyte infusions (DLI) or T-cell add back, or chronic steroid refractory GVHD in acute phase. Patients may be receiving local best treatment for steroid refractory GVHD. A positive biopsy for GvHD is not required if clinical signs and symptoms are characteristic for GvHD and other etiologies are excluded. See 6.4 for acute GvHD grading.\n\nSteroids have been given, for instance methylprednisolone 2 mg/kg/day, for at least 72h in case of progressive acute GvHD, 5 days in case of stable acute GVHD (grade II to IV) or chronic GvHD in active phase, according to the local policy.\nDespite this treatment, the patient has unresponsive GvHD after 5 days, or progressive acute GvHD after 72 hours. If single organ acute GvHD grade II from gut or liver, either progression from single organ or addition of one or two more organs. As an example, if the patient has grade II acute GvHD of the skin, GvHD is more intense and more widespread, or GvHD also includes liver and/or gut.\nPatients with steroid refractory GvHD fulfilling the requirements mentioned in a) - b) may be treated with second line therapy according to the clinical guidelines at each center prior to enrolment in this study.\nPatients under treatment with best available local treatment for steroid resistant GVHD will not interrupt the ongoing treatment unless clinically required for safety reasons.\n\nExclusion Criteria:\n\nInability to obtain informed consent.\nPatients with documented uncontrolled EBV, CMV or fungal infection.\nPatients in poor clinical conditions with life expectancy of less than 30 days.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Ettore Biagi, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+39 039 233",
                                                            "CentralContactPhoneExt": "2232",
                                                            "CentralContactEMail": "e.biagi@hsgerardo.org"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Ettore Biagi, MD",
                                                            "OverallOfficialAffiliation": "San Gerardo Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "U.O. Ematologia - Ospedali Riuniti di Bergamo",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Bergamo",
                                                            "LocationState": "BG",
                                                            "LocationZip": "24128",
                                                            "LocationCountry": "Italy",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Alessandro Rambaldi, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactEMail": "arambaldi@ospedaliriuniti.bergamo.it"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Alessandro Rambaldi, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Clinica Pediatrica CTMO - Azienda Ospedaliera San Gerardo",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Monza",
                                                            "LocationState": "MB",
                                                            "LocationZip": "20052",
                                                            "LocationCountry": "Italy",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Ettore Biagi, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactEMail": "e.biagi@hsgerardo.org"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Ettore Biagi, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "U.O. Ematologia CTMO - Azienda Ospedaliera San Gerardo",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Monza",
                                                            "LocationState": "MB",
                                                            "LocationZip": "20052",
                                                            "LocationCountry": "Italy",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Matteo Parma, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactEMail": "m.parma@hsgerardo.org"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Matteo Parma, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "24321746",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Introna M, Lucchini G, Dander E, Galimberti S, Rovelli A, Balduzzi A, Longoni D, Pavan F, Masciocchi F, Algarotti A, Mic\u00f2 C, Grassi A, Deola S, Cavattoni I, Gaipa G, Belotti D, Perseghin P, Parma M, Pogliani E, Golay J, Pedrini O, Capelli C, Cortelazzo S, D'Amico G, Biondi A, Rambaldi A, Biagi E. Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. Biol Blood Marrow Transplant. 2014 Mar;20(3):375-81. doi: 10.1016/j.bbmt.2013.11.033. Epub 2013 Dec 7."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000006086",
                                                            "ConditionMeshTerm": "Graft vs Host Disease"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8341",
                                                            "ConditionBrowseLeafName": "Graft vs Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft vs Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2832",
                                                            "ConditionBrowseLeafName": "Homologous Wasting Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 22,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02215811",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSC-ARDS"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Karolinska University Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells",
                                          "OfficialTitle": "Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "August 2014",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "March 2014"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2015",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "April 11, 2014",
                                          "StudyFirstSubmitQCDate": "August 12, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "August 13, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "August 12, 2014",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "August 13, 2014",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Karl-Henrik Grinnemo",
                                                "ResponsiblePartyInvestigatorTitle": "MD, PhD",
                                                "ResponsiblePartyInvestigatorAffiliation": "Karolinska University Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Karolinska University Hospital",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Karolinska Institutet",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This is a multi-center, open-label, non-randomized controlled trial. Patients with viral-induced acute respiratory distress syndrome (ARDS) on extracorporeal membrane oxygenation (ECMO) will be eligible. Ten patients will be enrolled and receive allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSC). Ventilator parameters as well as preoperative clinical characteristics and postoperative clinical outcomes will be registered. Routine blood sampling, radiography, and bronchioalveolar lavage will be performed pre- and postoperatively. Spirometry, quality of life assessment, and 6 minute walk test will be performed postoperatively. All available data will be collected prospectively. Follow-up is 12 months. Informed consent will be obtained from relatives to patients meeting the inclusion criteria before the initiation of any study-specific procedures."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Acute Respiratory Distress Syndrome, Adult"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Extracorporeal membrane oxygenation"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stromal cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stromal cells",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "In-hospital mortality",
                                                            "PrimaryOutcomeTimeFrame": "During hospital stay, an expected average 2 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Pulmonary compliance",
                                                            "SecondaryOutcomeTimeFrame": "During ventilator treatment, an expected average of 1 month"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Pulmonary tidal volume",
                                                            "SecondaryOutcomeTimeFrame": "During ventilator treatment, an expected average of 1 month"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Adverse events",
                                                            "SecondaryOutcomeDescription": "I.e infection, fever, effect on end-organ function",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "All-cause mortality",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Recovery of organ functions",
                                                            "SecondaryOutcomeDescription": "kidney, liver, heart functions",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "Immune modulation",
                                                            "OtherOutcomeDescription": "Change in T-cell, mononuclear cell, cytokine ans microRNA response towards an immunomodulatory phenotype",
                                                            "OtherOutcomeTimeFrame": "3 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\n\u2265 18 years of age\nViral-induced acute respiratory distress syndrome\nVentilator treatment\nExtracorporeal membrane oxygenation treatment\nRelatives provide written informed consent\n\nExclusion Criteria:\n\nNone",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Karl-Henrik Grinnemo, MD, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+46 70 886 89 68",
                                                            "CentralContactEMail": "karl-henrik.grinnemo@karolinska.se"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Karl-Henrik Grinnemo",
                                                            "OverallOfficialAffiliation": "Karolinska Institutet",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Karolinska University Hospital",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Stockholm",
                                                            "LocationCountry": "Sweden",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Karl-Henrik Grinnemo, MD, PhD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+46 70 886 89 68"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Karl-Henrik Grinnemo, MD, PhD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Katarina Le Blanc, MD, PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Magnus Dal\u00e9n, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Oscar E Simonson, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Uppsala University Hospital",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Uppsala",
                                                            "LocationCountry": "Sweden",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Laila Johansson Hellgren, MD, PhD",
                                                                              "LocationContactRole": "Contact"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Laila Johansson Hellgren, MD, PhD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000012128",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012127",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome, Newborn"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000055371",
                                                            "ConditionMeshTerm": "Acute Lung Injury"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000013577",
                                                            "ConditionMeshTerm": "Syndrome"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000004194",
                                                            "ConditionAncestorTerm": "Disease"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012120",
                                                            "ConditionAncestorTerm": "Respiration Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14117",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14116",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Newborn",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27297",
                                                            "ConditionBrowseLeafName": "Acute Lung Injury",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14109",
                                                            "ConditionBrowseLeafName": "Respiration Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4927",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Infant",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T192",
                                                            "ConditionBrowseLeafName": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 23,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02291770",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "No.GRDEC 2014210H"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Guangdong Provincial People's Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells",
                                          "OfficialTitle": "Treatment of of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells. A Phase III Randomized Open Label Multi-center Study in Southern China.",
                                          "Acronym": "MSC-cGvHD"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "November 2014",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "October 2014"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "November 2015",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2019",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "November 5, 2014",
                                          "StudyFirstSubmitQCDate": "November 11, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "November 14, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "November 11, 2014",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "November 14, 2014",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Guangdong Provincial People's Hospital",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Sun Yat-sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Nanfang Hospital of Southern Medical University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Guangzhou General Hospital of Guangzhou Military Command",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Third Affiliated Hospital, Sun Yat-Sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Guangzhou First People's Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Academy Military Medical Science, China",
                                                            "CollaboratorClass": "INDUSTRY"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Chronic Graft-versus-Host Disease (cGvHD) is a potentially lethal disorder. A variety of second line immunosuppressive agents have been investigated but no optimal treatment has emerged. There is therefore a need for novel treatment strategies. Mesenchymal stromal cells (MSC) exhibit immunomodulatory properties and a recent pilot study suggests a response rate of 70% in steroid- refractory patients. In the present randomized study the efficacy and safety of MSC treatment will be further studied in patients with cGvHD."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Chronic Graft-Versus-Host Disease"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Chronic Graft-Versus-Host Disease",
                                                      "Mesenchymal Stromal Cells"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 3"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "130",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stem cells (MSC)",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Patients with newly diagnosed cGvHD receive primary treatment plus MSC:\n\nMSC+prednisone+cyclosporine;\nMSC+prednisone+tacrolimus;\nMSC+prednisone+mycophenolate mofetil.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Placebo",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Patients with newly diagnosed cGvHD receive primary treatment:\n\nPlacebo+prednisone+cyclosporine;\nPlacebo+prednisone+tacrolimus;\nPlacebo+prednisone+mycophenolate mofetil."
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stromal Cells",
                                                            "InterventionDescription": "Mesenchymal stem cell(MSC). Patients with newly diagnosed cGvHD: prednisone 1mg/kg + cyclosporine or tacrolimus and MSC 2\u00d71,000,000 MSC/kg, IV twice a week for the first two weeks and weekly for the following two weeks(6 doses totally).",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stem cells (MSC)"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "MSC"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Proportion of patients responding to treatment of cGvHD with MSC",
                                                            "PrimaryOutcomeTimeFrame": "90 days"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Overall survival",
                                                            "SecondaryOutcomeTimeFrame": "2 year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Progression-free survival",
                                                            "SecondaryOutcomeTimeFrame": "2 year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Time without systemic immunosuppression",
                                                            "SecondaryOutcomeTimeFrame": "2 year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Cumulative incidents of non-relapse mortality",
                                                            "SecondaryOutcomeTimeFrame": "2 year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Adverse events",
                                                            "SecondaryOutcomeTimeFrame": "2 year"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "Quality of life",
                                                            "OtherOutcomeTimeFrame": "2 year"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Immune reconstitution including monitoring of absolute T-cell subsets, B-cells, NK-cells as well as biomarkers of cGvHD",
                                                            "OtherOutcomeTimeFrame": "2 year"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nNewly diagnosed cGvHD\nInformed consent obtained from patient and donor.\nAny patient who has undergone allogeneic stem cell transplantation with c GvHD.\nHave not received additional agent for cGVHD within 3 months.\nExpected life is more than 90 days.\nAdequate pulmonary function with no evidence of chronic obstructive or severe restrictive pulmonary disease.\nAdequate cardiac function with no evidence of uncontrolled high blood pressure,congestive heart failure, angina pectoris, acute myocardial infarction within 6 months prior to the process.\n\nExclusion Criteria:\n\nInvasive fungal disease.\nActive cytomegalovirus (CMV)/Epstein-Barr virus(EBV)/varicella disease).\nPatient is with a history of hypersensitivity to bovine products.\nRelapsed malignancy.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "14 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Xin Du, Prof.",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+86 02083827812-62122",
                                                            "CentralContactEMail": "miyadu@hotmail.com"
                                                      },
                                                      {
                                                            "CentralContactName": "Jianyu Weng, Prof.",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+86 02083827812-62122",
                                                            "CentralContactEMail": "wengjianyu1969@163.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Xin Du, Prof.",
                                                            "OverallOfficialAffiliation": "Guangdong Provincial People's Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Xin Du",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Guangzhou",
                                                            "LocationState": "Guangdong",
                                                            "LocationZip": "510080",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Xin Du, Prof.",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactEMail": "miaydu@hotmail.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Peilong Lai, Dr.",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+86 02083827812-62121",
                                                                              "LocationContactEMail": "lai_peilong@163.com"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "23070118",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Weng J, He C, Lai P, Luo C, Guo R, Wu S, Geng S, Xiangpeng A, Liu X, Du X. Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease. Mol Ther. 2012 Dec;20(12):2347-54. doi: 10.1038/mt.2012.208. Epub 2012 Oct 16."
                                                      },
                                                      {
                                                            "ReferencePMID": "20818445",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Weng JY, Du X, Geng SX, Peng YW, Wang Z, Lu ZS, Wu SJ, Luo CW, Guo R, Ling W, Deng CX, Liao PJ, Xiang AP. Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant. 2010 Dec;45(12):1732-40. doi: 10.1038/bmt.2010.195. Epub 2010 Sep 6."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000006086",
                                                            "ConditionMeshTerm": "Graft vs Host Disease"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8341",
                                                            "ConditionBrowseLeafName": "Graft vs Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2832",
                                                            "ConditionBrowseLeafName": "Homologous Wasting Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1303",
                                                            "ConditionBrowseLeafName": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M18113",
                                                            "InterventionBrowseLeafName": "Cyclosporine",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M18102",
                                                            "InterventionBrowseLeafName": "Tacrolimus",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M5882",
                                                            "InterventionBrowseLeafName": "Cyclosporins",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M11280",
                                                            "InterventionBrowseLeafName": "Mycophenolic Acid",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M13273",
                                                            "InterventionBrowseLeafName": "Prednisone",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Infe",
                                                            "InterventionBrowseBranchName": "Anti-Infective Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ARhu",
                                                            "InterventionBrowseBranchName": "Antirheumatic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Derm",
                                                            "InterventionBrowseBranchName": "Dermatologic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ANeo",
                                                            "InterventionBrowseBranchName": "Antineoplastic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Infl",
                                                            "InterventionBrowseBranchName": "Anti-Inflammatory Agents"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 24,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04445454",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "TJT2012"
                                          },
                                          "Organization": {
                                                "OrgFullName": "University of Liege",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection",
                                          "OfficialTitle": "Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2022",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "June 12, 2020",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 30, 2024",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "September 30, 2024",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "June 19, 2020",
                                          "StudyFirstSubmitQCDate": "June 22, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 24, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "September 19, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 21, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Yves Beguin",
                                                "ResponsiblePartyInvestigatorTitle": "MD,PhD",
                                                "ResponsiblePartyInvestigatorAffiliation": "University of Liege"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "University of Liege",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The overall objective of the study is to evaluate the safety and efficacy of MSC therapy combined with best supportive care in hospitalized patients with COVID-19.",
                                          "DetailedDescription": "This study is a monocentric prospective phase I/II clinical trial, aiming at evaluating the safety and efficacy of 3 intravenous administrations of BM-MSC in 20 patients with severe to critical COVID-19 pneumonia.\n\nAfter signed informed consent, patients will receive 3 infusions of (1.5)-3.0 x106/kg BM-MSC (from the same donor) at 3-4 days interval, in addition to the standard of care for COVID-19 disease.\n\nThe trial will be open for inclusion for 2 years after initiation. Each patient will be followed for 90 days after inclusion. The total study duration will thus be 2 years and 90 days."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Coronavirus Infection"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "mesenchymal stromal cells"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignInterventionModelDescription": "This study is a monocentric prospective phase I/II clinical trial, aiming at evaluating the safety and efficacy of 3 intravenous administrations of BM-MSC in 20 patients with severe to critical COVID-19 pneumonia.",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "20",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "MSC therapy for severe COVID-19 infection",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "After signed informed consent, patients will receive 3 infusions of (1.5)-3.0 x106/kg BM-MSC (from the same donor) at 3-4 days interval, in addition to the standard of care for COVID-19 disease.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stromal cells",
                                                            "InterventionDescription": "Bone marrow collection and MSC expansion cultures will be carried out at the Laboratory of Cell and Gene Therapy (LTCG) at the University of Li\u00e8ge as described in IMPD and its SOPs.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "MSC therapy for severe COVID-19 infection"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "MSC"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "To evaluate the safety of intravenous infusion of MSC in patients with severe to critical COVID-19 pneumonia",
                                                            "PrimaryOutcomeDescription": "To assess the infusional toxicity",
                                                            "PrimaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "To evaluate the safety of intravenous infusion of MSC in patients with severe to critical COVID-19 pneumonia",
                                                            "PrimaryOutcomeDescription": "To assess the number of Adverse events of special interest : Incidence of infections (bacterial, viral, fungal, parasitic) and thrombo-embolic events.",
                                                            "PrimaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "To evaluate the efficacy of intravenous infusion of MSC in patients with severe to critical COVID-19 pneumonia",
                                                            "PrimaryOutcomeDescription": "Group A (patients not under mechanical ventilation): to determine the pourcentage of patients requiring mechanical ventilation",
                                                            "PrimaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "To evaluate the efficacy of intravenous infusion of MSC in patients with severe to critical COVID-19 pneumonia",
                                                            "PrimaryOutcomeDescription": "Group B (patients under mechanical ventilation): to determine the vital status (dead/alive)",
                                                            "PrimaryOutcomeTimeFrame": "Day 28"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate the effect of MSC administration associated with the standard of care (SOC including anti-viral therapy)",
                                                            "SecondaryOutcomeDescription": "To assess the clinical status (on a 7-point WHO ordinal scale)",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate the effect of MSC administration associated with the standard of care (SOC including anti-viral therapy)",
                                                            "SecondaryOutcomeDescription": "To assess the duration of oxygen therapy and/or mechanical ventilation",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate the effect of MSC administration associated with the standard of care (SOC including anti-viral therapy)",
                                                            "SecondaryOutcomeDescription": "To assess the length of stay at the intensive care unit and of hospitalization",
                                                            "SecondaryOutcomeTimeFrame": "Day 90"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate the effect of MSC administration associated with the standard of care (SOC including anti-viral therapy)",
                                                            "SecondaryOutcomeDescription": "To assess the number of organ failures",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate the effect of MSC administration associated with the standard of care (SOC including anti-viral therapy)",
                                                            "SecondaryOutcomeDescription": "To assess the intensity of the inflammatory response",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate the effect of MSC administration associated with the standard of care (SOC including anti-viral therapy)",
                                                            "SecondaryOutcomeDescription": "To assess the evolution of coagulation parameter",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate the effect of MSC administration associated with the standard of care (SOC including anti-viral therapy)",
                                                            "SecondaryOutcomeDescription": "To assess the presence of Biomarker of lung lesion, repair and scarring",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate the effect of MSC administration associated with the standard of care (SOC including anti-viral therapy)",
                                                            "SecondaryOutcomeDescription": "To assess the v iral load over the 28 days after inclusion and seroconversion to COVID-19 over the 90 days after inclusion",
                                                            "SecondaryOutcomeTimeFrame": "Day 90"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate the effect of MSC administration associated with the standard of care (SOC including anti-viral therapy)",
                                                            "SecondaryOutcomeDescription": "To assess the pulmonary function",
                                                            "SecondaryOutcomeTimeFrame": "Day 90"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate the effect of MSC administration associated with the standard of care (SOC including anti-viral therapy)",
                                                            "SecondaryOutcomeDescription": "To assess the number of adverse reactions (ARs), ARs grade > 3, serious adverse events (SAEs), serious ARs (SARs), suspected expected and unexpected SARs (SESARs and SUSARs).",
                                                            "SecondaryOutcomeTimeFrame": "Day 90"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "To investigate immune modulation",
                                                            "OtherOutcomeDescription": "To determine the FACS analysis of regulatory T-cell (Treg) levels and Treg and Tconv sub-populations",
                                                            "OtherOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "To compare the cytotoxic activity of PBMCs from healthy control and COVID-19 patients (divided in responders / non-responders to MSC therapy) against MSCs in vitro",
                                                            "OtherOutcomeDescription": "To assess the cytotoxic activity by MLR",
                                                            "OtherOutcomeTimeFrame": "Day 28"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "COVID-19 patients Inclusion criteria\n\nMale or female patients aged at least 18 years and up to 70 years\nDiagnosed with microbiologically or radiologically confirmed COVID-19 pneumonia as defined by:\nExtensive interstitial pneumonia on CT scan, consistent with viral pneumonia, within 10 days prior to randomization\nAnd either positive result of COVID-19 PCR test within 14 days prior to inclusion or positive result of SARS-CoV2 PCR or serology within 14 days after inclusion.\n\nRequiring oxygen administration (SpO2 \u2264 93% on room air):\n\nGroup A: in standard or intensive care unit requiring supplemental oxygen\nGroup B: in intensive care unit under mechanical ventilation administered through a tracheal tube, either:\nfor less than or equal to 7 days\nfor 7 to 14 days, with persisting high inflammation (ferritin > 2,000 \u00b5g/L; ferritin > 1,000 \u00b5g/L and rising; lymphocytes < 800 with CRP > 70 mg/L and rising or ferritin > 700 \u00b5g/L and rising or LDH > 300 UI/L or D-Dimers > 1000 ng/ml), not explained by superinfection. Rising = compared to previous 24H.\nWritten consent of the patient, or - if impossible (clinical condition precluding capacity to consent) - of his/her legal representative, or - if impossible - of an impartial witness such as a physician from a non-participating department or member of the Ethics Committee. Any consent obtained this way shall be documented and confirmed by way of normal consent procedures at the earliest opportunity when the patient has recovered\n\nExclusion criteria\n\nOngoing pregnancy. Women of childbearing potential (WOCBP, defined as a premenopausal female capable of becoming pregnant) should use an appropriate method of contraception (oral, injectable, or mechanical contraception; women whose partners have been vasectomized or have received or are utilizing mechanical contraceptive devices).\nExtracorporeal membrane oxygenation\nLimitations to intensity of care\nLife expectancy < 24 hours\nKnown allergy to IMP component\nActive secondary infection\nAny malignancy (except non-melanoma skin carcinoma) within 2 years before inclusion\nPre-existing thrombo-embolic pathology\nSigns of an active drug or alcohol dependence, serious current illness, mental illness or any factors which, in the opinion of the Investigator, may interfere with subject's ability to understand and comply with study requirements\nPatients with any serious medical condition or abnormality of clinical laboratory tests that, in the Investigator's judgment, precludes the patient's safe participation in and completion of the study.\nParticipation in another clinical trial(use of anti-viral/supportive drugs for COVID-19 infection on a compassionate use basis is not an exclusion criterion).\n\nMSC donors Inclusion criteria\n\nUnrelated to the patient\nMale or female\nAge > 18 yrs\nNo HLA matching required\nFulfills generally accepted criteria for allogeneic HSC donation\nInformed consent given by donor\n\nExclusion criteria\n\nAny condition not fulfilling inclusion criteria\nKnown allergy to lidocaine\nAny risk factor for transmissible infectious diseases, in particular HIV",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "70 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Yves Beguin, MD,PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "(0032)43667201",
                                                            "CentralContactEMail": "yves.beguin@chuliege.be"
                                                      },
                                                      {
                                                            "CentralContactName": "Audrey Janssen",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "(0032)43667470",
                                                            "CentralContactEMail": "audrey.janssen@chuliege.be"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Yves Beguin, MD,PhD",
                                                            "OverallOfficialAffiliation": "CHU de Li\u00e8ge",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "CHU de Li\u00e8ge",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Li\u00e8ge",
                                                            "LocationZip": "4000",
                                                            "LocationCountry": "Belgium",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Yves Beguin, MD,PhD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "(0032)43667201",
                                                                              "LocationContactEMail": "yves.beguin@chuliege.be"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Benoit Misset, MD,PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Nathalie Layios, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Bernard Lambermont, MD,PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Michel Moutschen, MD,PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Gilles Darcis, MD,PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "35860245",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Gr\u00e9goire C, Layios N, Lambermont B, Lechanteur C, Briquet A, Bettonville V, Baudoux E, Thys M, Dardenne N, Misset B, Beguin Y. Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial. Front Immunol. 2022 Jul 4;13:932360. doi: 10.3389/fimmu.2022.932360. eCollection 2022."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000007239",
                                                            "ConditionMeshTerm": "Infections"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000003141",
                                                            "ConditionMeshTerm": "Communicable Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000018352",
                                                            "ConditionMeshTerm": "Coronavirus Infections"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000020969",
                                                            "ConditionAncestorTerm": "Disease Attributes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003333",
                                                            "ConditionAncestorTerm": "Coronaviridae Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030341",
                                                            "ConditionAncestorTerm": "Nidovirales Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012327",
                                                            "ConditionAncestorTerm": "RNA Virus Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014777",
                                                            "ConditionAncestorTerm": "Virus Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M9435",
                                                            "ConditionBrowseLeafName": "Infections",
                                                            "ConditionBrowseLeafAsFound": "Infection",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5520",
                                                            "ConditionBrowseLeafName": "Communicable Diseases",
                                                            "ConditionBrowseLeafAsFound": "Infection",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M2562",
                                                            "ConditionBrowseLeafName": "COVID-19",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M19643",
                                                            "ConditionBrowseLeafName": "Coronavirus Infections",
                                                            "ConditionBrowseLeafAsFound": "Coronavirus Infection",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21853",
                                                            "ConditionBrowseLeafName": "Disease Attributes",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5707",
                                                            "ConditionBrowseLeafName": "Coronaviridae Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22838",
                                                            "ConditionBrowseLeafName": "Nidovirales Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16674",
                                                            "ConditionBrowseLeafName": "Virus Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14301",
                                                            "ConditionBrowseLeafName": "RNA Virus Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC01",
                                                            "ConditionBrowseBranchName": "Infections"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 25,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02814864",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "P130935"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "2014-001462-99",
                                                            "SecondaryIdType": "EudraCT Number"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Assistance Publique - H\u00f4pitaux de Paris",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy",
                                          "OfficialTitle": "Clinical Phase II Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy",
                                          "Acronym": "PRISME"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "July 2021",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "April 14, 2021",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "April 2022",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "April 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "June 9, 2016",
                                          "StudyFirstSubmitQCDate": "June 23, 2016",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 28, 2016",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "July 31, 2021",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "August 3, 2021",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Assistance Publique - H\u00f4pitaux de Paris",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Patients receiving radiation therapy are still at risk for side effects due to off-target radiation damage of normal tissues The number of cancer patients is expected to increase from 14.1 million around the world in 2012 to 19.3 million in 2025. Up to ten percent will develop late severe gastrointestinal complications (i.e. Pelvic Radiation Disease - PRD). Symptoms are proctopathy (5-20%) and radiation-induced cystitis (3,5%) that affect quality of life. The treatment of PRD is limited to managing the symptoms; new alternatives should be proposed.\n\nClinical trials using MSCs to treat hemorrhagic cystitis, proctopathy have demonstrated the feasibility to used MSCs in these pathologies :\n\nMSCs successfully repair hemorrhagic cystitis, and perforated colon in patients with hemorrhagic cystitis, perforated colon and peritonitis.\nSix clinical trials are currently ongoing for proctopathy, 3 are phase III. Results suggest an inhibition of chronic inflammation and fistulization and interruption of hemorrhagic syndromes.\nClinical trials to evaluate the efficacy of MSCs to treat hemorrhagic cystitis is in progress.\nA decrease in pain after the injection of MSCs was observed in patients treated by radiotherapy for breast cancer, radiation burns, and radiotherapy over-dosage.\nFour patients, were treated with MSCs after receiving overdose pelvic irradiation for prostate cancer. A decrease in pain (EN score), bleeding and diarrhea was observed.\n\nMSCs will represent a promising alternative strategy in the treatment of severe enteritis, rectitis and cystitis after radiotherapy, and may avoid surgical treatment and may diminish the adverse effect of PRD in terms of chronicity, morbidity, mortality and health costs.",
                                          "DetailedDescription": "-Chemo-radiation enhances survival but also increases the risk of PRD. The result will be an increasing\n\nCost for society (repeated hospitalization for palliative care)\nAn ethical problem to help these patients with irreversible degraded quality of life.\n\nResults from conventional therapies for PRD reveal a poor long-term efficacy:\n\ni. Coagulation by plasma argon is insufficient, 58% at 6 months; ii. The efficacy of formalin is questionable (48%), as is 5-amino-salicylate, sulfasalazine, vitamin E and pentoxifylline ; iii. The efficacy of short chain fatty acids and hyperbaric oxygen therapy is low (40%); iv. Steroids are of limited efficacy (37%). v. A surgical operation in an irradiated field is associated with difficult or impossible healing as well as with risks of infection (mortality of 5% within 40 months) Furthermore, conventional therapies are palliative and badly tolerated. More effective approaches are thus crucial.\n\nPRD unfortunately remains a major side effect of radiotherapy and there is no established effective treatment. Consequently, the recruitment of the aforementioned number of patients by participating radiotherapy centers is ensured.\n\nMSC therapy is a safe and suitable option in severe PRD.\n\nThe investigators propose a proof of concept.\nMSC production and injection protocol has already been successfully employed in compassionate therapy on four patients, who suffered from chronic and fistulizing colitis, after radiotherapy for prostate cancer.\n\nPRISME is a network project which includes St Antoine Hospital, INSERM (National Institute of Health and Medical Research), EFS (French Blood Establishment ), CTSA (Army Centre of Blood Transfusion) ECellFrance, IRSN (Institute for Radiological Protection and Nuclear Safety), IGR (Gustave Roussy Institute), and Institute of cancerology of west France. Our consortium has robust experience of the treatment of radiation damages, preclinical models and the medical management of PRD using biotherapy. Clinical and scientific achievements, previous collaborations of the different groups and preliminary partner's data assure the fulfillment of the program.\n\nPatient selection will be performed by the six radiotherapy centers participating in this study. The expected recruitment per center had been concluded from the average number of potentially eligible patients treated and surveyed in each of the following centers (St Antoine Hospital, Gustave Roussy Institute, Institute of cancerology of west France).\nThe ECellFrance platform will ensure MSC production. This platform includes two locations in Parisian region: EFS (in the city of Creteil) and CTSA.\nSupport, trials and intervention protocols will be handled in the Department of Clinical Hematology at St Antoine Hospital, renowned for its expertise in the treatment of overdosed radiation therapy patients, i.e. Epinal cases) and which has managed a PHRC using MSCs.\nParticipation of a research group with robust experience in stem cells, transplantation (Research centre Saint Antoine, INSERM) and radiobiology, cell therapy treatment of radiation accidents (IRSN, CTSA). These groups will carry out the characterization of the biological activity and immunological properties of the native MSC bone marrow tissue in vitro (INSERM) and in vivo (IRSN) and immunological monitoring of patients treated with the MSC (INSERM).\n\nIt is expected to achieve the healing of chronic refractory diseases, leading to lower health expenses by reducing patient treatment and hospitalization, and to an increase in their quality of life by a:\n\nDecrease in rectorrhagia and hematuria, pain, drug-consumption;\nInhibition of hemorrhagic syndromes and chronic inflammation accompanied by a sustained fistulization arrest due to the repairing capability of MSC.\n\nThe expected results for the public will be the healing of chronic refractory diseases, leading to lower health expenses by reducing patient treatment and hospitalization, and to an increase in their quality of life.\n\nHypothesis: MSC injections provide an efficient alternative approach in the treatment of PRD for patient refractories to conventional treatments.\n\nPatient study scheduled:\n\nD-60: Screening by 6 radiotherapy centers. D-1: Inclusion in Saint Antoine Hospital. D0, D7 and D14: IV MSC injection (2x106 - 6x106/kg MSC). M2 and M4: follow-up visit. End of patient's participation to the study at M4. Total number of scheduled patients: 12 patients suffering from PRD. Simon minimax plan, P0=25%, P1=60%, Alpha=5% and Beta=20%.\n\nStopping rules:\n\nStep 1: (n1=5) inclusion of 5 patients r1=1: if the number of success is <2, the study will end for MSC inefficacy. If the number of success is \u22652, proceed to step 2. Step 2: (n2=7) inclusion of up to 7 patients r2=5: as soon as the number of successes reaches 6 (>r2), inclusions will be discontinued and MSC will be considered as sufficiently promising for further studies."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Pelvic Radiation Therapy",
                                                      "Radiation-induced Hemorrhagic Cystitis"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Hematology",
                                                      "Mesenchymal Stromal Cell",
                                                      "radiotherapy",
                                                      "gastro-intestinal complications",
                                                      "lower digestive tract cancers",
                                                      "colitis",
                                                      "bleeding",
                                                      "diarrhea",
                                                      "pelvic radiation disease"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "12",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal Cell (MSC)",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Patient with chronic radiotherapy-induced abdomino-pelvic complications refractory to standard therapy: 12 patients suffering of PRD (LENT-SOMA scale>2)",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Mesenchymal Stromal Cell (MSC) injections"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Mesenchymal Stromal Cell (MSC) injections",
                                                            "InterventionDescription": "12 patients suffering of PRD (LENT-SOMA scale>2) will receive Mesenchymal Stromal Cell (MSC) injections",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal Cell (MSC)"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Cell therapy"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Decrease of one grade on the LENT SOMA",
                                                            "PrimaryOutcomeDescription": "Decrease of one grade for rectorrhagia or hematuria on the LENT SOMA scale (Late Effects Normal Tissue Task Force -Subjective, Objective, Management, Analytic), 4 months after the first injection of MSCs.",
                                                            "PrimaryOutcomeTimeFrame": "4 months after the first injection of MSCs"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "The effect of treatment on analgesic drug consumption (analgesic, opiates).",
                                                            "SecondaryOutcomeDescription": "Frequency of drug consumption (analgesic, opiate)",
                                                            "SecondaryOutcomeTimeFrame": "4 months after the first injection of MSCs"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "The effect of treatment on quality of life with SF36 questionnaire",
                                                            "SecondaryOutcomeDescription": "Quality of life evaluated by SF36 questionnaire (short form survey)",
                                                            "SecondaryOutcomeTimeFrame": "4 months after the first injection of MSCs"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "The effect of treatment on quality of life with HADS questionnaire",
                                                            "SecondaryOutcomeDescription": "Quality of life evaluated by questionnaire Hospital Anxiety and Depression Scale (HADS)",
                                                            "SecondaryOutcomeTimeFrame": "4 months after the first injection of MSCs"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "The effect of treatment on pain",
                                                            "SecondaryOutcomeDescription": "Mean pain intensity evaluated by Visual Analogue Scale (VAS) during the week prior to the visit.",
                                                            "SecondaryOutcomeTimeFrame": "4 months after the first injection of MSCs"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Frequency of diarrhea",
                                                            "SecondaryOutcomeDescription": "diminution of the frequency of diarrhea",
                                                            "SecondaryOutcomeTimeFrame": "4 months after the first injection of MSCs"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAge \u226518 years and <80 years;\nAny pelvic cancerous pathology irradiated with a history of pelvic complications of grade > 2 LENT SOMA scale);\nAbsence of metastasis objectified by bone scintigraphy;\nAfter failure following at least three lines of conventional treatment;\nGood physical condition (WHO-performance status 0-1)\n\nExclusion Criteria:\n\nPregnancies (Pregnancy test carried out during the inclusion examination).",
                                          "HealthyVolunteers": "Accepts Healthy Volunteers",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "80 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Mohamad MOHTY, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "01 49 28 26 20",
                                                            "CentralContactPhoneExt": "+33",
                                                            "CentralContactEMail": "mohamad.mohty@inserm.fr"
                                                      },
                                                      {
                                                            "CentralContactName": "Alain CHAPEL, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "0158359546",
                                                            "CentralContactPhoneExt": "-33",
                                                            "CentralContactEMail": "alain.chapel@irsn.fr"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Mohamad MOHTY, PhD",
                                                            "OverallOfficialAffiliation": "mohamad.mohty@inserm.fr",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "H\u00e9matologie et th\u00e9rapie cellulaire, H\u00f4pital Saint Antoine",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Paris",
                                                            "LocationZip": "75012",
                                                            "LocationCountry": "France",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Mohamad MOHTY, PhD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "01 49 28 26 20",
                                                                              "LocationContactPhoneExt": "+33",
                                                                              "LocationContactEMail": "mohamad.mohty@inserm.fr"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Alain CHAPEL, PhD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "0158359546",
                                                                              "LocationContactPhoneExt": "+33",
                                                                              "LocationContactEMail": "alain.chapel@irsn.fr"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Undecided"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003556",
                                                            "ConditionMeshTerm": "Cystitis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000001745",
                                                            "ConditionAncestorTerm": "Urinary Bladder Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014570",
                                                            "ConditionAncestorTerm": "Urologic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8708",
                                                            "ConditionBrowseLeafName": "Hemorrhage",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5472",
                                                            "ConditionBrowseLeafName": "Colitis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5913",
                                                            "ConditionBrowseLeafName": "Cystitis",
                                                            "ConditionBrowseLeafAsFound": "Cystitis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6311",
                                                            "ConditionBrowseLeafName": "Diarrhea",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4178",
                                                            "ConditionBrowseLeafName": "Urinary Bladder Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16471",
                                                            "ConditionBrowseLeafName": "Urologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1303",
                                                            "ConditionBrowseLeafName": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC06",
                                                            "ConditionBrowseBranchName": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 26,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03211793",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MANUS"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "2015-000168-32",
                                                            "SecondaryIdType": "EudraCT Number"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "UMC Utrecht",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis",
                                          "OfficialTitle": "Mesenchymal Stromal Cells for Angiogenesis and Neovascularisation in Digital Ulcers of Systemic Sclerosis: the MANUS Trial",
                                          "Acronym": "MANUS"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "March 2022",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "October 6, 2021",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "November 1, 2023",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "November 1, 2023",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "April 27, 2017",
                                          "StudyFirstSubmitQCDate": "July 5, 2017",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "July 7, 2017",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "March 21, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "March 22, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "prof dr. M. C. Verhaar",
                                                "ResponsiblePartyInvestigatorTitle": "prof. dr.",
                                                "ResponsiblePartyInvestigatorAffiliation": "UMC Utrecht"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "UMC Utrecht",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "ZonMw: The Netherlands Organisation for Health Research and Development",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No",
                                          "IsUSExport": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The MANUS Trial aims to examine the safety, feasibility and potential efficacy of intramuscularly injected allogeneic mesenchymal stromal cells as treatment for digital ulcers of systemic sclerosis.",
                                          "DetailedDescription": "The MANUS Trial is a randomized double-blind, placebo-controlled clinical trial. Patients with systemic sclerosis (SSc) and digital ischemia with intractable ischemic digital ulcers refractory to conventional treatments are eligible to participate.\n\n20 participants will be randomised (1:1) to undergo intramuscular injection (8 sites) of allogeneic bone marrow derived mesenchymal stromal cells (BM-MSC) (45-50*10^6) or placebo in the most affected limb.\n\nMain study parameters/endpoints: The primary outcome is the toxicity of the treatment at 12 weeks after MSC administration, defined as\n\nLocal toxicity, including signs of local inflammation (swelling, warmth, impairment of function), worsening of ulcers or new ulcers or hematomas after MSC administration\nOther adverse events, graded according to the Common Terminology Criteria for Adverse Events version 4.0, expressed as maximum grade toxicity per organ system.\n\nSecondary outcome measures are: number of serious adverse events, pain and disability parameters; healing, time to healing and reduction of new ischemic digital ulcers; modified Rodnan skin score; Scleroderma Health Assessment Questionnaire (S-HAQ) including visual analogue scales (VAS) for scleroderma-specific symptoms; Quality-of-life (SF-36, EuroQol (EQ-5D); Cochin hand function score. We will also evaluate changes in capillary morphology and architecture using capillaroscopy; biochemical parameters; markers for endothelial activation and injury, inflammation, oxidative stress, circulating cells including endothelial cells, hematopoietic and endothelial progenitor cells, cytokines and growth factors, immunological responses. Follow-up visits will be scheduled at 48 hours and 2, 4, 8, 12, 24 and 52 weeks post-treatment."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Systemic Sclerosis",
                                                      "Digital Ulcer"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "systemic sclerosis",
                                                      "scleroderma",
                                                      "digital ulcer",
                                                      "vasculopathy",
                                                      "mesenchymal stromal cell",
                                                      "mesenchymal stem cell"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Quadruple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "20",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "MSC injections",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intramuscular injection of mesenchymal stromal cells (50 million allogeneic MSCs in 0.9% NaCl and 10% human serum albumin).",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Placebo injections",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Intramuscular injection of placebo (NaCl 0.9% + 10% human serum albumin)",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Mesenchymal stromal cells",
                                                            "InterventionDescription": "8 intramuscular injections at designated sites in the hand/forearm muscles of the most affected side. Blinded syringes will be used. Injections will be administered by an experienced clinician (plastic surgeon or hand surgeon).",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "MSC injections"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "Placebo",
                                                            "InterventionDescription": "8 intramuscular injections at designated sites in the hand/forearm muscles of the most affected side. Blinded syringes will be used. Injections will be administered by an experienced clinician (plastic surgeon or hand surgeon).",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Placebo injections"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Toxicity of the treatment",
                                                            "PrimaryOutcomeDescription": "Toxicity of the treatment is defined as 1. Local toxicity, including signs of local inflammation (swelling, warmth, impairment of function), worsening of ulcers or new ulcers or hematomas after MSC administration 2. Other adverse events, graded according to the Common Terminology Criteria for Adverse Events version 4.0, expressed as maximum grade toxicity per organ system.",
                                                            "PrimaryOutcomeTimeFrame": "12 weeks after MSC administration"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Serious adverse events",
                                                            "SecondaryOutcomeDescription": "Any treatment-related serious adverse events (SAE) defined as events leading to hospitalization, death, or persistent or significant disability. To establish the presence or absence of a causal relationship, the World Health Organisation guidelines for pharmacovigilance will be followed.",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12, 24 weeks and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in perceived pain based on the Numerical Rating Scale",
                                                            "SecondaryOutcomeDescription": "Change in pain as assessed using the Numerical Rating Scale,",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12, 24 weeks and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in perceived pain based on the digital ulcer visual analogue scale (part of the S-HAQ)",
                                                            "SecondaryOutcomeDescription": "Change in pain as assessed using the digital ulcer visual analogue scale (part of the S-HAQ).",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12, 24 weeks and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in perceived pain based on the pain VAS ( part of the S-HAQ)",
                                                            "SecondaryOutcomeDescription": "Change in pain as assessed using the pain VAS (S-HAQ), use of analgesics.",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12, 24 weeks and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in perceived pain based on the use of analgesics.",
                                                            "SecondaryOutcomeDescription": "Change in pain as assessed by analyzing the use of analgesics.",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12, 24 weeks and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Quality of life - SF-36",
                                                            "SecondaryOutcomeDescription": "SF-36 questionnaire.",
                                                            "SecondaryOutcomeTimeFrame": "12, 24 and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Quality of life - Euroqol",
                                                            "SecondaryOutcomeDescription": "EuroQol questionnaire",
                                                            "SecondaryOutcomeTimeFrame": "12, 24 and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Disability",
                                                            "SecondaryOutcomeDescription": "Assessed with the HAQ-DI questionnaire.",
                                                            "SecondaryOutcomeTimeFrame": "12, 24 and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Hand function",
                                                            "SecondaryOutcomeDescription": "Cochin Hand Function Score",
                                                            "SecondaryOutcomeTimeFrame": "12, 24 and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number (and change in number) of digital ulcers",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12, 24 weeks and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Healing of digital ulcers",
                                                            "SecondaryOutcomeDescription": "Healing of ulcers is defined as complete epithelialization, regardless of residual pain. This will be established using sequential pictures in addition to the clinical examination.",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12, 24 weeks and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Ulcer size",
                                                            "SecondaryOutcomeDescription": "Using sequential pictures, ulcer area and circumference will be measured.",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12, 24 weeks and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Time to healing of digital ulcers",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12, 24 weeks and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Need to alter medication regime",
                                                            "SecondaryOutcomeDescription": "The need to alter the medication regime as determined by the patient's attending rheumatologist.",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12, 24 weeks and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Modified Rodnan Skin Score",
                                                            "SecondaryOutcomeTimeFrame": "12, 24 and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Severity of Raynaud's symptoms",
                                                            "SecondaryOutcomeDescription": "Raynaud Condition Score",
                                                            "SecondaryOutcomeTimeFrame": "12 , 24 and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in capillary morphology and architecture",
                                                            "SecondaryOutcomeDescription": "as visualized with video-assisted nailfold capillaroscopy by a trained investigator. The images will be scored by a certified rheumatologist and a trained investigator.",
                                                            "SecondaryOutcomeTimeFrame": "2, 12, 24 weeks and 52 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in laboratory parameters",
                                                            "SecondaryOutcomeDescription": "A range of haematological and chemical parameters will be measured for safety assessment. Additionally, serum, plasma and peripheral blood mononuclear cells will be collected and stored for analysis at a later time point. Samples will be analysed and used to assess markers for endothelial activation and injury, proangiogenic factors, inflammation and oxidative stress. The presence of HLA-antibodies will be determined as well.",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12 weeks after MSC administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in circulating cell populations",
                                                            "SecondaryOutcomeDescription": "Circulating cell populations will be studied by immunofluorescence labelling and analysis using fluorescence assisted cell sorting (FACS Canto machine).",
                                                            "SecondaryOutcomeTimeFrame": "48 hours, 2, 4, 8, 12 weeks after MSC administration"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nEstablished diagnosis of SSc according to the 2013 ACR/EULAR criteria\n\nAt least one active digital ulcer (painful area, >2 mm in diameter with visible depth and loss of dermis) refractory to intravenous prostacyclins\n\n'Refractory to prostacyclins' is defined as\nWorsening of ulcer(s) within 1 month after prostacyclins iv\nNo improvement of ulcer(s) after 2 months after prostacyclins iv, as judged by the referring physician\nRecurrence of exactly the same ulcer(s) (same location) within 3 months after prostacyclins iv\nWritten informed consent\n\nExclusion Criteria:\n\nUlcer with underlying calcinosis (ruled out by X-ray prior to screening/inclusion)\nHistory of neoplasm or malignancy in the past 10 years\nPregnancy or unwillingness to use adequate contraception during study\nSerious known concomitant disease with life expectancy <1 year\nUncontrolled hypertension\nUncontrolled acute or chronic infection with systemic symptoms (e.g. fever)\nFollow-up impossible",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Femke van Rhijn, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "0031887557329",
                                                            "CentralContactEMail": "f.c.c.brouwer-3@umcutrecht.nl"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Marianne Verhaar, MD, PhD",
                                                            "OverallOfficialAffiliation": "UMC Utrecht",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Universitair Medisch Centrum Utrecht",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Utrecht",
                                                            "LocationZip": "3584 CX",
                                                            "LocationCountry": "Netherlands",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Marianne Verhaar, MD, PhD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Jaap van Laar, MD, PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Femke van Rhijn, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "30127049",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "van Rhijn-Brouwer FCC, Gremmels H, Fledderus JO, Schuurman AH, Bonte-Mineur F, Vonk MC, Voskuyl AE, de Vries-Bouwstra JK, Coert JH, Radstake TRDJ, van Laar JM, Verhaar MC; MANUS Study Group. A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol. BMJ Open. 2018 Aug 20;8(8):e020479. doi: 10.1136/bmjopen-2017-020479."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Undecided"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000012595",
                                                            "ConditionMeshTerm": "Scleroderma, Systemic"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000045743",
                                                            "ConditionMeshTerm": "Scleroderma, Diffuse"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012883",
                                                            "ConditionMeshTerm": "Skin Ulcer"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012598",
                                                            "ConditionMeshTerm": "Sclerosis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000014456",
                                                            "ConditionMeshTerm": "Ulcer"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003240",
                                                            "ConditionAncestorTerm": "Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012871",
                                                            "ConditionAncestorTerm": "Skin Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M14567",
                                                            "ConditionBrowseLeafName": "Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14564",
                                                            "ConditionBrowseLeafName": "Scleroderma, Systemic",
                                                            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M24713",
                                                            "ConditionBrowseLeafName": "Scleroderma, Diffuse",
                                                            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16358",
                                                            "ConditionBrowseLeafName": "Ulcer",
                                                            "ConditionBrowseLeafAsFound": "Ulcer",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16552",
                                                            "ConditionBrowseLeafName": "Vascular Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11486",
                                                            "ConditionBrowseLeafName": "Neovascularization, Pathologic",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14838",
                                                            "ConditionBrowseLeafName": "Skin Ulcer",
                                                            "ConditionBrowseLeafAsFound": "Digital Ulcers",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5616",
                                                            "ConditionBrowseLeafName": "Connective Tissue Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14826",
                                                            "ConditionBrowseLeafName": "Skin Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T5565",
                                                            "ConditionBrowseLeafName": "Systemic Scleroderma",
                                                            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC14",
                                                            "ConditionBrowseBranchName": "Heart and Blood Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 27,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02805855",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "15-008179"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Mayo Clinic",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis",
                                          "OfficialTitle": "Safety and Feasibility of Autologous Culture Expanded Adipose Derived Mesenchymal Stromal Cells in the Treatment of Painful Knee Osteoarthritis"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2022",
                                          "OverallStatus": "Active, not recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "October 26, 2016",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "April 26, 2023",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "April 26, 2023",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "June 16, 2016",
                                          "StudyFirstSubmitQCDate": "June 16, 2016",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 20, 2016",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "April 4, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 6, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Jacob L. Sellon, M.D.",
                                                "ResponsiblePartyInvestigatorTitle": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorAffiliation": "Mayo Clinic"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Jacob L. Sellon, M.D.",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The study seeks to determine the safety and feasibility of using adipose-derived mesenchymal stromal cells to treat symptoms of mild to severe knee osteoarthritis.",
                                          "DetailedDescription": "Interventions to alter the natural course of osteoarthritis (OA) in the knee are elusive and joint replacement remains the definitive management for refractory, end-stage disease. The Mayo Clinic has a large, ongoing experience using autologous adipose derived mesenchymal stromal cells (AMSCs) for the treatment of a variety of other diseases under INDs. Thus far, the treatments have been well tolerated. These data along with the investigators' pre-clinical animal studies and published experiences using related approaches lead the investigators to believe that this approach provides a reasonable safety profile to treat patients with refractory painful knee OA. The purpose of the current study is to investigate the safety and feasibility of single and multiple injections of autologous, culture expanded AMSCs in subjects with painful, refractory knee OA. Subjects with unilaterally symptomatic mild to severe knee OA will be enrolled based on satisfaction of inclusion and exclusion criteria."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Osteoarthritis, Knee"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "24",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "S50",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Subjects in the S50 cohort will receive one injection of 50 million AMSCs.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Autologous Adipose-Derived Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "S100",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Subjects in the S100 cohort will receive one injection of 100 million AMSCs.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Autologous Adipose-Derived Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "M50",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Subjects in the M50 cohort will receive three injections of 50 million AMSCs at one-month intervals.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Autologous Adipose-Derived Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "M100",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Subjects in the M100 cohort will receive three injections of 100 million AMSCs at one-month intervals.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Autologous Adipose-Derived Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Autologous Adipose-Derived Mesenchymal Stromal Cells",
                                                            "InterventionDescription": "Human, autologous, culture expanded, adipose derived, mesenchymal stromal cells (AMSCs) produced on site in the Mayo Clinic Human Cellular Therapy Laboratory using current good manufacturing practices (cGMPs).",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "M100",
                                                                        "M50",
                                                                        "S100",
                                                                        "S50"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "AMSCs"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of subjects experiencing adverse events.",
                                                            "PrimaryOutcomeDescription": "Assess the local and systemic safety of single and multiple injections of human, autologous, culture expanded AMSCs in the treatment of symptomatic knee OA.",
                                                            "PrimaryOutcomeTimeFrame": "2 years post final injection"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria\n\nMale or female ages 40-70 years\n\nFemales of childbearing potential must have a negative pregnancy test prior to receiving the study drug and will agree use adequate contraception (hormonal or barrier method or abstinence) from the time of screening to a period of 1 year following completion of the drug treatment cycle. Females of childbearing potential are defined as premenopausal and not surgically sterilized, or post-menopausal for fewer than 2 years. A urine pregnancy test will be performed prior to the administration of the study drug to confirm negative results. If the urine pregnancy test is positive, the study drug will not be administered and the result will be confirmed by a serum pregnancy test. Serum pregnancy tests will be performed at a central clinical laboratory, whereas urine pregnancy tests will be performed by qualified personnel using kit\nFemales becoming pregnant during the study will continue to be monitored for the duration of the study or completion of the pregnancy, whichever is longer. Monitoring will include perinatal and neonatal outcome. Any SAEs associated with pregnancy will be recorded. Females in the multiple-dose cohorts (M50 and M100) who become pregnant during the treatment cycle will not receive their remaining injections.\nChronic (> 3 months), unilaterally symptomatic, primary femorotibial knee OA\nRadiographic medial and/or lateral femorotibial knee OA at least Kellgren-Lawrence grade 2 accompanied by definite joint space narrowing as agreed upon by two study co-investigators\nPrevious 6 week or longer trial of one of the following conservative treatments: activity modification, weight loss, physical therapy, anti-inflammatory medications or injection therapy (e.g. cortisone, hyaluronic acid/viscosupplement)\nAble to routinely walk without assistance (e.g. cane, walker)\nClinically stable target knee\nNo surgery planned in the target knee for at least 12 months following the last injection\nCompleted general physical evaluation with primary care provider within 12 months of enrollment\nFully understanding of the requirements of the study and willingness to comply with the treatment plan, including fat harvesting, laboratory tests, diagnostic imaging, repeated knee injections/aspirations, arthroscopic examination and follow-up visits and assessments\nCan provide written informed consent and complete HIPAA documentation after the nature of the study is fully explained and prior to any study-related procedure\n\nExclusion Criteria\n\nPregnant or nursing, or planning on becoming pregnant during the study period\nCongenital or acquired malformation of the target knee resulting in significant deformity or leading to problems with the study treatment or analysis of the results\nSignificant malalignment on full length, standing radiographs\nArthroplasty hardware or implantable devices in the index knee (intraosseous screws or other hardware not contacting the articular space are not excluded)\nSurgery on the index knee within 1 year of study enrollment\nInjections of any into the index knee within 3 months prior to study enrollment\nLocking, catching, give-away or another major mechanical symptoms of the target knee\nSymptomatic patellofemoral arthritis or chondromalacia in the index knee\nHistory of intra-articular infection in the index knee\nHistory of superficial infection in the index knee within 6 months of study enrollment, or evidence of current superficial infection affecting the index knee\nHistory of falls requiring medical attention, or gait instability\nClinically significant abnormal hematology (complete blood count with differential), blood chemistry, or urinalysis screening laboratory results, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, creatinine, and CRP\nBody mass index (BMI) > 40 kg/m2\nTaking anticoagulant medications (e.g. warfarin, heparin) or clopidogrel (Plavix)\nTaking herbal therapies or supplements within 4 weeks of enrollment or unwilling to avoid use of herbal therapies or supplements until at least 30 days following completion of the study drug treatment cycle (includes, but not limited to chondroitin sulfate, diacerein, n-glucosamine, piascledine, and capsaicin)\nTaking non-steroidal anti-inflammatory medications (e.g. COX-2 inhibitors) without a stable dosing regimen for at least 4 weeks before baseline evaluation, or anticipating not remaining on a stable dose until at least 30 days following completion of the study drug treatment cycle\nUse of electrotherapy or acupuncture for OA, unless there is a stable regimen for at least 4 weeks before baseline assessment\nTaking anti-rheumatic disease medication (including methotrexate or other antimetabolites) within 3 months prior to study enrollment\nOn chronic, immunosuppressive transplant therapy or having a chronic, immunosuppressive state, including use of systemic steroids/corticosteroids\nCurrent tobacco product use, including nicotine patch or other nicotine products\nSystemic inflammatory, rheumatological or connective tissue disorder including but not limited to rheumatoid arthritis, systemic sclerosis, system lupus erythematosus, and Ehlers-Danlos Syndrome\nRheumatological or inflammatory disease of the knee or chondrocalcinosis/calcium pyrophosphate disease (CPPD), hemochromatosis, inflammatory arthritis, arthropathy of the knee associated with juxta-articular Paget's disease of the femur or tibia, ochronosis, hemophilic arthropathy, infectious arthritis, Charcot's knee joint, villonodular synovitis, and synovial chondromatosis\nOngoing infectious disease, including but not limited to tuberculosis, HIV, hepatitis, and syphilis\nClinically significant cardiovascular (e.g. history of myocardial infarction, congestive heart failure or uncontrolled hypertension > 90 mmHg diastolic and/or 180 mmHg systolic), neurologic (e.g. stroke, TIA) renal, hepatic, orthopedic (e.g. surgery on other weight bearing joints that will interfere with study, osteoporosis, acute lower body fractures), or endocrine disease (e.g. diabetes).\nVascular or neurological disorder affecting the index either lower limb\nHistory of cancer/malignancy with the exception of adequately treated basal cell or squamous cell carcinoma of the skin not associated with the target knee\nHistory of blood dyscrasia, including but not limited to anemia, thrombocytopenia, and monoclonal gammopathy\nParticipation in a study of an experimental drug or medical device within 3 months of study enrollment\nKnown allergy to local anesthetics of other components of the study drug\nAny contraindication to MRI scan according to MRI guidelines, or unwillingness to undergo MRI procedures\nHistory of or current evidence of alcohol or drug abuse or dependence, recreational use of illicit drug or prescription medications, or have use of medical marijuana within 30 days of study entry\nAny illness or condition which, in the investigators' judgement will interfere with the patient's ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of the study results",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "40 Years",
                                          "MaximumAge": "70 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Jacob Sellon, MD",
                                                            "OverallOfficialAffiliation": "Mayo Clinic",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Mayo Clinic in Rochester",
                                                            "LocationCity": "Rochester",
                                                            "LocationState": "Minnesota",
                                                            "LocationZip": "55905",
                                                            "LocationCountry": "United States"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "Mayo Clinic Clinical Trials",
                                                            "SeeAlsoLinkURL": "https://www.mayo.edu/research/clinical-trials"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000010003",
                                                            "ConditionMeshTerm": "Osteoarthritis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000020370",
                                                            "ConditionMeshTerm": "Osteoarthritis, Knee"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000001168",
                                                            "ConditionAncestorTerm": "Arthritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007592",
                                                            "ConditionAncestorTerm": "Joint Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009140",
                                                            "ConditionAncestorTerm": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012216",
                                                            "ConditionAncestorTerm": "Rheumatic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M21321",
                                                            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
                                                            "ConditionBrowseLeafAsFound": "Osteoarthritis, Knee",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12078",
                                                            "ConditionBrowseLeafName": "Osteoarthritis",
                                                            "ConditionBrowseLeafAsFound": "Osteoarthritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12218",
                                                            "ConditionBrowseLeafName": "Pain",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3628",
                                                            "ConditionBrowseLeafName": "Arthritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9773",
                                                            "ConditionBrowseLeafName": "Joint Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11249",
                                                            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14197",
                                                            "ConditionBrowseLeafName": "Rheumatic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5475",
                                                            "ConditionBrowseLeafName": "Collagen Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 28,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04626583",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2020-0334"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "W81XWH-18-1-0661",
                                                            "SecondaryIdType": "Other Grant/Funding Number",
                                                            "SecondaryIdDomain": "United States Department of Defense"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "University of Illinois at Chicago",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells",
                                          "OfficialTitle": "Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells for Promoting Corneal Repair"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2022",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "March 5, 2021",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 30, 2023",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 30, 2023",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "November 10, 2020",
                                          "StudyFirstSubmitQCDate": "November 10, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "November 12, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "April 19, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 21, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Ali R Djalilian",
                                                "ResponsiblePartyInvestigatorTitle": "Professor of Ophthalmology",
                                                "ResponsiblePartyInvestigatorAffiliation": "University of Illinois at Chicago"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "University of Illinois at Chicago",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "United States Department of Defense",
                                                            "CollaboratorClass": "FED"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This study is a longitudinal assessment using a classic dose-escalation study design to assess the safety and maximal tolerated dose (MTD) of locally delivered allogeneic mesenchymal stromal cells (MSC) for promoting corneal repair. The study will be conducted at Illinois Eye and Ear Infirmary located at University of Illinois at Chicago. The study will use digital conjunctival and corneal photography and corneal Scheimpflug Imaging, densitometry, and pachymetry for assessment of safety and corneal wound healing.",
                                          "DetailedDescription": "The \"Safety of Locally Delivered Allogeneic Mesenchymal Stem Cells for Promoting Corneal Repair Study\" otherwise known as the \"MSC Study,\" is designed to assess the safety of allogeneic bone marrow-derived MSC secreted factor on the ocular surface via subconjunctival injection of MSC, and also obtain a preliminary observation on the following:\n\nEpithelial barrier integrity and/or wound closure.\nDevelopment of Scarring.\nFinal Visual Acuity.\n\nThe objective is to improve clinical outcomes in significant non-healing corneal wounds. To achieve these goals, the MSC Study will include a Phase I dose-escalation safety study."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Mesenchymal Stromal Cells",
                                                      "Cornea",
                                                      "Safety",
                                                      "Corneal Defect"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal Stromal Cells",
                                                      "Corneal Defect"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Sequential Assignment",
                                                "DesignInterventionModelDescription": "A longitudinal assessment using a classic dose-escalation study design to assess the safety of locally delivered allogenic mesenchymal stromal cells for promoting corneal repair.",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "18",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Low dose of allogeneic MSC",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Escalating doses of allogeneic MSC subconjunctival injection will be assigned 1,000,000 cells/50 \u00b5L at the low dose level.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Allogeneic MSC"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Medium dose of allogeneic MSC",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Escalating doses of allogeneic MSC subconjunctival injection will be assigned 3,000,000 cells/150 \u00b5L at the medium dose level.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Allogeneic MSC"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "High dose of allogeneic MSC",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Escalating doses of allogeneic MSC subconjunctival injection will be assigned 6,000,000 cells total consisting of injection at 2 sites of 3,000,000 cells/150 \u00b5L each at the high dose level.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Allogeneic MSC"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Allogeneic MSC",
                                                            "InterventionDescription": "Subconjunctival Injection of Allogeneic Mesenchymal Stromal Cells",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "High dose of allogeneic MSC",
                                                                        "Low dose of allogeneic MSC",
                                                                        "Medium dose of allogeneic MSC"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Primary Safety Outcome: Incidence of treatment emergent adverse events (TEAE) assessed at 28 days.",
                                                            "PrimaryOutcomeDescription": "Slit lamp exam will assess the safety of the treatment via TEAE at 28 days (participants will receive continued monitoring through 90 days). TEAE will be defined according to the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE v5) adverse event reference, and used to identify dose-limiting toxicity (DLT).\n\nThe DLT will be defined as any non-corneal, ocular or systemic TEAE, with a Grade 2 toxicity without resolution after 14 days OR a Grade 3 toxicity, unless it can clearly be attributed to another cause. The DLT will be used to define the maximal tolerated dose (MTD).\n\nThe MTD will be defined as the highest dose at which 0 to 1 of 6 patients experiences a dose-limiting toxicity (DLT). If a DLT occurs in 2 patients in a dosing cohort, then the MTD is considered exceeded and the dose will not be escalated.",
                                                            "PrimaryOutcomeTimeFrame": "Day #28"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Primary Efficacy Outcome: Proportion of participants with improvement in epithelial defect or barrier integrity relative to baseline (based on fluorescein staining)",
                                                            "PrimaryOutcomeDescription": "Presence or absence of epithelial defect and epithelial staining grade following treatment, as determined by fluorescein staining observed via slit lamp examination, and photo-documented with digital corneal photography.",
                                                            "PrimaryOutcomeTimeFrame": "Day #28"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Secondary Efficacy Outcomes: Visual Acuity",
                                                            "SecondaryOutcomeDescription": "Best-corrected distance visual acuity will be measured using standard e-ETDRS protocols.",
                                                            "SecondaryOutcomeTimeFrame": "Enrollment, Treatment, and Days #1, #7, #14, #28, #90"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Secondary Efficacy Outcomes: Time to Completion of Corneal Epithelialization",
                                                            "SecondaryOutcomeDescription": "Time to completion of corneal epithelialization will be assessed at each visit throughout the trial. Corneal epithelialization will be assessed as previously described.",
                                                            "SecondaryOutcomeTimeFrame": "Enrollment, Treatment, and Days #1, #7, #14, #28, #90"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Secondary Efficacy Outcomes: Durability of the Corneal Epithelialization and Healing",
                                                            "SecondaryOutcomeDescription": "Durability of the corneal epithelization and healing will be assessed as an outcome measure at DAY #28 and DAY #90. Participants with corneal epithelialization prior to DAY #28 will be assessed at each subsequent follow-up visit (e.g., DAYS #7, #14, #28) to assess persistence of the healing response. Corneal epithelialization will be assessed as previously described.",
                                                            "SecondaryOutcomeTimeFrame": "Enrollment, Treatment, and Days #1, #7, #14, #28, #90"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Secondary Efficacy Outcomes: Corneal stromal haze",
                                                            "SecondaryOutcomeDescription": "Corneal stromal haze will be measured from Scheimpflug imaging and anterior segment OCT images (using Image J software). The treatment effect on corneal haze on DAY #28 will be compared relative to baseline.",
                                                            "SecondaryOutcomeTimeFrame": "Enrollment and Days #7, #14, #28, #90"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Secondary Efficacy Outcomes: Corneal epithelial thickness",
                                                            "SecondaryOutcomeDescription": "Corneal epithelial thickness measured by anterior segment OCT imaging will assess the treatment effect on thickness on DAY #28 and compared relative to baseline.",
                                                            "SecondaryOutcomeTimeFrame": "Enrollment and Days #7, #14, #28, #90"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAge:\n\n\u2022 Patients 18 years of age or older\n\nVisual Acuity:\n\n\u2022 Best corrected distance visual acuity (BCDVA) score \u2264 75 ETDRS letters, (\u2265 0.2 LogMAR, \u2264 20/32 Snellen or \u2264 0.625 decimal fraction) in the affected eye.\n\nOcular Health:\n\nPatients with moderate to severe chronic corneal epithelial disease in the setting of neurotrophic keratitis, limbal stem cell deficiency, or inflammatory dry eye disease.\nEpithelial disease refractory to all applicable standard / FDA approved non-surgical treatments (e.g., preservative-free artificial tears, gels or ointments; discontinuation of preserved topical drops; anti-inflammatory therapy, and soft bandage contact lens).\nEvidence of impaired epithelial barrier manifested by fluorescein staining of the epithelium with a score 6 or higher by National Eye Institute grading.\nNo objective clinical evidence of improvement since the last visit (\u226450% reduction in fluorescein staining or \u226450% reduction in longest diameter of the epithelial defect).\nPatients with stage 1 (no epithelial defect) stage 2 (persistent epithelial defect, PED; without stromal loss) or stage 3 (corneal ulcer; with stromal loss) neurotrophic keratopathy 28-30 limited to \u226480% corneal diameter. Stromal loss in corneal ulcers cannot exceed 50%.\nEtiology of all persistent epithelial defects and corneal ulcers will be neurotrophic in nature. Neurotrophic keratopathy may be due to previous trauma such as chemical and thermal burns, systemic diseases like diabetes, post-infectious keratitis such as herpetic disease, or cranial nerve V palsies such as surgery for trigeminal neuralgia.\nPED or corneal ulceration refractory to one or more conventional non-surgical treatments (e.g., preservative-free artificial tears, gels or ointments; discontinuation of preserved topical drops and medications that can decrease corneal sensitivity; therapeutic contact lenses).\nNo objective clinical evidence of improvement in the PED or corneal ulceration within the week prior to study enrollment (e.g., \u226450% reduction in longest diameter in 1 week).\nEvidence of decreased corneal sensitivity (\u2264 4 cm using the Cochet-Bonnet aesthesiometer) within the area of the PED or corneal ulcer and outside of the area of the defect in at least one corneal quadrant.\n\nExclusion Criteria:\n\nVisual Acuity:\n\n\u2022 Patients with severe vision loss in the affected eye with no potential for visual improvement in the opinion of the investigator as a result of the study treatment.\n\nOcular Health:\n\nAny active ocular infection (bacterial, viral, fungal or protozoal) or active ocular inflammation not related to PED in the affected eye.\nHistory of any ocular surgery (including laser or refractive surgical procedures) in the affected eye within the three months before study enrollment. An exception to the preceding statement will be allowed if the ocular surgery is considered to be the cause of the PED. Ocular surgery in the affected eye will not be allowed during the study treatment period and elective ocular surgery procedures should not be planned during the duration of the follow-up period.\nPrior surgical procedure(s) for the treatment of a PED (e.g., complete tarsorrhaphy, conjunctival flap, etc.) in the affected eye with the exception of amniotic membrane transplantation. Patients previously treated with amniotic membrane transplantation may only be enrolled two weeks after the membrane has disappeared within the area of the PED or corneal ulcer or at least six weeks after the date of the amniotic membrane transplantation procedure. Patients previously treated with Botox (botulinum toxin) injections used to induce pharmacologic blepharoptosis are eligible for enrollment only if the last injection was given at least 90 days prior to enrollment in the study.\nAnticipated need for punctual occlusion during the study treatment period. Patients with punctual occlusion or punctual plugs inserted prior to the study are eligible for enrollment provided that the punctual occlusion is maintained during the study.\nEvidence of corneal ulceration involving the posterior third of the corneal stroma, corneal melting or perforation in the affected eye.\nPresence or history of any ocular or systemic disorder or condition that might hinder the efficacy of the study treatment or its evaluation, could possibly interfere with the interpretation of study results, or could be judged by the investigator to be incompatible with the study visit schedule or conduct (e.g., progressive or degenerative corneal or retinal conditions, uveitis, optic neuritis, poorly controlled diabetes, autoimmune disease, systemic infection, neoplastic diseases).\nAny need for or anticipated change in the dose of systemic medications known to impair the function of the trigeminal nerve (e.g., neuroleptics, antipsychotic and antihistamine drugs). These treatments are allowed during the study if initiated prior to 30 days before study enrollment provided they remain stable throughout the course of the study treatment periods.\n\nStudy Procedures:\n\nKnown hypersensitivity to one of the components of the study or procedural medications (e.g., fluorescein).\nHistory of drug, medication or alcohol abuse or addiction.\nUse of any investigational agent within 4 weeks of screening visit.\nParticipation in another clinical study at the same time as the present study.\nParticipants who are pregnant at the time of study enrollment.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Ali R Djalilian, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "312-996-8937",
                                                            "CentralContactEMail": "adjalili@uic.edu"
                                                      },
                                                      {
                                                            "CentralContactName": "Charlotte E Joslin, OD, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "312-996-5410",
                                                            "CentralContactEMail": "charjosl@uic.edu"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Ali R Djalilian, MD",
                                                            "OverallOfficialAffiliation": "University of Illinois Chicago",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Charlotte E Joslin, OD, PhD",
                                                            "OverallOfficialAffiliation": "University of Illinois Chicago",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "University of Illinois, Department of Ophthalmology and Visual Sciences",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Chicago",
                                                            "LocationState": "Illinois",
                                                            "LocationZip": "60612",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Ali R Djalilian, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "312-996-8937",
                                                                              "LocationContactEMail": "adjalili@uic.edu"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Charlotte Joslin, OD, PhD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "3129965410",
                                                                              "LocationContactEMail": "charjosl@uic.edu"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "25124272",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Cockerham GC, Lemke S, Rice TA, Wang G, Glynn-Milley C, Zumhagen L, Cockerham KP. Closed-globe injuries of the ocular surface associated with combat blast exposure. Ophthalmology. 2014 Nov;121(11):2165-72. doi: 10.1016/j.ophtha.2014.06.009. Epub 2014 Aug 11."
                                                      },
                                                      {
                                                            "ReferencePMID": "23321357",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Cockerham GC, Lemke S, Glynn-Milley C, Zumhagen L, Cockerham KP. Visual performance and the ocular surface in traumatic brain injury. Ocul Surf. 2013 Jan;11(1):25-34. doi: 10.1016/j.jtos.2012.09.004. Epub 2012 Oct 5."
                                                      },
                                                      {
                                                            "ReferencePMID": "21631351",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Cockerham GC, Rice TA, Hewes EH, Cockerham KP, Lemke S, Wang G, Lin RC, Glynn-Milley C, Zumhagen L. Closed-eye ocular injuries in the Iraq and Afghanistan wars. N Engl J Med. 2011 Jun 2;364(22):2172-3. doi: 10.1056/NEJMc1010683."
                                                      },
                                                      {
                                                            "ReferencePMID": "21791191",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Baradaran-Rafii A, Eslani M, Tseng SC. Sulfur mustard-induced ocular surface disorders. Ocul Surf. 2011 Jul;9(3):163-78. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "27650263",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Baradaran-Rafii A, Eslani M, Haq Z, Shirzadeh E, Huvard MJ, Djalilian AR. Current and Upcoming Therapies for Ocular Surface Chemical Injuries. Ocul Surf. 2017 Jan;15(1):48-64. doi: 10.1016/j.jtos.2016.09.002. Epub 2016 Sep 17. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "25105018",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Eslani M, Baradaran-Rafii A, Movahedan A, Djalilian AR. The ocular surface chemical burns. J Ophthalmol. 2014;2014:196827. doi: 10.1155/2014/196827. Epub 2014 Jul 1. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "26226389",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Al-Moujahed A, Chodosh J. Outcomes of an algorithmic approach to treating mild ocular alkali burns. JAMA Ophthalmol. 2015 Oct;133(10):1214-6. doi: 10.1001/jamaophthalmol.2015.2302."
                                                      },
                                                      {
                                                            "ReferencePMID": "22008910",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther. 2012 Jan;20(1):14-20. doi: 10.1038/mt.2011.211. Epub 2011 Oct 18. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "27693426",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Mittal SK, Omoto M, Amouzegar A, Sahu A, Rezazadeh A, Katikireddy KR, Shah DI, Sahu SK, Chauhan SK. Restoration of Corneal Transparency by Mesenchymal Stem Cells. Stem Cell Reports. 2016 Oct 11;7(4):583-590. doi: 10.1016/j.stemcr.2016.09.001. Epub 2016 Sep 29."
                                                      },
                                                      {
                                                            "ReferencePMID": "27809910",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Wang LT, Ting CH, Yen ML, Liu KJ, Sytwu HK, Wu KK, Yen BL. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. J Biomed Sci. 2016 Nov 4;23(1):76. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "27840134",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Yun YI, Park SY, Lee HJ, Ko JH, Kim MK, Wee WR, Reger RL, Gregory CA, Choi H, Fulcher SF, Prockop DJ, Oh JY. Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury. Cytotherapy. 2017 Jan;19(1):28-35. doi: 10.1016/j.jcyt.2016.10.007. Epub 2016 Nov 10."
                                                      },
                                                      {
                                                            "ReferencePMID": "15895027",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ye J, Yao K, Kim JC. Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: engraftment and involvement in wound healing. Eye (Lond). 2006 Apr;20(4):482-90."
                                                      },
                                                      {
                                                            "ReferencePMID": "22363499",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Yao L, Li ZR, Su WR, Li YP, Lin ML, Zhang WX, Liu Y, Wan Q, Liang D. Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn. PLoS One. 2012;7(2):e30842. doi: 10.1371/journal.pone.0030842. Epub 2012 Feb 17."
                                                      },
                                                      {
                                                            "ReferencePMID": "21837654",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Roddy GW, Oh JY, Lee RH, Bartosh TJ, Ylostalo J, Coble K, Rosa RH Jr, Prockop DJ. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-\u03b1 stimulated gene/protein 6. Stem Cells. 2011 Oct;29(10):1572-9. doi: 10.1002/stem.708."
                                                      },
                                                      {
                                                            "ReferencePMID": "18192235",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Oh JY, Kim MK, Shin MS, Lee HJ, Ko JH, Wee WR, Lee JH. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells. 2008 Apr;26(4):1047-55. doi: 10.1634/stemcells.2007-0737. Epub 2008 Jan 10."
                                                      },
                                                      {
                                                            "ReferencePMID": "16109757",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ma Y, Xu Y, Xiao Z, Yang W, Zhang C, Song E, Du Y, Li L. Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells. 2006 Feb;24(2):315-21. Epub 2005 Aug 18."
                                                      },
                                                      {
                                                            "ReferencePMID": "27110252",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Li F, Zhao SZ. Control of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface Diseases. Stem Cells Int. 2016;2016:7961816. doi: 10.1155/2016/7961816. Epub 2016 Mar 24. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "24145108",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Cejkova J, Trosan P, Cejka C, Lencova A, Zajicova A, Javorkova E, Kubinova S, Sykova E, Holan V. Suppression of alkali-induced oxidative injury in the cornea by mesenchymal stem cells growing on nanofiber scaffolds and transferred onto the damaged corneal surface. Exp Eye Res. 2013 Nov;116:312-23. doi: 10.1016/j.exer.2013.10.002. Epub 2013 Oct 18."
                                                      },
                                                      {
                                                            "ReferencePMID": "27637759",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Bartlett RS, Guille JT, Chen X, Christensen MB, Wang SF, Thibeault SL. Mesenchymal stromal cell injection promotes vocal fold scar repair without long-term engraftment. Cytotherapy. 2016 Oct;18(10):1284-96. doi: 10.1016/j.jcyt.2016.07.005."
                                                      },
                                                      {
                                                            "ReferencePMID": "24449458",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Bara JJ, Richards RG, Alini M, Stoddart MJ. Concise review: Bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic. Stem Cells. 2014 Jul;32(7):1713-23. doi: 10.1002/stem.1649. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "20215542",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ivy SP, Siu LL, Garrett-Mayer E, Rubinstein L. Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee. Clin Cancer Res. 2010 Mar 15;16(6):1726-36. doi: 10.1158/1078-0432.CCR-09-1961. Epub 2010 Mar 9."
                                                      },
                                                      {
                                                            "ReferencePMID": "27514011",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ghazaryan E, Zhang Y, He Y, Liu X, Li Y, Xie J, Su G. Mesenchymal stem cells in corneal neovascularization: Comparison of different application routes. Mol Med Rep. 2016 Oct;14(4):3104-12. doi: 10.3892/mmr.2016.5621. Epub 2016 Aug 11."
                                                      },
                                                      {
                                                            "ReferencePMID": "19506718",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Stevens S. Administering a subconjunctival injection. Community Eye Health. 2009 Mar;22(69):15."
                                                      },
                                                      {
                                                            "ReferencePMID": "25160636",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Cook N, Hansen AR, Siu LL, Abdul Razak AR. Early phase clinical trials to identify optimal dosing and safety. Mol Oncol. 2015 May;9(5):997-1007. doi: 10.1016/j.molonc.2014.07.025. Epub 2014 Aug 14. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "24672223",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014 Mar 19;8:571-9. doi: 10.2147/OPTH.S45921. eCollection 2014. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "14631406",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Bonini S, Rama P, Olzi D, Lambiase A. Neurotrophic keratitis. Eye (Lond). 2003 Nov;17(8):989-95. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "24107451",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Semeraro F, Forbice E, Romano V, Angi M, Romano MR, Filippelli ME, Di Iorio R, Costagliola C. Neurotrophic keratitis. Ophthalmologica. 2014;231(4):191-7. doi: 10.1159/000354380. Epub 2013 Oct 2. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "24008847",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Arnalich-Montiel F, Hern\u00e1ndez-Verdejo JL, Oblanca N, Mu\u00f1oz-Negrete FJ, De Miguel MP. Comparison of corneal haze and visual outcome in primary DSAEK versus DSAEK following failed DMEK. Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2575-84. doi: 10.1007/s00417-013-2460-y. Epub 2013 Sep 6."
                                                      },
                                                      {
                                                            "ReferencePMID": "23685998",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Elflein HM, Hofherr T, Berisha-Ramadani F, Weyer V, Lampe C, Beck M, Pitz S. Measuring corneal clouding in patients suffering from mucopolysaccharidosis with the Pentacam densitometry programme. Br J Ophthalmol. 2013 Jul;97(7):829-33. doi: 10.1136/bjophthalmol-2012-302913. Epub 2013 May 17."
                                                      },
                                                      {
                                                            "ReferencePMID": "27027920",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Pahuja N, Shetty R, Subbiah P, Nagaraja H, Nuijts RM, Jayadev C. Corneal Densitometry: Repeatability in Eyes With Keratoconus and Postcollagen Cross-Linking. Cornea. 2016 Jun;35(6):833-7. doi: 10.1097/ICO.0000000000000800."
                                                      },
                                                      {
                                                            "ReferencePMID": "28872519",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Akkaya Turhan S, Toker E. Changes in Corneal Density After Accelerated Corneal Collagen Cross-linking With Different Irradiation Intensities and Energy Exposures: 1-Year Follow-up. Cornea. 2017 Nov;36(11):1331-1335. doi: 10.1097/ICO.0000000000001362."
                                                      },
                                                      {
                                                            "ReferencePMID": "27841786",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Enders P, Holtick U, Schaub F, Tuchscherer A, Hermann MM, Scheid C, Cursiefen C, Bachmann BO. Corneal Densitometry for Quantification of Corneal Deposits in Monoclonal Gammopathies. Cornea. 2017 Apr;36(4):470-475. doi: 10.1097/ICO.0000000000001078."
                                                      },
                                                      {
                                                            "ReferencePMID": "23347372",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Guti\u00e9rrez R, Lopez I, Villa-Collar C, Gonz\u00e1lez-M\u00e9ijome JM. Corneal transparency after cross-linking for keratoconus: 1-year follow-up. J Refract Surg. 2012 Nov;28(11):781-6. doi: 10.3928/1081597X-20121011-06."
                                                      },
                                                      {
                                                            "ReferencePMID": "21111314",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Greenstein SA, Fry KL, Bhatt J, Hersh PS. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg. 2010 Dec;36(12):2105-14. doi: 10.1016/j.jcrs.2010.06.067."
                                                      },
                                                      {
                                                            "ReferencePMID": "24767909",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Weiner X, Baumeister M, Kohnen T, B\u00fchren J. Repeatability of lens densitometry using Scheimpflug imaging. J Cataract Refract Surg. 2014 May;40(5):756-63. doi: 10.1016/j.jcrs.2013.10.039."
                                                      },
                                                      {
                                                            "ReferencePMID": "27492105",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Kim BZ, Jordan CA, McGhee CN, Patel DV. Natural history of corneal haze after corneal collagen crosslinking in keratoconus using Scheimpflug analysis. J Cataract Refract Surg. 2016 Jul;42(7):1053-9. doi: 10.1016/j.jcrs.2016.04.019."
                                                      },
                                                      {
                                                            "ReferencePMID": "27824385",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Boulze-Pankert M, Dariel R, Hoffart L. Corneal Scheimpflug Densitometry Following Photorefractive Keratectomy in Myopic Eyes. J Refract Surg. 2016 Nov 1;32(11):788-791. doi: 10.3928/1081597X-20160720-02."
                                                      },
                                                      {
                                                            "ReferencePMID": "26803798",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "McLaren JW, Wacker K, Kane KM, Patel SV. Measuring Corneal Haze by Using Scheimpflug Photography and Confocal Microscopy. Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):227-35. doi: 10.1167/iovs.15-17657."
                                                      }
                                                ]
                                          },
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products",
                                                            "SeeAlsoLinkURL": "https://www.fda.gov/media/106369/download"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M5691",
                                                            "ConditionBrowseLeafName": "Corneal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC11",
                                                            "ConditionBrowseBranchName": "Eye Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 29,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04466098",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2020LS075"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "MT2020-12",
                                                            "SecondaryIdType": "Other Identifier",
                                                            "SecondaryIdDomain": "University of Minnesota Masonic Cancer Center"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Masonic Cancer Center, University of Minnesota",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)",
                                          "OfficialTitle": "Multi-center, Randomized, Placebo Controlled, Interventional Phase 2A Clinical Trial Evaluating the Safety and Potential Efficacy of Multiple Dosing of Mesenchymal Stromal Cells in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2)"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2022",
                                          "OverallStatus": "Active, not recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "July 30, 2020",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "February 25, 2022",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "July 8, 2020",
                                          "StudyFirstSubmitQCDate": "July 8, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "July 10, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "September 22, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 26, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Masonic Cancer Center, University of Minnesota",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This is a multi-center, randomized, placebo controlled, interventional phase 2A trial to evaluate the safety profile and potential efficacy of multi-dosing of mesenchymal stromal cells (MSC) for patients with SARS-CoV-2 associated Acute Respiratory Distress Syndrome (ARDS). After informed consent, treatment assignment will be made by computer-generated randomization to administer either MSC or vehicle placebo control with a 2:1 allocation to the MSC: placebo arm.",
                                          "DetailedDescription": "MSCs are adult, non-hematopoietic precursor cells derived from a variety of tissues (e.g., bone marrow, adipose tissue, and placenta) and have been used as therapy in multiple conditions, especially in immune-mediated inflammatory diseases, such as graft versus-host disease (GVHD) and systemic lupus erythematosus (SLE) with evidence of benefit.\n\nIn preclinical models, MSC are effective in ameliorating acute lung injury due to their ability to secrete paracrine factors that regulate lung endothelial and epithelial permeability, including growth factors, anti-inflammatory cytokines, and antimicrobial peptides. Based on the promising pre-clinical preliminary data and intriguing results in patients with COVID-19 associated pneumonia and ARDS as well as an established safety profile of MSC generally and in ARDS in particular, the researchers propose multiple dosing of MSCs as a study treatment to ameliorate the severity and duration of SARS-CoV-2 associated pneumonia and ARDS potentially improve survival.\n\nPatients will receive study agent (MSC or placebo) within 48 hours of enrollment. Three doses will be administered unless a severe infusion adverse event occurs that is related to the MSC infusion. Doses will be repeated approximately every 48-72 hours with the aim of completing 3 doses within 7 days of the first dose. All patients will receive standard of care treatments for ARDS."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Acute Respiratory Distress Syndrome",
                                                      "ARDS (Moderate or Severe)",
                                                      "COVID-19 Pneumonia"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "cytokine storm",
                                                      "Mesenchymal Stem Cells",
                                                      "SARS-CoV-2",
                                                      "COVID-19",
                                                      "Mesenchymal Stromal Cells",
                                                      "MSC"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignInterventionModelDescription": "This is a randomized (2:1 ratio) placebo controlled trial.",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Triple",
                                                      "DesignMaskingDescription": "Patients will be randomly assigned (2:1) to receive either 300 \u00d7 10^6 MSC or vehicle placebo control. Randomization will be stratified by risk (high versus standard risk based on the presence of preexisting co-morbidities), using permuted block sizes of 3. The allocation sequence will be accessed by each cell processing laboratory through ONCORE. Personnel in the cell processing laboratories are not masked to the treatment group, but patients, clinical staff, and investigators will be unaware of treatment assignment. To maintain masking of the investigators and clinicians, bags containing the study products and intravenous tubing had opaque coverings applied in the cell laboratories.",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "9",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal Cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Three fixed doses of MSC approximately 48 hours apart.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Placebo",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Three fixed doses of placebo control approximately 48 hours apart.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stromal cells",
                                                            "InterventionDescription": "Thawed product containing MSC(300x10^6) in DMSO resuspended 1:1 with Dextran 40 + 5% human serum albumin [total volume 60 mL]",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal Cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "MSC"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "Placebo",
                                                            "InterventionDescription": "Dextran 40 + 5% human serum albumin [total volume 60 mL]",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Incidence of grade 3-5 infusional toxicities and predefined hemodynamic or respiratory adverse events related to the infusion of MSC",
                                                            "PrimaryOutcomeTimeFrame": "Within 6 hours of the start of the infusion"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence of a reduction in one or more biomarkers of inflammation by day 7",
                                                            "SecondaryOutcomeTimeFrame": "Day 7 after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Trend changes in PaO2:FiO2 ratio",
                                                            "SecondaryOutcomeTimeFrame": "On the day of screening and on days 3, 7 and 14 after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Trend changes in Mean Airway Pressure",
                                                            "SecondaryOutcomeTimeFrame": "On the day of screening and on days 3, 7 and 14 after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Trend changes in peak pressure",
                                                            "SecondaryOutcomeTimeFrame": "On the day of screening and on days 3, 7 and 14 after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Trend changes in plateau pressure",
                                                            "SecondaryOutcomeTimeFrame": "On the day of screening (baseline) and on days 3, 7 and 14 after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Trend changes in Positive end-expiratory airway pressure (PEEP)",
                                                            "SecondaryOutcomeTimeFrame": "On the day of screening and on days 3, 7 and 14 after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence of mortality",
                                                            "SecondaryOutcomeTimeFrame": "28 days after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence of mortality",
                                                            "SecondaryOutcomeTimeFrame": "100 days after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of ICU-free days",
                                                            "SecondaryOutcomeTimeFrame": "28 days after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of days alive and ventilator free composite score 3",
                                                            "SecondaryOutcomeTimeFrame": "28 days after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in acute lung injury (ALI) score 2",
                                                            "SecondaryOutcomeDescription": "Acute Lung Injury Score is a composite 4 point scoring system validated by the NHLBI ARDS Network that considers PaO2/FiO2, the level of positive end-expiratory airway pressure, respiratory compliance, and the extent of pulmonary infiltrates on the chest radiograph",
                                                            "SecondaryOutcomeTimeFrame": "Baseline and Day 28 after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence of serious adverse events",
                                                            "SecondaryOutcomeTimeFrame": "28 days after first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of days alive off supplemental oxygen",
                                                            "SecondaryOutcomeTimeFrame": "100 days after first infusion"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAge 18-80 years\nMeets 'Berlin Criteria' for diagnosis of moderate to severe ARDS for a minimum of 4 hours\nLess than 48 hours on a ventilator after meeting criteria for diagnosis of ARDS\nSARS-CoV-2 (proven by RT-PCR assay) with radiographic infiltrates\nPaO2/FiO2 < 250\nPositive end-expiratory airway pressure (PEEP) >5 cm H20\nElevated C-reactive protein (above laboratory upper limit of normal)\nMeets organ function requirements, including left ventricular ejection fraction (LVEF) >35% ( as defined below)\nOff other investigational agents directed against inflammatory cytokines 48 hours prior to enrollment; agents directed against the replication of SARS-CoV-2 [e.g., Remdesivir] are permitted\nVoluntary informed consent in person or virtually by the patient or patient surrogate considering the face to face limitations during the COVID-19 pandemic and, given the nature of the study population, which frequently requires mechanical ventilation with sedation, surrogate consent will likely occur in a substantial proportion of the study population (this will remain a valid consent until the patient is fully alert, and aware, and can provide a second consent to continue participation in the study).\n\nAdequate organ function is defined as:\n\nRenal: Calculated estimated glomerular filtration rate >30 mL/min/1.73 m2 (on chemistry panel)\nHepatic: Bilirubin <3x upper limit of normal (ULN) and AST, ALT and alkaline phosphatase <5x ULN\nCardiac: Absence of uncontrolled arrhythmia and LVEF >35%\n\nExclusion Criteria:\n\nVentilator support of FiO2 >0\u00b78 or PEEP >20 cm H2O and ongoing use of more than two vasopressors for 2 or more hours with any agent at doses shown below in the supine position.\n\nNorepinephrine >12 \u03bcg/min or 0.2 \u03bcg/kg per min\nPhenylephrine >150 \u03bcg/min or 3 \u03bcg/kg per min\nEpinephrine >10 ug/min or 0.2 \u03bcg/kg per min\nVasopressin >0.04 units/min\nConcurrent use of other investigational agents specifically for treatment of ARDS or inflammatory cytokines. (Note: Agents established to be efficacious and/or those used outside of formal trials are permitted as supportive data emerge)\nKnown ineligibility for use of a ventilator for a minimum of 7 days, as judged by the institution's Triage Team\nKnown allergy to MSC components: fetal calf serum, human albumin or DMSO\nActive invasive malignant disease requiring chemotherapy/radiation\nOther concurrent life-threatening disease (life expectancy <6 months) or eligible for hospice care\nKnown history of HIV infection on active treatment\nFemales who are pregnant or breastfeeding\nCurrent mean arterial pressure (MAP) <60 mmHg while on 2 or more vasopressors at above doses for more than 2 hours\nHistory of any significant cardiac (myocardial infarction within 12 months of screening visit or unstable angina), chronic ongoing hepatic, or renal disease (grade 3 or higher); diagnosis of congestive heart failure with hypoxemia primarily due to decompensated heart failure; diagnosis of severe chronic obstructive pulmonary disease (COPD) or interstitial lung disease requiring supplemental oxygen at home\nConcurrent diagnosis of diffuse alveolar hemorrhage\nRequiring continuous dialysis (unable to stop dialysis during study agent infusion)",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "80 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "David Ingbar, MD",
                                                            "OverallOfficialAffiliation": "Masonic Cancer Center, University of Minnesota",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "University of Minnesota",
                                                            "LocationCity": "Minneapolis",
                                                            "LocationState": "Minnesota",
                                                            "LocationZip": "55455",
                                                            "LocationCountry": "United States"
                                                      },
                                                      {
                                                            "LocationFacility": "University of Pittsburgh",
                                                            "LocationCity": "Pittsburgh",
                                                            "LocationState": "Pennsylvania",
                                                            "LocationZip": "15261",
                                                            "LocationCountry": "United States"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000086382",
                                                            "ConditionMeshTerm": "COVID-19"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012128",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012127",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome, Newborn"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000055371",
                                                            "ConditionMeshTerm": "Acute Lung Injury"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000013577",
                                                            "ConditionMeshTerm": "Syndrome"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000004194",
                                                            "ConditionAncestorTerm": "Disease"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012141",
                                                            "ConditionAncestorTerm": "Respiratory Tract Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007239",
                                                            "ConditionAncestorTerm": "Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000011024",
                                                            "ConditionAncestorTerm": "Pneumonia, Viral"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000011014",
                                                            "ConditionAncestorTerm": "Pneumonia"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014777",
                                                            "ConditionAncestorTerm": "Virus Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000018352",
                                                            "ConditionAncestorTerm": "Coronavirus Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003333",
                                                            "ConditionAncestorTerm": "Coronaviridae Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030341",
                                                            "ConditionAncestorTerm": "Nidovirales Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012327",
                                                            "ConditionAncestorTerm": "RNA Virus Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012120",
                                                            "ConditionAncestorTerm": "Respiration Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M2562",
                                                            "ConditionBrowseLeafName": "COVID-19",
                                                            "ConditionBrowseLeafAsFound": "COVID-19",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13056",
                                                            "ConditionBrowseLeafName": "Pneumonia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M19643",
                                                            "ConditionBrowseLeafName": "Coronavirus Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M24598",
                                                            "ConditionBrowseLeafName": "Severe Acute Respiratory Syndrome",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14117",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14116",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Newborn",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27297",
                                                            "ConditionBrowseLeafName": "Acute Lung Injury",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9435",
                                                            "ConditionBrowseLeafName": "Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5520",
                                                            "ConditionBrowseLeafName": "Communicable Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14130",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13066",
                                                            "ConditionBrowseLeafName": "Pneumonia, Viral",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16674",
                                                            "ConditionBrowseLeafName": "Virus Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5707",
                                                            "ConditionBrowseLeafName": "Coronaviridae Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22838",
                                                            "ConditionBrowseLeafName": "Nidovirales Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14301",
                                                            "ConditionBrowseLeafName": "RNA Virus Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14109",
                                                            "ConditionBrowseLeafName": "Respiration Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T5186",
                                                            "ConditionBrowseLeafName": "Severe Acute Respiratory Syndrome",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4927",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Infant",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T192",
                                                            "ConditionBrowseLeafName": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC01",
                                                            "ConditionBrowseBranchName": "Infections"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M6258",
                                                            "InterventionBrowseLeafName": "Dextrans",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "AnCoag",
                                                            "InterventionBrowseBranchName": "Anticoagulants"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "BlSubst",
                                                            "InterventionBrowseBranchName": "Blood Substitutes"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 30,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03233074",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2017-0701"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "2017-A02088-45",
                                                            "SecondaryIdType": "Other Identifier",
                                                            "SecondaryIdDomain": "ANSM"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Centre Hospitalier Universitaire de Saint Etienne",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors",
                                          "OfficialTitle": "Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors (COSMOS)",
                                          "Acronym": "COSMOS"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "February 2022",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "November 17, 2017",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 30, 2022",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "September 30, 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "July 17, 2017",
                                          "StudyFirstSubmitQCDate": "July 25, 2017",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "July 28, 2017",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "February 7, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "February 8, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Centre Hospitalier Universitaire de Saint Etienne",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Institut de Canc\u00e9rologie de la Loire",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "It is of clinical significance to better characterize the intrinsic defects harbored by mesenchymal stromal cells (MSC) in Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) context, as compared to physiological conditions. Such research initiative aims to dissect the cross-talk between malignant hematopoietic stem cells (HSC) and their bone marrow (BM) partners in crime, further prospecting for innovative stromal-directed strategies for the treatment of Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).",
                                          "DetailedDescription": "Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal malignancies that are characterized by ineffective hematopoiesis, progressive bone marrow failure, cytogenetic and molecular abnormalities, and increased risk for progression to acute myeloid leukemia (AML). It is a well-accepted theory that MDS and AML originate from primary alterations of hematopoietic stem cells (HSC) compartment, which confer a survival advantage to them at the expense of physiological hematopoiesis. More recently, there is growing evidences regarding the contribution of the bone marrow (BM) microenvironment to the pathogenesis of MDS and AML. Of particular interest, several studies have pointed towards a pivotal role of mesenchymal stromal cells (MSC), one of the main components of the BM niche, in the initiation and propagation of myeloid disorders. In this context, it is of clinical significance to better characterize the intrinsic defects harbored by MSC in MDS and AML context, as compared to physiological conditions. Such research initiative aims to dissect the cross-talk between malignant HSC and their BM partners in crime, further prospecting for innovative stromal-directed strategies for the treatment of MDS and AML."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Myelodysplastic Syndromes",
                                                      "Acute Myeloid Leukemia",
                                                      "Cardio-vascular Surgery"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Myelodysplastic Syndromes",
                                                      "Acute Myeloid Leukemia",
                                                      "Bone Marrow",
                                                      "Mesenchymal stromal cell",
                                                      "Healthy donor"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Observational",
                                          "PatientRegistry": "No",
                                          "DesignInfo": {
                                                "DesignObservationalModelList": {
                                                      "DesignObservationalModel": [
                                                            "Case-Control"
                                                      ]
                                                },
                                                "DesignTimePerspectiveList": {
                                                      "DesignTimePerspective": [
                                                            "Prospective"
                                                      ]
                                                }
                                          },
                                          "BioSpec": {
                                                "BioSpecRetention": "Samples With DNA",
                                                "BioSpecDescription": "Bone marrow"
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "150",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Acute Myeloid Leukemia patients",
                                                            "ArmGroupDescription": "For diagnosis purpose, bone marrow sampling is performed for acute myeloid leukemia patients. 2 milliliters of this sample will be collected and analysed for the COSMOS study.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: Bone marrow analyses"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Healthy donors",
                                                            "ArmGroupDescription": "Healthy donors are patients undergoing cardio-vascular surgery for their usual support. During this surgery, 2 milliliters of the bone marrow will be collected, and analysed for the COSMOS study.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: Bone marrow analyses"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "Bone marrow analyses",
                                                            "InterventionDescription": "This is a non-interventional study for the constitution of a biobank of bone marrows, in order to further investigate in vitro the cellular properties of bone marrow-isolated mesenchymal stromal cells.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Acute Myeloid Leukemia patients",
                                                                        "Healthy donors"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Cellular properties of mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Changes in cellular properties of mesenchymal stromal cells",
                                                            "PrimaryOutcomeDescription": "Changes in cellular properties of mesenchymal stromal cells isolated from bone marrow aspirates by comparing normal cells (i.e. healthy donors) and MDS/AML cells.",
                                                            "PrimaryOutcomeTimeFrame": "Day 0"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of differential biomarkers in mesenchymal stromal cells",
                                                            "SecondaryOutcomeDescription": "Number of differential biomarkers expressed by MDS or AML-derived mesenchymal stromal cells",
                                                            "SecondaryOutcomeTimeFrame": "Day 0"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with diagnosed myelodysplasia or acute myeloid leukemia (study place: ICLN) - Specific to the cases cohort\nAge-matched healthy donors undergoing a cardiovascular surgery - Specific to the control cohort\nSigned written informed consent form\nPatient affiliated to a social security regimen or beneficiary of the same\n\nExclusion Criteria:\n\nMedical history of hematological disorders\nThrombocytopenia, anemia\u2026\nPatient under guardianship or deprived of his liberty or any condition that may affect the patient's ability to understand and sign the informed consent (art. L.1121-6, L.112-7, L.1211-8, L.1211-9)\nPregnant or breastfeeding women\nRefusing participation",
                                          "HealthyVolunteers": "Accepts Healthy Volunteers",
                                          "Gender": "All",
                                          "MinimumAge": "50 Years",
                                          "MaximumAge": "80 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          },
                                          "StudyPopulation": "Acute Myeloid Leukemia patients undergoing a bone marrow sampling for diagnosis purposes, and healthy donors undergoing cardio-vascular surgery for their usual support.",
                                          "SamplingMethod": "Non-Probability Sample"
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Denis Guyotat, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "(0)4 77 91 70 70",
                                                            "CentralContactPhoneExt": "+33",
                                                            "CentralContactEMail": "denis.guyotat@chu-st-etienne.fr"
                                                      },
                                                      {
                                                            "CentralContactName": "Elisabeth Daguenet, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "(0)4 77 91 70 89",
                                                            "CentralContactPhoneExt": "+33",
                                                            "CentralContactEMail": "Elisabeth.daguenet@chu-st-etienne.fr"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Denis Guyotat, PhD",
                                                            "OverallOfficialAffiliation": "CHU de Saint-Etienne",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "CHU de Saint-Etienne",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Saint-Priest-en-Jarez",
                                                            "LocationZip": "42270",
                                                            "LocationCountry": "France",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Jean-Fran\u00e7ois Fuzelier, PhD",
                                                                              "LocationContactRole": "Contact"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Jean-Fran\u00e7ois Fuzelier, PhD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "CHU de Saint-Etienne",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Saint-\u00c9tienne",
                                                            "LocationZip": "42055",
                                                            "LocationCountry": "France",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Denis Guyotat, PhD",
                                                                              "LocationContactRole": "Contact"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Denis Guyotat, PhD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "J\u00e9r\u00f4me Cornillon, PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Fressia Honeyman, PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Caroline Lejeune, PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Christiane Mounier, PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Christelle Portois, PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Gilbert Soglu, PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Emmanuelle Tavernier, PhD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000007951",
                                                            "ConditionMeshTerm": "Leukemia, Myeloid"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000015470",
                                                            "ConditionMeshTerm": "Leukemia, Myeloid, Acute"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000011289",
                                                            "ConditionMeshTerm": "Preleukemia"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000009190",
                                                            "ConditionMeshTerm": "Myelodysplastic Syndromes"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000007938",
                                                            "ConditionAncestorTerm": "Leukemia"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009370",
                                                            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009369",
                                                            "ConditionAncestorTerm": "Neoplasms"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001855",
                                                            "ConditionAncestorTerm": "Bone Marrow Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000006402",
                                                            "ConditionAncestorTerm": "Hematologic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000011230",
                                                            "ConditionAncestorTerm": "Precancerous Conditions"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10097",
                                                            "ConditionBrowseLeafName": "Leukemia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M17279",
                                                            "ConditionBrowseLeafName": "Leukemia, Myeloid, Acute",
                                                            "ConditionBrowseLeafAsFound": "Acute Myeloid Leukemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10107",
                                                            "ConditionBrowseLeafName": "Leukemia, Myeloid",
                                                            "ConditionBrowseLeafAsFound": "Myeloid Leukemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11297",
                                                            "ConditionBrowseLeafName": "Myelodysplastic Syndromes",
                                                            "ConditionBrowseLeafAsFound": "Myelodysplastic Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13316",
                                                            "ConditionBrowseLeafName": "Preleukemia",
                                                            "ConditionBrowseLeafAsFound": "Myelodysplastic Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11467",
                                                            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4286",
                                                            "ConditionBrowseLeafName": "Bone Marrow Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8642",
                                                            "ConditionBrowseLeafName": "Hematologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13263",
                                                            "ConditionBrowseLeafName": "Precancerous Conditions",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T3995",
                                                            "ConditionBrowseLeafName": "Myeloid Leukemia",
                                                            "ConditionBrowseLeafAsFound": "Myeloid Leukemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T182",
                                                            "ConditionBrowseLeafName": "Acute Myeloid Leukemia",
                                                            "ConditionBrowseLeafAsFound": "Acute Myeloid Leukemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T188",
                                                            "ConditionBrowseLeafName": "Acute Non Lymphoblastic Leukemia",
                                                            "ConditionBrowseLeafAsFound": "Acute Myeloid Leukemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T3993",
                                                            "ConditionBrowseLeafName": "Myelodysplastic Syndromes",
                                                            "ConditionBrowseLeafAsFound": "Myelodysplastic Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC04",
                                                            "ConditionBrowseBranchName": "Neoplasms"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC15",
                                                            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 31,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04345601",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "H-47561 MSC for COVID-19"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Baylor College of Medicine",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)",
                                          "OfficialTitle": "Single Donor Banked Bone Marrow Mesenchymal Stromal Cells for the Treatment of COVID-19 Induced ARDS: A Non-Blinded Randomized, Controlled Study"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2022",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "February 12, 2021",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "October 2022",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "October 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "April 10, 2020",
                                          "StudyFirstSubmitQCDate": "April 13, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "April 14, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "September 26, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 28, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "LaQuisa Hill",
                                                "ResponsiblePartyInvestigatorTitle": "Assistant Professor",
                                                "ResponsiblePartyInvestigatorAffiliation": "Baylor College of Medicine"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Baylor College of Medicine",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Center for Cell and Gene Therapy, Baylor College of Medicine",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "The Methodist Hospital Research Institute",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No",
                                          "IsUSExport": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "***At this time, we are only enrolling at Houston Methodist Hospital (HMH)/Baylor College of Medicine (BCM) and are not shipping cells outside of BCM/HMH.***\n\nThis is a study for patients who have respiratory infection caused by SARS-CoV-2 that have not gotten better. Because there is no standard treatment for this infection, patients are being asked to volunteer for a gene transfer research study using mesenchymal stem cells (MSCs).\n\nStem cells are cells that do not yet have a specific function in the body. Mesenchymal stem cells (MSCs) are a type of stem cell that can be grown from bone marrow (the spongy tissue inside of bones). Stem cells can develop into other types of more mature (specific) cells, such as blood and muscle cells.\n\nThe purpose of this study is to see if MSCs versus controls can help to treat respiratory infections caused by SARS-CoV-2.",
                                          "DetailedDescription": "Earlier, a healthy donor provided blood cells to generate MSCs. These cells were grown and frozen for later use.\n\nBefore being treated, the patient will receive a series of standard medical tests: These tests are done to assess the patient's eligibility to receive the cells.\n\nPhysical exam and history\nSARS-CoV-2 test\nBlood tests\nChest X-ray or chest CT Scan\nA urine pregnancy test, when applicable\n\nThe patient will be randomly assigned to a study group. We'll use a computer to put the patient into study group A (study drug) or group B (control) by chance (randomized). Patients randomized to the control group, will receive the standard treatment for their respiratory infection.\n\nOn the day that the patient is scheduled to receive the cells they will be pre-medicated with Benadryl and Tylenol. The patient will then receive an intravenous (into the vein) infusion of 1 x 10^8 cells/kg of MSCs. The patient will be monitored closely for two hours after the infusion. The patient will receive a second infusion at the same dose within 3-5 days of the initial infusion (at the discretion of the investigator) if there is no improvement in respiratory parameters or if there is a worsening of Acute respiratory distress syndrome (ARDS).\n\nThe patient will receive standard medical tests when getting the infusion(s) and afterwards. As part of the research study, the patient will be evaluated daily for 7 days and then weekly at weeks 2, 3, and 4. The evaluations that will be done at these visits include:\n\nPhysical exam and history\nSARS-CoV-2 test\nBlood tests\nChest X-ray or chest CT Scan"
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Sars-CoV2",
                                                      "Acute Respiratory Distress Syndrome",
                                                      "COVID-19"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal Stromal Cells",
                                                      "Respiratory failure"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "66",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stromal cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Patients will receive up to 2 infusions of mesenchymal stem cells.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Control Group",
                                                            "ArmGroupType": "Other",
                                                            "ArmGroupDescription": "Patients will receive supportive care or treatment designated by their treating doctor.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: Supportive Care"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stromal Cells",
                                                            "InterventionDescription": "Patients will be given the cell product by intravenous injection (into the vein through an IV line). Dose:1 x 10^8 MSCs.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stromal cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "MSCs"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "Supportive Care",
                                                            "InterventionDescription": "Patients will receive supportive care per their treating physician",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Control Group"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Treatment-related serious adverse events (tSAEs)",
                                                            "PrimaryOutcomeDescription": "Treatment-related serious adverse events (tSAE) will be considered as those directly related to the investigational infusion product per protocol defined criteria.",
                                                            "PrimaryOutcomeTimeFrame": "28 days post cell infusion"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Change in clinical status at day 14",
                                                            "PrimaryOutcomeDescription": "Change by at least two categories on a six category ordinal scale at day 14 post randomization per protocol defined criteria. The six-category ordinal scale ranges from 6 to 1 with a higher score indicates worse clinical outcome",
                                                            "PrimaryOutcomeTimeFrame": "14 days post cell infusion"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\n18 years or older\nConfirmed SARS-CoV2 infection real-time reverse transcription polymerase chain reaction (RT-PCR) assay\n\nModerate OR severe ARDS, based on the degree of impairment of oxygenation as defined by the ratio of arterial oxygen tension to fraction of inspired oxygen (PaO2/FiO2):\n\nModerate ARDS: PaO2/FiO2 100-200 mmHg OR\nSevere ARDS: PaO2/FiO2 \u2264100 mmHg\nIf on invasive or noninvasive (BiPAP) mechanical ventilator, PEEP \u22655 cm H2O\nBilateral opacities present on chest radiograph or computed tomographic (CT) scan, that are not fully explained by pleural effusions, lung collapse, or lung nodules.\n\nExclusion Criteria:\n\nCurrently receiving extracorporeal membrane oxygenation (ECMO)\nSevere chronic respiratory disease requiring use of home oxygen\nPregnant or lactating\nKnown hypersensitivity to dimethyl sulfoxide (DMSO)\nUnstable hemodynamics (ventricular tachycardia or fibrillation)\nUncontrolled bacterial or fungal co-infection\nAny end-stage organ disease or condition, which in the opinion of the Investigator, makes the patient an unsuitable candidate for treatment\nInability to obtain informed consent (from patient or legally appropriate proxy)\nPresence of any contraindication to receiving prophylactic low dose unfractionated or low molecular weight heparin.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "LaQuisa Hill, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "(713) 441-1450",
                                                            "CentralContactEMail": "LaQuisa.Hill@bcm.edu"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "LaQuisa Hill, MD",
                                                            "OverallOfficialAffiliation": "Baylor College of Medicine",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Houston Methodist Hospital",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Houston",
                                                            "LocationState": "Texas",
                                                            "LocationZip": "77030",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "LaQuisa Hill, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "713-441-1450",
                                                                              "LocationContactEMail": "LaQuisa.Hill@bcm.edu"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000086382",
                                                            "ConditionMeshTerm": "COVID-19"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012128",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012127",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome, Newborn"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000055371",
                                                            "ConditionMeshTerm": "Acute Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000012141",
                                                            "ConditionAncestorTerm": "Respiratory Tract Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007239",
                                                            "ConditionAncestorTerm": "Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000011024",
                                                            "ConditionAncestorTerm": "Pneumonia, Viral"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000011014",
                                                            "ConditionAncestorTerm": "Pneumonia"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014777",
                                                            "ConditionAncestorTerm": "Virus Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000018352",
                                                            "ConditionAncestorTerm": "Coronavirus Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003333",
                                                            "ConditionAncestorTerm": "Coronaviridae Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030341",
                                                            "ConditionAncestorTerm": "Nidovirales Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012327",
                                                            "ConditionAncestorTerm": "RNA Virus Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012120",
                                                            "ConditionAncestorTerm": "Respiration Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M2562",
                                                            "ConditionBrowseLeafName": "COVID-19",
                                                            "ConditionBrowseLeafAsFound": "COVID-19",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14120",
                                                            "ConditionBrowseLeafName": "Respiratory Insufficiency",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14117",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14116",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Newborn",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27297",
                                                            "ConditionBrowseLeafName": "Acute Lung Injury",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9435",
                                                            "ConditionBrowseLeafName": "Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5520",
                                                            "ConditionBrowseLeafName": "Communicable Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14130",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13056",
                                                            "ConditionBrowseLeafName": "Pneumonia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13066",
                                                            "ConditionBrowseLeafName": "Pneumonia, Viral",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16674",
                                                            "ConditionBrowseLeafName": "Virus Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M19643",
                                                            "ConditionBrowseLeafName": "Coronavirus Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5707",
                                                            "ConditionBrowseLeafName": "Coronaviridae Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22838",
                                                            "ConditionBrowseLeafName": "Nidovirales Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14301",
                                                            "ConditionBrowseLeafName": "RNA Virus Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14109",
                                                            "ConditionBrowseLeafName": "Respiration Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4927",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Infant",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T192",
                                                            "ConditionBrowseLeafName": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC01",
                                                            "ConditionBrowseBranchName": "Infections"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 32,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01038596",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "HipMSC-Osteoarthritis"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Technische Universit\u00e4t Dresden",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells and Osteoarthritis",
                                          "OfficialTitle": "Proliferation and Osteogenic Differentiation of Bone Marrow-derived Mesenchymal Stromal Cells From Osteoarthritic Versus Healthy Donors"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2017",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2009"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "June 2016",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2016",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "December 23, 2009",
                                          "StudyFirstSubmitQCDate": "December 23, 2009",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "December 24, 2009",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "April 13, 2017",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 14, 2017",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Technische Universit\u00e4t Dresden",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "German Federal Ministry of Education and Research",
                                                            "CollaboratorClass": "OTHER_GOV"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Osteoarthritis (OA) is one of the most frequent musculoskeletal disorders and represents the main indication for total joint arthroplasty. Multipotent mesenchymal stromal cells (MSCs) can be easily isolated and culture expanded from bone marrow aspirates and provide an excellent source of progenitor cells for cell-based regeneration strategies due to their ex vivo differentiation and proliferation capacity. Although there are hints that MSCs derived from OA patients may exhibit altered function the role of MSCs with respect to disease development and progression of OA is not clearly understood to date. To assess whether advanced-stage OA affects MSCs' suitability for musculoskeletal regenerative therapy, in the present study, we compare proliferation and differentiation potential of MSCs from osteoarthritic versus healthy donors.",
                                          "DetailedDescription": "Clinical data (range of motion of lower limb joints, sociodemographic score dataset, WOMAC score, EQ-5D score, Harris Hip Score, radiological evaluation (OA group only), routine laboratory parameters, and bone metabolism parameters)\n\nOsteogenic, chondrogenic, and adipogenic differentiation is proofed qualitatively by cell staining\n\nosteogenic, chondrogenic and adipogenic marker gene expression analysis using quantitative real-time RT-PCR\n\ncell-specific alkaline phosphatase (ALP) activity assay\n\nlarge-scale gene expression profile\n\nFluorescence-activated cell sorting (FACS)- CD44, CD105 (SH2; endoglin), CD106 (vascular cell adhesion molecule; VCAM-1), CD166, CD29, CD73 (SH3 and SH4), CD90 (Thy-1), CD117, STRO-1 and Sca-1 [%]"
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Osteoarthritis"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "osteoarthritis, mesenchymal stromal cells, proliferation"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Observational",
                                          "DesignInfo": {
                                                "DesignObservationalModelList": {
                                                      "DesignObservationalModel": [
                                                            "Case-Control"
                                                      ]
                                                },
                                                "DesignTimePerspectiveList": {
                                                      "DesignTimePerspective": [
                                                            "Prospective"
                                                      ]
                                                }
                                          },
                                          "BioSpec": {
                                                "BioSpecRetention": "Samples With DNA",
                                                "BioSpecDescription": "bone marrow aspirates"
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "30",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "osteoarthritic donors",
                                                            "ArmGroupDescription": "pelvic compartment advanced-stage (Kellgren and Lawrence grade 3 or 4) osteoarthritic donors"
                                                      },
                                                      {
                                                            "ArmGroupLabel": "healthy donors",
                                                            "ArmGroupDescription": "age-matched healthy donors"
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Global Gene expression profile of bone marrow-derived mesenchymal stromal cells from osteoarthritic versus healthy donors",
                                                            "PrimaryOutcomeTimeFrame": "after msc isolation"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Flow cytometric analysis of cell surface antigens, Alkaline phosphatase activity, DNA content as measure for cellular proliferation",
                                                            "SecondaryOutcomeTimeFrame": "variable 2 days up to 21 days after msc cultivation"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nindication for hip THR\nprimary osteoarthritis of the hip\nPatient's consent\n\nExclusion Criteria:\n\nsecondary osteoarthritis of the hip\nAny malignancies\ninfectious disease\nrheumatic disease\nosteoporosis\nAny additional serious disease complicating the participation in this study",
                                          "HealthyVolunteers": "Accepts Healthy Volunteers",
                                          "Gender": "All",
                                          "MinimumAge": "50 Years",
                                          "MaximumAge": "90 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          },
                                          "StudyPopulation": "pelvic compartment advanced-stage (Kellgren and Lawrence grade 3 or 4, mean 67\u00b16 years) osteoarthritic and age-matched healthy donors",
                                          "SamplingMethod": "Probability Sample"
                                    },
                                    "ContactsLocationsModule": {
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "University Hospital Dresden, Orthopaedic Department",
                                                            "LocationCity": "Dresden",
                                                            "LocationZip": "01307",
                                                            "LocationCountry": "Germany"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000010003",
                                                            "ConditionMeshTerm": "Osteoarthritis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000001168",
                                                            "ConditionAncestorTerm": "Arthritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007592",
                                                            "ConditionAncestorTerm": "Joint Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009140",
                                                            "ConditionAncestorTerm": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012216",
                                                            "ConditionAncestorTerm": "Rheumatic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M12078",
                                                            "ConditionBrowseLeafName": "Osteoarthritis",
                                                            "ConditionBrowseLeafAsFound": "Osteoarthritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3628",
                                                            "ConditionBrowseLeafName": "Arthritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9773",
                                                            "ConditionBrowseLeafName": "Joint Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11249",
                                                            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14197",
                                                            "ConditionBrowseLeafName": "Rheumatic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5475",
                                                            "ConditionBrowseLeafName": "Collagen Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 33,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04356287",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MP-05-2020-2251"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Sir Mortimer B. Davis - Jewish General Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis",
                                          "OfficialTitle": "Phase I/II Randomized Controlled Trial of Umbilical Cord-derived mesenChymAl stRomal cElls in Systemic Sclerosis",
                                          "Acronym": "CARE-SSc"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2022",
                                          "OverallStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "November 2022",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2024",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2025",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "April 15, 2020",
                                          "StudyFirstSubmitQCDate": "April 21, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "April 22, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "September 19, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 22, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Marie Hudson, MD",
                                                "ResponsiblePartyInvestigatorTitle": "Rheumatologist, Jewish General Hospital; Physician-scientist, Lady Davis Institute for Medical Research",
                                                "ResponsiblePartyInvestigatorAffiliation": "Sir Mortimer B. Davis - Jewish General Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Marie Hudson, MD",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Medical University of South Carolina",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "McGill University Health Centre/Research Institute of the McGill University Health Centre",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Universit\u00e9 de Montr\u00e9al",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Assistance Publique - H\u00f4pitaux de Paris",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CHUM)",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "University Paris 7 - Denis Diderot",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this study is to test the safety and efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (UCMSC) for the treatment of Systemic Sclerosis (SSc).",
                                          "DetailedDescription": "A single-center, three-arm, randomized, double-blind, placebo-controlled trial is proposed. A total of 18 SSc patients will be enrolled in 3 successive blocks of 6 patients each. After being informed about the study and potential risks, all patients giving written informed consent will be randomized to one of two treatment arms or a placebo arm (total of 6 patients per arm). Within each block, the 6 patients will be randomized in a 2:2:2 ratio in one of the following arms: placebo, 1 infusion of UCMSC (M0), or 2 infusions of UCMSC (M0, M3). Second infusions of UCMSC will be performed only in the absence of Treatment Related Severe Adverse Events (TRSAE). Randomization into blocks 2 and 3 will be staggered, to allow the detection of TRSAE prior to inclusion of patients in a subsequent block, i.e. the second block will be randomized only in the absence of TRSAE one month after the first infusion of all 6 patients in block one, and similarly for the third block."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Sclerosis, Systemic",
                                                      "Mesenchymal Stem Cells"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Systemic Sclerosis",
                                                      "Umbilical cord-derived mesenchymal stromal cells",
                                                      "Scleroderma, Systemic"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Quadruple",
                                                      "DesignMaskingDescription": "Study participants, physicians (including the outcome assessors) and research nurses will be blinded to treatment arm. Only the study statistician and the personnel at the manufacturing laboratory at the Medical University of South Carolina will be aware of the subject's treatment allocation. The Medical University of South Carolina will send blinded infusion bag(s) to the Clinical Research Unit of the Jewish General Hospital.",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "18",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "One infusion of UCMSC",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Patients receive one intravenous infusion of UCMSC at month 0 and one intravenous infusion of placebo at month 3. Each experimental infusion will consist of 1 million UCMSC/kg suspended in 50 ml of PlasmaLyte A. Each placebo infusion will consist of a similar volume of PlasmaLyte A.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: UCMSC"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Two infusions of UCMSC",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Patients receive one intravenous infusion of UCMSC at month 0 and one intravenous infusion of UCMSC at month 3. Each experimental infusion will consist of 1 million UCMSC/kg suspended in 50 ml of PlasmaLyte A.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: UCMSC"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Placebo infusions",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Patients receive intravenous placebo infusions at months 0 and 3. Each placebo infusion will consist of 50 ml of PlasmaLyte A.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "UCMSC",
                                                            "InterventionDescription": "Each infusion will consist of 1 million MSC/kg suspended in 50 mL of PlasmaLyte A.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "One infusion of UCMSC",
                                                                        "Two infusions of UCMSC"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "umbilical cord derived mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "Placebo",
                                                            "InterventionDescription": "Each infusion will consist of 50 mL of PlasmaLyte A.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Placebo infusions"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Measure of safety one month after first infusion",
                                                            "PrimaryOutcomeDescription": "Treatment related severe adverse event using the NCI Common Terminology Criteria for Adverse Events (CTCAE) v5.0 classification [https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm]",
                                                            "PrimaryOutcomeTimeFrame": "Month 1"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in modified Rodnan skin score (mRss) between Month 0 and Month 12",
                                                            "SecondaryOutcomeDescription": "A measure of skin thickness; difference between Month 12 and Month 0 on the mRss [Khanna et al., 2017]",
                                                            "SecondaryOutcomeTimeFrame": "Month 0 and Month 12"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "Safety at the time of infusion, 24 hours, 10 days +/- 24 hours, Month 6, Month 9 and Month 12 (adverse events)",
                                                            "OtherOutcomeDescription": "Measure of safety of UCMSC in severe SSc using the NCI Common Terminology Criteria for Adverse Events (CTCAE) v5.0 classification [https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm]",
                                                            "OtherOutcomeTimeFrame": "24 hours, 10 days +/- 24 hours, Month 6, Month 9 and Month 12"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Mortality occurring after randomization and up to study completion",
                                                            "OtherOutcomeDescription": "Causes of death and their relation to SSc versus the study intervention will be evaluated by the Data and Safety Monitoring Committee (DSMC).",
                                                            "OtherOutcomeTimeFrame": "1 year"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Modified Rodnan skin score",
                                                            "OtherOutcomeDescription": "A measure of skin thickness [Khanna et al., 2017]",
                                                            "OtherOutcomeTimeFrame": "Month 0, Month 3, Month 6 and Month 9"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "World Health Organization (WHO) performance status",
                                                            "OtherOutcomeDescription": "WHO performance status [Oken et al., 1982] describes a patient's level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).",
                                                            "OtherOutcomeTimeFrame": "Month 0, Month 3, Month 6, Month 9 and Month 12"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Scleroderma-Health Assessment Questionnaire",
                                                            "OtherOutcomeDescription": "Disease status as measured by the Scleroderma-Health Assessment Questionnaire [Steen & Medsger, 1997]",
                                                            "OtherOutcomeTimeFrame": "Month 0, Month 3, Month 6, Month 9 and Month 12"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "36-Item Short Form Survey version 2 for health-related quality of life (SF-36v2)",
                                                            "OtherOutcomeDescription": "Health-related quality of life as measured by the SF-36v2 [Ware et al., 2007]",
                                                            "OtherOutcomeTimeFrame": "Month 0, Month 3, Month 6, Month 9 and Month 12"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "EuroQoL health status measure (EQ-5D-5L)",
                                                            "OtherOutcomeDescription": "Health related quality of life in cost effectiveness analysis as measured by the EQ-5D-5L [Herdman et al., 2011] using five levels of severity in five dimensions.",
                                                            "OtherOutcomeTimeFrame": "Month 0, Month 3, Month 6, Month 9 and Month 12"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Response to treatment",
                                                            "OtherOutcomeDescription": "Defined as decrease in mRss > 25%, increase in FVC > 10% predicted (forced vital capacity) and/or increase in DLCO >15% predicted (diffusing capacity of the lungs for carbon monoxide), without need for further immunosuppression except low dose steroids",
                                                            "OtherOutcomeTimeFrame": "Month 0, Month 12"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Progression-free survival",
                                                            "OtherOutcomeDescription": "Progression defined as any one of the following: decrease in FVC > 10% predicted; decrease in DLCO > 15% predicted; decrease in left ventricular ejection fraction on cardiac echocardiography > 15%; decrease in weight > 15%; decrease in creatinine clearance > 30%; increase in mRss > 25%; and/or increase in Scleroderma-Health Assessment Questionnaire > 0.5",
                                                            "OtherOutcomeTimeFrame": "Month 0, Month 12"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Global Rank Composite Score",
                                                            "OtherOutcomeDescription": "A composite score consisting of a hierarchy of ordered outcomes: death, event-free survival (survival without respiratory, renal, or cardiac failure), FVC, score on the Disability Index of the Health Assessment Questionnaire (HAQ-DI; range, 0 to 3, with higher scores indicating more disability), and the modified Rodnan skin score. [Sullivan et al., 2018]",
                                                            "OtherOutcomeTimeFrame": "Month 0, Month 12"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "ACR Provisional Composite Response Index",
                                                            "OtherOutcomeDescription": "ACR Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis (CRISS) [Khanna et al., 2016], a composite measure of treatment response in SSc",
                                                            "OtherOutcomeTimeFrame": "Month 0, Month 12"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nSSc according to American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) 2103 classification criteria for systemic sclerosis\n\nSevere disease defined as:\n\ni) disease duration of 2 years or less with an mRss of > 20 and (ESR > 25 mm and/or hemoglobin < 11 g/dL, not explained by other causes than SSc), or ii) mRss >15 without any restriction as to disease duration plus at least one major organ involvement as defined by: a) respiratory involvement consisting of lung diffusion capacity for carbon monoxide (DLCO) and/or forced vital capacity (FVC) < 80% predicted and evidence of interstitial lung disease (chest X-ray and/or high resolution computed tomography (HRCT) scan); b) renal involvement consisting of past renal crisis and/or stage 2 or 3 chronic kidney disease (glomerular filtration rate between 30-89 mL/min) not explained by other causes than SSc; c) cardiac involvement consisting of reversible congestive heart failure, atrial or ventricular rhythm disturbances such as recurrent episodes of atrial fibrillation or flutter, recurrent atrial paroxysmal tachycardia, conduction abnormalities (2nd or 3rd degree atrioventricular block), and/or mild to moderate pericardial effusion. All causes of organ involvement should be attributed to SSc.\n\nInadequate response (determined by patient and physician judgement) or adverse events necessitating discontinuation of standard therapy (usually consisting of methotrexate 25 mg subcutaneous (or as tolerated) per week and/or mycophenolate mofetil 2-3 gm/d (or as tolerated) for at least 3 months\nIneligibility or unwillingness to undergo autologous hematopoietic stem cell transplant\n\nExclusion Criteria:\n\nAge < 18 years\nPregnancy or unwillingness to use adequate contraception\n\nLife-threatening end-organ damage defined as:\n\nFVC < 45% and/or DLCO (corrected for hemoglobin) < 30% predicted;\nLeft ventricular ejection fraction < 40% by cardiac echocardiography;\nPulmonary hypertension with baseline resting systolic pulmonary arterial pressures > 50 mmHg by cardiac echocardiography, or mean pulmonary artery pressure > 25 mmHg (and pulmonary wedge pressure < 15 mmHg) on right heart catheterization;\nstage 4 or more chronic kidney disease (glomerular filtration rate < 30 ml/min)\nLiver failure defined as an abnormal transaminase level (aspartate aminotransferase (ASAT), alanine aminotransaminase (ALAT) > 3 normal) unless related to activity of the disease\nConcurrent neoplasms or myelodysplasia\nUncontrolled hypertension\nUncontrolled acute or chronic infection (HIV, HTLV-1/2 (Human T-lymphotropic virus), hepatitis B surface Ag positive, hepatitis C positive) or high risk thereof\nSignificant malnutrition with BMI < 18 kg/m2\nSevere concomitant psychiatric disorder\nBone marrow insufficiency defined as neutropenia < 0.5 x 109 cell/L, thrombocytopenia < 30 x 109 cell/L, anemia < 8g/dL, CD4+ T lymphopenia < 200 x 106 cell/L due to other diseases than SSc (CD4 - cluster of differentiation 4)\nHistory of poor compliance\nConcurrent enrolment in any other protocol using an investigational drug\nInability to provide informed consent",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Marie Hudson, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "514-340-8222",
                                                            "CentralContactPhoneExt": "23476",
                                                            "CentralContactEMail": "marie.hudson@mcgill.ca"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Marie Hudson, MD",
                                                            "OverallOfficialAffiliation": "Sir Mortimer B. Davis - Jewish General Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "29478901",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Wang D, Zhang H, Liang J, Wang H, Hua B, Feng X, Gilkeson GS, Farge D, Shi S, Sun L. A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus. Stem Cell Reports. 2018 Mar 13;10(3):933-941. doi: 10.1016/j.stemcr.2018.01.029. Epub 2018 Mar 1."
                                                      },
                                                      {
                                                            "ReferencePMID": "30428931",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Liang J, Zhang H, Kong W, Deng W, Wang D, Feng X, Zhao C, Hua B, Wang H, Sun L. Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study. Stem Cell Res Ther. 2018 Nov 14;9(1):312. doi: 10.1186/s13287-018-1053-4."
                                                      }
                                                ]
                                          },
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "US Department of Health and Human Services. National Cancer Institute Common Terminology Criteria For Adverse Events (CTCAE), Version 5.0. 2017",
                                                            "SeeAlsoLinkURL": "https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000012595",
                                                            "ConditionMeshTerm": "Scleroderma, Systemic"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000045743",
                                                            "ConditionMeshTerm": "Scleroderma, Diffuse"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012598",
                                                            "ConditionMeshTerm": "Sclerosis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003240",
                                                            "ConditionAncestorTerm": "Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012871",
                                                            "ConditionAncestorTerm": "Skin Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M14567",
                                                            "ConditionBrowseLeafName": "Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14564",
                                                            "ConditionBrowseLeafName": "Scleroderma, Systemic",
                                                            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M24713",
                                                            "ConditionBrowseLeafName": "Scleroderma, Diffuse",
                                                            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5616",
                                                            "ConditionBrowseLeafName": "Connective Tissue Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14826",
                                                            "ConditionBrowseLeafName": "Skin Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T5565",
                                                            "ConditionBrowseLeafName": "Systemic Scleroderma",
                                                            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M85407",
                                                            "InterventionBrowseLeafName": "Plasma-lyte 148",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "PhSol",
                                                            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 34,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04549285",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Pro00106044"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Duke University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Infusions of Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome",
                                          "OfficialTitle": "A Phase I Pilot Study of the Safety of Infusions of Allogeneic Human Cord Tissue Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome in Children (MIS-C)",
                                          "Acronym": "MISTIC"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2021",
                                          "OverallStatus": "Withdrawn",
                                          "WhyStopped": "No accrual",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "March 12, 2021",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "February 1, 2022",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "February 1, 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "September 8, 2020",
                                          "StudyFirstSubmitQCDate": "September 8, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "September 16, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "September 7, 2021",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 14, 2021",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Joanne Kurtzberg, MD",
                                                "ResponsiblePartyInvestigatorTitle": "Jerome Harris Distinguished Professor of Pediatrics, Professor of Pathology; Director, Marcus Center for Cellular Cures; Director, Pediatric Blood and Marrow Transplant Program;",
                                                "ResponsiblePartyInvestigatorAffiliation": "Duke University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Joanne Kurtzberg, MD",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this multi-site, pilot study is to test whether infusions of human cord tissue mesenchymal stromal cells (hCT-MSC) are safe in children with multi system inflammatory syndrome (MIS-C). We will also describe the symptom course and duration of this hyper-inflammatory syndrome in these patients. Six patients less than 21 years old with MIS-C that is refractory to intravenous immune globulin (IVIG) and/or steroids will be given intravenous infusions of hCT-MSCs. Doses of 2x10^6 cells/kg (up to a maximum dose of 100x10^6 cells) will be given on days 1, 2, 3, +/-7 (day 7 is optional). Participants will be followed up to 90 days after administration for severe adverse events and survival. Safety will be evaluated through adverse event monitoring, clinical evaluations (i.e., vital signs, physical examinations), laboratory tests (i.e., hematology, serum chemistries, and urinalysis), and cardiac function (i.e., echocardiogram, ECG) from the signing of informed consent and throughout the patient's participation in this treatment protocol.",
                                          "DetailedDescription": "This phase I, multisite, pilot study will test whether infusions of human cord tissue derived MSCs (hCT-MSC) are safe in children with multisystem inflammatory syndrome (MIS-C).\n\nThe study population will consist of six patients 18 to <21 years old with a life expectancy \u2265 72 hours and COVID-19 related MIS-C that is refractory to treatment with intravenous immune globulin (IVIG).\n\nMultisystem inflammatory syndrome in children (MIS-C) is a newly recognized, serious, hyper-inflammatory syndrome that is occurring in small numbers of children, many of whom are within a month or so of recovering from a COVID-19 infection. While the clinical presentation varies, affected patients are typically previously healthy individuals who are less than 21 years of age. The diagnostic criteria include fever, laboratory evidence of inflammation, and multisystem involvement requiring hospitalization. Up to 75% of patients present with an element of cardiogenic shock requiring inotropic support, with some also requiring intubation with mechanical ventilation. Reported supportive treatments have included intravenous immune globulin (IVIG), tocilizumab, methylprednisolone, and aspirin. In the limited cases reported, up to 50% of children with MIS-C have antibodies to COVID-19 in their blood and may or may not be PCR positive on a nasal swab or throat culture. The disease is incompletely understood but currently believed, at least in part, to be a hyper-immune response to a recent COVID-19 infection.\n\nIn laboratory experiments, MSCs have been shown to inhibit T-cell proliferation and decrease production of pro-inflammatory cytokines. In animal models, up to 70% of infused cells are engulfed by lung macrophages, leading to secretion of anti-inflammatory molecules by these macrophages. These observations have led to the hypothesis that MSCs may work through both anti-inflammatory, immune-modulatory, and regenerative mechanisms.\n\nOver the past several months, MSCs have been tested in small cohorts of adult patients with COVID-19 Acute Respiratory Distress Syndrome to determine if the cytokine storm hypothesized to cause this complication could be suppressed by MSCs. Early results are encouraging, and formal clinical trials are underway. Extending this work into the pediatric population, the hypothesis of this study is that infusion of hCT-MSC can reverse the pro-inflammatory state in children with MIS-C.\n\nThis is a 6 patient, multisite, pilot study to test whether infusions of hCT-MSC are safe in pediatric patients with MIS-C. Information will also be gathered about the duration and severity of the participant's multisystem inflammatory syndrome. hCT-MSCs will be manufactured at Duke University Medical Center in the Robertson GMP Cell Manufacturing Laboratory and shipped frozen to the treatment site, where they will remain stored in the vapor phase of liquid nitrogen until the day of dosing.\n\nThe baseline evaluation will include vital signs (heart rate, blood pressure, temperature, respiratory rate), echocardiogram, ECG or telemetry strip, HLA typing, Panel Reactive Antibody (anti-HLA antibody), inflammatory markers, blood counts, blood chemistry, coagulation, and COVID-19 PCR and antibody tests.Patients will be dosed with 2x10^6 hCT-MSCs/kg. Doses will be given on days 1, 2, 3, and a fourth, optional dose may be given on day 7 at the discretion of the investigator and the treating physician. Prior to the infusion, premedications (Benadryl, Hydrocortisone, 0.5mg/kg each) will be administered. The hCT-MSCs will be administered intravenously over 30-60 minutes via a syringe pump. Pulse oximetry will be monitored continuously throughout the infusion and IV fluids will be managed by the care team. Afterwards, the participant will continue to be monitored in their care setting per institutional standards. Participants will be evaluated by study staff the day after the infusion to assess for any infusion-related adverse reactions or complications.\n\nThe participant will be monitored by study staff to assess for any infusion related adverse reactions or complications until discharge. Additional follow-up will occur on days 14, 28, and 90. Follow up testing will include assessment for adverse events as well as the tests done at baseline (with the exception of HLA typing and COVID PCR."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Multisystem Inflammatory Syndrome in Children"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "0",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "hCT-MSC infusion",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Doses will be given on days 1, 2, 3, and a fourth, optional dose may be given on day 7 at the discretion of the investigator and the treating physician.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Human Cord Tissue Mesenchymal Stromal Cells (hCT-MSCs)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Human Cord Tissue Mesenchymal Stromal Cells (hCT-MSCs)",
                                                            "InterventionDescription": "Human Umbilical Cord Tissue-derived Mesenchymal Stromal Cells (hCT-MSC):\n\nhCT-MSCs is an allogeneic cell product manufactured from donated umbilical cord tissue that is digested and expanded in culture, cryopreserved and banked. Doses contain 2x10^6 cells/kg (up to a maximum dose of 100x10^6 cells) diluted in plasmalyte-A with 5% HSA to a volume of 20-40mL.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "hCT-MSC infusion"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Safety of the Investigational Product, hCT-MSCs, infusion reactions",
                                                            "PrimaryOutcomeDescription": "Incidence of infusion reactions",
                                                            "PrimaryOutcomeTimeFrame": "2 days post infusion"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Safety of the Investigational Product, hCT-MSCs, related adverse events",
                                                            "PrimaryOutcomeDescription": "Incidence of later reactions attributed to the investigational product",
                                                            "PrimaryOutcomeTimeFrame": "90 days post initial infusion"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Safety of the Investigational Product, hCT-MSCs, anti-HLA antibodies",
                                                            "PrimaryOutcomeDescription": "Incidence of formation of new anti-HLA antibodies post infusion as compared to pre-infusion levels.",
                                                            "PrimaryOutcomeTimeFrame": "from first dose of MSCs to 28 days after first dose"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Survival",
                                                            "SecondaryOutcomeDescription": "Survival rate at 28 days after the first dose of MSCs",
                                                            "SecondaryOutcomeTimeFrame": "from first dose of MSCs to 28 days after first dose"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Inotrope support",
                                                            "SecondaryOutcomeDescription": "Description of duration of inotrope support after the first dose of MSCs",
                                                            "SecondaryOutcomeTimeFrame": "from first dose of MSCs to 90 days after first dose"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Hospital Discharge",
                                                            "SecondaryOutcomeDescription": "Description of number of days to hospital discharge to home",
                                                            "SecondaryOutcomeTimeFrame": "from first dose of MSCs to 90 days after first dose"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Duration of ICU stay",
                                                            "SecondaryOutcomeDescription": "Description of Duration of ICU stay",
                                                            "SecondaryOutcomeTimeFrame": "from first dose of MSCs to 90 days after first dose"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "cardiac abnormalities",
                                                            "SecondaryOutcomeDescription": "Incidence of cardiac abnormalities at day 28, defined as persistent abnormalities in ECG, Echo, or biochemical markers (pro-BNP, troponin).",
                                                            "SecondaryOutcomeTimeFrame": "from first dose of MSCs to 28 days after first dose"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAge: 18 to <21 years\n\nDiagnosis: must meet ALL below criteria for COVID-19 related MIS-C as defined by the CDC.\n\nAge <21 years\nNo alternative plausible diagnoses\nPositive for current or recent SARS-CoV-2 infection or COVID-19 exposure within the 4 weeks prior to the onset of symptoms. Exposure may be measure by RT-PCR, Serology, Antigen test, or History.\n\nALL of the following clinical symptoms:\n\nFever \u226538.0 degrees C for \u226524 hours or report of subjective fever lasting\n\n24 hours\nLaboratory evidence of inflammation, including, but not limited to, one or more of the following: an elevated CRP, ESR, fibrinogen, procalcitonin, d- dimer, ferritin, LDH, or IL-6; elevated neutrophils, reduced lymphocytes, low albumin\nClinically severe disease that requires hospitalization\nMultisystem (\u22652) organ involvement:\n\nI. Cardiovascular involvement (ANY of the listed criteria):\n\nCardiac dysrhythmia or arrythmia (NOTE: patients with prolonged QT interval or unstable dys/arrythmias are not eligible)\nEjection fraction 35%-<55%\nPulmonary edema due to left heart failure\nPericarditis or pericardial effusion (not requiring drainage)\nB-type natriuretic peptide (BNP) >400 pg/mL\nElevated troponin (based on the upper limit of normal for the laboratory running the assay)\nReceipt of vasopressor or vasoactive support\n\nII. Respiratory Involvement (includes ANY of the listed criteria)\n\nReceipt of mechanical ventilation or any type of supplemental oxygen (or increased support for patients receiving respiratory support at baseline)\nPulmonary infiltrates on chest radiograph\nLower respiratory infection\nPleural effusion (not requiring chest tube)\nPneumothorax (not requiring chest tube)\n\nIII. Ophthalmologic involvement\n\nIritis or uveitis\n\nIV. Gastrointestinal involvement (includes ANY of the listed criteria)\n\nNausea/vomiting\nDiarrhea\nAbdominal pain\nPancreatitis (amylase and/or lipase >200 U/L or radiologic findings)\nHepatitis (AST and/or ALT >500 U/L)\nGallbladder hydrops or edema\n\nV. Hematologic involvement (includes ANY of the listed criteria)\n\nTotal white blood cell <4 x10^3/\u03bcL\nAnemia (hemoglobin <9 g/dL)\nPlatelet count <150,000 /\u03bcL\nHemolysis VI. Mucocutaneous involvement (includes ANY of the listed criteria)\nBilateral conjunctival injection\nOral mucosal changes\nPeripheral extremity changes\nRash or skin ulcers\n'COVID' toes\nSwollen red cracked lips\nErythema of palms or soles\nEdema of hands or feet\nPeriungual (nails) desquamation\nConjunctivitis\nPeripheral gangrene\n\nVII. Musculoskeletal involvement (includes ANY of the listed criteria)\n\nArthritis or arthralgia involvement\nMyositis or myalgia\nPrior therapy: must have been treated with IVIG (maximum cumulative dose of 5g/kg) 1-7 days prior to enrollment. Patients will be eligible if they have progressive symptoms \u226524 hours after initiation of IVIG or lack of response \u226548 hours after initiation of IVIG. Lack of response is defined as inability wean off of supportive care measures (ie. vasopressors, mechanical ventilation, oxygen support) or lack of improvement in inflammatory markers.\nPrior treatment with immunomodulators (e.g. tocilizumab, etc) is allowed if there was no response or progressive disease 2 days (48 hours) or more after initiation of this therapy.\nLife expectancy \u2265 72 hours\nLegal authorized representative consent\n\nExclusion Criteria:\n\nEvidence of acquired or congenital immunodeficiency (due to immunosuppressive therapy, HIV, previous treatment for cancer, etc.)\nHistory of cancer\nHistory of previous treatments with MSCs or other cell therapies\nPatient is enrolled in any other IND-sponsored clinical trials for COVID-19\nEvidence of pregnancy or lactation\nMoribund patient not expected to survive > 24 hours\nPatient is receiving Extracorporeal Membrane Oxygenation (ECMO)\nPatient received CPR for this condition\nPatients who have acquired thrombotic risk due to COVID, e.g., VTE, pulmonary embolism, stroke, intracranial hemorrhage, ischemia of an extremity, or prone to thrombotic conditions, e.g., Factor V Leiden mutations, lupus anti-coagulant, etc.\nPatients with history of DMSO allergies\n\nECG exclusions: prolonged QT interval, changes suggestive of myocardial ischemia, unstable cardiac dys/arrythmia that requires medical stabilization (ie.\n\nunstable supraventricular tachycardia, ventricular tachycardia, or ventricular fibrillation)\n\nEchocardiogram exclusions: Dilated coronary artery(ies) (z score >2), aneurysms, ectasia, pericardial effusion requiring drainage, or focal wall abnormalities suggestive of myocardial ischemia\nChest tube\nConcurrent dialysis\nSuspected CNS infection\nSevere bronchospasm requiring continuous bronchodilators\nPulmonary hemorrhage\nA formal diagnosis of full Kawasaki disease (KD).\nFailure to perform COVID-19 PCR and serology testing prior to IVIG administration.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "20 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Joanne Kurtzberg, MD",
                                                            "OverallOfficialAffiliation": "Duke University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Emory University School of Medicine",
                                                            "LocationCity": "Atlanta",
                                                            "LocationState": "Georgia",
                                                            "LocationZip": "30322",
                                                            "LocationCountry": "United States"
                                                      },
                                                      {
                                                            "LocationFacility": "New York Medical College, Westchester Medical Center (WMC)",
                                                            "LocationCity": "Westchester",
                                                            "LocationState": "New York",
                                                            "LocationZip": "10595",
                                                            "LocationCountry": "United States"
                                                      },
                                                      {
                                                            "LocationFacility": "Duke University Medical Center",
                                                            "LocationCity": "Durham",
                                                            "LocationState": "North Carolina",
                                                            "LocationZip": "27705",
                                                            "LocationCountry": "United States"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000013577",
                                                            "ConditionMeshTerm": "Syndrome"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000004194",
                                                            "ConditionAncestorTerm": "Disease"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M85407",
                                                            "InterventionBrowseLeafName": "Plasma-lyte 148",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M8814",
                                                            "InterventionBrowseLeafName": "Altretamine",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "PhSol",
                                                            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ANeo",
                                                            "InterventionBrowseBranchName": "Antineoplastic Agents"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 35,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04348461",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "BALMYS-19"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Instituto de Investigaci\u00f3n Sanitaria de la Fundaci\u00f3n Jim\u00e9nez D\u00edaz",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "BAttLe Against COVID-19 Using MesenchYmal Stromal Cells",
                                          "OfficialTitle": "Two-treatment,Randomized, Controlled, Multicenter Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Expanded Allogeneic Adipose Tissue Adult Mesenchymal Stromal Cells in Critically Ill Patients COVID-19"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "May 2020",
                                          "OverallStatus": "Suspended",
                                          "WhyStopped": "lack of financial support",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "May 6, 2020",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 15, 2020",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "September 30, 2021",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "April 10, 2020",
                                          "StudyFirstSubmitQCDate": "April 14, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "April 16, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "March 15, 2021",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "March 17, 2021",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Instituto de Investigaci\u00f3n Sanitaria de la Fundaci\u00f3n Jim\u00e9nez D\u00edaz",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Instituto de Investigaci\u00f3n Sanitaria y Biom\u00e9dica de Alicante",
                                                            "CollaboratorClass": "UNKNOWN"
                                                      },
                                                      {
                                                            "CollaboratorName": "Hospital General Universitario Gregorio Mara\u00f1on",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Clinica Universidad de Navarra, Universidad de Navarra",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "University of Salamanca",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Hospital General Universitario de Alicante",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Hospital Cl\u00ednico Universitario Virgen de la Arrixaca",
                                                            "CollaboratorClass": "UNKNOWN"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The investigational medicinal product consists of expanded allogeneic mesenchymal stromal cells derived from adipose tissue and administered intravenously.\n\nThe objective of this project is to evaluate the safety and efficacy of the administration of expanded allogeneic adipose tissue adult mesenchymal stem cells, in patients infected with SARS-COV-2 with COVID-19 type complications."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "COVID",
                                                      "Respiratory Distress Syndrome"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Quadruple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "100",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Control",
                                                            "ArmGroupType": "No Intervention",
                                                            "ArmGroupDescription": "Patients receiving regular respiratory distress treatment"
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Treatment",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Patients receiving two serial doses of allogeneic and expanded adipose tissue-derived mesenchymal stromal cells",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells",
                                                            "InterventionDescription": "Two serial doses of 1.5 million adipose-tissue derived mesenchymal stem cells per kg",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Treatment"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Efficacy of the administration of allogeneic mesenchymal stem cells derived from adipose tissue assessed by Survival Rate)",
                                                            "PrimaryOutcomeTimeFrame": "28 days"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Safety of the administration of allogeneic mesenchymal stem cells derived from adipose tissue assessed by Adverse Event Rate",
                                                            "PrimaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients of both sexes.\nOver 18 years.\nConfirmation of SARS-COV-2 infection by RT-PCR in respiratory sample.\nRespiratory failure requiring intubation and connection to mechanical ventilation, secondary to SARS-CoV-2 infection.\nCriteria for acute respiratory distress: acute bilateral alveolar-interstitial infiltrate not compatible with left ventricular failure (demonstrated with ultrasound or hemodynamic parameters), sudden onset, and blood gas compromise with a PaO2 / FiO2 ratio <200 mm-Hg.\nWomen of childbearing potential should have a negative urine pregnancy test performed at the time of study enrollment.\nWritten or verbal informed consent from the patient, family member or legal representative.\n\nExclusion Criteria:\n\nAny other cause of acute respiratory distress not attributable to SARS-Cov-2.\nRT-PCR of SARS-Cov-2 negative.\nMulti-organ failure (more than three organs)\nSevere respiratory failure requiring extracorporeal support (ECMO) Grave Moderate severe COPD requiring chronic home oxygen therapy, need for prior home oxygen therapy for any reason.\nPregnancy, lactation and women of childbearing age but who do not take effective contraceptive measures.\nActive tumor disease.\nPrevious immunosuppressive treatment.\nAllergy or hypersensitivity to the administered products.\nHistory of deep vein thrombosis or pulmonary embolism in the last 3 years.\nParticipation in other clinical trials during the 3 months prior to the initial visit.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Fundacion Jimenez Diaz",
                                                            "LocationCity": "Madrid",
                                                            "LocationZip": "28002",
                                                            "LocationCountry": "Spain"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000012128",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012127",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome, Newborn"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012120",
                                                            "ConditionAncestorTerm": "Respiration Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M18162",
                                                            "ConditionBrowseLeafName": "Critical Illness",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M2562",
                                                            "ConditionBrowseLeafName": "COVID-19",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14117",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14116",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Newborn",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14109",
                                                            "ConditionBrowseLeafName": "Respiration Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4927",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Infant",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T192",
                                                            "ConditionBrowseLeafName": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC01",
                                                            "ConditionBrowseBranchName": "Infections"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 36,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03608631",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2018-0126"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "NCI-2018-01441",
                                                            "SecondaryIdType": "Registry Identifier",
                                                            "SecondaryIdDomain": "CTRP (Clinical Trial Reporting Program)"
                                                      },
                                                      {
                                                            "SecondaryId": "2018-0126",
                                                            "SecondaryIdType": "Other Identifier",
                                                            "SecondaryIdDomain": "M D Anderson Cancer Center"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "M.D. Anderson Cancer Center",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation",
                                          "OfficialTitle": "Phase I Study of Mesenchymal Stromal Cells-Derived Exosomes With KrasG12D siRNA for Metastatic Pancreas Cancer Patients Harboring KrasG12D Mutation"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2022",
                                          "OverallStatus": "Recruiting",
                                          "StartDateStruct": {
                                                "StartDate": "January 27, 2021",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "March 31, 2023",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "March 31, 2023",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "July 16, 2018",
                                          "StudyFirstSubmitQCDate": "July 24, 2018",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "August 1, 2018",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "April 25, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 26, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "M.D. Anderson Cancer Center",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This phase I trial studies the best dose and side effects of mesenchymal stromal cells-derived exosomes with KrasG12D siRNA (iExosomes) in treating participants with pancreatic cancer with KrasG12D mutation that has spread to other places in the body. iExosomes may work better at treating pancreatic cancer.",
                                          "DetailedDescription": "PRIMARY OBJECTIVES:\n\nI. To identify the maximum tolerated dose (MTD) of mesenchymal stem cell (MSC)-derived exosomes loaded with small interference RNA (siRNA) against KrasG12D (iExosomes) in metastatic pancreatic ductal adenocarcinoma (PDAC) patients with KrasG12D mutation.\n\nII. To identify the dose-limiting toxicities (DLT) of mesenchymal stem cell (MSC)-derived exosomes loaded with siRNA against KrasG12D (iExosomes) in metastatic PDAC patients with KrasG12D mutation.\n\nSECONDARY OBJECTIVES:\n\nI. Evaluate the pharmacokinetic profile of iExosomes. II. Assess the overall response rate of iExosomes in the chosen patient population.\n\nIII. Assess the disease control rate (partial response + stable disease) with therapy.\n\nIV. Determine median progression-free survival (PFS) with this treatment. V. Determine the median overall survival (OS) with this treatment.\n\nEXPLORATORY OBJECTIVES:\n\nI. Evaluate optional tissue collection and serum-derived exosomes and circulating-free deoxyribonucleic acid (DNA) (cfDNA) for detection of DNA and ribonucleic acid (RNA) showing KrasG12D sequence; evaluate DNA and RNA showing KrasG12D sequence in optional tissue collection.\n\nII. Evaluate the siRNA content in blood and optional tissue collection.\n\nOUTLINE: This is a dose-escalation study.\n\nParticipants receive mesenchymal stromal cells-derived exosomes with KrasG12D siRNA intravenously (IV) over 15-20 minutes on days 1, 4, and 10. Treatment repeats every 14 days for up to 3 courses in the absence of disease progression or unacceptable toxicity. Participants who respond may continue 3 additional courses.\n\nAfter completion of study treatment, participants are followed up at 30 days, then every 3 months for up to 1 year."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "KRAS NP_004976.2:p.G12D",
                                                      "Metastatic Pancreatic Adenocarcinoma",
                                                      "Pancreatic Ductal Adenocarcinoma",
                                                      "Stage IV Pancreatic Cancer AJCC v8"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "28",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Treatment (iExosomes)",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Participants receive mesenchymal stromal cells-derived exosomes with KrasG12D siRNA IV over 15-20 minutes on days 1, 4, and 10. Treatment repeats every 14 days for up to 3 courses in the absence of disease progression or unacceptable toxicity. Participants who respond may continue 3 additional courses.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA",
                                                            "InterventionDescription": "Given IV",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Treatment (iExosomes)"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "MSC-derived Exosomes with KrasG12D siRNA (SY); KrasG12D siRNA-loaded Mesenchymal Stromal Cells-derived Exosomes (SY)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Maximum Tolerated Dose Determined by Dose Limiting Toxicity",
                                                            "PrimaryOutcomeDescription": "Dose limiting toxicity graded according to the NCI CTCAE, Version 4.0",
                                                            "PrimaryOutcomeTimeFrame": "First 4 weeks of treatment"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Minimal residual disease rate in high-risk patients",
                                                            "PrimaryOutcomeDescription": "Will be modeled using logistic regression.",
                                                            "PrimaryOutcomeTimeFrame": "Up to 1 year"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Overall survival (OS)",
                                                            "PrimaryOutcomeDescription": "Estimated using the Kaplan-Meier product limit estimator.",
                                                            "PrimaryOutcomeTimeFrame": "Up to 1 year"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Progression-free survival (PFS)",
                                                            "PrimaryOutcomeDescription": "Estimated using Kaplan-Meier product limit estimator.",
                                                            "PrimaryOutcomeTimeFrame": "Up to 1 year"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with histologically confirmed metastatic pancreatic ductal adenocarcinoma harboring KrasG12D mutation\nPatients must have documented progression or stable disease on one or more lines of systemic therapy. If stable disease, patient must have completed at least 4 months of chemotherapy with cytotoxic therapy\nKrasG12D mutation status will be informed from any previous routine molecular profiling (using commercial assays such as Foundation One, Caris, Oncomine or other) of tissue or blood. Additional KrasG12D mutation status may be confirmed using tissue biopsy or blood prior to enrolling into the trial\nECOG (Eastern Cooperative Oncology Group) performance status of 0-1\nAbsolute neutrophil count (ANC) more or equal to 1,500 cells/mm3\nPlatelets more or equal to 100,000/ul\nHemoglobin more than 9.0 g/dL\nTotal bilirubin between 1 and 1.5 mg/dL\nAST (aspartate aminotransferase) and ALT (alanine transaminase) less than 2.5 x ULN (upper limit of normal)\nAlkaline phosphatase less than 2.5 x ULN\nCreatinine less than 1.5 gm/dL\nIn patients with known Gilbert's syndrome, direct bilirubin less or equal to 1.5 x ULN will be used as organ function criteria, instead of total bilirubin\nNegative serum pregnancy test in women with childbearing potential (WOCBP) defined as not post-menopausal for 12 months or no previous surgical sterilization, within one week prior to initiation of treatment. WOCBP must be using an adequate method of contraception to avoid pregnancy throughout the study and for up to 12 weeks after the last dose of study drug to minimize the risk of pregnancy. WOCBP must be using an adequate method of contraception to avoid pregnancy throughout the study and for up to 12 weeks after the last dose of study drug to minimize the risk of pregnancy\nA male subject of fathering potential must use an adequate method of contraception to avoid conception throughout the study and for up to 12 weeks after the last dose of study drug to minimize the risk of pregnancy. If the partner is pregnant or breastfeeding, the subject must use a condom\nPatients must sign an informed consent and authorization indicating that they are aware of the investigational nature of this study and the known risks involved\n\nExclusion Criteria:\n\nConcurrent severe and/or uncontrolled medical conditions which could compromise participation in the study such as unstable angina, myocardial infarction within 6 months, unstable symptomatic arrhythmia, uncontrolled diabetes, serious active or uncontrolled infection\nPregnancy (positive pregnancy test) or lactation\nKnown CNS (central nervous system) disease, except for treated brain metastasis. Treated brain metastases are defined as having no evidence of progression or hemorrhage after treatment and no ongoing requirement for dexamethasone, as ascertained by clinical examination and brain imaging (magnetic resonance imaging-MRI or computerized tomography-CT) during the screening period. Anticonvulsants (stable dose) are allowed. Treatment for brain metastases may include whole brain radiotherapy (WBRT), radiosurgery (RS; gamma knife, linear accelerator [LINAC], or equivalent) or a combination as deemed appropriate by the treating physician. Patients with CNS metastases treated by neurosurgical resection or brain biopsy performed within 3 months prior to day 1 will be excluded",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Brandon Smaglo, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "(713) 745-8763",
                                                            "CentralContactEMail": "bgsmaglo@mdanderson.org"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Brandon Smaglo, MD",
                                                            "OverallOfficialAffiliation": "M.D. Anderson Cancer Center",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "M D Anderson Cancer Center",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Houston",
                                                            "LocationState": "Texas",
                                                            "LocationZip": "77030",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Brandon Smaglo, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "713-792-2828",
                                                                              "LocationContactEMail": "spant@mdanderson.org"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Brandon Smaglo",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "33855751",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Tang M, Chen Y, Li B, Sugimoto H, Yang S, Yang C, LeBleu VS, McAndrews KM, Kalluri R. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. FASEB J. 2021 May;35(5):e21557. doi: 10.1096/fj.202002777RR."
                                                      }
                                                ]
                                          },
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "MD Anderson Cancer Center Website",
                                                            "SeeAlsoLinkURL": "http://www.mdanderson.org"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000000230",
                                                            "ConditionMeshTerm": "Adenocarcinoma"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000010190",
                                                            "ConditionMeshTerm": "Pancreatic Neoplasms"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000002277",
                                                            "ConditionAncestorTerm": "Carcinoma"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009375",
                                                            "ConditionAncestorTerm": "Neoplasms, Glandular and Epithelial"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009370",
                                                            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009369",
                                                            "ConditionAncestorTerm": "Neoplasms"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004067",
                                                            "ConditionAncestorTerm": "Digestive System Neoplasms"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009371",
                                                            "ConditionAncestorTerm": "Neoplasms by Site"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004701",
                                                            "ConditionAncestorTerm": "Endocrine Gland Neoplasms"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004066",
                                                            "ConditionAncestorTerm": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010182",
                                                            "ConditionAncestorTerm": "Pancreatic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004700",
                                                            "ConditionAncestorTerm": "Endocrine System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M2737",
                                                            "ConditionBrowseLeafName": "Adenocarcinoma",
                                                            "ConditionBrowseLeafAsFound": "Adenocarcinoma",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12262",
                                                            "ConditionBrowseLeafName": "Pancreatic Neoplasms",
                                                            "ConditionBrowseLeafAsFound": "Pancreas Cancer",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4686",
                                                            "ConditionBrowseLeafName": "Carcinoma",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11472",
                                                            "ConditionBrowseLeafName": "Neoplasms, Glandular and Epithelial",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11467",
                                                            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8038",
                                                            "ConditionBrowseLeafName": "Gastrointestinal Neoplasms",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6408",
                                                            "ConditionBrowseLeafName": "Digestive System Neoplasms",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7015",
                                                            "ConditionBrowseLeafName": "Endocrine Gland Neoplasms",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8035",
                                                            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6407",
                                                            "ConditionBrowseLeafName": "Digestive System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12254",
                                                            "ConditionBrowseLeafName": "Pancreatic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7014",
                                                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4387",
                                                            "ConditionBrowseLeafName": "Pancreatic Cancer",
                                                            "ConditionBrowseLeafAsFound": "Pancreatic Cancer",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC04",
                                                            "ConditionBrowseBranchName": "Neoplasms"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC06",
                                                            "ConditionBrowseBranchName": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC19",
                                                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M21707",
                                                            "InterventionBrowseLeafName": "Pancrelipase",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M12266",
                                                            "InterventionBrowseLeafName": "Pancreatin",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Gast",
                                                            "InterventionBrowseBranchName": "Gastrointestinal Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 37,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03014219",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "15-005574"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Mayo Clinic",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Phase 1 Crohn's Pediatric Sub-study of MSC AFP",
                                          "OfficialTitle": "A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease: Pediatric Sub-study"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "July 2017",
                                          "OverallStatus": "Withdrawn",
                                          "WhyStopped": "FDA approval was not obtained until adult trial completes accrual",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "July 2017",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "July 2019",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "July 2020",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "January 4, 2017",
                                          "StudyFirstSubmitQCDate": "January 5, 2017",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "January 9, 2017",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "July 3, 2017",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "July 6, 2017",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "William A. Faubion, M.D.",
                                                "ResponsiblePartyInvestigatorTitle": "Sponsor Investigator",
                                                "ResponsiblePartyInvestigatorAffiliation": "Mayo Clinic"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "William A. Faubion, M.D.",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The investigators propose to study the safety of autologous mesenchymal stromal cell transfer using a biomatrix (the Gore Bio-A Fistula Plug) in a Phase I study using a single dose of 20 million cells. 20 patients (age 12 to 17 years) with Crohns perianal fistulas will be enrolled.\n\nSubjects will undergo standard adjuvant therapy including drainage of infection and placement of a draining seton. Six weeks post placement of the draining seton, the seton will be replaced with the MSC loaded Gore fistula plug as per current clinical practice. The subjects will be subsequently followed for fistula response and closure for 24 months. This is an autologous product derived from the patient and used only for the same patient.",
                                          "DetailedDescription": "Visit 1: Patients will be evaluated for eligibility (inclusion/exclusion checklist) and written, informed consent will be obtained. Patients will undergo general exam with vital signs. Patients will be scheduled for a fat biopsy to collect the tissue needed to grow MSC. In the event there is no cell growth from the tissue obtained from the first biopsy, one further attempt will made from a second tissue sample from this patient. However, if the second attempt fails to grow cells, no further attempts will be made, and the subject will not continue in the study.\n\nThe subjects will be subsequently followed for fistula response and closure for 24 months. Study visits are Day 1, Week 2, Week 4, Week 8, Week 12, Week 24, Week 52, and Week 104. This is an autologous product derived from the patient and used only for the same patient."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Perianal Fistula"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "0",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Only 1 arm: treatment with MSC-AFP",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Single Treatment Group: Eligible patients will be treated with a Gore Bio-A Fistula Plug that has been coated with autologous mesenchymal stromal cells. This is a drug study, specifically phase 1 study of autologous mesenchymal stromal cells. Single dose of 20 million cells.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Only 1 arm: treatment with MSC-AFP"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Only 1 arm: treatment with MSC-AFP",
                                                            "InterventionDescription": "Eligible patients will be treated with a fistula plug that has been coated with autologous mesenchymal stromal cell. Drug study. Single dose of 20 million cells.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Only 1 arm: treatment with MSC-AFP"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of Subjects with any Adverse Events that are related to study drug",
                                                            "PrimaryOutcomeDescription": "The primary endpoint of this study is to determine the safety of using adipose derived, autologous mesenchymal stromal cells (MSC) bound to the Gore Bio-A Fistula Plug for treatment of refractory CD perianal fistulae.",
                                                            "PrimaryOutcomeTimeFrame": "[Time Frame: 2-24 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of Subjects with healing in response to the study drug treatment",
                                                            "SecondaryOutcomeDescription": "The Outcome Measure will be the presence or absence of fistula drainage (Yes vs. No)",
                                                            "SecondaryOutcomeTimeFrame": "Time Frame: 2-24 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria\n\nMales and females 12-17 years of age.\nResidents of the United States.\nCrohn's disease with single or multiple draining complex perianal fistulae (definition as below) for at least three months despite standard therapy (definition below).\nConcurrent therapies with corticosteroids, 5-ASA drugs, thiopurines, MTX, antibiotics, and anti-TNF therapy are permitted.\nAll patients should have undergone a colonoscopy in last 12 months to rule out malignant or premalignant condition\nHave no contraindications to MR evaluations: e.g. pacemaker or magnetically active metal fragments, claustrophobia\nAbility to comply with protocol\nCompetent and able to provide written informed consent (and assent where appropriate).\nMust have failed standard medical therapy including anti-TNF agents\n\nExclusion Criteria\n\nInability to obtain informed consent (and assent where appropriate).\nClinically significant medical conditions within the six months before administration of MSCs: e.g. sepsis, pneumonia active serious infection or other conditions that would, in the opinion of the investigators, compromise the safety of the patient.\n\nSpecific exclusions;\n\na. Evidence of hepatitis B, C, or HIV\n\nHistory of cancer including melanoma (with the exception of localized skin cancers)\nInvestigational drug within thirty (30) days of baseline\nA resident outside the United States\nPregnant or trying to become pregnant, or breast feeding.\nHistory of clinically significant auto-immunity (other than Crohn's disease) or any previous example of fat-directed autoimmunity\nPrevious allergic reaction to a perianal fistula plug.\nIf adipose tissue is not technically feasible\nWeight less than 35 kg\nAllergic to local anesthetics\nNon-enterocutaneous tracts (i.e. recto-vaginal, entero-vesicular)",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "12 Years",
                                          "MaximumAge": "17 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Michael C Stephens",
                                                            "OverallOfficialAffiliation": "Mayo Clinic",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "William Faubion",
                                                            "OverallOfficialAffiliation": "Mayo Clinic",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Mayo Clinic in Rochester",
                                                            "LocationCity": "Rochester",
                                                            "LocationState": "Minnesota",
                                                            "LocationZip": "55905",
                                                            "LocationCountry": "United States"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000005402",
                                                            "ConditionMeshTerm": "Fistula"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000020763",
                                                            "ConditionAncestorTerm": "Pathological Conditions, Anatomical"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M7684",
                                                            "ConditionBrowseLeafName": "Fistula",
                                                            "ConditionBrowseLeafAsFound": "Fistula",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5790",
                                                            "ConditionBrowseLeafName": "Crohn Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21672",
                                                            "ConditionBrowseLeafName": "Pathological Conditions, Anatomical",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC06",
                                                            "ConditionBrowseBranchName": "Digestive System Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 38,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04236479",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Pro00011914"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Children's National Research Institute",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP)",
                                          "OfficialTitle": "Mesenchymal Stromal Cells Delivery Through Cardiopulmonary Bypass in Pediatric Cardiac Surgery"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "May 2022",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "July 29, 2020",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 2024",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "April 2025",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "January 15, 2020",
                                          "StudyFirstSubmitQCDate": "January 17, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "January 22, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "May 11, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "May 13, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Catherine Bollard",
                                                "ResponsiblePartyInvestigatorTitle": "Director, Center for Cancer and Immunology/ Center for Emerging Technologies in Immune Cell Therapies (CETI)",
                                                "ResponsiblePartyInvestigatorAffiliation": "Children's National Research Institute"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Catherine Bollard",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The proposed study will be a prospective, open-label, single-center, safety and feasibility phase 1 trial of allogeneic bone marrow-derived mesenchymal stromal cell (BM-MSC) delivery though cardiopulmonary bypass (CPB) using a homogeneous population of infants with congenital heart disease (CHD) who will be undergoing a two-ventricle repair within the first six months of life",
                                          "DetailedDescription": "This study is a prospective, open-label, single-center, safety and feasibility phase 1 trial of allogeneic bone marrow-derived mesenchymal stromal cell (BM-MSC) delivery though cardiopulmonary bypass (CPB) using a homogeneous population of infants with congenital heart disease (CHD) who will be undergoing a two-ventricle repair within the first six months of life. The dose-escalation methods with a modified continual reassessment at the five dose levels (1x10^6, 10x10^6, 20x10^6, 40x10^6, 80x10^6, cells/kg) will be performed to determine safety and feasibility of allogeneic BM-MSC infusion during pediatric cardiac surgery and the maximum tolerated dose in infants with CHD. In addition to the primary objective of assessing the safety and feasibility of BM-MSC delivery through CPB, our secondary objectives are designed to develop biological signature measures and clinical outcome measures feasible for use in larger efficacy and effectiveness trials with a particular focus on neurodevelopmental outcome and early postoperative course after BM-MSC treatment. We will determine actual magnitude of differences in neuroimaging and neurodevelopmental variables and postoperative inflammatory and pathophysiological variables after BM-MSC delivery in infants with CHD. Enrollment, follow-up, and analysis are planned to occur over 36 months for the treatment and initial follow-up portions of the study. Long-term follow-up until 18 months of age will be subsequently reported."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Congenital Heart Disease (CHD)"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "36",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Bone marrow-derived mesenchymal stromal cell (BM-MSC)",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "The dose-escalation methods with a modified continual reassessment at the five dose levels (1x10^6, 10x10^6, 20x10^6, 40x10^6, 80x10^6 cells/kg) will be performed to determine safety and feasibility of allogeneic BM-MSC infusion during pediatric cardiac surgery and the maximum tolerated dose in infants with CHD.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: BM-MSC"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "BM-MSC",
                                                            "InterventionDescription": "Allogeneic bone marrow-derived mesenchymal stromal cell (BM-MSC) delivery through cardiopulmonary bypass (CPB) using a homogeneous population of infants with congenital heart disease (CHD) who will be undergoing a two-ventricle repair within the first six months of life.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Bone marrow-derived mesenchymal stromal cell (BM-MSC)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of subjects who experience serious adverse events, adverse events, and/or early treatment discontinuations.",
                                                            "PrimaryOutcomeDescription": "Dose Limiting Toxicity is attributable to the MSC administration.",
                                                            "PrimaryOutcomeTimeFrame": "45 days following the MSC administration"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Actual magnitude of differences in neuroimaging and neurodevelopmental variables will be measured after MSC delivery.",
                                                            "SecondaryOutcomeDescription": "Secondary objective will be measured by using the Pediatric Cardiac Critical Care Consortium (PC4) registry system.",
                                                            "SecondaryOutcomeTimeFrame": "18 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nNeonatal and young infantile patients who are \u2264 3 months of age\n\nScheduled to undergo reparative two-ventricle repair for congenital heart defects without aortic arch reconstruction, including the following:\n\na. D-Transposition of the Great Arteries (d-TGA) Group: i. d-TGA with intact ventricular septum (d-TGA, IVS) ii. d-TGA with ventricular septal defect (d-TGA, VSD) b. Ventricular Septal Defect (VSD) Group: i. VSD without aortic arch obstruction (AAO) ii. Complete common atrioventricular canal defect (CAVC) c. Tetralogy of Fallot (TOF) Group: i. Tetralogy of Fallot (TOF) ii. Tetralogy of Fallot with Pulmonary Atresia (TOF,PA) iii. Truncus arteriosus (TA) iv. Double outlet right ventricle (DORV)\n\nScheduled surgery at or before three months of age.\nParent/guardian capable of providing informed consent.\n\nExclusion Criteria:\n\nBirth weight less than 2.0 kg\nRecognizable phenotypic syndrome\nAssociated extracardiac anomalies of greater than minor severity\nPrevious cardiac surgery\nAssociated cardiovascular anomalies requiring aortic arch reconstruction and/or additional open cardiac surgical procedures in infancy\nPrior severe hypoxic event\nSignificant screening test values that place subjects at increased risk of complications from participation in the study",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MaximumAge": "6 Months",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Nobuyuki Ishibashi, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "202-476-2388",
                                                            "CentralContactEMail": "NIshibas@childrensnational.org"
                                                      },
                                                      {
                                                            "CentralContactName": "Fahmida Hoq, MBBS, MS",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "202-476-3634",
                                                            "CentralContactEMail": "fhoq@childrensnational.org"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Richard Jonas, MD",
                                                            "OverallOfficialAffiliation": "CNMC",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Children's National Health System",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Washington",
                                                            "LocationState": "District of Columbia",
                                                            "LocationZip": "20010",
                                                            "LocationCountry": "United States",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Nobuyuki Ishibashi,, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "202-476-2388",
                                                                              "LocationContactEMail": "NIshibas@childrensnational.org"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Richard Jonas, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000006331",
                                                            "ConditionMeshTerm": "Heart Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000006330",
                                                            "ConditionMeshTerm": "Heart Defects, Congenital"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000002318",
                                                            "ConditionAncestorTerm": "Cardiovascular Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000018376",
                                                            "ConditionAncestorTerm": "Cardiovascular Abnormalities"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000000013",
                                                            "ConditionAncestorTerm": "Congenital Abnormalities"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8571",
                                                            "ConditionBrowseLeafName": "Heart Diseases",
                                                            "ConditionBrowseLeafAsFound": "Heart Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8570",
                                                            "ConditionBrowseLeafName": "Heart Defects, Congenital",
                                                            "ConditionBrowseLeafAsFound": "Congenital Heart Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12",
                                                            "ConditionBrowseLeafName": "Congenital Abnormalities",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M19656",
                                                            "ConditionBrowseLeafName": "Cardiovascular Abnormalities",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC14",
                                                            "ConditionBrowseBranchName": "Heart and Blood Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 39,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01659762",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "IRB00051454"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "EPIC001",
                                                            "SecondaryIdType": "Other Identifier",
                                                            "SecondaryIdDomain": "Other"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Emory University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.",
                                          "OfficialTitle": "A Phase I Study Evaluating Safety and Tolerability of Autologous Bone Marrow Derived Mesenchymal Stromal (MSC) Cells in Adults With Moderate to Severe Crohn's Disease.",
                                          "Acronym": "EPIC/MSC/IBD"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "October 2016",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "July 2012"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "July 2015",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "August 6, 2012",
                                          "StudyFirstSubmitQCDate": "August 7, 2012",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "August 8, 2012",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "October 13, 2016",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "October 17, 2016",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Jacques Galipeau, MD",
                                                "ResponsiblePartyInvestigatorTitle": "Professor",
                                                "ResponsiblePartyInvestigatorAffiliation": "Emory University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Emory University",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Atlanta Clinical and Translational Science Institute",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "In this Phase I trial the investigators intend to show safety and tolerability of autologous MSC, expanded using a non-xenogeneic, human component platelet lysate expansion media. Fresh, non cryopreserved, autologous MSCs will delivered intravenously as a single bolus dose in a dose escalation phase I study. The investigators intend to test whether the product is clinically safe in adults (18-65 years old) with CD and to determine maximal deliverable dose. Secondary endpoint will monitor effectiveness using CDAI as an endpoint.",
                                          "DetailedDescription": "EPIC MSC/IBD is made up of autologous marrow-derived mesenchymal stromal cells ex vivo expanded numerically for approximately 14 days using pooled human Platelet Lysate (phPL), harvested on the day of infusion, washed and suspended at a concentration of 4 million cells/ml in Plasmalyte A with 0.5% human serum albumin. This is a phase I dose-escalation, open label, non-randomized, non-placebo controlled, single group assignment study to evaluate the safety and tolerability of a single intravenous infusion of EPIC MSC2011-001. EPIC EPIC MSC/IBD will be infused intravenously and will be administered at one of three dose levels: (Tier 1) 2 million cells/kg patient body weight; (Tier 2) 5 million cells/kg, and (Tier 3) 10 million cells/kg. This Phase I clinical trial will enroll 16-20 subjects with moderate to severe Crohn's. The duration of this study for each patient is 12 weeks. The investigators anticipate that this study will be completed within 2 years of commencement.\n\nPrimary objective: To describe and compare the safety and tolerability of a single infusion of fresh autologous bone marrow derived Mesenchymal stromal cells infused to patients with moderate to severe Crohn's disease.\n\nSecondary objective: Efficacy of autologous bone marrow derived Mesenchymal stromal cells infusion to patients with moderate to severe Crohn's disease as assessed through disease activity index, and quality of life index.\n\nSafety variables:Adverse events (AEs),Laboratory parameters (hematology, biochemistry, urinalysis), Vital signs."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Crohn's Disease"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "inflammatory bowel disease",
                                                      "Crohn's disease"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "16",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "autologous mesenchymal stromal cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: autologous mesenchymal stromal cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "autologous mesenchymal stromal cell",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "autologous mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of adverse events",
                                                            "PrimaryOutcomeDescription": "Monitoring for adverse events at time of MSC infusion and in 12 months following",
                                                            "PrimaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Crohn's disease activity Index (CDAI)",
                                                            "SecondaryOutcomeDescription": "CDAI score before and after intervention will be monitored over 12 months",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria\n\nMen and women 18-65 years of age.\nPatient must have had CD for at least 3 months from the time of initial diagnosis. The diagnosis of CD must have been confirmed by endoscopic and histological evidence.\nPatients must have active Crohn's disease as defined by a Crohns Disease Activity Index (CDAI) score between >220 at screening and baseline.\nPatients should have no need for immediate surgery (i.e. due to obstruction, strictures, active abscess or perforations ).\nSubjects must be refractory (defined as lack of response for at least 3 months) to immunomodulators (including 6-mercaptopurine and azathioprine and methotrexate) or anti-TNF therapy at present or some point in the course of their disease. Lack of response is defined by failure to reduce the CDAI score by at least 70 points.\nThe following medications will be allowed: mesalamine and prednisone (stable dose for at least 2 weeks prior to enrollment).\nSubjects on anti TNF therapy will require a minimum of 4 weeks washout period prior to screening.\nSubjects on non-steroidal analgesics require a minimum of 2 weeks washout period prior to screening\nIf female and of child-bearing age, patient must be non-pregnant, non-breastfeeding, and use adequate contraception;\nPatient is willing to participate in the study and has signed the informed consent.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Subra Kugathasan, MD",
                                                            "OverallOfficialAffiliation": "Emory University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Tanvi Dhere, MD",
                                                            "OverallOfficialAffiliation": "Emory University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Emory University",
                                                            "LocationCity": "Atlanta",
                                                            "LocationState": "Georgia",
                                                            "LocationZip": "30322",
                                                            "LocationCountry": "United States"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "27385373",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Dhere T, Copland I, Garcia M, Chiang KY, Chinnadurai R, Prasad M, Galipeau J, Kugathasan S. The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses. Aliment Pharmacol Ther. 2016 Sep;44(5):471-81. doi: 10.1111/apt.13717. Epub 2016 Jul 7."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003424",
                                                            "ConditionMeshTerm": "Crohn Disease"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000015212",
                                                            "ConditionAncestorTerm": "Inflammatory Bowel Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005759",
                                                            "ConditionAncestorTerm": "Gastroenteritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005767",
                                                            "ConditionAncestorTerm": "Gastrointestinal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004066",
                                                            "ConditionAncestorTerm": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007410",
                                                            "ConditionAncestorTerm": "Intestinal Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M9596",
                                                            "ConditionBrowseLeafName": "Intestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M17069",
                                                            "ConditionBrowseLeafName": "Inflammatory Bowel Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5790",
                                                            "ConditionBrowseLeafName": "Crohn Disease",
                                                            "ConditionBrowseLeafAsFound": "Crohn's Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8027",
                                                            "ConditionBrowseLeafName": "Gastroenteritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8035",
                                                            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6407",
                                                            "ConditionBrowseLeafName": "Digestive System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC06",
                                                            "ConditionBrowseBranchName": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 40,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02646007",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Royan-Bone-014"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Royan Institute",
                                                "OrgClass": "OTHER_GOV"
                                          },
                                          "BriefTitle": "Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease",
                                          "OfficialTitle": "Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation for Human Avascular Necrosis of the Lunate Bone of the Wrist (Kienbock's Disease)"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "July 2016",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "November 2015"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "November 2018",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2018",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "December 3, 2015",
                                          "StudyFirstSubmitQCDate": "January 3, 2016",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "January 5, 2016",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "July 18, 2016",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "July 20, 2016",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Royan Institute",
                                                "LeadSponsorClass": "OTHER_GOV"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Kienb\u00f6ck's disease is characterized by avascular necrosis of the lunate wrist bone, which is usually progressive without treatment.\n\nCell therapy is useful in treatment of degenerated bone and mesenchymal stromal/stem cells are the best candidates for this kind of treatment.\n\nThis study examined lunate core decompression in combination with implantation of autologous bone marrow derived mesenchymal stromal cells for Its treatment potential.\n\nBone decompression in combination with implantation of autologous bone marrow derived mesenchymal stromal/stem cell will be done in 30 patients with Kienb\u00f6ck disease.\n\nThe patients will be followed at 2weeks, 3months, 6m and 12 months after implantation.\n\nThe Spss(v16) software will be used for data analysis.",
                                          "DetailedDescription": "Kienb\u00f6ck's disease is characterized by avascular necrosis of the lunate wrist There is probably no single cause of avascular necrosis of the lunate. Its origin may involve multiple factors, such as the blood supply (arteries), the blood drainage (veins), and skeletal variations.\n\nCurrent treatments are: at the early phase only observation. In the more advanced phases surgical techniques such as bone decompression.\n\nA potential therapeutic strategy would be cell therapy, A source of such cells with a regenerative potential could be mesenchymal stem cells (MSCs).\n\nThe investigators will evaluate safety and efficacy of implantation of autologous BM-MSC (bone marrow-derived mesenchymal stromal cell) in 30 patients with Kienb\u00f6ck's disease in combination with bone decompression surgery. These patients will be followed up and data will be analyzed with spss(v16)."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Kienb\u00f6ck's Disease"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Autologous Cell therapy Kienb\u00f6ck's disease",
                                                      "bone marrow derived mesenchymal stromal/stem cell"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "30",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "BM-MSC",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Bone marrow derived mesenchymal stromal/stem cells injection during decompressive surgery in patients with Kienb\u00f6ck's disease.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: BM-MSC transplantation"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "BM-MSC transplantation",
                                                            "InterventionDescription": "Transplantation of bone marrow derived mesenchymal stem/ stromal cells in combination with bone decompression surgery in Kienb\u00f6ck's disease.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "BM-MSC"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Pain",
                                                            "PrimaryOutcomeDescription": "The pain reduction at least 3 months after BM-MSC transplantation cells in combination with bone decompression.",
                                                            "PrimaryOutcomeTimeFrame": "3months"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Bone density",
                                                            "PrimaryOutcomeDescription": "The improvement of bone density at least 3months after BM-MSC transplantation in MRI.",
                                                            "PrimaryOutcomeTimeFrame": "3 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Quality of life evaluated by Visual Analogue Score (VAS)",
                                                            "SecondaryOutcomeDescription": "Improvement of quality of life inpatients after at least 3months of BM-MSC transplantation that is evaluated by Visual Analogue Score (VAS). The patients depends on their severity of the pain during daily activity choose a score between 1-10. The score will be saved in score sheets.",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Infection: Presence of any sign or symptoms of infection",
                                                            "SecondaryOutcomeDescription": "presence of any sign or symptoms of infection in site of surgery during 1 week.",
                                                            "SecondaryOutcomeTimeFrame": "1week"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Cyst formation: Presence of any cyst or mass formation",
                                                            "SecondaryOutcomeDescription": "presence of any cyst or mass formation at least 3 months after BM-MSC transplantation with surgery.",
                                                            "SecondaryOutcomeTimeFrame": "3months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nKienb\u00f6ck's disease without response to conservative treatment (physical and medical) for over 6 months\nBoth genders\nVisual Analogue Scale of 4 or higher\nHematological and biochemical analysis with no significant alterations that contraindicates intervention\nThe patient is able to understand the nature of the study\nInformed written consent of the patient\n\nExclusion Criteria:\n\nAge over 65 or under 18 or legally dependent\nInfection signs or positive serology for HIV, hepatitis and syphilis\nAllergy to gentamicin, or to bovine, cattle or horse serum\nPregnancy or lactating\nPregnancy or breast-feeding\nNeoplasia\nImmunosuppression\nParticipation in another clinical trial or treatment with another investigational product within 30 days prior to inclusion in the study\nOther conditions that may, according to medical criteria, discourage participation in the study",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Nasser Aghdami, MD,PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "(+98)23562000",
                                                            "CentralContactPhoneExt": "516",
                                                            "CentralContactEMail": "nasser.aghdami@royaninstitute.org"
                                                      },
                                                      {
                                                            "CentralContactName": "Leila Arab, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "(+98)23562000",
                                                            "CentralContactPhoneExt": "414",
                                                            "CentralContactEMail": "leara91@gmail.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Hamid Gourabi, PhD",
                                                            "OverallOfficialAffiliation": "Head of Royan Institute",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Nasser Aghdami, MD,PhD",
                                                            "OverallOfficialAffiliation": "Head of department of Regenerative Medicine & Cell therapy center, Royan Institute",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Hamidreza Mehrpour, MD",
                                                            "OverallOfficialAffiliation": "Tehran university of medical science, department of orthopedic surgery",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Mohsen Emadedin, MD",
                                                            "OverallOfficialAffiliation": "Department of Regenerative Biomedicine at the Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Narges Labibzadeh, MD",
                                                            "OverallOfficialAffiliation": "Department of Regenerative Biomedicine at the Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Royan Institute",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Tehran",
                                                            "LocationCountry": "Iran, Islamic Republic of",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Nasser Aghdami, MD,PhD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "(+98)23562000",
                                                                              "LocationContactPhoneExt": "516",
                                                                              "LocationContactEMail": "nasser.aghdami@royaninstitute.org"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Leila Arab, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "(+98)23562000",
                                                                              "LocationContactPhoneExt": "414",
                                                                              "LocationContactEMail": "Leara91@gmail.com"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "Related Info",
                                                            "SeeAlsoLinkURL": "http://royaninstitute.org"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000010020",
                                                            "ConditionMeshTerm": "Osteonecrosis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000001847",
                                                            "ConditionAncestorTerm": "Bone Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009140",
                                                            "ConditionAncestorTerm": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009336",
                                                            "ConditionAncestorTerm": "Necrosis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M11436",
                                                            "ConditionBrowseLeafName": "Necrosis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12095",
                                                            "ConditionBrowseLeafName": "Osteonecrosis",
                                                            "ConditionBrowseLeafAsFound": "Kienbock Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4278",
                                                            "ConditionBrowseLeafName": "Bone Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11249",
                                                            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T3234",
                                                            "ConditionBrowseLeafName": "Kienbock's Disease",
                                                            "ConditionBrowseLeafAsFound": "Kienbock Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 41,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04255147",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "HULC-1"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Ottawa Hospital Research Institute",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia",
                                          "OfficialTitle": "Helping Underdeveloped Lungs With Cells (HULC): Mesenchymal Stromal Cells in Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia - Phase 1 Study"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2022",
                                          "OverallStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "June 2022",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "June 2023",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2035",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "January 14, 2020",
                                          "StudyFirstSubmitQCDate": "February 3, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "February 5, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "April 19, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 21, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Ottawa Hospital Research Institute",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Canadian Institutes of Health Research (CIHR)",
                                                            "CollaboratorClass": "OTHER_GOV"
                                                      },
                                                      {
                                                            "CollaboratorName": "Ontario Institute of Regenerative Medicine (OIRM)",
                                                            "CollaboratorClass": "UNKNOWN"
                                                      },
                                                      {
                                                            "CollaboratorName": "Stem Cell Network",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No",
                                          "IsUSExport": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Bronchopulmonary dysplasia (BPD) is a common and chronic lung disease that occurs in preterm infants following ventilator and oxygen therapy and is associated with long-term health consequences. Preclinical research shows that mesenchymal stromal cells (MSCs) can modify a number of pathophysiological processes that are central to the progression of BPD and thus present as a promising new treatment option. The main purpose of this Phase I study is to evaluate the safety of human umbilical cord tissue-derived MSCs in extremely preterm infants at risk of developing BPD.",
                                          "DetailedDescription": "Complications of extreme preterm birth are the primary cause of mortality in children under the age of five. Bronchopulmonary dysplasia (BPD), the chronic lung disease that follows ventilator and oxygen therapy for acute respiratory failure, is the most common complication of extreme prematurity and contributes to life-long respiratory and neurological impairment. Currently, there is no effective treatment for BPD. The multi-factorial nature of BPD makes it challenging for traditional pharmacological therapies targeting a single pathway to have a major impact on outcome. Mesenchymal stromal cells (MSCs) may provide a promising new treatment avenue due to their pleiotropic effects that may prevent neonatal lung injury while promoting lung (and other organ) growth. A systematic review and meta-analysis of all preclinical studies testing MSCs in neonatal lung injury models provides strong evidence for the lung protective effect of MSCs. Additionally, studies in a large preclinical model of extreme prematurity and chronic lung injury suggest feasibility, safety and short-term hemodynamic benefit of intravenously delivered human umbilical cord tissue-derived MSCs (uc-MSC).\n\nThe aim of this study is to establish the safety, maximum feasible dose and feasibility of intravenously delivered allogeneic uc-MSCs in preterm infants at risk of developing BPD. This will be a Phase 1, open-label, single center, dose-escalating trial using a 3+3+3 design."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Bronchopulmonary Dysplasia"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Phase I clinical trial",
                                                      "Stem cells",
                                                      "Mesenchymal stromal cell",
                                                      "Bronchopulmonary Dysplasia",
                                                      "Preterm birth",
                                                      "Cell therapy"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Prevention",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "9",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal Cell Therapy",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Patients are enrolled into one of three escalating dose panels based on the time of enrolment. The first three patients will receive 1 million cells/kg of body weight, the next three patients will receive 3 million cells/kg of body weight, and the final three patients will receive 10 million cells/kg of body weight. Progression through the escalating dose panels is subject to review by an independent Data Safety Monitoring Committee.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells",
                                                            "InterventionDescription": "Cryopreserved allogeneic umbilical cord tissue-derived mesenchymal stromal cells are thawed and administered intravenously.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal Cell Therapy"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Occurrence and rate of dose limiting toxicity",
                                                            "PrimaryOutcomeDescription": "Dose limiting toxicity consists of the following events:\n\nDeath occurring within 24 hours of injection;\nPulmonary embolism defined as acute increase in right ventricular afterload (identified by serial targeted neonatal echocardiography) and signs of acute increased dead space ventilation (respiratory distress, increased PaCO2, increased minute ventilation) occurring within 24 hours of injection;\nHypersensitivity / anaphylactic to uc-MSCs defined as any severe systemic inflammatory response syndrome with negative blood culture not consistent with the overall clinical course of the infant occurring within 72 hours of injection;\nAny other serious adverse event not expected in this patient population for which there is no alternative explanation but the administration of uc-MSCs, occurring within 1 week of injection.",
                                                            "PrimaryOutcomeTimeFrame": "Up to 1 week following uc-MSC injection"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Rate of Death",
                                                            "SecondaryOutcomeDescription": "Rate of death until discharge or 40 weeks corrected gestational age, whichever comes first",
                                                            "SecondaryOutcomeTimeFrame": "From enrollment until discharge or 40 weeks corrected gestational age (whichever occurs first)"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Occurrence of Other Severe Complications of Prematurity",
                                                            "SecondaryOutcomeDescription": "Blood culture-proven sepsis\nPatent ductus arteriosus (treated medically or surgically)\nNecrotizing enterocolitis\nIsolated intestinal perforation\nRetinopathy of prematurity requiring treatment\nSevere intraventricular hemorrhage (\u2265 grade 3)\nCystic periventricular leukomalacia",
                                                            "SecondaryOutcomeTimeFrame": "From enrollment until discharge or 40 weeks corrected gestational age (whichever occurs first)"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "FiO2 and Oxygen Index",
                                                            "SecondaryOutcomeDescription": "Measures of gas exchange",
                                                            "SecondaryOutcomeTimeFrame": "From enrollment until discharge, 40 weeks corrected gestational age, or death (whichever occurs first)"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Need for Ventilatory Support",
                                                            "SecondaryOutcomeDescription": "Time to extubation\nDuration of mechanical ventilation\nDuration of non-invasive positive pressure respiratory support\nDuration of supplemental oxygen",
                                                            "SecondaryOutcomeTimeFrame": "From enrollment until discharge, 40 weeks corrected gestational age, or death (whichever occurs first)"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Need for Postnatal Steroids",
                                                            "SecondaryOutcomeDescription": "This is a yes/no measure",
                                                            "SecondaryOutcomeTimeFrame": "From enrollment until discharge, 40 weeks corrected gestational age, or death (whichever occurs first)"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence and Severity of BPD",
                                                            "SecondaryOutcomeDescription": "Measured as mild, moderate, or severe",
                                                            "SecondaryOutcomeTimeFrame": "From enrollment until discharge, 40 weeks corrected gestational age, or death (whichever occurs first)"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Rate of Survival Without (moderate or severe) BPD",
                                                            "SecondaryOutcomeDescription": "Measured according to the physiological definition of BPD (BPD at 36 weeks corrected age)",
                                                            "SecondaryOutcomeTimeFrame": "From enrollment until 36 weeks corrected gestational age"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in Pulmonary Hemodynamics",
                                                            "SecondaryOutcomeDescription": "Targeted neonatal echocardiography to assess pulmonary hypertension using validated parameters",
                                                            "SecondaryOutcomeTimeFrame": "At enrollment, 48 hours following uc-MSC injection, 28 days of life, and 36 weeks corrected gestational age"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Biological Measure of Clinical Improvement",
                                                            "SecondaryOutcomeDescription": "Markers of inflammation will be assessed in patient serum samples",
                                                            "SecondaryOutcomeTimeFrame": "72-96 hours following uc-MSC injection"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Biological Measure of Lung Improvement",
                                                            "SecondaryOutcomeDescription": "Biomarkers of lung improvement will be assessed in patient tracheal aspirate samples",
                                                            "SecondaryOutcomeTimeFrame": "72-96 hours following uc-MSC injection"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Feasibility: Cell Administration",
                                                            "SecondaryOutcomeDescription": "Successful recruitment and administration of cells to nine patients in 18 months",
                                                            "SecondaryOutcomeTimeFrame": "Day of life 7-21"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Feasibility: Recruitment Efficiency",
                                                            "SecondaryOutcomeDescription": "Proportion of potentially eligible patients that are successfully screened\nProportion of participants successfully screened who do not enroll (reason for failure to enroll will be recorded)",
                                                            "SecondaryOutcomeTimeFrame": "Day of life 7-21"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Feasibility: Recruitment Timing",
                                                            "SecondaryOutcomeDescription": "Median time from screening to enrollment\nMedian time from screening to cell administration",
                                                            "SecondaryOutcomeTimeFrame": "Day of life 7-21"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Feasibility: Participant Retainment",
                                                            "SecondaryOutcomeDescription": "Proportion of patients that do not complete cell infusion\nProportion of patients enrolled that do not undergo scheduled follow-up",
                                                            "SecondaryOutcomeTimeFrame": "From enrollment until follow-up at 18-24 months-of-age"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Bayley Scale of Infant and Toddler Development",
                                                            "SecondaryOutcomeDescription": "Assessment of cognitive, language, and motor development",
                                                            "SecondaryOutcomeTimeFrame": "18-24 months-of-age"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Long-term Safety Follow-Up",
                                                            "SecondaryOutcomeDescription": "Participant's overall health will be assessed through a questionnaire administered over the phone, once a year for 10 years",
                                                            "SecondaryOutcomeTimeFrame": "Ten years following follow-up visit"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Animated Information Video",
                                                            "SecondaryOutcomeDescription": "Characterize parental views of an animated MSC information video through brief semi-structured interviews",
                                                            "SecondaryOutcomeTimeFrame": "Day of life 7-21"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAdmission to The Ottawa Hospital General Campus Neonatal Intensive Care Unit\nGestational age at birth < 28 weeks\nDay of life 7-21\nIntubated on mechanical ventilation\nFraction of inspired oxygen \u2265 35%\nParents or surrogates must provide written informed consent\n\nExclusion Criteria:\n\nSevere congenital anomaly by antenatal ultrasound and physical examination\nOngoing shock and severe sepsis\nActive pulmonary hemorrhage\nActive pneumothorax (with chest tube in-situ)",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "7 Days",
                                          "MaximumAge": "21 Days",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Study Coordinator",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "613-737-7600",
                                                            "CentralContactPhoneExt": "6041",
                                                            "CentralContactEMail": "chorth@cheo.on.ca"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Bernard Th\u00e9baud, MD, PhD",
                                                            "OverallOfficialAffiliation": "Ottawa Hospital Research Institute",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "The Ottawa Hospital - General Campus",
                                                            "LocationCity": "Ottawa",
                                                            "LocationState": "Ontario",
                                                            "LocationZip": "K1H 8L6",
                                                            "LocationCountry": "Canada"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Undecided",
                                          "IPDSharingDescription": "Due to the small sample size, the sharing of individual data has privacy and confidentiality implications."
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000001997",
                                                            "ConditionMeshTerm": "Bronchopulmonary Dysplasia"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000006965",
                                                            "ConditionMeshTerm": "Hyperplasia"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055397",
                                                            "ConditionAncestorTerm": "Ventilator-Induced Lung Injury"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4425",
                                                            "ConditionBrowseLeafName": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafAsFound": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9168",
                                                            "ConditionBrowseLeafName": "Hyperplasia",
                                                            "ConditionBrowseLeafAsFound": "Dysplasia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27305",
                                                            "ConditionBrowseLeafName": "Ventilator-Induced Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T874",
                                                            "ConditionBrowseLeafName": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafAsFound": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 42,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02580695",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "C4COA01"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Universidad de los Andes, Chile",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis",
                                          "OfficialTitle": "A Phase I/II, Randomized, Double-blind, Controlled Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (UC-MSCs) in Patients With Knee Osteoarthritis"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "December 2018",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "December 2015"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "January 2017",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "April 2017",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "October 15, 2015",
                                          "StudyFirstSubmitQCDate": "October 19, 2015",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "October 20, 2015",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "December 24, 2018",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "December 26, 2018",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Francisco Espinoza, MD",
                                                "ResponsiblePartyInvestigatorTitle": "Alternative Investigator",
                                                "ResponsiblePartyInvestigatorAffiliation": "Universidad de los Andes, Chile"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Francisco Espinoza, MD",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Knee-osteoarthritis (OA) is a common and disabling problem, that represents a global health issue since none of the current therapies are truly disease modifying. The use of mesenchymal stem cells (MSCs) in OA-preclinical models has been associated with a reduction in cartilage degradation, the attenuation of bone sclerosis and an effective anti-inflammatory response. Investigators have designed a randomized phase I/II placebo controlled trial of UC-MSCs in knee OA. Outcomes will be evaluated at 12 months, comparing monodosis versus double intra-articular injection, re-randomized at 6 months."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Osteoarthritis"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Quadruple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "30",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Umbilical-cord mesenchymal stromal cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Umbilical-cord mesenchymal stromal cells (UC-MSCs)\n\nAllogeneic UC-MSCs 20 x 10e6 diluted on 3 mL of saline solution + 5% of Plasma AB\n\nArm 2a: single infusion group. UC-MSCs at 0 month\n\nArm 2b: double infusion group. UC-MSCs at 0 and 6 months",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: umbilical-cord mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Hyaluronic Acid (HA)",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Drug: Hyaluronic Acid 3 mL of HA intra-articular injection at baseline and 6 months",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Hyaluronic Acid"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "umbilical-cord mesenchymal stromal cells",
                                                            "InterventionDescription": "Intra-articular knee injection of UC-MSC 20x10e6 at 0 and 6 months",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Umbilical-cord mesenchymal stromal cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "UC-MSCs"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Hyaluronic Acid",
                                                            "InterventionDescription": "Intra-articular knee injection of Hyaluronic Acid (3ml) at 0 and 6 months",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Hyaluronic Acid (HA)"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Durolane"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Proportion of patients who experience an adverse event",
                                                            "PrimaryOutcomeDescription": "according to National Cancer Institute Common Terminology Criteria for Adverse Effects (NCI-CTCAE)",
                                                            "PrimaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Physical function improvement measured by WOMAC OA index",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in pain density measured by Visual analogue scale (VAS)",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "QoL improvement measured by SF-36",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in WORMS scale measured by knee MRI",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nSymptomatic Knee OA, Kellgren and Lawrence grade I, II, III on plain Rx films.\nChondromalacia patella grade I-III on knee MRI. With or without meniscal tear.\nStable knee and normal clinical exam of involved extremity\nWritten informed consent for patients.\n\nExclusion Criteria:\n\nBilateral symptomatic knee OA\nLocal or systemic infection.\nActive neoplasia or immunosuppressive state\nPregnancy or Breastfeeding\nBody Mass Index \u2265 30\nPresence of Pacemaker or Lower extremity metal implant\nAnticoagulant treatment other than aspirin.\nRecent use of oral (previous month) or intra-articular (previous 3 months) corticosteroids\nConcomitant inflammatory joint disease (cristal, connective tissue disease)\nValgus (>10o) or Varus (>5o) deformity of involved extremity\nCondilar or Tibial plateau Generalized Bone Marrow edema on MRI\nSignificant symptomatic hip or spine disease\nSignificant abnormality in baseline lab tests",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "70 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Jose Matas, MD",
                                                            "OverallOfficialAffiliation": "Universidad de los Andes",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Clinica Universidad de los Andes",
                                                            "LocationCity": "Santiago",
                                                            "LocationCountry": "Chile"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "AnnotationSection": {
                                    "AnnotationModule": {
                                          "UnpostedAnnotation": {
                                                "UnpostedResponsibleParty": "Francisco Espinoza, Alternative Investigator, Universidad de los Andes, Chile",
                                                "UnpostedEventList": {
                                                      "UnpostedEvent": [
                                                            {
                                                                  "UnpostedEventType": "Release",
                                                                  "UnpostedEventDate": "January 17, 2019"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Reset",
                                                                  "UnpostedEventDate": "April 12, 2019"
                                                            }
                                                      ]
                                                }
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022",
                                          "SubmissionTracking": {
                                                "SubmissionInfoList": {
                                                      "SubmissionInfo": [
                                                            {
                                                                  "SubmissionReleaseDate": "January 17, 2019",
                                                                  "SubmissionResetDate": "April 12, 2019"
                                                            }
                                                      ]
                                                }
                                          }
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000010003",
                                                            "ConditionMeshTerm": "Osteoarthritis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000020370",
                                                            "ConditionMeshTerm": "Osteoarthritis, Knee"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000001168",
                                                            "ConditionAncestorTerm": "Arthritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007592",
                                                            "ConditionAncestorTerm": "Joint Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009140",
                                                            "ConditionAncestorTerm": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012216",
                                                            "ConditionAncestorTerm": "Rheumatic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M21321",
                                                            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
                                                            "ConditionBrowseLeafAsFound": "Knee Osteoarthritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12078",
                                                            "ConditionBrowseLeafName": "Osteoarthritis",
                                                            "ConditionBrowseLeafAsFound": "Osteoarthritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3628",
                                                            "ConditionBrowseLeafName": "Arthritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9773",
                                                            "ConditionBrowseLeafName": "Joint Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11249",
                                                            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14197",
                                                            "ConditionBrowseLeafName": "Rheumatic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5475",
                                                            "ConditionBrowseLeafName": "Collagen Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionMeshList": {
                                                "InterventionMesh": [
                                                      {
                                                            "InterventionMeshId": "D000006820",
                                                            "InterventionMeshTerm": "Hyaluronic Acid"
                                                      }
                                                ]
                                          },
                                          "InterventionAncestorList": {
                                                "InterventionAncestor": [
                                                      {
                                                            "InterventionAncestorId": "D000000276",
                                                            "InterventionAncestorTerm": "Adjuvants, Immunologic"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000007155",
                                                            "InterventionAncestorTerm": "Immunologic Factors"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000045505",
                                                            "InterventionAncestorTerm": "Physiological Effects of Drugs"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000055675",
                                                            "InterventionAncestorTerm": "Viscosupplements"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000020011",
                                                            "InterventionAncestorTerm": "Protective Agents"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M9030",
                                                            "InterventionBrowseLeafName": "Hyaluronic Acid",
                                                            "InterventionBrowseLeafAsFound": "Concurrent",
                                                            "InterventionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M21013",
                                                            "InterventionBrowseLeafName": "Pharmaceutical Solutions",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M2780",
                                                            "InterventionBrowseLeafName": "Adjuvants, Immunologic",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M9353",
                                                            "InterventionBrowseLeafName": "Immunologic Factors",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M27448",
                                                            "InterventionBrowseLeafName": "Viscosupplements",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M21022",
                                                            "InterventionBrowseLeafName": "Protective Agents",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "PhSol",
                                                            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 43,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01175655",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "EC 28105"
                                          },
                                          "Organization": {
                                                "OrgFullName": "The Prince Charles Hospital",
                                                "OrgClass": "OTHER_GOV"
                                          },
                                          "BriefTitle": "A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation",
                                          "OfficialTitle": "A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation",
                                          "Acronym": "MSC in OB"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2022",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "February 2010"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "July 2015",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "July 2016",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "June 25, 2010",
                                          "StudyFirstSubmitQCDate": "August 4, 2010",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "August 5, 2010",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "April 19, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 26, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Daniel Chambers",
                                                "ResponsiblePartyInvestigatorTitle": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorAffiliation": "The Prince Charles Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "The Prince Charles Hospital",
                                                "LeadSponsorClass": "OTHER_GOV"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Cell and Tissue Therapies Western Australia",
                                                            "CollaboratorClass": "UNKNOWN"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The primary aim of this study is to establish the safety of infusions of Mesenchymal Stromal Cells (MSC) from related or unrelated Human Leukocyte Antigen (HLA) identical or HLA mismatched donors in the management of bronchiolitis obliterans syndrome after lung transplantation."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Bronchiolitis Obliterans",
                                                      "Lung Transplantation"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal stromal cells",
                                                      "Bronchiolitis obliterans",
                                                      "Lung transplant"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "MSC",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: MSC"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "MSC",
                                                            "InterventionDescription": "mesenchymal stromal cells (MSC), aiming for 2 x 106 /kg cells recipient body weight, aiming for a frequency of twice weekly for two weeks",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "MSC"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "To establish the safety of infusions of MSC from related or unrelated HLA identical or HLA mismatched donors in the management of bronchiolitis obliterans syndrome after lung transplantation.",
                                                            "PrimaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "To document changes in lung function and 6 minute walk distance (6MWD) following infusion of MSC",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To document survival post MSC infusion",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with single, bilateral or heart-lung allografts\nPatients with bronchiolitis obliterans syndrome (BOS) grades 2 & 3 (defined and graded according to international criteria (Appendix 1)), with evidence of deterioration in allograft function (i.e. deteriorating FEV1 or worsening BOS grade) within the last 12 months.\n\nPatients with BOS grade 1 and evidence of deterioration in allograft function (i.e. deteriorating FEV1 or worsening BOS grade) within the last 12 months and at least one of the following additional risk factors for subsequent death:\n\nSingle lung transplant\nRapid deterioration (>20% fall in FEV1 in the previous 12 months)\nA pre-transplant diagnosis of usual interstitial pneumonia (pulmonary fibrosis) or pulmonary hypertension\n\nExclusion Criteria:\n\nPatients with active infection, acute allograft rejection, or airway anastomotic complications\nPatients with > 3 infective exacerbations of BOS in the last 12 months\nPatients with a history of cytomegalovirus (CMV) pneumonitis\nPatients with poor performance status and/or not expected to survive 3 months\nPatients who are pregnant or breastfeeding\nPatients with an allergy to beef products.\nAny condition that in the opinion of the Investigator may interfere with the safety of the patient, his / her completion of required follow-up visits or evaluation of the study objectives.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Daniel Chambers, A/Prof",
                                                            "OverallOfficialAffiliation": "The Prince Charles Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "TPCH",
                                                            "LocationCity": "Brisbane",
                                                            "LocationState": "Queensland",
                                                            "LocationZip": "4032",
                                                            "LocationCountry": "Australia"
                                                      },
                                                      {
                                                            "LocationFacility": "RPH",
                                                            "LocationCity": "Perth",
                                                            "LocationState": "Western Australia",
                                                            "LocationZip": "6000",
                                                            "LocationCountry": "Australia"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000001988",
                                                            "ConditionMeshTerm": "Bronchiolitis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000001989",
                                                            "ConditionMeshTerm": "Bronchiolitis Obliterans"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000001991",
                                                            "ConditionAncestorTerm": "Bronchitis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012141",
                                                            "ConditionAncestorTerm": "Respiratory Tract Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007239",
                                                            "ConditionAncestorTerm": "Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001982",
                                                            "ConditionAncestorTerm": "Bronchial Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008173",
                                                            "ConditionAncestorTerm": "Lung Diseases, Obstructive"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M4416",
                                                            "ConditionBrowseLeafName": "Bronchiolitis",
                                                            "ConditionBrowseLeafAsFound": "Bronchiolitis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4417",
                                                            "ConditionBrowseLeafName": "Bronchiolitis Obliterans",
                                                            "ConditionBrowseLeafAsFound": "Bronchiolitis Obliterans",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4419",
                                                            "ConditionBrowseLeafName": "Bronchitis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9435",
                                                            "ConditionBrowseLeafName": "Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5520",
                                                            "ConditionBrowseLeafName": "Communicable Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14130",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4410",
                                                            "ConditionBrowseLeafName": "Bronchial Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10322",
                                                            "ConditionBrowseLeafName": "Lung Diseases, Obstructive",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T871",
                                                            "ConditionBrowseLeafName": "Bronchiolitis Obliterans",
                                                            "ConditionBrowseLeafAsFound": "Bronchiolitis Obliterans",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC01",
                                                            "ConditionBrowseBranchName": "Infections"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 44,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02565459",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Third-party MSC-Tx tolerance A"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "2015-002186-27",
                                                            "SecondaryIdType": "EudraCT Number"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "A.O. Ospedale Papa Giovanni XXIII",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "MSC and Kidney Transplant Tolerance (Phase A)",
                                          "OfficialTitle": "Third-party Bone Marrow-derived Mesenchymal Stromal Cells to Induce Tolerance in Recipients of Kidney Transplants From Deceased Donors (Phase A)"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2018",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "September 2015"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 2021",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2021",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "September 24, 2015",
                                          "StudyFirstSubmitQCDate": "September 30, 2015",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "October 1, 2015",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "April 5, 2018",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 6, 2018",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Monia Lorini",
                                                "ResponsiblePartyInvestigatorTitle": "EC Secretary",
                                                "ResponsiblePartyInvestigatorAffiliation": "A.O. Ospedale Papa Giovanni XXIII"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Monia Lorini",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Mario Negri Institute for Pharmacological Research",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The general aim of the present study is to test a cell therapy with third-party ex-vivo expanded bone marrow-derived mesenchymal stromal cells (MSCs) as a strategy to induce tolerance in kidney transplant recipients with a deceased donor. MSCs will be prepared accordingly to established protocols, starting from the remnants in the bag and filter at the end of the bone marrow infusions. From these samples, MSCs will be expanded in good manufacturing practice (GMP) approved facilities and used for the present study in patients undergoing kidney transplantation.\n\nThe proposed study will be developed in two phases: i) a pilot explorative safety/biologic-mechanistic phase (Phase A), ii) a pilot efficacy phase (Phase B)."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Chronic Renal Failure"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal stromal cells",
                                                      "kidney transplantation",
                                                      "tolerance"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "22",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal Cells (MSC)",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "A single intravenous infusion (1-2 millions of MSCs per kilogram body weight) of ex-vivo expanded third-party (from healthy donors) MSCs will be performed in patients randomized to the MSC procedure in addition to the kidney transplantation.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "No intervention",
                                                            "ArmGroupType": "No Intervention"
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stromal Cells",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal Cells (MSC)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of adverse events",
                                                            "PrimaryOutcomeDescription": "At each visit overall clinical condition of the patient will be evaluated and any adverse event will be recorded.",
                                                            "PrimaryOutcomeTimeFrame": "Changes from baseline through study completion, up to 12 months after transplant."
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Circulating naive and memory T cell count (CD45RA/CD45RO) (flow cytometry analysis)",
                                                            "PrimaryOutcomeTimeFrame": "Changes from baseline at 7, 14, 30 days after transplant and then every six months through study completion, up to 12 months after transplant."
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Circulating regulatory T cell count.",
                                                            "PrimaryOutcomeTimeFrame": "Changes from baseline at 7, 14, 30 days after transplant and then every six months through study completion, up to 12 months after transplant."
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "T-cell function in mixed lymphocyte reaction.",
                                                            "PrimaryOutcomeDescription": "IFNg-producing T cells (spots/300.000 cells) and CD8+ T cell-mediated cytotoxicity (percentage of specific lysis) will be measured in mixed lymphocyte reaction.",
                                                            "PrimaryOutcomeTimeFrame": "Changes from baseline at 6 and 12 months after transplant."
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Urinary FOXP3 mRNA expression evaluated by real time quantitative PCR",
                                                            "PrimaryOutcomeTimeFrame": "Changes from baseline at 6 and 12 months after transplant."
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nFirst single kidney transplant;\nCapable of understanding the purpose and risk of the study;\nWritten informed consent.\n\nExclusion Criteria:\n\nPRA >10%;\nSpecific contraindication to MSC infusion;\nAny clinical relevant condition that might affect study participation and/or study results;\nChildbearing potential without effective contraception;\nPregnant women and nursing mothers;\nUnwillingness or inability to follow study protocol in the investigator's opinion.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "75 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Norberto Perico, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "0039 035 45351",
                                                            "CentralContactEMail": "norberto.perico@marionegri.it"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Giuseppe Remuzzi, MD",
                                                            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Norberto Perico, MD",
                                                            "OverallOfficialAffiliation": "Istituto Di Ricerche Farmacologiche Mario Negri",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Giovanni Rota, MD",
                                                            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Federica Casiraghi",
                                                            "OverallOfficialAffiliation": "Istituto Di Ricerche Farmacologiche Mario Negri",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Martino Introna, MD",
                                                            "OverallOfficialAffiliation": "Laboratorio G. Lanzani, Bergamo, Italy",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Alessandro Rambaldi, MD",
                                                            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "U.O. Nefrologia e Dialisi",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Bergamo",
                                                            "LocationZip": "24127",
                                                            "LocationCountry": "Italy",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Piero Ruggenenti, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "0039 035 2674037",
                                                                              "LocationContactEMail": "pruggenenti@hpg23.it"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Eliana Gotti, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000007676",
                                                            "ConditionMeshTerm": "Kidney Failure, Chronic"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000051437",
                                                            "ConditionAncestorTerm": "Renal Insufficiency"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007674",
                                                            "ConditionAncestorTerm": "Kidney Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014570",
                                                            "ConditionAncestorTerm": "Urologic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000051436",
                                                            "ConditionAncestorTerm": "Renal Insufficiency, Chronic"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M9851",
                                                            "ConditionBrowseLeafName": "Kidney Failure, Chronic",
                                                            "ConditionBrowseLeafAsFound": "Chronic Renal Failure",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25871",
                                                            "ConditionBrowseLeafName": "Renal Insufficiency",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5997",
                                                            "ConditionBrowseLeafName": "Death",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9850",
                                                            "ConditionBrowseLeafName": "Kidney Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16471",
                                                            "ConditionBrowseLeafName": "Urologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25870",
                                                            "ConditionBrowseLeafName": "Renal Insufficiency, Chronic",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1303",
                                                            "ConditionBrowseLeafName": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 45,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT05061030",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "WJMSC-P01"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Uppsala University Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents",
                                          "OfficialTitle": "A Double-blinded, Randomized, Parallel, Placebo-controlled Trial of Wharton's Jelly-derived Allogeneic Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "May 2022",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 14, 2022",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 2028",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2028",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "September 20, 2021",
                                          "StudyFirstSubmitQCDate": "September 20, 2021",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "September 29, 2021",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "May 16, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "May 23, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Per-Ola Carlsson",
                                                "ResponsiblePartyInvestigatorTitle": "Professor, Senior consultant in Endocrinology and Diabetology",
                                                "ResponsiblePartyInvestigatorAffiliation": "Uppsala University Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Uppsala University Hospital",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This is a combined phase 1 and 2 study in 66 subjects, male or female, between 7-21 years of age that have recently (< 6 months) been diagnosed with type 1 diabetes. The first phase 1 part of the study includes six subjects openly receiving allogeneic Wharton's jelly derived mesenchymal stromal cells as the Advanced Therapy Medicinal Product (ATMP) Protrans, three each in the age ranges 7-11 and 12-18.The second part is a randomized, double-blinded placebo-controlled phase 2 study in parallel design comparing allogeneic Wharton's jelly derived mesenchymal stromal cells treatment (as Protrans) to placebo in children and adolescent subjects (7-21 years of age) diagnosed with type 1 diabetes, The primary objectives of this study will be to investigate the safety, tolerance and efficacy after an allogieneic infusion of Wharton's jelly derived mesenchymal stromal cells."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Type1diabetes"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Quadruple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "66",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Wharton's jelly derived mesenchymal stromal cells (Protrans)",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Cells are dissolved in saline and given intravenously over a period of 20-40 min. 100 million cells to subjects < 50 kg and 200 million cells to subjects 50-100 kg (>100 kg is an exclusion criterion).",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: the ATMP Protrans"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Placebo",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Placebo (saline) is given intravenously over a period of 20-40 min.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: the ATMP Protrans"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "the ATMP Protrans",
                                                            "InterventionDescription": "Protrans consists of Wharton's jelly derived mesenchymal stromal cells",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Placebo",
                                                                        "Wharton's jelly derived mesenchymal stromal cells (Protrans)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Safety at one year evaluated as adverse events",
                                                            "PrimaryOutcomeDescription": "Safety parameters will be evaluated at each study visit and recorded as adverse events.",
                                                            "PrimaryOutcomeTimeFrame": "One year"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Safety at five years evaluated as adverse events",
                                                            "PrimaryOutcomeDescription": "Safety parameters will be evaluated at each study visit and recorded as adverse events.",
                                                            "PrimaryOutcomeTimeFrame": "Five years"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Efficacy measured as change in C-peptide Area under the curve to a mixed mealtolerance test.",
                                                            "PrimaryOutcomeDescription": "Change in C-peptide Area under the curve (AUC) (0-120 min) for mixed meal tolerance test (MMTT) at 12 months following Protrans/Placebo infusion when compared to test performed before the start of treatment (baseline).",
                                                            "PrimaryOutcomeTimeFrame": "One year"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Insulin independency",
                                                            "SecondaryOutcomeDescription": "The proportion of study participants independent of insulin at 6 months",
                                                            "SecondaryOutcomeTimeFrame": "One year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Insulin independency",
                                                            "SecondaryOutcomeDescription": "The proportion of study participants independent of insulin at 12 months",
                                                            "SecondaryOutcomeTimeFrame": "One year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Low insulin needs",
                                                            "SecondaryOutcomeDescription": "The proportion of study participants with daily insulin needs <0.25 U/kg at 6 months",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Low insulin needs",
                                                            "SecondaryOutcomeDescription": "The proportion of study participants with daily insulin needs <0.25 U/kg at 12 months",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Insulin needs",
                                                            "SecondaryOutcomeDescription": "Insulin requirement/kg body weigh at 6 months",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Insulin needs",
                                                            "SecondaryOutcomeDescription": "Insulin requirement/kg body weigh at 12 months",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "HbA1c",
                                                            "SecondaryOutcomeDescription": "HbA1c at 6 months",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "HbA1c",
                                                            "SecondaryOutcomeDescription": "HbA1c at 12 months",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Time in target",
                                                            "SecondaryOutcomeDescription": "Time in target (4-8 mmol/l) as measured by flash glucose monitoring for 14 days at 6 months",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Time in target",
                                                            "SecondaryOutcomeDescription": "Time in target (4-8 mmol/l) as measured by flash glucose monitoring for 14 days at 12 months",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Time in range",
                                                            "SecondaryOutcomeDescription": "Time in target (3.9-10 mmol/l) as measured by flash glucose monitoring for 14 days at 6 months",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Time in range",
                                                            "SecondaryOutcomeDescription": "Time in target (3.9-10 mmol/l) as measured by flash glucose monitoring for 14 days at 12 months",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "C-peptide",
                                                            "SecondaryOutcomeDescription": "Change in C-peptide Area under the curve (AUC) (0-120 min) for mixed meal tolerance test (MMTT) at 6 months following Protrans/Placebo infusion when compared to test performed before the start of treatment (baseline).",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in peak C-peptide",
                                                            "SecondaryOutcomeDescription": "Change in peak C-peptide concentration during the first 6 months",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change in peak C-peptide",
                                                            "SecondaryOutcomeDescription": "Change in peak C-peptide concentration during the first 12 months",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "Gender differences",
                                                            "OtherOutcomeDescription": "Differences in parameters of primary and secondary endpoints between genders",
                                                            "OtherOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Gender differences",
                                                            "OtherOutcomeDescription": "Differences in parameters of primary and secondary endpoints between genders",
                                                            "OtherOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "HLA class 1 genotypes",
                                                            "OtherOutcomeDescription": "Differences in parameters of primary and secondary endpoints between HLA class 1 genotypes",
                                                            "OtherOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "HLA class 1 genotypes",
                                                            "OtherOutcomeDescription": "Differences in parameters of primary and secondary endpoints between HLA class 1 genotypes",
                                                            "OtherOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "age",
                                                            "OtherOutcomeDescription": "Differences in parameters of primary and secondary endpoints between ages 7-11 and 12-21",
                                                            "OtherOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "age",
                                                            "OtherOutcomeDescription": "Differences in parameters of primary and secondary endpoints between ages 7-11 and 12-21",
                                                            "OtherOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Autoantibodies",
                                                            "OtherOutcomeDescription": "Change of levels of diabetes-related autoantibodies when compared to test before the start of treatment (baseline)",
                                                            "OtherOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Autoantibodies",
                                                            "OtherOutcomeDescription": "Change of levels of diabetes-related autoantibodies when compared to test before the start of treatment (baseline)",
                                                            "OtherOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Peripheral blood mononuclear cells",
                                                            "OtherOutcomeDescription": "Change in reactivity and cytokine production of peripheral blood mononuclear cells when compared to test before the start of treatment (baseline)",
                                                            "OtherOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Peripheral blood mononuclear cells",
                                                            "OtherOutcomeDescription": "Change in reactivity and cytokine production of peripheral blood mononuclear cells when compared to test before the start of treatment (baseline)",
                                                            "OtherOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nWritten informed consent for participation of the study (for subjects below 18 years of age also from both caregivers), given before undergoing any study-specific procedures\nClinical history compatible with type 1 diabetes diagnosed less than 6 months before enrolment\nIn the first part of the study, six subjects, three between 7-11 and three between 12-18 years of age (both groups inclusive at both ends), will be included. The sixty subjects in the second part of the study are stratified by age (12-21 and 7-11 years, respectively) and randomized to one of two treatment arms (active or placebo), with a 6-month safety delay for the younger stratum.\nMentally stable and, in the opinion of the investigator, able to comply with the procedures of the study protocol.\nFasting plasma C-peptide concentration >0.12 nmol/L.\n\nSubjects of child-bearing potential must agree to using adequate contraception until one year after the administration of WJMSC/Placebo. Adequate contraception is as follows:\n\noral (except low-dose gestagen (lynestrenol and noretisteron), injectable or implanted hormonal contraceptives.\nintrauterine device\nintrauterine system (for example progestin-releasing coil)\nvasectomized male (with appropriate postvasectomy documentation of the absence of sperm in the ejaculate)\n\nExclusion Criteria:\n\nSubjects with body weight >100 kg\nSubjects with unstable cardiovascular status incl. NYHA class III/IV or symptoms of angina pectoris.\nSubjects with uncontrolled hypertension (\u2265160/105 mmHg).\nSubjects with active on-going infections.\nSubjects with latent or previous as well as on-going therapy against tuberculosis, or exposed to tuberculosis or has traveled in areas with a high risk of tuberculosis or mycosis within the last 3 months.\nSubjects with serological evidence of infection with HIV, Treponema pallidum, hepatitis B antigen (subjects with serology consistent with previous vaccination and a history of vaccination are acceptable), or hepatitis C.\nSubjects with any systemic immune suppressive treatment\nSubjects with a known demyelinating disease or with symptoms or physical examination findings consistent with possible demyelinating disease.\nPregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive hCG laboratory test.\nSubjects with known, or previous, malignancy.\nTaking oral anti-diabetic therapies or any other concomitant medication which may interfere with glucose regulation other than insulin.\nSubjects with GFR <60 ml/min/1.73 m2 body surface.\nSubject with any condition or any circumstance that, in the opinion of the investigator, would make it unsafe to undergo treatment with MSC.\nKnown hypersensitivity against any excipients, i.e., dimethyl sulfoxide (DMSO).",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "7 Years",
                                          "MaximumAge": "21 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Per-Ola Carlsson, MD, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+46186110000",
                                                            "CentralContactEMail": "per-ola.carlsson@mcb.uu.se"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Per-Ola Carlsson, MD, PhD",
                                                            "OverallOfficialAffiliation": "Uppsala University Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Uppsala University Hospital",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Uppsala",
                                                            "LocationZip": "75185",
                                                            "LocationCountry": "Sweden",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Per-Ola Carlsson, MD, PhD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+46186110000",
                                                                              "LocationContactEMail": "per-ola.carlsson@mcb.uu.se"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003920",
                                                            "ConditionMeshTerm": "Diabetes Mellitus"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000003922",
                                                            "ConditionMeshTerm": "Diabetes Mellitus, Type 1"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000044882",
                                                            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008659",
                                                            "ConditionAncestorTerm": "Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004700",
                                                            "ConditionAncestorTerm": "Endocrine System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001327",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M6267",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafAsFound": "Diabetes",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6269",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 1",
                                                            "ConditionBrowseLeafAsFound": "Type 1 Diabetes",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10791",
                                                            "ConditionBrowseLeafName": "Metabolic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M24556",
                                                            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7014",
                                                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC19",
                                                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 46,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03973827",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "ProTrans-Repeat"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "2018-004158-11",
                                                            "SecondaryIdType": "EudraCT Number"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "NextCell Pharma Ab",
                                                "OrgClass": "INDUSTRY"
                                          },
                                          "BriefTitle": "Wharton\u00b4s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes",
                                          "OfficialTitle": "An Open Label, Parallel Single Center Trial of Wharton's Jelly Derived Allogeneic Mesenchymal Stromal Cells Repeatedly Treated to Preserve Endogenous Insulin Production in Adult Patients Diagnosed With Type 1 Diabetes"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "December 2021",
                                          "OverallStatus": "Active, not recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "May 17, 2019",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 10, 2020",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "October 30, 2024",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "May 16, 2019",
                                          "StudyFirstSubmitQCDate": "June 3, 2019",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 4, 2019",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "December 17, 2021",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 11, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "NextCell Pharma Ab",
                                                "LeadSponsorClass": "INDUSTRY"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "An open label, parallel single centre trial of Wharton's Jelly derived allogenic mesenchymal stromal cells repeated treatment to preserve endogenous insulin production in adult patients diagnosed with type 1 diabetes"
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Type1diabetes"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "type 1 diabetes",
                                                      "diabetes",
                                                      "MSC's",
                                                      "Mesenchymal",
                                                      "Stem Cells",
                                                      "Stromal",
                                                      "Wharton\u00b4s Jelly"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "15",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Low dose",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "3 patients receiving low dose",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: ProTrans"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Medium dose",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "3 patients receiving medium dose",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: ProTrans"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "High dose",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "3 patients receiving high dose",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: ProTrans"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Control",
                                                            "ArmGroupType": "No Intervention",
                                                            "ArmGroupDescription": "6 patients"
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "ProTrans",
                                                            "InterventionDescription": "ProTrans is an pooled allogenic mesenchymal stromal cell treatment",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "High dose",
                                                                        "Low dose",
                                                                        "Medium dose"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "The primary safety endpoint in this study is; safety parameters include adverse events, hypoglycemia and allergic reactions",
                                                            "PrimaryOutcomeDescription": "To investigate the safety and tolerance after a repeated allogeneic infusion of Whartons Jelly Mesenchymal Stromal Cells (WJMSCs) intravenously in adult patients diagnosed with type 1 diabetes after one year following the repeated treatment.",
                                                            "PrimaryOutcomeTimeFrame": "372 days"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Delta-change of C-peptide AreaUnder the Curve (AUC) (0-120 min) for Mixed Meal Tolerance Test (MMTT) at day 372 following WJMSC infusion when compared to test performed before start of treatment.",
                                                            "PrimaryOutcomeTimeFrame": "372 days"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of patients insulin independent (ADA criteria) at day 372.",
                                                            "SecondaryOutcomeTimeFrame": "372 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of patients with daily insulin needs <0.25U/kg at day 372.",
                                                            "SecondaryOutcomeTimeFrame": "372 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "HbA1c at day 372",
                                                            "SecondaryOutcomeTimeFrame": "372 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Glucose variability (mean amplitude of glycaemic excursions and glycaemic lability index) duration derived from the continuous glucose monitoring system\u00ae at day 372",
                                                            "SecondaryOutcomeTimeFrame": "372 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Delta change of levels of fasting C-peptide at day 372 when compared to test before start of treatment",
                                                            "SecondaryOutcomeTimeFrame": "372 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Numbers of patients with peak C-peptide >0.20 nmol/l, in response to the MMTT, at day 372.",
                                                            "SecondaryOutcomeTimeFrame": "372 days"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nA new written informed consent for participation of the study is required to be given before undergoing any study-specific procedures.\nOnly patients that have previously been dosed by the IMP according to protocol Protrans-1 are eligible for a second dose of Protrans.\nNo identified IMP related on-going adverse event, neither history of any adverse event that is evaluated potentially to be related to the previous IMP dosing in Protrans I.\nClinical history compatible with type 1 diabetes diagnosed less than 3 years before enrolment. This also includes control patients not receiving IMP.\nOnly male patients between 18-41 years of age will be included.\nMentally stable and, in the opinion of the investigator, able to comply with the procedures of the study protocol.\n\nExclusion Criteria:\n\nInability to provide informed consent\nPatients with body mass index (BMI) > 30, or weight >100 kg\nPatients with weight <50 kg\nPatients with unstable cardiovascular status incl. NYHA class III/IV or symptoms of angina pectoris.\nPatients with uncontrolled hypertension (\u2265160/105 mmHg).\nPatients with active infections unless treatment is not judged necessary by the investigators\nPatients with latent or previous as well as on-going therapy against tuberculosis, or exposed to tuberculosis or has travelled in areas with high risk of tuberculosis or mycosis within the last 3 months.\nPatients with serological evidence of infection with HIV, Treponema pallidum, hepatitis B antigen (patients with serology consistent with previous vaccination and a history of vaccination are acceptable) or hepatitis C.\nPatients with any immune suppressive treatment\nPatients with known demyelinating disease or with symptoms or physical examination findings consistent with possible demyelinating disease.\nPatients with known, or previous, malignancy.\nTaking oral anti-diabetic therapies or any other concomitant medication which may interfere with glucose regulation other than insulin\nPatients with GFR <80 ml/min/1.73 m2 body surface\nPatients with proliferative retinopathy\nPatient with any condition or any circumstance that in the opinion of the investigator would make it unsafe to undergo treatment with MSC.\nKnown hypersensitivity against any excipients, i.e. dimethyl sulfoxide (DMSO).",
                                          "HealthyVolunteers": "No",
                                          "Gender": "Male",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "41 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Per-Ola Carlsson, PhD",
                                                            "OverallOfficialAffiliation": "Uppsala University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Karolinska Trial Alliance, Fas 1 enheten, Karolinska Universitetssjukhuset Huddinge",
                                                            "LocationCity": "Huddinge",
                                                            "LocationCountry": "Sweden"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003920",
                                                            "ConditionMeshTerm": "Diabetes Mellitus"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000003922",
                                                            "ConditionMeshTerm": "Diabetes Mellitus, Type 1"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000044882",
                                                            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008659",
                                                            "ConditionAncestorTerm": "Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004700",
                                                            "ConditionAncestorTerm": "Endocrine System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001327",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M6267",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafAsFound": "Diabetes",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6269",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 1",
                                                            "ConditionBrowseLeafAsFound": "Type 1 Diabetes",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10791",
                                                            "ConditionBrowseLeafName": "Metabolic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M24556",
                                                            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7014",
                                                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC19",
                                                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M9517",
                                                            "InterventionBrowseLeafName": "Insulin",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M172956",
                                                            "InterventionBrowseLeafName": "Insulin, Globin Zinc",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Hypo",
                                                            "InterventionBrowseBranchName": "Hypoglycemic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 47,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT00957931",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSC01"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Stanford University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs",
                                          "OfficialTitle": "Pilot Study MUD HCT:Pts High Risk Sickle Cell,Other Non-Malignant RBC Disorders- Reduced Intensity Preparative Regimen, HAPLO-Identical Mesenchymal Stromal Cells"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "July 2018",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "March 2009",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "August 2013",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "August 2013",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "August 12, 2009",
                                          "StudyFirstSubmitQCDate": "August 12, 2009",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "August 13, 2009",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "ResultsFirstSubmitDate": "May 30, 2018",
                                          "ResultsFirstSubmitQCDate": "July 9, 2018",
                                          "ResultsFirstPostDateStruct": {
                                                "ResultsFirstPostDate": "August 6, 2018",
                                                "ResultsFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "July 9, 2018",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "August 6, 2018",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Sandhya Kharbanda",
                                                "ResponsiblePartyInvestigatorTitle": "Principle Investigator",
                                                "ResponsiblePartyInvestigatorAffiliation": "Stanford University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Stanford University",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "University of Minnesota",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "University of Alabama at Birmingham",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The main purpose of this project is to cure patients with high risk Sickle cell disease and other red cell disorders including thalassemia and diamond-blackfan anemia by bone marrow transplantation. The patients enrolled in this study will be those who lack matched sibling donors and therefore have no other option but to undergo bone marrow transplantation using matched but unrelated bone marrow or umbilical cord blood from the national marrow donor program registry. Since bone marrow transplantation for these disorders using matched unrelated donors has two major problems i.e. engraftment, or , the process of new marrow being accepted and allowed to grow in the the patient; and graft-versus-host disease, or the process where the new marrow \"rejects\" the host or the patient, this study has been devised with methods to overcome these two problems and thus make transplantation from unrelated donors both successful in terms of engraftment and safe in terms of side effects, both acute and long term.\n\nIn order to accomplish these two goals, two important things will be done. Firstly, patients will get three medicines which are considered reduced intensity because they are not known to cause the serious organ damage seen with conventional chemotherapy. These medicines, however, do cause intense immune suppression so these can cause increased infections. Secondly, in addition to transplantation of bone marrow from unrelated donors, patients will also transplanted with mesenchymal stromal cells derived from the bone marrow of their parents. Mesenchymal stromal cells are adult stem cells that are normally found in the bone marrow and are thought to create the right background for the blood cells to grow. They have been shown in many animal and human studies to improve engraftment. In addition, they have a special property by which they prevent and are now even considered to treat graft versus host disease. Therefore, by using a reduced intensity chemotherapy regimen before transplant and transplanting mesenchymal stromal cells, we hope to improve engraftment while at the same time decrease the potential for severe side effects associated with a conventional transplant which uses extremely high doses of chemotherapy."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Sickle Cell Disease",
                                                      "Thalassemia",
                                                      "Diamond-Blackfan Anemia"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "6",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stromal cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Procedure: Bone marrow transplantation",
                                                                        "Biological: Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Procedure",
                                                            "InterventionName": "Bone marrow transplantation",
                                                            "InterventionDescription": "Bone marrow transplantation using matched unrelated donors, reduced intensity conditioning regimen, and co-transplanting mesenchymal stromal cells derived from parental bone marrow.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stromal Cells",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Count of Participants With Stable Engraftment Post Hematopoietic Cell Transplantation (HCT)",
                                                            "PrimaryOutcomeDescription": "Stable engraftment was defined as absolute neutrophil count (ANC) >500 cells /\u00b5L for 3 consecutive days and platelet count >50,000 for one week without transfusion; subsequently stable engraftment was measured by percentage of donor cells.",
                                                            "PrimaryOutcomeTimeFrame": "Up to 1 year"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Overall Survival 6 Months Following HCT",
                                                            "SecondaryOutcomeDescription": "Overall survival is reported at the count of participants alive 6 months following HCT.",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Overall Survival 1 Year Following HCT",
                                                            "SecondaryOutcomeDescription": "Overall survival is reported at the count of participants alive 1 year following HCT.",
                                                            "SecondaryOutcomeTimeFrame": "1 year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Count of Participants With Disease-free Survival 6 Months Following HCT",
                                                            "SecondaryOutcomeDescription": "Disease-free survival is defined as alive without underlying disease.",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Count of Participants With Disease-free Survival 1 Year Following HCT",
                                                            "SecondaryOutcomeDescription": "Disease-free survival is defined as alive without underlying disease.",
                                                            "SecondaryOutcomeTimeFrame": "1 year"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with sickle cell disease (SCD) 1-25 years of age with an HLA-identical, but unrelated, donor or 1 human leukocyte antigen (HLA) allele mismatched bone marrow or up to 2 HLA antigen mismatched umbilical cord blood (UCB) donor with one or more of the following:\n\nStroke, central nervous system (CNS) hemorrhage or a neurologic event lasting longer than 24 hours.\nAcute chest syndrome with a history of recurrent hospitalizations or exchange transfusions.\nRecurrent vaso-occlusive pain, 3 or more episodes per year for 3 years or more years; or recurrent priapism.\nImpaired neuropsychological function and/or abnormal cerebral MRI scan or abnormal transcranial Doppler (TCD).\nStage I or II sickle lung disease.\nSickle nephropathy (moderate or severe proteinuria or a glomerular filtration rate (GFR) 30-50% of the predicted normal value).\nBilateral proliferative retinopathy and major visual impairment in at least one eye.\nOsteonecrosis of multiple joints with documented destructive changes.\nRequirement for chronic transfusions but with RBC alloimmunization >2 antibodies during long term transfusion therapy.\nFailure of hydroxyurea (HU) therapy.\nPatients aged 0-21 years with transfusion dependent alpha- or beta-thalassemia who have an HLA-identical or 1 HLA allele mismatched bone marrow or up to 2 HLA mismatched UCB donor.\nPatients aged 0-21 years with Diamond-Blackfan anemia who have an HLA-identical or 1 HLA allele mismatched bone marrow or up to 2 HLA mismatched UCB donor. Diamond- Blackfan anemia patients will only be eligible if they have failed steroid therapy.\n\nExclusion Criteria:\n\nPatients with one or more of the following:\n\nKarnofsky or Lansky performance score <70 (See Appendices I and II).\nStage III-IV lung disease (Appendix III).\nGFR<30% predicted normal values.\nPregnant or lactating females.\nActive serious infection whereby patient has been on intravenous antibiotics for one week prior to study entry.\nAny patient with AIDS or HIV seropositivity.\nAny patient with invasive aspergillus infection within one year of study entry.\nPsychologically incapable of undergoing bone marrow transplant (BMT) with associated strict isolation or documented history of medical non-compliance.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "1 Year",
                                          "MaximumAge": "25 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Sandhya Kharbanda, M.D.",
                                                            "OverallOfficialAffiliation": "Stanford University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Children's Hospital of Alabama",
                                                            "LocationCity": "Birmingham",
                                                            "LocationState": "Alabama",
                                                            "LocationZip": "35233",
                                                            "LocationCountry": "United States"
                                                      },
                                                      {
                                                            "LocationFacility": "University of Minnesota",
                                                            "LocationCity": "Minneapolis",
                                                            "LocationState": "Minnesota",
                                                            "LocationZip": "55455",
                                                            "LocationCountry": "United States"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "24370862",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Kharbanda S, Smith AR, Hutchinson SK, McKenna DH, Ball JB, Lamb LS Jr, Agarwal R, Weinberg KI, Wagner JE Jr. Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells. Biol Blood Marrow Transplant. 2014 Apr;20(4):581-6. doi: 10.1016/j.bbmt.2013.12.564. Epub 2013 Dec 24."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "ResultsSection": {
                                    "ParticipantFlowModule": {
                                          "FlowGroupList": {
                                                "FlowGroup": [
                                                      {
                                                            "FlowGroupId": "FG000",
                                                            "FlowGroupTitle": "Mesenchymal Stromal Cells",
                                                            "FlowGroupDescription": "Patients received bone marrow transplantation using matched unrelated donors, reduced intensity conditioning regimen, and co-transplanting mesenchymal stromal cells derived from parental bone marrow."
                                                      }
                                                ]
                                          },
                                          "FlowPeriodList": {
                                                "FlowPeriod": [
                                                      {
                                                            "FlowPeriodTitle": "Overall Study",
                                                            "FlowMilestoneList": {
                                                                  "FlowMilestone": [
                                                                        {
                                                                              "FlowMilestoneType": "STARTED",
                                                                              "FlowAchievementList": {
                                                                                    "FlowAchievement": [
                                                                                          {
                                                                                                "FlowAchievementGroupId": "FG000",
                                                                                                "FlowAchievementNumSubjects": "6"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        },
                                                                        {
                                                                              "FlowMilestoneType": "COMPLETED",
                                                                              "FlowAchievementList": {
                                                                                    "FlowAchievement": [
                                                                                          {
                                                                                                "FlowAchievementGroupId": "FG000",
                                                                                                "FlowAchievementNumSubjects": "2"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        },
                                                                        {
                                                                              "FlowMilestoneType": "NOT COMPLETED",
                                                                              "FlowAchievementList": {
                                                                                    "FlowAchievement": [
                                                                                          {
                                                                                                "FlowAchievementGroupId": "FG000",
                                                                                                "FlowAchievementNumSubjects": "4"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "FlowDropWithdrawList": {
                                                                  "FlowDropWithdraw": [
                                                                        {
                                                                              "FlowDropWithdrawType": "Death",
                                                                              "FlowReasonList": {
                                                                                    "FlowReason": [
                                                                                          {
                                                                                                "FlowReasonGroupId": "FG000",
                                                                                                "FlowReasonNumSubjects": "4"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "BaselineCharacteristicsModule": {
                                          "BaselineGroupList": {
                                                "BaselineGroup": [
                                                      {
                                                            "BaselineGroupId": "BG000",
                                                            "BaselineGroupTitle": "Mesenchymal Stromal Cells",
                                                            "BaselineGroupDescription": "Patients received bone marrow transplantation using matched unrelated donors, reduced intensity conditioning regimen, and co-transplanting mesenchymal stromal cells derived from parental bone marrow."
                                                      }
                                                ]
                                          },
                                          "BaselineDenomList": {
                                                "BaselineDenom": [
                                                      {
                                                            "BaselineDenomUnits": "Participants",
                                                            "BaselineDenomCountList": {
                                                                  "BaselineDenomCount": [
                                                                        {
                                                                              "BaselineDenomCountGroupId": "BG000",
                                                                              "BaselineDenomCountValue": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "BaselineMeasureList": {
                                                "BaselineMeasure": [
                                                      {
                                                            "BaselineMeasureTitle": "Age, Continuous",
                                                            "BaselineMeasureParamType": "Median",
                                                            "BaselineMeasureDispersionType": "Full Range",
                                                            "BaselineMeasureUnitOfMeasure": "years",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "10",
                                                                                                                  "BaselineMeasurementLowerLimit": "8",
                                                                                                                  "BaselineMeasurementUpperLimit": "18"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Sex: Female, Male",
                                                            "BaselineMeasureParamType": "Count of Participants",
                                                            "BaselineMeasureUnitOfMeasure": "Participants",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Female",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "1"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Male",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "5"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Number of known transfusions prior to HSCT",
                                                            "BaselineMeasureDescription": "HSCT = hematopoietic stem cell transplantation",
                                                            "BaselineMeasureParamType": "Median",
                                                            "BaselineMeasureDispersionType": "Full Range",
                                                            "BaselineMeasureUnitOfMeasure": "transfusions",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "47.5",
                                                                                                                  "BaselineMeasurementLowerLimit": "4",
                                                                                                                  "BaselineMeasurementUpperLimit": "220"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "BaselineMeasureTitle": "Diagnosis",
                                                            "BaselineMeasureParamType": "Count of Participants",
                                                            "BaselineMeasureUnitOfMeasure": "Participants",
                                                            "BaselineClassList": {
                                                                  "BaselineClass": [
                                                                        {
                                                                              "BaselineCategoryList": {
                                                                                    "BaselineCategory": [
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Sickle cell disease",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "4"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          },
                                                                                          {
                                                                                                "BaselineCategoryTitle": "Thalassemia major",
                                                                                                "BaselineMeasurementList": {
                                                                                                      "BaselineMeasurement": [
                                                                                                            {
                                                                                                                  "BaselineMeasurementGroupId": "BG000",
                                                                                                                  "BaselineMeasurementValue": "2"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomeMeasuresModule": {
                                          "OutcomeMeasureList": {
                                                "OutcomeMeasure": [
                                                      {
                                                            "OutcomeMeasureType": "Primary",
                                                            "OutcomeMeasureTitle": "Count of Participants With Stable Engraftment Post Hematopoietic Cell Transplantation (HCT)",
                                                            "OutcomeMeasureDescription": "Stable engraftment was defined as absolute neutrophil count (ANC) >500 cells /\u00b5L for 3 consecutive days and platelet count >50,000 for one week without transfusion; subsequently stable engraftment was measured by percentage of donor cells.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Count of Participants",
                                                            "OutcomeMeasureUnitOfMeasure": "Participants",
                                                            "OutcomeMeasureTimeFrame": "Up to 1 year",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Mesenchymal Stromal Cells",
                                                                              "OutcomeGroupDescription": "Patients received bone marrow transplantation using matched unrelated donors, reduced intensity conditioning regimen, and co-transplanting mesenchymal stromal cells derived from parental bone marrow."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "6"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "3"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Overall Survival 6 Months Following HCT",
                                                            "OutcomeMeasureDescription": "Overall survival is reported at the count of participants alive 6 months following HCT.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Count of Participants",
                                                            "OutcomeMeasureUnitOfMeasure": "Participants",
                                                            "OutcomeMeasureTimeFrame": "6 months",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Mesenchymal Stromal Cells",
                                                                              "OutcomeGroupDescription": "Patients received bone marrow transplantation using matched unrelated donors, reduced intensity conditioning regimen, and co-transplanting mesenchymal stromal cells derived from parental bone marrow."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "6"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "2"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Overall Survival 1 Year Following HCT",
                                                            "OutcomeMeasureDescription": "Overall survival is reported at the count of participants alive 1 year following HCT.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Count of Participants",
                                                            "OutcomeMeasureUnitOfMeasure": "Participants",
                                                            "OutcomeMeasureTimeFrame": "1 year",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Mesenchymal Stromal Cells",
                                                                              "OutcomeGroupDescription": "Patients received bone marrow transplantation using matched unrelated donors, reduced intensity conditioning regimen, and co-transplanting mesenchymal stromal cells derived from parental bone marrow."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "6"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "2"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Count of Participants With Disease-free Survival 6 Months Following HCT",
                                                            "OutcomeMeasureDescription": "Disease-free survival is defined as alive without underlying disease.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Count of Participants",
                                                            "OutcomeMeasureUnitOfMeasure": "Participants",
                                                            "OutcomeMeasureTimeFrame": "6 months",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Mesenchymal Stromal Cells",
                                                                              "OutcomeGroupDescription": "Patients received bone marrow transplantation using matched unrelated donors, reduced intensity conditioning regimen, and co-transplanting mesenchymal stromal cells derived from parental bone marrow."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "6"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "0"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "OutcomeMeasureType": "Secondary",
                                                            "OutcomeMeasureTitle": "Count of Participants With Disease-free Survival 1 Year Following HCT",
                                                            "OutcomeMeasureDescription": "Disease-free survival is defined as alive without underlying disease.",
                                                            "OutcomeMeasureReportingStatus": "Posted",
                                                            "OutcomeMeasureParamType": "Count of Participants",
                                                            "OutcomeMeasureUnitOfMeasure": "Participants",
                                                            "OutcomeMeasureTimeFrame": "1 year",
                                                            "OutcomeGroupList": {
                                                                  "OutcomeGroup": [
                                                                        {
                                                                              "OutcomeGroupId": "OG000",
                                                                              "OutcomeGroupTitle": "Mesenchymal Stromal Cells",
                                                                              "OutcomeGroupDescription": "Patients received bone marrow transplantation using matched unrelated donors, reduced intensity conditioning regimen, and co-transplanting mesenchymal stromal cells derived from parental bone marrow."
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeDenomList": {
                                                                  "OutcomeDenom": [
                                                                        {
                                                                              "OutcomeDenomUnits": "Participants",
                                                                              "OutcomeDenomCountList": {
                                                                                    "OutcomeDenomCount": [
                                                                                          {
                                                                                                "OutcomeDenomCountGroupId": "OG000",
                                                                                                "OutcomeDenomCountValue": "6"
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            },
                                                            "OutcomeClassList": {
                                                                  "OutcomeClass": [
                                                                        {
                                                                              "OutcomeCategoryList": {
                                                                                    "OutcomeCategory": [
                                                                                          {
                                                                                                "OutcomeMeasurementList": {
                                                                                                      "OutcomeMeasurement": [
                                                                                                            {
                                                                                                                  "OutcomeMeasurementGroupId": "OG000",
                                                                                                                  "OutcomeMeasurementValue": "0"
                                                                                                            }
                                                                                                      ]
                                                                                                }
                                                                                          }
                                                                                    ]
                                                                              }
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "AdverseEventsModule": {
                                          "EventsFrequencyThreshold": "0",
                                          "EventsTimeFrame": "1 year",
                                          "EventGroupList": {
                                                "EventGroup": [
                                                      {
                                                            "EventGroupId": "EG000",
                                                            "EventGroupTitle": "Mesenchymal Stromal Cells",
                                                            "EventGroupDescription": "Patients received bone marrow transplantation using matched unrelated donors, reduced intensity conditioning regimen, and co-transplanting mesenchymal stromal cells derived from parental bone marrow.",
                                                            "EventGroupDeathsNumAffected": "4",
                                                            "EventGroupDeathsNumAtRisk": "6",
                                                            "EventGroupSeriousNumAffected": "6",
                                                            "EventGroupSeriousNumAtRisk": "6",
                                                            "EventGroupOtherNumAffected": "0",
                                                            "EventGroupOtherNumAtRisk": "6"
                                                      }
                                                ]
                                          },
                                          "SeriousEventList": {
                                                "SeriousEvent": [
                                                      {
                                                            "SeriousEventTerm": "Graft failure with autologous recovery",
                                                            "SeriousEventOrganSystem": "Blood and lymphatic system disorders",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "2",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "SOS",
                                                            "SeriousEventOrganSystem": "Hepatobiliary disorders",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventNotes": "SOS = Sinusoidal obstruction syndrome",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "EBV-PTLD",
                                                            "SeriousEventOrganSystem": "Immune system disorders",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventNotes": "EPV = Epstein-Barr virus post-transplant lymphoproliferative disorder",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Grade II GVHD",
                                                            "SeriousEventOrganSystem": "Immune system disorders",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventNotes": "GVHD = Graft-versus-host disease",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Grade III acute GVHD",
                                                            "SeriousEventOrganSystem": "Immune system disorders",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Adenovirus reactivation",
                                                            "SeriousEventOrganSystem": "Infections and infestations",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "BK virus reactivation",
                                                            "SeriousEventOrganSystem": "Infections and infestations",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "CMV pneumonitis",
                                                            "SeriousEventOrganSystem": "Infections and infestations",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventNotes": "CMV = Cytomegalovirus",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "CMV reactivation",
                                                            "SeriousEventOrganSystem": "Infections and infestations",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "CMV viremia",
                                                            "SeriousEventOrganSystem": "Infections and infestations",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "2",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Disseminated toxoplasmosis",
                                                            "SeriousEventOrganSystem": "Infections and infestations",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Gram-negative septic shock",
                                                            "SeriousEventOrganSystem": "Infections and infestations",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "HHV-6 viremia",
                                                            "SeriousEventOrganSystem": "Infections and infestations",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventNotes": "HHV-6 = Human Herpesvirus 6",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Klebsiella and enterobacter",
                                                            "SeriousEventOrganSystem": "Infections and infestations",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Klebsiella bacteremia",
                                                            "SeriousEventOrganSystem": "Infections and infestations",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Intracranial bleeding",
                                                            "SeriousEventOrganSystem": "Nervous system disorders",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "Intracranial hemorrhage",
                                                            "SeriousEventOrganSystem": "Nervous system disorders",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "SeriousEventTerm": "PRES",
                                                            "SeriousEventOrganSystem": "Nervous system disorders",
                                                            "SeriousEventAssessmentType": "Systematic Assessment",
                                                            "SeriousEventNotes": "PRES = Posterior reversible encephalopathy syndrome",
                                                            "SeriousEventStatsList": {
                                                                  "SeriousEventStats": [
                                                                        {
                                                                              "SeriousEventStatsGroupId": "EG000",
                                                                              "SeriousEventStatsNumAffected": "1",
                                                                              "SeriousEventStatsNumAtRisk": "6"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "MoreInfoModule": {
                                          "CertainAgreement": {
                                                "AgreementPISponsorEmployee": "Yes"
                                          },
                                          "PointOfContact": {
                                                "PointOfContactTitle": "Dr. Sandhya Kharbanda, MD",
                                                "PointOfContactOrganization": "University of California, San Francisco",
                                                "PointOfContactEMail": "Sandhya.Kharbanda@ucsf.edu"
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000000755",
                                                            "ConditionMeshTerm": "Anemia, Sickle Cell"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000013789",
                                                            "ConditionMeshTerm": "Thalassemia"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000029503",
                                                            "ConditionMeshTerm": "Anemia, Diamond-Blackfan"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000000745",
                                                            "ConditionAncestorTerm": "Anemia, Hemolytic, Congenital"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000000743",
                                                            "ConditionAncestorTerm": "Anemia, Hemolytic"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000000740",
                                                            "ConditionAncestorTerm": "Anemia"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000006402",
                                                            "ConditionAncestorTerm": "Hematologic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000006453",
                                                            "ConditionAncestorTerm": "Hemoglobinopathies"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030342",
                                                            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000029502",
                                                            "ConditionAncestorTerm": "Anemia, Hypoplastic, Congenital"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000000741",
                                                            "ConditionAncestorTerm": "Anemia, Aplastic"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012010",
                                                            "ConditionAncestorTerm": "Red-Cell Aplasia, Pure"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000080984",
                                                            "ConditionAncestorTerm": "Congenital Bone Marrow Failure Syndromes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000080983",
                                                            "ConditionAncestorTerm": "Bone Marrow Failure Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001855",
                                                            "ConditionAncestorTerm": "Bone Marrow Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15709",
                                                            "ConditionBrowseLeafName": "Thalassemia",
                                                            "ConditionBrowseLeafAsFound": "Thalassemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3222",
                                                            "ConditionBrowseLeafName": "Anemia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3237",
                                                            "ConditionBrowseLeafName": "Anemia, Sickle Cell",
                                                            "ConditionBrowseLeafAsFound": "Sickle Cell Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22609",
                                                            "ConditionBrowseLeafName": "Anemia, Diamond-Blackfan",
                                                            "ConditionBrowseLeafAsFound": "Diamond Blackfan Anemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8699",
                                                            "ConditionBrowseLeafName": "Hemolysis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3225",
                                                            "ConditionBrowseLeafName": "Anemia, Hemolytic",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3227",
                                                            "ConditionBrowseLeafName": "Anemia, Hemolytic, Congenital",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8642",
                                                            "ConditionBrowseLeafName": "Hematologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8691",
                                                            "ConditionBrowseLeafName": "Hemoglobinopathies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22839",
                                                            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22608",
                                                            "ConditionBrowseLeafName": "Anemia, Hypoplastic, Congenital",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3223",
                                                            "ConditionBrowseLeafName": "Anemia, Aplastic",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14004",
                                                            "ConditionBrowseLeafName": "Red-Cell Aplasia, Pure",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12270",
                                                            "ConditionBrowseLeafName": "Pancytopenia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M2241",
                                                            "ConditionBrowseLeafName": "Bone Marrow Failure Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M2242",
                                                            "ConditionBrowseLeafName": "Congenital Bone Marrow Failure Syndromes",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4286",
                                                            "ConditionBrowseLeafName": "Bone Marrow Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T5622",
                                                            "ConditionBrowseLeafName": "Thalassemia",
                                                            "ConditionBrowseLeafAsFound": "Thalassemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T5229",
                                                            "ConditionBrowseLeafName": "Sickle Cell Anemia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1837",
                                                            "ConditionBrowseLeafName": "Diamond-Blackfan Anemia",
                                                            "ConditionBrowseLeafAsFound": "Diamond Blackfan Anemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4833",
                                                            "ConditionBrowseLeafName": "Pure Red Cell Aplasia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC15",
                                                            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 48,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03917797",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Phase II Lupus MSC"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Universidad de los Andes, Chile",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stromal Cells (MSC\u00b4s) in Renal Lupus",
                                          "OfficialTitle": "Dose-response and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Renal Systemic Lupus Erythematosus",
                                          "Acronym": "MSC-ROLE"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "November 2020",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "April 2, 2019",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2022",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "April 2, 2019",
                                          "StudyFirstSubmitQCDate": "April 13, 2019",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "April 17, 2019",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "November 13, 2020",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "November 16, 2020",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Fernando E. Figueroa MD",
                                                "ResponsiblePartyInvestigatorTitle": "Program Director Translational Research in Cell Therapy",
                                                "ResponsiblePartyInvestigatorAffiliation": "Universidad de los Andes, Chile"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Universidad de los Andes, Chile",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Phase II Clinical Trial to Assess the dose-response and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (MSCs) in Severe Renal Systemic Lupus Erythematosus (SLE).",
                                          "DetailedDescription": "Phase IIa trial of escalating doses of intravenous (i.v.) MSCs in active SLE, followed by a Phase IIb, triple blind, controlled assessment of the selected MSC dosing versus Placebo, in SLE patients receiving Standard of Care Therapy for Severe Renal Disease,"
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Lupus Erythematosus, Systemic",
                                                      "Lupus Glomerulonephritis"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Systemic Lupus Erythematosus",
                                                      "Mesenchymal Stromal Cells",
                                                      "Lupus nephritis"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignInterventionModelDescription": "Superiority trial comparing MSCs versus Placebo in SLE patients with severe renal disease receiving Standard of Care treatment.",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Quadruple",
                                                      "DesignMaskingDescription": "Masking for patients, physicians providing patient care and outcome assessors.",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "39",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "MSC treatment",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intervention: a previously selected dose of MSCs (Phase IIa) will be administered by i.v. infusion at baseline and 6 months of follow-up (total 12 months), to patients with Severe Renal SLE subject also to Standard of Care treatment with Methylprednisolone and Cyclophosphamide followed by Mycophenolate.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: MSC treatment",
                                                                        "Drug: Standard of Care"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Placebo",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Intervention: A Placebo (infusion vehicle) will be administered by i.v. infusion at baseline and 6 months of follow-up (total 12 months), to patients with Severe Renal SLE subject also to Standard of Care treatment with Methylprednisolone and Cyclophosphamide followed by Mycophenolate.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Standard of Care",
                                                                        "Drug: Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "MSC treatment",
                                                            "InterventionDescription": "Umbilical cord-derived Mesenchymal Stromal Cell",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "MSC treatment"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Cellistem \u00ae Lupus"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Standard of Care",
                                                            "InterventionDescription": "Methylprednisolone; Cyclophosphamide; Prednisone; Mycophenolate",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "MSC treatment",
                                                                        "Placebo"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Standard of Care for Lupus Nephritis"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Placebo",
                                                            "InterventionDescription": "MSC infusion vehicle",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Placebo"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Placebo (for MSC)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Achievement of Global Renal Response (GR) at Study Endpoint",
                                                            "PrimaryOutcomeDescription": "Proportion of Patients that achieve Complete (CR) or Partial (PR) Renal Response at Endpoint",
                                                            "PrimaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Achievement of Complete Renal Response (CR) at Study Endpoint",
                                                            "SecondaryOutcomeDescription": "Proportion of Patients that achieve CR criteria including: 1) Urinary Protein:Creatinine (UPC) ratio < 0.5; 2) estimated Glomerular Filtration Rate (GFR) \u2265 120 ml/min/m2, or at least 80% of baseline; 3) urinalysis < 10 red blood cells (RBC) and no RBC casts per high power field; 4) Prednisone dose \u226410 mg/day.",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Achievement of Partial Renal Response (PR) at Study Endpoint",
                                                            "SecondaryOutcomeDescription": "Proportion of Patients that achieve PR criteria including: 1) reduction of UPC ratio to at least 50% of baseline; 2) estimated GFR \u2265120 ml/min/m2, or at least 80% of baseline; 3) Prednisone dose \u226410 mg/day.",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Treatment Failure",
                                                            "SecondaryOutcomeDescription": "Proportion of Patients that fulfill any of the following criteria for Treatment Failure including: 1) Daily Prednisone dose cannot be reduced \u2264 10 mg at week 24; 2) Daily Prednisone is increased above 10 mg after week 24; 3) Introduction of a new immunosuppressive regimen, not included in the trial; 4) Use of Rituximab prior to month 12.",
                                                            "SecondaryOutcomeTimeFrame": "24 weeks and 12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Response of SLE Responder Index (SRI).",
                                                            "SecondaryOutcomeDescription": "Proportion of Patients that achieve SRI response, defined as a >4-point reduction in the SELENA-SLEDAI score, no new British Isles Lupus Assessment Group [BILAG] A organ domain score and no more than 1 new BILAG B score, with no worsening in physician's global assessment score versus baseline).\n\nThe Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA) version of the SLE Disease Activity Index (SLEDAI) is employed for this calculation.(SELENA-SLEDAI score). The SELENA-SLEDAI score addresses 24 descriptors in 9 organ-systems. Disease worsening increases the score that ranges from 0-105.\n\nThe BILAG addresses 97 items in organ-system domains, in an ordinal (A-E) scale, converted to a numerical (0-96) scale for usual calculations.",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Selena Sledai",
                                                            "SecondaryOutcomeDescription": "Average change in Selena Sledai Score in patients and controls",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "BILAG score",
                                                            "SecondaryOutcomeDescription": "Average hange in BILAG score in patients and controls",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Disease Flares",
                                                            "SecondaryOutcomeDescription": "Proportion of patients that experience flares as defined in the Selena Flare Index (SFI). Mild/Moderate Flares are defined by change of 3 or more points in the SELENA-SLEDAI score. Severe Flares are defined as an increase in the SELENA-SLEDAI score to more than 12 points",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Biomarker Response",
                                                            "SecondaryOutcomeDescription": "Changes in the levels of disease relevant biomarkers in peripheral blood/plasma, including 1) anti-dsDNA antibodies by ELISA; 2) complement proteins C3/C4 by nephelometry (mg/dL); 3) Percentage of CD4+ T helper cell subpopulations (Th1, Th17, Treg) and 4) B cell subpopulations (Naive, Memory, Transitional) by Flow cytometry; and 5) Cytokine Panel by Luminex, including Tumor Necrosis Factor (TNF) alpha, Transforming Growth Factor (TGF) Beta1, Interleukin (lL) 6, IL-17A, IL-10, B-cell activating factor/B Lymphocyte Stimulator (BAFF/BLys), Monocyte chemoattractant protein-1 (MCP-1/CCL2), C-X-C motif chemokine 10 (CXCL10), Interferon (IFN) gamma.",
                                                            "SecondaryOutcomeTimeFrame": "24 weeks and 12 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nFulfilling 1997 updated American College of Rheumatology (ACR) Criteria or 2012 SLICC Classification Criteria for SLE\nSeropositive for antinuclear (\u22651:80) and/or anti-DNA antibodies\nFulfilling following criteria for active renal disease:\n\nClass III or IV proliferative disease (ISN/RPS) Renal Biopsy within 12 months plus...\n\nActive Urinary Sediment (> 5 red blood cells/high-power field and/or >8 white blood cells/high-power field and/or cylindruria during the current flare).\n\nUPC ratio \u2265 1\n\nExclusion Criteria:\n\nEstimated GFR < 40ml/min/m2\nAddition during prior 3 months of randomization of: Bolus methylprednisolone or new immunosuppressive drug or intravenous immunoglobulin (IVIG) or Plasmapheresis.\nAddition during prior 6 months of randomization of Cyclophosphamide\nAddition during prior 12 months of randomization of Biological anti-B cell therapy\nCoexisting uncontrolled morbidity; Pregnancy or planned Pregnancy within next 12 months; uncontrolled infection or neoplastic disease. Pending unresolved surgical indication.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "75 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Fernando F E, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+56226181455",
                                                            "CentralContactEMail": "ffigueroa@uandes.cl"
                                                      },
                                                      {
                                                            "CentralContactName": "Francisco Espinoza, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+56226181008",
                                                            "CentralContactEMail": "fespinoza@c4c.cl"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Fernando F E, MD",
                                                            "OverallOfficialAffiliation": "Professor School of Medicine",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Cl\u00ednica Universidad de los Andes",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Santiago de Chile",
                                                            "LocationState": "Regi\u00f3n Metropolitana",
                                                            "LocationZip": "7591278",
                                                            "LocationCountry": "Chile",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Fernando F E",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "226181455",
                                                                              "LocationContactEMail": "ffigueroa@uandes.cl"
                                                                        }
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "LocationFacility": "Hospital Barros Luco Trudeau",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Santiago de Chile",
                                                            "LocationState": "Regi\u00f3n Metropolitana",
                                                            "LocationCountry": "Chile",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Jacqueline Pefaur, M.D.",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+56998221921",
                                                                              "LocationContactEMail": "jacquelinepefaur@gmail.com"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000005921",
                                                            "ConditionMeshTerm": "Glomerulonephritis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000008181",
                                                            "ConditionMeshTerm": "Lupus Nephritis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000008180",
                                                            "ConditionMeshTerm": "Lupus Erythematosus, Systemic"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000003240",
                                                            "ConditionAncestorTerm": "Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001327",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009393",
                                                            "ConditionAncestorTerm": "Nephritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007674",
                                                            "ConditionAncestorTerm": "Kidney Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014570",
                                                            "ConditionAncestorTerm": "Urologic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M10329",
                                                            "ConditionBrowseLeafName": "Lupus Erythematosus, Systemic",
                                                            "ConditionBrowseLeafAsFound": "Lupus Erythematosus, Systemic",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8183",
                                                            "ConditionBrowseLeafName": "Glomerulonephritis",
                                                            "ConditionBrowseLeafAsFound": "Glomerulonephritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11490",
                                                            "ConditionBrowseLeafName": "Nephritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10330",
                                                            "ConditionBrowseLeafName": "Lupus Nephritis",
                                                            "ConditionBrowseLeafAsFound": "Lupus Glomerulonephritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5616",
                                                            "ConditionBrowseLeafName": "Connective Tissue Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9850",
                                                            "ConditionBrowseLeafName": "Kidney Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16471",
                                                            "ConditionBrowseLeafName": "Urologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2525",
                                                            "ConditionBrowseLeafName": "Glomerulonephritis",
                                                            "ConditionBrowseLeafAsFound": "Glomerulonephritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T3523",
                                                            "ConditionBrowseLeafName": "Lupus Nephritis",
                                                            "ConditionBrowseLeafAsFound": "Lupus Glomerulonephritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M5879",
                                                            "InterventionBrowseLeafName": "Cyclophosphamide",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M11280",
                                                            "InterventionBrowseLeafName": "Mycophenolic Acid",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M10901",
                                                            "InterventionBrowseLeafName": "Methylprednisolone",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M1833",
                                                            "InterventionBrowseLeafName": "Methylprednisolone Acetate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M10902",
                                                            "InterventionBrowseLeafName": "Methylprednisolone Hemisuccinate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M13272",
                                                            "InterventionBrowseLeafName": "Prednisolone",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M229437",
                                                            "InterventionBrowseLeafName": "Prednisolone acetate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M211896",
                                                            "InterventionBrowseLeafName": "Prednisolone hemisuccinate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M248768",
                                                            "InterventionBrowseLeafName": "Prednisolone phosphate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M13273",
                                                            "InterventionBrowseLeafName": "Prednisone",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ANeo",
                                                            "InterventionBrowseBranchName": "Antineoplastic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ARhu",
                                                            "InterventionBrowseBranchName": "Antirheumatic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Infe",
                                                            "InterventionBrowseBranchName": "Anti-Infective Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Infl",
                                                            "InterventionBrowseBranchName": "Anti-Inflammatory Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "AnEm",
                                                            "InterventionBrowseBranchName": "Antiemetics"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "NeuroAg",
                                                            "InterventionBrowseBranchName": "Neuroprotective Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Gast",
                                                            "InterventionBrowseBranchName": "Gastrointestinal Agents"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 49,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04467047",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "20200148"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Hospital de Clinicas de Porto Alegre",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19",
                                          "OfficialTitle": "Safety and Feasibility of Allogenic Mesenchymal Stromal Cells in the Treatment of COVID-19",
                                          "Acronym": "COVID19"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "July 2020",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "July 25, 2020",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "October 30, 2020",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 30, 2020",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "July 7, 2020",
                                          "StudyFirstSubmitQCDate": "July 9, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "July 10, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "July 9, 2020",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "July 10, 2020",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Hospital de Clinicas de Porto Alegre",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Coronavirus Disease 2019 (COVID-19) is spreading worldwide and has become a public health emergency of major international concern. Currently, no specific drugs or vaccines are available. For severe cases, it was found that aberrant pathogenic T cells and inflammatory monocytes are rapidly activated and then producing a large number of cytokines and inducing an inflammatory storm. Mesenchymal stem cells (MSCs) have been shown to possess a comprehensive powerful immunomodulatory function. This study aims to investigate the safety and efficacy of intravenous infusion of mesenchymal stem cells in severe patients with COVID-19.",
                                          "DetailedDescription": "Coronavirus-19 Disease (COVID-19), caused by the Sars-Cov-2 virus, which occurs as a growing pandemic in early 2020 and currently represents an emergency state worldwide. Several reports have shown that the first step in the pathogenesis of Sars-Cov-2 is the recognition of the angiotensin I converting enzyme (ACE2) receptor by the virus. This ACE2 receptor is widely distributed on the surface of human cells, especially as type II alveolar cells and capillary endothelium, however bone marrow, lymph nodes, thymus and spleen are known as immune cells, such as T and lymphocytes. B and macrophages, are negatives to ACE2. These results suggest that immunotherapy can be used to treat infected patients. However, an immunomodulatory capacity cannot be so strong, if just one or two major immunological factors used, as the virus can cause a \"cytokine storm\", such as IL-2, IL-6, IL-7, GSCF, IP10 , MCP1, MIP1A and TNF\u03b1, followed by edema, gas exchange dysfunction, acute respiratory distress syndrome, cardiac injury and secondary infection that can lead to death. Therefore, avoiding a \"cytokine storm\" may be the key to treating patients infected with Sars-Cov-2. Mesenchymal stem cells (MSCs), due to their potential for immunomodulatory activity, can have beneficial effects in preventing or attenuating the cytokine storm. Because MSCs have been widely used in cell therapy, from basic research to clinical trials. Safety and efficacy have been clearly documented in several clinical trials, especially in immune-mediated inflammatory diseases, such as graft versus host disease (GVHD). The objective of the study is to verify the safety and feasibility of using allogeneic bone marrow mesenchymal stem cells in patients with SARS-CoV-2."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "COVID-19",
                                                      "Sars-CoV2"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal Stromal Cells",
                                                      "COVID-19",
                                                      "Sars-CoV2"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Intervention",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intravenous 1*10E6 MSCs/kg body weight Mesenchymal Stromal Cells infusion",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stromal Cells infusion"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stromal Cells infusion",
                                                            "InterventionDescription": "Intravenous 1*10E6 MSCs/kg body weight Mesenchymal Stromal Cells infusion",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Intervention"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Overall survival",
                                                            "PrimaryOutcomeDescription": "Assessment of Overall survival at 30 days post intervention",
                                                            "PrimaryOutcomeTimeFrame": "60 days"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes on inflammatory C-reactive protein",
                                                            "SecondaryOutcomeDescription": "To assess the anti-inflammatory effect of the proposed treatment with assessment of the levels of C-reactive protein (mg/dL)",
                                                            "SecondaryOutcomeTimeFrame": "60 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Hospital stay",
                                                            "SecondaryOutcomeDescription": "days of the patients in hospital",
                                                            "SecondaryOutcomeTimeFrame": "60 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Oxygenation index (PaO2/FiO2)",
                                                            "SecondaryOutcomeDescription": "Evaluation of functional respiratory changes: PaO2 / FiO2 ratio",
                                                            "SecondaryOutcomeTimeFrame": "60 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Improvement in Liao's score (2020)",
                                                            "SecondaryOutcomeDescription": "Improvement in Liao's score (2020)",
                                                            "SecondaryOutcomeTimeFrame": "60 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Radiological improvement",
                                                            "SecondaryOutcomeDescription": "Computed tomography Chest assesment will be done to assess improvement in radiological findings of COVID-19",
                                                            "SecondaryOutcomeTimeFrame": "60 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Time of COVID19 PCR negativity",
                                                            "SecondaryOutcomeDescription": "PCR testing to check PCR negativity",
                                                            "SecondaryOutcomeTimeFrame": "28 days"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nLaboratory confirmation of COVID19 infection by reverse-transcription polymerase chain reaction (RT-PCR)\nThe patient or legal donor agrees to participate in the study and signs the informed consent.\nPatients with orange or red criteria according to the score proposed by Liao et al (2020)\n\nExclusion Criteria:\n\nPatient with pregnancy, are planning to become pregnant or breastfeeding\nPatients with malignant blood-borne diseases such as HIV or syphilis\nNot consenting for clinical trial\nPatients with other than orange or red criteria according to the score proposed by Liao et al (2020)",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Lucia Silla, MD, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "55 51 33598371",
                                                            "CentralContactEMail": "lsilla@hcpa.edu.br"
                                                      },
                                                      {
                                                            "CentralContactName": "Annelise Pezzi, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactEMail": "annepezzi@gmail.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Lucia Silla, MD, PhD",
                                                            "OverallOfficialAffiliation": "Hospital de Clinicas de Porto Alegre",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000086382",
                                                            "ConditionMeshTerm": "COVID-19"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000012141",
                                                            "ConditionAncestorTerm": "Respiratory Tract Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007239",
                                                            "ConditionAncestorTerm": "Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000011024",
                                                            "ConditionAncestorTerm": "Pneumonia, Viral"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000011014",
                                                            "ConditionAncestorTerm": "Pneumonia"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014777",
                                                            "ConditionAncestorTerm": "Virus Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000018352",
                                                            "ConditionAncestorTerm": "Coronavirus Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003333",
                                                            "ConditionAncestorTerm": "Coronaviridae Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030341",
                                                            "ConditionAncestorTerm": "Nidovirales Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012327",
                                                            "ConditionAncestorTerm": "RNA Virus Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M2562",
                                                            "ConditionBrowseLeafName": "COVID-19",
                                                            "ConditionBrowseLeafAsFound": "COVID-19",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9435",
                                                            "ConditionBrowseLeafName": "Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5520",
                                                            "ConditionBrowseLeafName": "Communicable Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14130",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13056",
                                                            "ConditionBrowseLeafName": "Pneumonia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13066",
                                                            "ConditionBrowseLeafName": "Pneumonia, Viral",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16674",
                                                            "ConditionBrowseLeafName": "Virus Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M19643",
                                                            "ConditionBrowseLeafName": "Coronavirus Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5707",
                                                            "ConditionBrowseLeafName": "Coronaviridae Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22838",
                                                            "ConditionBrowseLeafName": "Nidovirales Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14301",
                                                            "ConditionBrowseLeafName": "RNA Virus Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC01",
                                                            "ConditionBrowseBranchName": "Infections"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 50,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04615429",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "COVID-AT"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "2020-002193-27",
                                                            "SecondaryIdType": "EudraCT Number"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Puerta de Hierro University Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19",
                                          "OfficialTitle": "Double-blind, Randomized, Controlled, Clinical Trial to Assess the Efficacy of Allogenic Mesenchymal Stromal Cells in Patients With Acute Respiratory Distress Syndrome Due to COVID-19"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "November 2021",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "September 15, 2020",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "January 2022",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "February 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "October 25, 2020",
                                          "StudyFirstSubmitQCDate": "November 2, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "November 4, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "November 9, 2021",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "November 10, 2021",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Cristina Avenda\u00f1o Sol\u00e1",
                                                "ResponsiblePartyInvestigatorTitle": "Head of Clinical Pharmacology Deptarment",
                                                "ResponsiblePartyInvestigatorAffiliation": "Puerta de Hierro University Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Cristina Avenda\u00f1o Sol\u00e1",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "A double-blind, randomized, controlled, clinical trial to evaluate the efficacy and safety of MSC (mesenchymal stromal cells) intravenous administration in patients with COVID-induced ARDS compared to a control arm.",
                                          "DetailedDescription": "A double-blind, randomized, controlled, clinical trial to evaluate the efficacy and safety of MSC (mesenchymal stromal cells) intravenous administration in patients with COVID-induced ARDS compared to a control arm.\n\nAll trial participants will receive SOC*.\n\nRandomization will be 1:1 between:\n\nTreatment arm: allogenic MSC.\n\nControl arm: Placebo (solution with the same composition as the experimental treatment, without the MSC).\n\nSOC can include any medicines that are being used in clinical practice (e.g. lopinavir/ritonavir; hydroxy/chloroquine, tocilizumab, etc.)."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Acute Respiratory Distress Syndrome",
                                                      "COVID-19 Pneumonia"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Acute Respiratory Distress Syndrome",
                                                      "COVID-19 Pneumonia",
                                                      "Mesenchymal stromal cells",
                                                      "Coronavirus",
                                                      "SARS-CoV-2"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Double",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Investigator"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "20",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stromal cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Approximately 1x10E6 MSC/kg",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stromal cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Control group",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Solution identical to experimental treatment, without the MSC",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stromal cells",
                                                            "InterventionDescription": "Administration of one single dose of allogenic Mesenchymal stromal cells",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stromal cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "Placebo",
                                                            "InterventionDescription": "Administration of placebo (solution identical to experimental treatment, without the MSC)",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Control group"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Change in the PaO2/FiO2* ratio from baseline to day 7 of treatment administration",
                                                            "PrimaryOutcomeDescription": "Primary endpoint",
                                                            "PrimaryOutcomeTimeFrame": "7 days"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "All-cause mortality",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint",
                                                            "SecondaryOutcomeTimeFrame": "Days 7, 14, and 28 after treatment"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Time to PaO2/FiO2 ratio greater than 200 mmHg",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Clinical status on the World Health Organization ordinal scale",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint.\n\nCategories:\n\nNot hospitalized, no limitations on activities.\nNot hospitalized, limitation on activities.\nHospitalized, not requiring supplemental oxygen.\nHospitalized, requiring supplemental oxygen.\nHospitalized, on non-invasive ventilation or high flow oxygen devices.\nHospitalized, on invasive mechanical ventilation or ECMO .\nDeath.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, daily until day 14, and on day 28 after treatment"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "PaO2/FiO2 ratio",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint",
                                                            "SecondaryOutcomeTimeFrame": "Baseline and days 2, 4, 14 and 28 after treatment"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "SOFA score",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint Sequential Organ Failure Assessment score (0-24)",
                                                            "SecondaryOutcomeTimeFrame": "Baseline and days 2, 4, 7, 14 and 28 after treatment"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Oxygen therapy-free days",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Duration of hospitalization",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Duration of ICU admission",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence of non-invasive ventilation",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint Proportion of patients with non-invasive ventilation",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence of invasive mechanical ventilation",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint Proportion of patients with invasive mechanical ventilation",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Duration of non-invasive ventilation",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint (number of days)",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Duration of invasive mechanical ventilation",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint (number of days)",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Mechanical ventilation-free days",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint",
                                                            "SecondaryOutcomeTimeFrame": "Day 28"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Survival rate",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint",
                                                            "SecondaryOutcomeTimeFrame": "3 and 12 months."
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Cumulative incidence SAEs, Grade 3 and 4 AEs, ADR and AEs of special interest.",
                                                            "SecondaryOutcomeDescription": "Secondary endpoint",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "Analytical endpoints",
                                                            "OtherOutcomeDescription": "Exploratory endpoint Analytical markers (e.g., neutrophil and lymphocyte counts). Changes from baseline to set time points will be calculated.",
                                                            "OtherOutcomeTimeFrame": "Baseline and days 2, 4, 7, 14 and 28 after treatment"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nInformed consent prior to performing study procedures (witnessed oral consent with written consent by representatives will be accepted to avoid paper handling). Written consent by patient or representatives will be obtained whenever possible.\nAdult patients \u226518 years of age at the time of enrolment.\nLaboratory-confirmed SARS-CoV-2 infection as determined by PCR, in oropharyngeal swabs or any other relevant specimen obtained during the course of the disease. Alternative tests (e.g., rapid antigenic tests) are also acceptable as laboratory confirmation if their specificity has been accepted by the Sponsor.\nModerate to severe ARDS (PaO2/FiO2 ratio equal or less than 200 mmHg) for less than 96 hours at the time of randomization.\nPatients requiring invasive ventilation are eligible within 72 hours from intubation.\nEligible for ICU admission, according to the clinical team.\n\nExclusion Criteria:\n\nImminent and unavoidable progression to death within 24 hours, irrespective of the provision of treatments (in the opinion of the clinical team).\n\"Do Not Attempt Resuscitation\" order in place.\nAny end-stage organ disease or condition, which in the investigator's opinion, makes the patient an unsuitable candidate for treatment.\nHistory of a moderate/severe lung disorder requiring home-based oxygen therapy.\nPatient requiring ECMO, hemodialysis or hemofiltration at the time of treatment administration.\nCurrent diagnosis of pulmonary embolism.\nActive neoplasm, except carcinoma in situ or basalioma.\nKnown allergy to the products involved in the allogenic MSC production process.\nCurrent pregnancy or lactation (women with childbearing potential should have a negative pregnancy test result at the time of study enrollment).\nCurrent participation in a clinical trial with an experimental treatment for COVID-19 (the use of any off-label medicine according to local treatment protocols is not an exclusion criteria).\nAny circumstances that in the investigator's opinion compromises the patient's ability to participate in the clinical trial.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Cristina Avendano-Sola, MD, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+34911916479",
                                                            "CentralContactEMail": "cavendano@salud.madrid.org"
                                                      },
                                                      {
                                                            "CentralContactName": "Maria C Payares, MD, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactEMail": "concepcion.payares@salud.madrid.org"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Rafael F Duarte, MD, PhD",
                                                            "OverallOfficialAffiliation": "Hematology Department. Hospital Universitario Puerta de Hierro",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Cristina Avedano-Sola, MD, PhD",
                                                            "OverallOfficialAffiliation": "Clinical Pharmacology Department. Hospital Universitario Puerta de Hierro",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Juan J Rubio, MD, PhD",
                                                            "OverallOfficialAffiliation": "ICU. Hospital Universitario Puerta de Hierro",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Rosa Malo, MD",
                                                            "OverallOfficialAffiliation": "Respiratory Medicine Department",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Hospital Universitario Puerta de Hierro-Majadahonda",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Majadahonda",
                                                            "LocationState": "Madrid",
                                                            "LocationZip": "28222",
                                                            "LocationCountry": "Spain",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Rafael F Duarte, MD, PhD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+34911916662",
                                                                              "LocationContactEMail": "rduarte.work@gmail.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Rafael F Duarte, MD, PhD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Juan J Rubio, MD, PhD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Rosa Malo, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "33407777",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Payares-Herrera C, Mart\u00ednez-Mu\u00f1oz ME, Vallhonrat IL, de Molina RM, Torres MP, Trisan A, de Diego IS, Alonso R, Zafra R, Donaire T, S\u00e1nchez R, Rubio JJ, Duarte Palomino RF, Sol\u00e1 CA. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 6;22(1):9. doi: 10.1186/s13063-020-04964-1."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000086382",
                                                            "ConditionMeshTerm": "COVID-19"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000011014",
                                                            "ConditionMeshTerm": "Pneumonia"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012128",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012127",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome, Newborn"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000055371",
                                                            "ConditionMeshTerm": "Acute Lung Injury"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000013577",
                                                            "ConditionMeshTerm": "Syndrome"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000004194",
                                                            "ConditionAncestorTerm": "Disease"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012141",
                                                            "ConditionAncestorTerm": "Respiratory Tract Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007239",
                                                            "ConditionAncestorTerm": "Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000011024",
                                                            "ConditionAncestorTerm": "Pneumonia, Viral"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014777",
                                                            "ConditionAncestorTerm": "Virus Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000018352",
                                                            "ConditionAncestorTerm": "Coronavirus Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003333",
                                                            "ConditionAncestorTerm": "Coronaviridae Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030341",
                                                            "ConditionAncestorTerm": "Nidovirales Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012327",
                                                            "ConditionAncestorTerm": "RNA Virus Infections"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012120",
                                                            "ConditionAncestorTerm": "Respiration Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M2562",
                                                            "ConditionBrowseLeafName": "COVID-19",
                                                            "ConditionBrowseLeafAsFound": "COVID-19",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13056",
                                                            "ConditionBrowseLeafName": "Pneumonia",
                                                            "ConditionBrowseLeafAsFound": "Pneumonia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M19643",
                                                            "ConditionBrowseLeafName": "Coronavirus Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14117",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14116",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Newborn",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27297",
                                                            "ConditionBrowseLeafName": "Acute Lung Injury",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9435",
                                                            "ConditionBrowseLeafName": "Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5520",
                                                            "ConditionBrowseLeafName": "Communicable Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14130",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13066",
                                                            "ConditionBrowseLeafName": "Pneumonia, Viral",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16674",
                                                            "ConditionBrowseLeafName": "Virus Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5707",
                                                            "ConditionBrowseLeafName": "Coronaviridae Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22838",
                                                            "ConditionBrowseLeafName": "Nidovirales Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14301",
                                                            "ConditionBrowseLeafName": "RNA Virus Infections",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14109",
                                                            "ConditionBrowseLeafName": "Respiration Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4927",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Infant",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T192",
                                                            "ConditionBrowseLeafName": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC01",
                                                            "ConditionBrowseBranchName": "Infections"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M21013",
                                                            "InterventionBrowseLeafName": "Pharmaceutical Solutions",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "PhSol",
                                                            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  }
            ]
      }
}